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Abstract  
The vertebrate planar cell polarity (PCP) pathway is an evolutionarily conserved 
signalling cascade which regulates numerous developmental processes. This thesis 
investigates the role of PCP signalling in two events, mammalian spinal neurulation 
and neural crest (NC) cell migration. In mouse embryos PCP signalling is required 
for initiation of neural tube closure, via regulation of midline convergent extension 
(CE). In this thesis, a genetic modifying role for the loop-tail (Vangl2Lp) mutation is 
shown to also predispose to failure of low spinal neurulation. Mutations in the core 
PCP gene Vangl2 increase the frequency and severity of spina bifida in the 
grainyhead-like-3 hypomorph curly tail (Grhl3ct/ct), a model of partially-penetrant 
NTDs. Affected Vangl2Lp/+;Grhl3ct/ct embryos exhibit abnormalities of axis elongation, 
suggesting a role for CE in spinal neurulation. Investigations of the mechanism 
underlying the Lp/ct interaction reveal two distinct types of effect: 1) Effects of 
expression of Vangl2Lp and Grhl3ct in different tissues: Vangl2 regulates midline CE 
and Grhl3 regulates proliferation of tail bud progenitors. These mutant effects likely 
summate, leading to severe spina bifida; 2) Cell-autonomous effects of Vangl2Lp 
and Grhl3ct co-expression in the same tissue: conditional genetic experiments 
suggest a requirement for Vangl2 and Grhl3 within the same cells during 
neurulation and evidence for a molecular interaction at the level of Rho-GTPase 
signalling is presented.  In amphibia and fish, early NC migration is PCP-dependent, 
but this has not yet been studied in mammals. Vangl2Lp/Lp embryos display normal 
NC cell migration, despite many severe PCP-related defects, and migration of 
Vangl2Lp/Lp NC in vitro is comparable to Vangl2+/+. The closely related gene Vangl1 
does not appear to compensate for loss of Vangl2. Acute down-regulation of Vangl2 
specifically in the NC lineage does not cause migratory defects. Hence, the core 
PCP pathway is not required for early NC migration in the mouse.  
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1.  General Introduction 
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1.1 Mammalian neurulation 
During embryonic development the process of neurulation generates the neural 
tube, the precursor of the brain and spinal cord. The morphological events of 
neurulation begin during late gastrulation following the induction of the neural plate, 
or neuroepithelium, from a region of ectoderm on the dorsal surface of the embryo. 
The neural plate originates as an elliptical-shaped sheet of thickened ectodermal 
tissue, which is subsequently shaped and converted into a tube during two phases 
of neurulation, primary and secondary.  
 
Primary neurulation generates the neural tube in the cranial and most of the spinal 
region and involves folding of the neuroepithelium, followed by fusion at the midline 
to form a closed tube (Copp et al., 2003; Greene and Copp, 2009). At low sacral 
and caudal levels the neural tube is formed by secondary neurulation, which does 
not involve bending and adhesion of neural folds. Instead, a population of 
mesenchymal cells within the tail bud, or caudal eminence, condense in the dorsal 
midline to form an epithelial rod beneath the surface ectoderm. This structure is 
reorganised by a process of ‘canalisation’ to create a secondary neural tube whose 
central lumen is continuous with that of the primary neural tube more rostrally 
(Schoenwolf, 1984). Neural tube defects (NTDs) arise when the normal processes 
of neurulation are disrupted (see Section 1.2). 
 
1.1.1 Primary neurulation in the mouse 
1.1.1.1 Closure sites and timing 
In mammals, neural tube closure is a discontinuous process which initiates 
sequentially at distinct levels of the anterior-posterior (A-P) axis. Mouse neural tube 
closure begins at the future hindbrain/cervical boundary at embryonic day (E) 8.0 
(‘closure 1’) and proceeds bi-directionally from this site to form the cranial and 
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spinal neural tube (Figure 1.1A, B). Subsequent closure events occur in the cranial 
region at E9: closure 2 at the forebrain/midbrain boundary, which also spreads bi-
directionally, and closure 3 at the rostral end of the future forebrain, from which 
closure progresses caudally (Figure 1.1C). The open regions, or ‘neuropores’, 
between these sites shorten and close to form an intact tube in the cranial region by 
E9.5. In the spine, fusion proceeds caudally from the site of closure 1 and 
culminates with the closure of the posterior neuropore (PNP) at E10.5, marking the 
end of primary neurulation (Greene and Copp, 2009). 
 
1.1.1.2 Shaping and folding of the neural plate 
Before the onset of neural tube closure, the initially disc-shaped neuroepithelium is 
converted to a keyhole-shaped layer with a broad cranial area and a narrow, 
elongated caudal region. Different processes are thought to contribute to neural 
plate shaping; elongation of the pseudostratified, columnar neuroepithelial cells 
along their apicobasal axis contributes to narrowing, while embryonic growth 
contributes to the A-P elongation (Colas and Schoenwolf, 2001). Importantly, 
convergent extension (CE) cell movements, whereby cells intercalate mediolaterally 
to simultaneously narrow and lengthen to neural plate, are also essential (Ueno and 
Greene, 2003). As discussed later, a crucial role for the non-canonical Wnt/planar 
cell polarity (PCP) pathway in driving these movements has been well documented 
(see Section 1.4.2.1 and Chapter 4).   
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Figure 1.1 Neural tube closure is a multi-site process in mammals 
Primary neurulation in the mouse embryo. (A, B) Closure 1 (1) occurs at the 
hindbrain/cervical boundary and spreads both rostrally and caudally from this site (arrows in 
B). (C, D) Two subsequent closure events occur in the cranial region (2 and 3) and 
progression of neurulation closes the anterior neuropore (ANP) and hindbrain neuropore 
(HNP). (E, F) Side and dorsal views of embryonic caudal regions, respectively. Spinal 
neurulation proceeds down the body (arrows) from the site of closure 1 to close the (PNP). A 
and B are modified from (Copp et al., 1990). 
 
Neural tube closure is achieved by bending of the neuroepithelium to produce 
bilateral neural folds which elevate and converge towards the midline, where they 
meet and fuse (Figure 1.2). Bending of the neural plate varies considerably along 
the A-P axis. In the cranial region the neural folds initially acquire a convex 
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morphology, bulging outwards away from the midline, before rapidly ‘flipping’ 
around to assume a biconcave shape. The mechanisms controlling this complex 
bending are not well understood but are thought to involve expansion of the 
underlying mesenchyme and the actin cytoskeleton (Morriss-Kay, 1981). Spinal 
neural tube closure does not involve a biconvex phase; here, bending occurs at 
specific hinge points, which also vary along different levels of the neuraxis. At E8.5, 
bending in the upper spine is achieved solely by the formation of the median hinge 
point (MHP) overlying the notochord, creating a V-shaped neuroepithelium with 
straight neural folds (mode 1). At E9.0 the transition from mode 1 to mode 2 of 
neurulation, in the intermediate spine, is marked by the appearance of paired 
dorsolateral hinge points (DLHPs) at the point where the surface ectoderm contacts 
the outside of each neural fold. DLHPs bring the tips of the neural folds towards 
each other at the dorsal midline, producing a diamond-shaped neuroepithelium. At 
E10.5, when the neural tube is closing in the low spine, the MHP disappears and 
bending occurs solely at the DLHPs (Mode 3) (Shum and Copp, 1996). 
 
Early studies showed that the induction of the MHP requires signals from the 
underlying notochord. In both mouse and chick embryos, ablation of the notochord 
results in loss of the MHP (Davidson et al., 1999; Smith and Schoenwolf, 1989; 
Ybot-Gonzalez et al., 2002), whereas pieces of notochord can induce an ectopic 
MHP-like bend when transplanted adjacent to the lateral neural tube (Smith and 
Schoenwolf, 1989). However, despite being the only site of neuroepithelial bending 
at E8.5, the MHP appears to be dispensable for neurulation. Following notochord 
ablation, spinal neural tube closure completes normally in the absence of the MHP 
by a ‘default’ mechanism involving the formation of ectopic DLHPs (Ybot-Gonzalez 
et al., 2002). A similar mechanism is also thought to explain the unaffected 
progression of neurulation in mouse embryos that lack a notochord or floor plate, 
such as sonic hedgehog (Shh), Gli2 and Foxa2 null mutants (Ang and Rossant, 
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1994; Chiang et al., 1996; Ding et al., 1998; Weinstein et al., 1994; Ybot-Gonzalez 
et al., 2002). Although Shh from the notochord, and later the floor plate, is required 
for dorsoventral patterning of the neural tube (Ulloa and Briscoe, 2007), evidence 
suggests that it is not the only MHP-inducing factor: Shh-/- mouse embryos are 
capable of forming a MHP, despite being reported to lack a floor plate (Chiang et 
al., 1996; Ybot-Gonzalez et al., 2002), and implanting Shh-soaked beads is not 
sufficient to induce a MHP in lateral E9.5 neural folds (Ybot-Gonzalez et al., 2002). 
Thus, it appears that the notochord also secretes other unidentified factors which 
induce MHP formation.  
 
The MHP is characterised by the localised enrichment of wedge-shaped cells, 
which are narrow apically and expanded at their basal (non-luminal) side. This cell 
wedging behaviour appears to be related to interkinetic nuclear migration (INM), the 
process whereby nuclei move up and down between the apical and basal sides of a 
pseudostratified epithelium during different stages of the cell cycle (Meyer et al., 
2011). Cell wedging in the MHP is correlated with the accumulation of basal, S-
phase nuclei and an increase in S-phase length (Gerrelli and Copp, 1997; Smith 
and Schoenwolf, 1988). The mechanisms underlying the prolonged cell cycle in the 
MHP are not known and are currently under investigation by members of our group; 
of particular interest is the role of the cell cycle inhibitor, p21, which is expressed in 
midline neuroepithelial cells prior to floor plate differentiation (Katrin Danielsen, 
unpublished data). Apical constriction via the contraction of circumferential actin 
microfilaments has also been suggested to play a role in cell wedging (Schoenwolf 
and Smith, 1990). However actin microfilaments are distributed evenly along the 
apical surface of the neuroepithelium, irrespective of bending. Furthermore, 
pharmacological inhibition of the actin cytoskeleton by cytochalasin D treatment 
does not disrupt hinge point formation (Schoenwolf et al., 1988; Ybot-Gonzalez and 
Copp, 1999) 
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Figure 1.2 Overview of primary neurulation 
Schematic diagram summarising the events of neuroepithelial bending and fusion. (1) 
Neural induction generates a thickened region of neural ectoderm, flanked by the future non-
neural (epidermal) ectoderm, which undergoes shaping. (2) Formation and elevation of the 
bilateral neural folds. (3) The neural folds meet and appose at the dorsal midline. (4) Fusion 
of the neural folds is followed by remodelling of the neural tube and overlying ectoderm. 
Delamination and migration of the NC cells (blue) also begins around this stage, although 
the timing varies between different species and axial level (see Section 1.4.4.2).   
 
The three stereotypical modes of neurulation mean that there is a transition from 
midline to dorsolateral bending as neurulation proceeds down the spine (Shum and 
Copp, 1996). A model has been proposed to explain the regulation of DLHP 
formation by the balance of antagonistic ventral and dorsal signals (Ybot-Gonzalez 
et al., 2007a). Shh is a key negative regulator of this process; the appearance of 
DLHPs correlates with decreasing notochordal Shh expression and a reduction in 
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strength of Shh signalling down the neuraxis which allows DLHPs to ‘break through’ 
when a sufficiently low threshold is reached. Furthermore, implanting Shh-soaked 
beads adjacent to the E9.5 neural folds suppresses DLHP formation (Ybot-
Gonzalez et al., 2002). According to the model, DLHP formation is blocked during 
mode 1 by high levels of Shh from the notochord. BMP2, secreted from the dorsal 
surface ectoderm, also inhibits bending. In the upper spine, strong Shh expression 
from the notochord inhibits the BMP antagonist noggin, allowing BMP2 to prevent 
DLHP formation. In the low spine, as the level of Shh diminishes, noggin is de-
repressed and can exert its antagonistic effects on BMP2, overcoming the inhibition 
of DLHPs (Ybot-Gonzalez et al., 2007a). Unlike the MHP, DLHPs are essential for 
the successful progression of spinal neurulation. Their absence, for example in the 
Zic2 loss of function mutant, Kumba (Zic2ku/ku), precludes neural tube closure, 
leading to spina bifida (Ybot-Gonzalez et al., 2007a). 
 
1.1.1.3 Neural fold fusion 
Following their bending and elevation, the neural folds become apposed at the 
dorsal midline. During this final stage of primary neurulation, fusion and remodelling 
of the two epithelia occur, resulting in an intact tube covered by future epidermal 
ectoderm. Several studies have described protrusions emanating from cells at the 
leading edge of the neural folds, which appear to extend across the gap and 
interdigitate as the folds contact each other (Pai et al., 2012). The nature of these 
protrusions appears to vary with axial level. In the spinal region, large lamellipodia-
like structures, originally described as membrane ruffles, extend from the tips of the 
neural folds just prior to fold contact (Geelen and Langman, 1979; Pai et al., 2012; 
Waterman, 1976). Additionally, a recent study involving live cell imaging of the 
closing mouse hindbrain reported the presence of filopodia-like extensions (Pyrgaki 
et al., 2010). The cells from which the protrusions originate also seem to vary; 
ruffles apparently extend from the junction between the neural folds and ectoderm 
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in the trunk (Geelen and Langman, 1979; Pai et al., 2012), while in the cranial 
region the initial contact has been observed to be ectodermal in the midbrain and 
hindbrain, and neuroepithelial in the forebrain (Geelen and Langman, 1979; Pyrgaki 
et al., 2010). Molecularly, the regulation of these cell protrusions is poorly 
understood, although there is most likely a role for cytoskeletal regulation via small 
GTPases such as Rac1 (Camerer et al., 2010) (Ana Rolo, unpublished data). 
 
It is unclear whether the initial contact between leading edge neural fold cells 
represents a distinct ‘adhesion’ step, or whether the mechanical bending and 
apposition of the neural folds is sufficient to allow their stabilisation during the 
subsequent remodelling phase. Studies on the role of EphA-ephrinA interactions 
(Abdul-Aziz et al., 2009) and the transcription factor Grhl2 (Pyrgaki et al., 2011) do 
point towards an early adhesion event and future research will hopefully evaluate 
this further. Finally, the mechanism of remodelling of the neural tube and overlying 
surface ectoderm is also poorly understood. A major focus of study has been 
programmed cell death, however experimental evidence shows that apoptosis is 
dispensable for neuroepithelial fusion and remodelling in the mouse (Massa et al., 
2009). 
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1.2 Neural tube defects 
In the mouse, primary neurulation takes place around halfway through gestation, 
from E8.5-E10.5. If the neural tube fails to close at any of the distinct sites along the 
neuraxis, or closure fails to progress from these sites, it results in open neural tube 
defects (NTDs) (Figure 1.3). Failure of initiation of closure at the hindbrain-cervical 
boundary (closure 1) leads to the most severe NTD, craniorachischisis, where 
almost the entire neural tube from the midbrain to the low spine remains open. 
Incomplete closure of the cranial neural tube initially leads to exencephaly, in which 
the neuroepithelium appears to protrude from the developing brain. As development 
proceeds, the skull vault cannot form over the open region and the exposed neural 
tissue degenerates, leading to the appearance of anencephaly during late gestation. 
Failure of closure 3 is rare, but results in anencephaly combined with a ‘split-face’ 
malformation (Copp and Greene, 2010). If closure fails to progress caudally from 
the site of closure 1 the PNP will remain open, yielding open spina bifida which, in 
mice, is often accompanied by a curled or bent tail. 
 
In human embryos, primary neurulation begins with the bending of the neural plate 
at 17-18 days post fertilisation (dpf) and concludes at around 28 dpf with closure of 
the PNP (Greene and Copp, 2009). As in mice, neural tube closure is a 
discontinuous process, but some differences have been reported. Events closely 
resembling closures 1 and 3 have been described, although the site of initial closure 
(at 22 dpf) appears to occur in the rhombencephalon, more rostrally than in mice 
(O'Rahilly and Muller, 2002). The existence of closure 2 in humans is controversial; 
there is evidence that an event analogous to mouse closure 2 doesn’t occur, with 
brain formation instead achieved by the closing of a single neuropore between sites 
1 and 3 (O'Rahilly and Muller, 2002). In mice, the axial level of closure 2 is known to 
vary between different genetic strains; those with a rostrally located closure 2 are 
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more highly predisposed to exencephaly, while those which exhibit closure 2 at a 
caudal position are more resistant. Interestingly, in the SELH/Bc strain, closure 2 
appears to be absent altogether. Although 17% of these mice show exencephaly, 
the remaining 83% successfully complete cranial closure, demonstrating that, even 
in mice, it is not essential for early brain formation (Macdonald et al., 1989). 
 
         
Figure 1.3 Sites of initiation of neural tube closure in mice and humans 
Schematic diagram showing the multiple sites of initiation of neural tube closure in mouse 
(A) and human (B) embryos. Red text and arrows indicate the NTDs arising from failure of 
each closure event. Images taken from (Copp and Greene, 2010).    
 
1.2.1 Classification of human NTDs  
Recent estimates suggest that congenital anomalies affect approximately 2-3% of 
pregnancies. For example, from 2003-2007, EUROCAT (European Surveillance of 
Congenital Anomalies) recorded a total prevalence of major abnormalities of 24 per 
1000 births (Dolk et al., 2010). NTDs are among the most common groups of birth 
defects, affecting 0.5-2 per 1000 established pregnancies worldwide (Copp and 
Greene, 2010). 
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1.2.1.1 Open defects 
Open defects, including craniorachischisis, anencephaly and spina bifida, arise due 
to the primary failure of neural tube closure and are the most severe group of NTDs. 
Craniorachischisis is considered rare and, although the forebrain often forms 
normally, is incompatible with postnatal life. In anencephalic foetuses, tissue 
degeneration during pregnancy leads to loss of almost the entire brain by birth. 
Human anencephaly cases can be sub-divided into those that predominantly affect 
the rostral brain and skull (meroacrania) and those affecting the posterior brain and 
skull (holoacrania), although precisely how these defects correlate with failure of 
neural tube closure is unclear (Greene and Copp, 2009). Anencephaly is also lethal; 
affected infants are often stillborn or die shortly after birth.   
 
Spina bifida (latin for ‘split spine’) represents the most common group of open NTDs 
and refers to the vertebral abnormalities which accompany the open lesions. Where 
the neural folds remains open the adjacent sclerotome cells, which normally migrate 
to cover the closed neural tube, cannot surround the neuroepithelium properly, 
leaving the midline exposed (Greene and Copp, 2009). Spina bifida varies in its 
clinical appearance; the more common form is myelomeningocele (spina bifida 
cystica), where the spinal cord tissue is contained within a meninges-covered sac 
which protrudes and contains cerebro-spinal fluid (CSF). Alternatively, the neural 
tissue may be directly exposed to the amniotic fluid, a more severe condition termed 
myelocele.  
 
The survival rates of individuals with spina bifida have improved greatly, with 
approximately 50-90% of patients now reaching adulthood (Webb, 2010). However, 
the outcome of spina bifida is variable, with the severity of the condition depending 
on the rostral limit of the lesion. Individuals often require lifelong medical care for 
the numerous complications that occur; neurodegeneration frequently leads to 
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paralysis and loss of sensation below the lesion, while disturbed innervation of the 
rectum and bladder can cause incontinence and urinary tract infections (Thompson, 
2009). In most cases spina bifida is accompanied by ‘tethering’, where the spinal 
cord becomes attached to the vertebral column via the surrounding tissues. 
Consequently, stretching of the spinal cord during growth reduces blood flow to the 
spinal nerves and can cause damage to the cord. Tethering, and the traction it 
generates on the upper spinal cord, has been suggested to contribute to Chiari II 
malformation, a condition where the hindbrain herniates through the foramen 
magnum, the large opening at the base of the skull through which the spinal cord 
passes (Greene and Copp, 2009). Chiari II malformation also blocks the circulation 
of CSF and is therefore associated with hydrocephalus, another condition that 
frequently accompanies spina bifida. In individuals with hydrocephalus there is an 
accumulation of CSF, leading to a build up of pressure and swelling of the brain. 
Hydrocephalus is usually treated by the insertion of a shunt to drain and divert the 
excess fluid, but this can itself cause problems due to blockages or infections 
(Thompson, 2009). 
  
1.2.1.2 Closed and herniation defects 
A milder group of NTDs, collectively referred to as closed defects, are thought to 
arise due to defective secondary neurulation or abnormal formation of the lower 
vertebrae. This group of NTDs are the least well defined, and are estimated to effect 
up to 10% of people, with the majority of cases being asymptomatic. Spina bifida 
occulta (‘hidden’ spina bifida) comprises the absence of one vertebra arch and is a 
variant of normal, although there may be visible signs on the lower back, such as a 
skin dimple or a patch of hair. Alternatively, ‘spinal dysraphism’ (thought to relate to 
defective secondary neurulation) comprises absence of two or more vertebral 
arches and is often associated with neurological abnormalities such as splitting or 
tethering of the lower cord. A third class of malformations, herniation defects, are 
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thought to arise later than open NTDs, after neural tube closure is complete. These 
conditions are characterised by the secondary herniation of neural tissue through a 
region of the skull or vertebral column, although the developmental basis of the 
bone defects are unclear. In the cranial region, the term ‘encephalocele’ refers to 
the protrusion of meninges, with or without brain tissue, through an opening in the 
skull, usually in the occipital region. In the spine, herniation of the meninges is 
called ‘meningocele’, which likely involves defective formation of the vertebrae 
around the closed neural tube (Copp and Greene, 2012).  
 
1.2.2 Aetiology 
NTDs appear to follow a ‘multifactorial’ pattern of inheritance, whereby interactions 
between multiple genes and environmental factors summate to increase the risk of 
the conditions (Juriloff and Harris, 2012a). 
 
1.2.2.1 Genetic factors  
The majority of NTD cases occur sporadically in families with no previous history. 
However, several lines of evidence indicate a genetic component in the causation of 
NTDs. Firstly, studies of recurrence rates within families have shown the risk of 
NTDs among siblings of affected individuals to be 2-5%, approximately 50-fold 
higher than in the general population, and this is increased further if two siblings are 
affected. Furthermore, concordance rates for spina bifida and anencephaly are 
higher in same sex twins (presumed to be monozygotic) than in opposite-sex twins 
(dizygotic) (Copp and Greene, 2010). NTDs also occur with chromosomal 
abnormalities such as aneuploidies, duplications and deletions, and have been 
reported in foetuses with abnormal karotypes that have spontaneously aborted 
(Zohn, 2012). These cases often represent one phenotypic feature of a syndrome, 
although it is estimated that less than 10% of human NTD cases are syndromic. 
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Although a strong genetic contribution is apparent, very few genes associated with 
NTD risk in humans have been identified to date. The sporadic nature of NTDs, 
along with the lethality of most forms, means there is a lack of large families with 
multiple affected individuals for analysis. Nevertheless, positional cloning studies 
have identified candidate risk loci on chromosomes two, seven and ten 
(Rampersaud et al., 2005; Stamm et al., 2006). The search for candidate genes has 
largely focused on those encoding proteins involved in folate metabolism; 
particularly the enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR), for 
which polymorphisms have been identified. One variant, 677C>T, has been 
associated with increased NTD risk in some populations, although in others an 
association is not present or is in fact protective (Amorim et al., 2007). 
 
Cohorts of case samples have also been screened for mutations in other genes that 
are known to cause NTDs in mice. In particular several putative mutations, defined 
as rare, nonsynonymous (amino acid-altering) sequence variants with possible 
defective function that are not present in controls (Juriloff and Harris, 2012a) have 
been identified in core PCP genes. For spina bifida cases, putative mutations have 
been identified in VANGL2, VANGL1, CELSR1, FZD6 and PRICKLE1 (Allache et 
al., 2012; Bosoi et al., 2011; De et al., 2012; Kibar et al., 2007; Kibar et al., 2009; 
Kibar et al., 2010). Anencephalic foetuses have been found to carry mutations in 
VANGL2 (Lei et al., 2010) and craniorachischisis cases have been associated with 
mutations or intronic duplications in VANGL2, CELSR1 and SCRIBBLE (Doudney et 
al., 2005; Robinson et al., 2012). Nonsynonymous PCP gene variants have also 
been identified in cases of closed NTDs (Juriloff and Harris, 2012a).  
 
1.2.2.2 Non-genetic factors 
Teratogenic agents have been recognised to increase the risk of NTDs. For 
example, valproic acid, a widely-used anti-epileptic drug, is associated with an 
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elevated risk of spina bifida when taken during the first trimester of pregnancy 
(Jentink et al., 2010). Agents that interfere with folate uptake also exacerbate NTD 
risk, such as the antibiotic trimethoprim, carbamazepine (another anti-convulsant) 
and the mycotoxin fumonisin (Copp and Greene, 2010). Fumonisin is produced by 
common maize-contaminating fungi and has been associated with higher NTD 
prevalence in populations that rely heavily on maize as a dietary staple (Gelineau-
van et al., 2009). Maternal health during pregnancy is also correlated with NTD 
occurrence; diabetes mellitus and obesity are risk factors, as is hyperthermia 
following fever or excessive sauna use during the first few weeks of pregnancy 
(Kondo et al., 2009; Moretti et al., 2005). Some studies have reported a link 
between increased NTD risk and low socioeconomic status, with factors such as 
maternal education, household income and parental occupation being associated 
with NTD occurrence in offspring. Other studies have also examined the effect of 
ethnicity and parental age (Au et al., 2010).  
 
Maternal nutritional status has received considerable interest, first being linked to 
NTDs following the Dutch Hunger Winter of 1944-1945, when increased NTD 
prevalence was seen in offspring of women exposed to famine during early 
pregnancy (Schorah, 2009). Research has predominantly focused on folates, the 
biological derivatives of the vitamin folic acid (see Section 1.2.3). The precise 
relationship between maternal folate levels and NTD risk is not fully understood; 
reduced serum folate and elevated plasma homocysteine (indicators of suboptimal 
folate status) are considered risk factors and are observed in mothers of some 
affected foetuses. However, for most NTD-affected pregnancies maternal folate 
levels fall within the ‘normal’ range (Kirke et al., 1993; Scott, 1999; Steegers-
Theunissen et al., 1994). These findings led to the theory that low folate status may 
increase susceptibility to NTDs when combined with another environmental factor or 
in genetically predisposed individuals, a hypothesis which has recently been 
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strengthened by work in animal models (Burren et al., 2008; Burren et al., 2010). 
Besides folates, deficiency for two other vitamins, inositol and vitamin B12, are risk 
factors (Groenen et al., 2003; Kirke et al., 1993), as is high vitamin A intake 
(Rothman et al., 1995). 
 
1.2.3 Treatment and prevention 
Spina bifida is usually treated by surgical closure of the lesion shortly after birth, to 
prevent meningitis and further neurodegeneration (Thompson, 2009). Studies of 
mouse models of spina bifida have shown that, although failure of neural tube 
closure leads to neurodegeneration and loss of neurological function during late 
gestation, the development of the exposed spinal cord is essentially normal during 
early pregnancy (Stiefel et al., 2007). Such findings suggested that covering the 
exposed spinal cord during development might alleviate or prevent 
neurodegeneration and therefore provided a rationale for performing in utero 
surgery. These operations are now performed in a few specialist centres; recent 
assessments of outcome suggest prenatal repair can improve neurological function 
and hydrocephalus, but is associated with increased risk of preterm delivery (Adzick 
et al., 2011; Saadai and Farmer, 2012).      
 
Over the last thirty years, primary prevention of NTDs has been a major public 
health issue. In the 1980s an early trial found that supplementation of women with a 
multivitamin preparation containing folic acid reduced NTD prevalence, although the 
specific effects of individual compounds were not evaluated (Smithells et al., 1981). 
In 1991 the MRC Vitamin Study Research Group published the findings of their 
pivotal study, the first randomised, placebo-controlled trial (RCT) which 
demonstrated that periconceptional folic acid supplementation can prevent up to 
72% of NTD recurrences (MRC, 1991). Their findings were strengthened further by 
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the results of a Hungarian RCT demonstrating prevention of the first occurrence of 
NTDs by folic acid (Czeizel and Dudas, 1992) and a Chinese study showing a large 
decrease in NTD prevalence after introducing folic acid supplements (Berry et al., 
1999). These early studies provided the impetus for international campaigns to 
increase dietary folate intake. In 1998 the U.S. and Canada were the first countries 
to introduce mandatory fortification of flour with folic acid, followed by Chile in 2000.  
 
Today around 50 countries, including some in Africa, the Middle East, Oceania and 
most of America, have mandatory fortification policies. A significant decline in NTD 
prevalence has been seen in several of these countries post-fortification, although 
not in all (Crider et al., 2011; Ricks et al., 2012). In Europe, while the voluntary 
addition of folic acid to food products is widespread, most countries have been 
reluctant to introduce universal fortification. Since 1992, the UK government has 
recommended that all women who could become pregnant consume more folate-
rich foods and supplement their diet with 0.4 mg folic acid before conceiving and 
until the twelfth week of pregnancy. Unfortunately these policies have been largely 
unsuccessful at reducing NTD rates and many women remain unprotected (Lane, 
2011).  
 
There is evidence that, even if folate levels were successfully increased in all 
women of child-bearing age, not all NTD cases would be prevented. No human trial 
has found a 100% prevention of NTDs with folic acid and there appears to be a 
‘floor effect’ in countries that have adopted fortification policies (Heseker et al., 
2009). The identification of folate-resistant animal models also implies that a 
proportion of human NTDs do not respond to folic acid therapy (Harris, 2009).  
Excitingly, the vitamin inositol is emerging as a candidate therapeutic agent for the 
prevention of folate-resistant NTDs (Cavalli et al., 2008). In animal studies, inositol 
deficiency during culture of both mouse and rat embryos increases the frequency of 
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cranial NTDs (Cockroft, 1988; Cockroft et al., 1992), while its administration 
significantly reduces the frequency of spinal NTDs in curly tail mouse embryos (see 
Section 1.3.1.2) (Cogram et al., 2002; Greene and Copp, 1997). A pilot RCT to 
examine the potential preventive effects of inositol is currently underway. 
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1.3 Modelling NTDs in the mouse 
Experimental animals have provided valuable insights into the developmental 
events of neurulation. The mouse embryo in particular offers several advantages; 
the process of neurulation in mice and humans is closely similar, the accessibility of 
embryos during neural tube closure allows analysis of the fundamental 
mechanisms, and the ability to culture whole embryos throughout neurulation allows 
experimental and chemical manipulations which would not otherwise be possible in 
a mammalian system. Importantly, the abundance of mouse models of NTDs 
means different combinations of mutant alleles and environmental influences can be 
studied, in order to determine the role of gene-gene and gene-environment 
interactions in both normal and abnormal neural tube closure. There are currently 
over 240 genetic mouse models of NTDs, a figure that highlights the complexity of 
neurulation and the large number of cellular and morphological processes required 
for successful neural tube closure (Harris and Juriloff, 2007; Harris and Juriloff, 
2010). This group includes mutants that display defects in neural plate shaping, in 
bending and elevation of the neural folds, and in the final stages of fusion and 
remodelling.  
 
The analysis of mouse mutants has identified several key biological processes 
during neurulation. For example, regulation of the balance between continued 
neuroepithelial cell proliferation and neuronal differentiation appears to be important 
for successful neurulation. Mutations in neurofibromin1 (Nf1) and nucleoporin 
(Nup50), which negatively regulate cell cycle inhibitors, cause exencephaly, while 
loss of Pax3, which promotes proliferation in the dorsal neuroepithelium, causes 
both spina bifida and exencephaly. NTDs are also seen when negative regulators of 
Notch signalling such as Hes1 and Hes3 are mutated; these are normally required 
to prevent premature differentiation (Copp and Greene, 2010). The role of apoptotic 
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cell death during neurulation is somewhat controversial. A characteristic pattern of 
dying cells is observed within the neural tube during its formation, particularly in 
dorsal regions during closure and post-fusion remodelling (Massa et al., 2009; 
Yamaguchi et al., 2011). A requirement for apoptosis was suggested by studies 
showing that suppression of apoptosis in chick leads to failure of neural tube 
closure (Weil et al., 1997) and from the appearance of cranial NTDs in mice when 
genes such as Caspase3, Caspase9 and Apaf1 are mutated (Copp and Greene, 
2010). However, despite the lack of apoptosis in Caspase3-/- and Apaf1-/- mouse 
knockouts, neurulation in the forebrain and spinal region completes normally. 
Furthermore, chemical suppression of apoptosis in wild type embryos during culture 
does not disrupt neurulation (Massa et al., 2009). 
 
The actin cytoskeleton also plays an important role during neurulation, particularly in 
the cranial region. NTDs have been observed in mice carrying mutations in several 
genes encoding cytoskeletal proteins, such as Vinculin and Shroom, or 
cytoskeleton-associated proteins, such as Palladin and Marcks. (Copp and Greene, 
2010). Strikingly, most of these models exhibit exencephaly alone; only Shroom and 
Mlp (Marcks-like protein) mutants also develop spina bifida (Hildebrand and 
Soriano, 1999; Wu et al., 1996). The relative resistance of spinal neurulation to 
cytoskeletal disturbance has also been demonstrated pharmacologically; while 
culturing embryos with cytochalasin D, which disrupts actin polymerisation, inhibits 
cranial neurulation, closure of the PNP is unaffected (Ybot-Gonzalez and Copp, 
1999). Recent work in our group has also shown that treatment with blebbistatin, 
which inhibits the formation of contractile actomyosin, does not adversely affect 
PNP closure. However, inhibition of Rho-kinase (ROCK) does inhibit spinal 
neurulation and is associated with an abnormal apical accumulation of actomyosin 
and components of the apical junction complex (Sarah Escuin, unpublished data). 
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Thus, although cranial neurulation is more dependent on the cytoskeleton, it 
appears that its regulation does also contribute to neural tube closure in the spine. 
Mouse NTD models also allow the mechanisms underlying the protective effect of 
agents such as folic acid to be investigated. A number of mutants are described as 
‘folate-responsive’, in that varying proportions (35-85%) of NTDs in these strains 
can be prevented by maternal administration or treatment in whole embryo culture 
(Greene and Copp, 2005; Harris, 2009). The most extensively studied folate-
responsive NTD mutant is Splotch (Sp and Sp2H) which carries a null allele of the 
transcription factor Pax3. Homozygous Splotch embryos develop spina bifida with a 
penetrance of 85-100% and show variable rates of exencephaly (Greene et al., 
2009). Studies have reported a reduction of both cranial and spinal NTDs in Splotch 
following folic acid treatment, by approximately 20% and 40%, respectively (Burren 
et al., 2008; Fleming and Copp, 1998; Wlodarczyk et al., 2006). Other folate-
responsive models are Cart1-null and Cited2-null mice, the Lrp6 hypermorph Cd 
and the Gcn5 hypomorphic mutant (Harris, 2009).    
 
However, similar to the folic acid resistance in an estimated 30% of human NTD 
cases, several mouse NTD models do not respond to folic acid treatment. These 
include Ephrin-A5 knockouts, Axial defects (Axd; Grhl2 hypermorph) and curly tail 
(ct; Grhl3 hypomorph) (Greene and Copp, 2005). For some of these mutants, the 
effect of other agents has been examined. For example, methionine 
supplementation was found to prevent approximately 40% of spinal NTDs in Axd 
(Essien and Wannberg, 1993). In curly tail mice, which do not respond to either 
folate or methionine, a protective effect was found for inositol (see Section 1.3.1.2). 
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1.3.1 The curly tail mouse model 
1.3.1.1 NTDs in curly tail 
The curly tail (ct) mouse mutant was first described nearly 60 years ago 
(Gruneberg, 1954) and has since become one of the most widely studied models of 
partially penetrant NTDs. Homozygous curly tail (ct/ct) embryos develop apparently 
normally (closed neural tube and straight tail) in approximately 40-60% of cases and 
the remaining proportion display NTDs comprising tail flexion defects alone (40-
50%) or tail defects with lumbosacral spina bifida (10-20%). Up to 5% of ct/ct 
embryos also exhibit exencephaly. Although variations in penetrance of the curly tail 
phenotype have been reported by different groups over the years, the overall 
incidence of NTDs has remained at around 50-60% (Gustavsson et al., 2008). 
 
The developmental mechanism underlying the spinal defects in curly tail has been 
well characterised (Figure 1.4). Affected ct/ct embryos exhibit a delay or failure of 
PNP closure which lead to tail defects (curled and often shortened tail) or spina 
bifida, respectively (Copp, 1985; Van Straaten et al., 1992). Early studies showed 
that at E10.5, the time when delayed PNP closure can be first detected, abnormal 
embryos display an abnormally low rate of cell proliferation specifically in the 
hindgut and notochord tissues (Copp et al., 1988a; Peeters et al., 1998b). This 
leads to a reduction in the growth rate of the ventral tissues, creating a dorsal-
ventral growth imbalance and causing excessive axial curvature in the caudal 
region of the embryo. In turn, the increase in ventral curvatures generates 
mechanical stress which opposes, and therefore delays, neural tube closure at the 
level of the PNP (Brook et al., 1991; Peeters et al., 1997). As described elsewhere, 
spinal NTDs in curly tail can be rescued by physically correcting the ventral 
curvature, or by normalising the balance between dorsal and ventral growth rates 
(see Chapter 3). 
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1.3.1.2 Similarities between curly tail and human NTDs 
Curly tail is particularly valuable as a model for human NTDs as there are several 
parallels between the mutant phenotype and the human conditions. One notable 
similarity is the difference in NTD occurrence between the two sexes: as in human 
fetuses, cranial NTDs predominantly affect female curly tail embryos, while spina 
bifida is seen slightly more often in males (Juriloff and Harris, 2012b; Van Straaten 
and Copp, 2001). NTDs in curly tail are also associated with increased levels of 
alpha fetoprotein (AFP) in the amniotic fluid and maternal serum (Adinolfi et al., 
1976) a biomarker of NTDs during human pregnancy (Cameron and Moran, 2009; 
Krantz et al., 2010). The penetrance of the curly tail phenotype is influenced by 
environmental factors such as temperature, anti-mitotic drugs, retinoic acid and 
nutrient levels which, along with the identification of modifier genes (see below), are 
indicative of multifactorial causation. Thus, curly tail appears to be a model for the 
complex aetiology of NTDs in humans.  
 
The resistance of curly tail NTDs to folic acid highlights it as a potential model for 
the subset of human NTDs that don’t respond to folic acid supplementation. 
Interestingly, a protective effect of inositol has been demonstrated for spinal NTDs 
in curly tail, both in whole embryo culture and in vivo by maternal administration 
(Cogram et al., 2002; Greene and Copp, 1997). Two inositol isomers have been 
evaluated; the naturally occurring form, myo-inositol, was found to prevent around 
50% of spinal NTDs when given to pregnant mice, while chiro-inositol was more 
effective, reducing the NTD frequency by up to 86% (Cogram et al., 2002). The 
mechanism of inositol action is most likely regulated via the downstream mediator 
protein kinase C (PKC), whose isoforms are ubiquitously expressed in mouse 
embryos during spinal neurulation. Ultimately, the phosphorylation of substrates 
downstream of PKC appears to specifically stimulate proliferation in the hindgut, 
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correcting the curly tail growth imbalance and normalising spinal neurulation 
(Cogram et al., 2004). 
 
   
Figure 1.4 Developmental basis of curly tail spinal NTDs 
Schematic diagram showing the mechanism underlying the delay or failure of spinal 
neurulation in affected curly tail embryos. 
 
1.3.1.3 ct is a hypomorphic allele of Grhl3 
Despite many studies of the curly tail phenotype, the major genetic defect remained 
undiscovered for many years. Mapping studies independently localised the ct gene 
to the distal region of mouse chromosome four (Beier et al., 1995; Brouns et al., 
2005; Neumann et al., 1994), at a position which also contains Grhl3. Grhl3 arose 
as a strong candidate for the ct gene when Grhl3 null (Grhl3-/-) embryos were found 
to exhibit fully penetrant spina bifida combined with reduced ventral proliferation in 
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the E9.5 caudal region, and low frequency exencephaly (Ting et al., 2003a). This 
study also reported genetic interaction between Grhl3- and curly tail: Grhl3-/ct mice 
displayed a higher incidence of spina bifida than ct/ct and a lower incidence than 
Grhl3-/-. Although this result did suggest that Grhl3 was the ct gene, it should be 
pointed out that ct also interacts with mutations in other genes (see Section 1.3.1.6) 
so the finding cannot be taken as definitive proof of allelism. Curly tail mice do not 
carry a mutation within the Grhl3 coding sequence (Gustavsson et al., 2007; Ting et 
al., 2003a), however a mutation in a putative enhancer region, comprising a single 
nucleotide substitution approximately 21 kb upstream of the Grhl3 start site, has 
been identified (Gustavsson et al., 2007). This study also showed Grhl3 to be 
expressed in the hindgut of wild type embryos from the 25-26 somite stage, 
corresponding precisely with the time and location of the curly tail cell proliferation 
defect. Moreover, ct/ct embryos display reduced Grhl3 expression in this region of 
the embryo during late neurulation (Gustavsson et al., 2007).  
 
The hypothesis that spina bifida in curly tail results from insufficient Grhl3 levels was 
tested by reinstating Grhl3 expression in ct/ct embryos via a bacterial artificial 
chromosome (BAC). Transgenic curly tail embryos showed a complete rescue of 
the spinal NTD phenotype, along with a up-regulation of Grhl3 and a higher mitotic 
index in the hindgut (Gustavsson et al., 2007). In summary, chromosome mapping, 
gene expression studies, the severe NTD phenotype in Grhl3-null embryos and the 
normalisation of curly tail neurulation by increasing Grhl3 expression strongly 
support the theory that ct is a hypomorphic allele of the Grhl3 gene. 
 
1.3.1.4 Modifier genes in curly tail  
The penetrance of the curly tail phenotype varies with different genetic 
backgrounds, suggesting that it is influenced by the presence of modifier genes 
(Van Straaten and Copp, 2001). Early studies identified three modifier loci that 
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mapped to chromosomes 3, 5 and 17, but the identity and function of these genes 
remain unknown (Letts et al., 1995; Neumann et al., 1994). Interestingly, one of 
these early studies also observed tail defects in a small proportion of heterozygous 
(ct/+) embryos implying that, despite the incomplete penetrance in homozygotes, 
the ct mutation can display dominance when inherited with particular combinations 
of modifiers. This finding suggested that ct should be thought of as a semi-dominant 
mutation rather than a recessive allele, as it had been previously considered 
(Neumann et al., 1994). 
 
Recently, lamin B1 was identified as a key modifier gene for NTDs in curly tail mice 
(de Castro et al., 2012). Lamin B1 lies on mouse chromosome 18 and codes for a 
component of the nuclear lamina, a protein complex that lies beneath the inner 
nuclear membrane and serves many functions, including structural support and cell 
cycle regulation. Curly tail mice were found to carry a polymorphic variant of lamin 
B1, containing only eight glutamic acid repeat sequences compared with the normal 
nine repeats in wild type background-matched mice and several other wild type 
strains. The ‘8E’ lamin B1 protein displayed reduced stability, was associated with 
abnormal nuclear morphology in vitro and caused reduced proliferative capacity, 
both in cultured cells and in embryos. When sub-strains of curly tail mice, carrying 
the different lamin B1 variants, were generated, spina bifida and exencephaly 
frequency were significantly lower in the presence of the 9E (wild type) alleles 
compared with the 8E (mutant) variants. Thus, the mutated form of lamin B1 confers 
a higher risk of NTDs in curly tail embryos and therefore represents a major modifier 
locus (de Castro et al., 2012). 
  
1.3.1.5 Grainyhead-like transcription factors 
Grhl3 is a member of a transcription factor family with homology to the Drosophila 
grainyhead gene (grh; also known as NTF-1 or Elf-1). In the fly, grh was originally 
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identified as a transcriptional regulator of Dopa decarboxylase (Ddc), and has been 
found to play early roles in embryo patterning and later functions during 
neurogenesis and cuticle development (Bray et al., 1988; Wilanowski et al., 2002). 
The importance of grh during Drosophila development is highlighted by the 
embryonic lethal phenotype of mutant embryos, which also show the characteristic 
granular appearance of the head skeleton, flimsy cuticles and patchy tracheal tubes 
(Bray and Kafatos, 1991). Interestingly overexpression of grh causes failure of 
dorsal closure, the process of contact and fusion between two regions of epidermis 
on the dorsal surface of the embryo (Attardi et al., 1993), which has parallels with 
epithelial morphogenetic events such as neural tube closure and wound healing in 
vertebrates (Jacinto et al., 2002). 
 
Three grainyhead-like family members have been identified in mammals: Grhl1 
(also called mammalian grainyhead; MGR), Grhl2 (brother of mammalian 
grainyhead; BOM) and Grhl3 (sister of mammalian grainyhead; SOM, or 
grainyhead-like epithelial transactivator; Get1). The proteins encoded by these three 
genes contain highly conserved DNA binding, protein dimerisation and activation 
domains, and can form homodimers and heterodimers (Kudryavtseva et al., 2003; 
Ting et al., 2003b; Wilanowski et al., 2002). Mouse Grhl genes show distinct 
patterns of expression during development; in particular they are highly expressed 
in regions of the surface ectoderm and developing epidermis, as well as in organs 
such as the heart, lungs, kidneys and gastro-intestinal tract (Auden et al., 2006).   
 
Mice lacking Grhl1 exhibit delayed hair growth, and later display coat loss due to 
defective anchoring of hairs within the follicles (Wilanowski et al., 2008). The recent 
generation of Grhl2-null alleles has demonstrated its crucial role during neurulation. 
Grhl2-/- embryos show fully penetrant cranial exencephaly and spilt face. When they 
die at approximately E11.5 they also display an open PNP, which would most likely 
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progress to spina bifida if they survived (Rifat et al., 2010). Embryos that are 
homozygous for either of two independently generated Grhl2 gene trap alleles also 
exhibit 100% cranial NTDs and either fully penetrant or highly frequent (88%) spina 
bifida (Brouns et al., 2011; Werth et al., 2010). For one of these gene trap strains, a 
low occurrence of cranial NTDs was also reported in heterozygous (Grhl2gt/+) mice 
(Brouns et al., 2011). Thirdly, 100% exencephaly was observed in an ENU-
generated strain (Grhl21Nisw/1Nisw), although spinal neurulation was reported to occur 
normally in these embryos (Pyrgaki et al., 2011). 
 
Overexpression of Grhl2 also exerts deleterious effects on neurulation, as shown by 
characterisation of the Axial defects (Axd) mouse mutant. Axd arose spontaneously 
over 20 years ago and was only recently identified as a likely hypermorphic Grhl2 
allele (Brouns et al., 2011). Homozygous Grhl2Axd/Axd embryos display fully penetrant 
spina bifida, while tail defects are seen in a proportion of Grhl2Axd/+ embryos. When 
Axd/Grhl2genetrap compound heterozygotes were generated, a significant reduction in 
PNP length was observed compared with Grhl2Axd/+ embryos, demonstrating that 
reducing Grhl2 expression to near-wild type levels acts to normalise spinal 
neurulation (Brouns et al., 2011). The role of Grhl2 during neurulation is not well 
understood, but there is emerging evidence that it regulates cell adhesion during the 
final stage of neural fold fusion (Pyrgaki et al., 2011; Werth et al., 2010). 
 
Evidence for a key role of Grhl3 during neurulation was provided by the generation 
of two mouse lines carrying null alleles. In the first study, homozygous embryos 
exhibited 100% thoracolumbosacral spina bifida and 2% exencephaly, while 
heterozygous embryos were indistinguishable from wild type controls (Ting et al., 
2003a). The second group also observed fully penetrant spina bifida in Grhl3-/- 
embryos, but in this case the incidence of exencephaly was 14% (Yu et al., 2006). 
The reason for the difference in cranial NTD frequency is unclear, but could be due 
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to variation in the genetic background of the strains. Indeed, the cellular basis of 
exencephaly in curly tail and Grhl3-null embryos has not been elucidated; it may be 
related to the expression of Grhl3 in the ventral forebrain at E8.5-E9.5 (see Chapter 
5 for a detailed description of Grhl3 expression during neurulation). Recent work in 
our lab has shown that over-expression of Grhl3 can also prevent spinal neural tube 
closure. When curly tail embryos are made doubly transgenic for the Grhl3-
containing BAC mentioned earlier (ctTgGrhl3/ctTgGrhl3), a significant increase (estimated 
to be ~70%) in spina bifida frequency is observed compared to ct/ct embryos 
(Sandra C.P. De Castro, unpublished data). Thus, insufficient or excessive Grhl3 
promotes failure of neurulation. 
 
In addition to its role in neural tube closure, Grhl3 is required during skin 
development in mice. Grhl3-/- embryos display defective epidermal terminal 
differentiation, with an increased number of cell layers, abnormal cellular 
morphology and impaired formation of the epidermal barrier (Ting et al., 2005; Yu et 
al., 2006). Null mutants also exhibit failed wound healing at both embryonic and 
adult stages (Ting et al., 2005). Expression profiling experiments revealed altered 
expression of several key epidermal genes in Grhl3-/- embryos, including those 
encoding structural proteins, enzymes involved in lipid metabolism and cell 
adhesion molecules. In particular, the cross-linking enzyme transglutaminase 1 
(TGase1) was identified as a direct downstream target of Grhl3 (Ting et al., 2005; 
Yu et al., 2006). Open eyes were also observed in a proportion of E18.5 Grhl3-/- 
embryos (Yu et al., 2006), indicating a failure or delay of eyelid closure during 
development. A subsequent study found that this phenotype was fully penetrant in 
Grhl3-/- at E16.5, the stage at which the two nascent eyelid epithelia normally meet 
over the centre of the developing cornea and fuse (Yu et al., 2008). Grhl3 was 
found to be highly expressed in keratinocytes at the leading edges of the eyelid 
epithelia, reminiscent of its activation in migratory cells at the epidermal wound 
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front. Further examination of mutant eyelids demonstrated a role for the gene in 
actin polymerisation and formation of cellular protrusions at the leading edges (Yu 
et al., 2008). Finally, Grhl3 is also required during terminal differentiation of the 
stomach epithelium and bladder urothelium (Yu et al., 2006; Yu et al., 2009). 
  
1.3.1.6 Interactions between Grhl3 and other genes during 
neurulation 
Several studies have examined the effects of combining mutations in Grhl3 with 
those in other genes. Genetic interactions between Grhl3 and Grhl2 have been 
reported; while embryos heterozygous for either null allele develop normally, NTDs 
are observed in compound heterozygotes and for other allelic combinations (see 
Table 1.1) (Rifat et al., 2010). The Grhl3ct and Grhl2Axd alleles also interact 
genetically, with a 2.5-fold increase in tail defects seen in Grhl3ct/+;Grhl2Axd/+ 
embryos compared with Grhl3ct/+;Grhl2+/+ (Brouns et al., 2011).  
 
Years before the identification of Grhl3 as the major ct gene, curly tail was found to 
interact with splotch mutations (Estibeiro et al., 1993). While Grhl3ct/+ and Pax3Sp/+ 
embryos rarely display spinal abnormalities, 10% of compound heterozygotes 
develop tail flexion defects. Backcrosses of these animals to curly tail homozygotes 
also generated offspring with spina bifida; embryos with the Grhl3ct/ct;Pax3Sp/+ 
genotype were estimated to develop spinal NTDs (spina bifida or curled tail) in 
almost all cases. The interaction between curly tail and splotch was not due to the 
exacerbation, by either allele, of the mutant effect caused by the other, suggesting 
that it instead represents a summation of the two effects, which promotes failure of 
spinal neurulation (Estibeiro et al., 1993).  
 
Another gene known to interact with Grhl3 is the transcriptional co-regulator Lmo4 
(LIM domain-only 4) (Yu et al., 2006). Lmo4-null mice die at birth and display 
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incompletely penetrant exencephaly (Lee et al., 2005). Grhl3-/-;Lmo4-/- mice were 
found to develop 100% exencephaly, which was significantly more frequent then in 
either Grhl3-/- or Lmo4-/- single knockouts (14% and 55%, respectively) (Yu et al., 
2006). In a later study, the loss of one Grhl3 allele in Lmo4-null embryos increased 
the incidence of exencephaly from 58% in Grhl3+/+;Lmo4-/- to 70% in Grhl3+/-;Lmo4-/- 
and was also associated with spinal NTDs, which were not observed in either 
Grhl3+/+;Lmo4-/- or Grhl3+/-;Lmo4+/- embryos (Hislop et al., 2008). Finally, and of 
particular interest in this thesis, Grhl3ct and Grhl3- interact during neurulation with 
mutations in Vangl2, a core member of the planar cell polarity (PCP) signalling 
pathway (Caddy et al., 2010; Stiefel et al., 2003; Stiefel et al., 2007). These 
interactions are investigated in subsequent chapters of this thesis.  
 
Mutant genotype NTD phenotype 
Grhl2
+/-
;Grhl3
+/-
 EX (5%), SB (low sacral; 6%) 
Grhl2
+/-
;Grhl3
-/-
 
EX (mid+hindbrain; 100%) 
SB (thoracolumbosacral; 100%) 
Grhl2
-/-
;Grhl3
+/-
 
EX and split face (100%) 
SB (thoracolumbosacral; 100%) 
Grhl2
-/-
;Grhl3
-/-
 
EX and split face (100%) 
SB (thoracolumbosacral; 100%) 
 
Table 1.1 NTD frequencies in embryos carrying Grhl2 and Grhl3 null alleles 
(Rifat et al., 2010) 
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1.4 The planar cell polarity pathway 
The term planar polarity was first used in the 1980s to describe the coordinated 
orientation of cells within the plane of epithelia, perpendicular to the apico-basal 
axis. The phenomenon has been most extensively studied in the fruitfly Drosophila, 
where it manifests as the precisely ordered arrangement of cuticular structures, 
such as the distally-orientated trichomes (stubbly hairs) produced by wing cells, the 
ommatidia (light-sensing units) of the compound eye and bristles on the legs. At the 
cellular level this tissue was found to be controlled by several factors, the so-called 
‘planar cell polarity’ genes, which have since been found to be highly evolutionarily 
conserved (Goodrich and Strutt, 2011) 
 
1.4.1 Vertebrate PCP genes  
Studies in vertebrates have identified a group of genes homologous to the 
Drosophila ‘core’ PCP genes Frizzled (Fzd), Dishevelled (Dvl), Strabismus/Van 
gogh, Flamingo/Starry night, Prickle (Pk) and Diego. In contrast to Drosophila, 
several family members have been found for many of the vertebrate PCP genes. 
For example there are three Dvl genes, two Vangl (homologous to Drosophila 
Strabismus) genes and three Celsr (Drosophila Flamingo) genes in the mouse. 
Consequently, redundancy between family members means that the study of 
vertebrate PCP often requires knockouts of multiple genes (Simons and Mlodzik, 
2008). 
 
Planar cell polarity is established by the formation of protein complexes at the 
plasma membrane. Signalling is mediated through interactions between the 
transmembrane Fzd receptors and intracellular, multi-domain Dvl proteins, which 
are recruited to the membrane on activation of the pathway. Other core components 
include Vangl2, a four-pass transmembrane protein that contains a PDZ-binding 
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motif within its C-terminal domain, the transmembrane cadherin Celsr1 and the 
cytoplasmic protein Pk. Vertebrates also have two homologues of the Drosophila 
Diego gene, Inversin and Diversin (Simons and Mlodzik, 2008). Two further proteins 
for which a role in vertebrate PCP has been identified are Scribble (Scrib) 
(Montcouquiol et al., 2003) and Protein tyrosine kinase 7 (Ptk7) (Lu et al., 2004). 
While Scrib was originally defined as a determinant of apico-basal polarity in 
Drosophila, there is increasing evidence for its involvement in PCP-regulation in 
vertebrates (Montcouquiol et al., 2003; Yates et al., 2013). The core components of 
the mammalian PCP pathway are shown in Figure 1.5. 
 
In Drosophila the establishment of PCP involves interactions between the different 
components, resulting in the assembly of asymmetric protein complexes at opposite 
poles of the cell (Simons and Mlodzik, 2008). In the wing cells, a Strabismus-Pk 
complex localises to the proximal surface, while a complex containing Fz, Dvl and 
Diego forms at the distal side. Flamingo co-localises with both the proximal and 
distal complexes and is thought to form stabilising, homophilic adhesions to link 
adjacent cells (Wang and Nathans, 2007). In vertebrates the sub-cellular 
distributions of PCP proteins has not been well characterised, although the 
asymmetric localisation of factors has been reported in some tissues. For example, 
in the hair cells of the mouse cochlea, Dvl localises to the outer edge, the site of 
stereocilia formation, while Vangl2 localises to the opposite, inner side 
(Montcouquiol et al., 2006; Wang et al., 2005). Unlike in the fly wing, Fzd3 and Fzd6 
appear to co-localise with Vangl2 in the inner ear of the mouse (Montcouquiol et al., 
2006; Wang et al., 2006b). Another example is the asymmetric distribution of Dvl 
and Pk in the zebrafish neuroepithelium and presomitic mesoderm (Ciruna et al., 
2006; Yin et al., 2008). 
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Figure 1.5 The mammalian PCP pathway 
Schematic diagram showing the core PCP proteins in a mammalian cell. For each 
component, the family members for which a role in PCP has been described are listed. 
Black arrows indicate the signalling cascade, green arrows indicate known genetic 
interactions and blue arrows indicate known biochemical interactions. 
 
Upstream of the Fzd/Dvl complex, vertebrate Wnt ligands have been found to 
regulate PCP signalling. In contrast to canonical Wnt signalling, PCP does not 
involve the stabilisation of cytoplasmic β-catenin, and is therefore often referred to 
as a ‘non-canonical’ branch of the Wnt signalling cascade (Yang, 2012). In 
particular, Wnt5a and Wnt11 have been clearly linked to PCP signalling; Wnt5a 
regulates PCP and interacts genetically with Vangl2 in mice (Gao et al., 2011; Qian 
et al., 2007), while roles for Wnt5 and Wnt11 in regulating convergent extension 
during zebrafish gastrulation have been identified (Heisenberg et al., 2000; Kilian et 
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al., 2003). Wnt11 has also been reported to regulate the PCP-dependant orientated 
elongation of myocytes during early chick myogenesis (Gros et al., 2009) and the 
migration of neural crest cells in the Xenopus embryo (see Chapter 7) (De Calisto et 
al., 2005). Finally, there is emerging evidence that Wnt9b also acts via the non-
canonical pathway to regulate kidney tubule morphogenesis in mice (Karner et al., 
2009). In Drosophila, no Wnt ligands have been implicated in PCP pathway activity 
and it is not clear how fields of cells are initially polarised. One model proposes the 
involvement of a second group of factors, including the two large cadherins Fat (Ft) 
and Dachsous (Ds) as well as Four-jointed (Fj). It has been suggested that the 
Ft/Ds system could act as an upstream regulator, setting up a global polarity signal 
that can then be sensed and propagated by the core protein complexes. However, 
the relationship between the core PCP proteins and the Ft/Ds group is not well 
understood; other studies have suggested that the two act in parallel (Simons and 
Mlodzik, 2008).  
 
Downstream of the vertebrate core PCP genes, an increasing number of effector 
proteins are emerging. The best studied PCP effectors are the family of Rho 
GTPases, including RhoA, Rac1 and Cdc42, which control cytoskeletal remodelling 
to regulate PCP-dependant processes such as orientated cell movement 
(Schlessinger et al., 2009). Rho GTPase signalling has been shown to be required 
downstream of PCP in Xenopus, zebrafish and mice (see Chapter 5) (Habas et al., 
2001; Marlow et al., 2002; Ybot-Gonzalez et al., 2007b). Signalling via Inturned and 
Fuzzy has also been identified in Xenopus and mouse (Gray et al., 2009a; Park et 
al., 2006), and via Jun N-terminal kinase (JNK) in Xenopus (Habas et al., 2003; 
Yamanaka et al., 2002).  
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1.4.2 Roles in development 
The PCP pathway regulates many aspects of vertebrate development, including CE 
during body axis elongation, neural tube closure in Xenopus and mice (see Section 
1.4.2.1), cell division orientation during neurulation in zebrafish, morphogenesis of 
organs such as the heart, lungs and kidneys, and the orientation of scales, feathers 
or fur on the skin. In Xenopus and zebrafish embryos, PCP signalling has been 
found to regulate the migration of neural crest cells (see Chapter 7) (Carmona-
Fontaine et al., 2008a; De Calisto et al., 2005; Matthews et al., 2008; Shnitsar and 
Borchers, 2008). In recent years a striking link between PCP and ciliogenesis has 
also emerged (Guirao et al., 2010; Park et al., 2006; Park et al., 2008; Ross et al., 
2005; Song et al., 2010; Wallingford and Mitchell, 2011). 
 
A classic example of vertebrate PCP is seen in the cochlea of the mammalian inner 
ear. Within the cochlea, the organ of Corti (auditory sensory organ) contains 
sensory epithelia composed of mechanosensory hair cells and nonsensory support 
cells. The hair cells are organised into four rows with each cell producing a V-
shaped bundle of actin-based sterocilia that are uniformly oriented (Wansleeben 
and Meijlink, 2011). Cochlear hair cell polarity is commonly used as a read-out of 
PCP when studying mouse mutant phenotypes; for example, the precise 
arrangement of the stereociliary bundles is disrupted in Vangl2, Celsr1, Scrib and 
Ptk7 mutants, as well as in mice doubly mutant for Dvl1/2 and Fzd3/6 (Curtin et al., 
2003; Lu et al., 2004; Montcouquiol et al., 2003; Wang et al., 2005; Wang et al., 
2006b). PCP also regulates CE of the cochlea during its formation (Chacon-Heszele 
et al., 2012; Wang et al., 2005).  
 
1.4.2.1 PCP and NT closure 
During late gastrulation, shaping of the vertebrate embryo is largely driven by the 
cell movements of CE, leading to narrowing and lengthening of the neural plate and 
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underlying mesoderm (Keller, 2002) (see Chapter 4). Work in Xenopus and 
zebrafish embryos provided the first link between PCP and CE, demonstrating a 
crucial role for the pathway in controlling this process. In Xenopus for example, 
over-expression of Dvl or Stbm, or disruption of their function by injecting mutant 
constructs or antisense morpholinos, inhibits CE in both the neural and axial 
mesoderm tissues. This leads to reduced elongation of the A-P axis and in some 
cases failure of neural tube closure (Darken et al., 2002; Wallingford et al., 2000; 
Wallingford and Harland, 2001). Similarly, in the zebrafish embryo, gain and loss-of-
function of Stbm or Prickle1 causes CE defects (Carreira-Barbosa et al., 2003; 
Jessen et al., 2002; Park and Moon, 2002). 
 
The precise requirement for PCP-mediated CE during neurulation was investigated 
further in another study (Wallingford and Harland, 2002). Here, the authors found 
that the expression of mutated Dvl constructs produces embryos with an open 
neural tube phenotype (Figure 1.6) and an abnormally short, broad neural plate at 
early neurula stages. Despite the failure of closure the neural folds appear to form 
normally and move towards the midline, but are too widely spaced apart to meet 
and fuse. The severity of the NTD was also observed to correlate with the extent of 
axis elongation. When the expression of mutant Dvl was targeted to the 
ventromedial neural plate (by medial blastomere injection) or the dorsolateral neural 
plate (by lateral blastomere injection), only medially-injected embryos displayed 
NTDs. Thus, PCP-dependent CE was found to be required specifically in the 
midline in order to reduce the distance between the neural folds. 
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Figure 1.6 Failure of neural tube closure in Xenopus and mouse PCP mutants 
(A-B) Dorsal views of stage 22 Xenopus embryos. The control embryo has a closed neural 
tube (A) while a proportion of embryos fail to achieve neural tube closure after injection of a 
mutant form of Dvl (Xdsh-D2; B), which disrupts PCP signalling without affecting the 
canonical Wnt pathway. (C-D) Sections through the neuroepithelium of E8.5 wild type and 
Vangl2
Lp/Lp
 embryos. Arrows indicate the abnormally broad neural plate midline in the 
mutant. (E-F) E9.5 wild type and Vangl2
Lp/Lp
 embryos. White arrows indicate the levels of the 
open neural tube. Images taken from (Wallingford and Harland, 2002) (A-B) and (Greene et 
al., 1998) (C-F). 
 
The phenotype of Xenopus embryos with defective CE was realised to be highly 
reminiscent of the widely spaced neural folds that preclude failure of closure 1 in the 
mouse mutant loop-tail (Lp), indicating a conserved underlying mechanism (Figure 
1.6) (Greene et al., 1998). The loop-tail mouse model is mutant for the core PCP 
gene Vangl2 and homozygous Vangl2Lp/Lp embryos display craniorachischisis with 
100% penetrance (see Section 1.4.3) (Kibar et al., 2001b; Murdoch et al., 2001a).  
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Gene(s) Mutant genotype 
Penetrance 
of CRN (%) 
References 
Vangl2 
Vangl2
Lp/Lp 
Vangl2
Lpm1Jus/Lpm1Jus 
100 
100 
(Kibar et al., 2001a; Kibar et 
al., 2001b; Murdoch et al., 
2001a) 
Celsr1 
Celsr1
Crsh/Crsh 
Celsr1
Scy/Scy 
100 
100 
(Curtin et al., 2003) 
Ptk7 
Ptk7
gt/gt 
Ptk7
chz/chz
 
100 
100 
(Lu et al., 2004; Paudyal et al., 
2010) 
Scribble Scrib
Crc/Crc
 100 
(Murdoch et al., 2001b; 
Murdoch et al., 2003) 
Sec24b 
Sec24b
Y613/Y613 
Sec24b
krabbel/krabbel
 
100 
~100 
(Merte et al., 2010; 
Wansleeben et al., 2010) 
Dishevelled1/2 Dvl1
-/-
;Dvl2
-/-
 ~100 
(Hamblet et al., 2002; Wang et 
al., 2006a) 
Dishevelled2/3 
Dvl2
+/-
;Dvl3
-/-
 
Dvl2
-/-
;Dvl3
+/-
 
? (low) 
100 
(Etheridge et al., 2008) 
Frizzled3/6 Fzd3
-/-
;Fzd6
-/-
 ~100 (Wang et al., 2006b) 
Smurf1/2 Smurf1
-/-
;Smurf2
-/-
 65 (Narimatsu et al., 2009) 
Sfrp1/2/5 Sfrp1
-/-
;Sfrp2
-/-
;Sfrp5
-/-
 100 (Satoh et al., 2008) 
 
Table 1.2 Failure of closure 1 in mouse PCP mutants 
Only single PCP gene effects and paralogous gene interactions that cause 
craniorachischisis (CRN) are included here. NTDs caused by interactions between Vangl2 
and other genes are listed in Chapter 3. Smurf1 and Smurf2 are ubiquitin ligases that have 
been found to regulate PCP during neurulation and inner ear development. Sfrp1, 2 and 5 
are secreted frizzled-related proteins that regulate the PCP pathway during axis elongation. 
All other genes are referred to in the text. 
 
Strikingly, since the characterisation of loop-tail, almost all of the loci associated 
with craniorachischisis in the mouse have been found to disturb PCP signalling. 
Closure 1 fails in several mice carrying homozygous mutations in core PCP genes 
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(such as Celsr1), in mice where transport of PCP proteins is perturbed (Sec24b 
mutants) and in mice with digenic and oligogenic PCP mutant combinations (such 
as Dvl1/Dvl2 double mutants) (Juriloff and Harris, 2012a). A list of these mutants is 
provided in Table 1.2. Additionally, the heterozygous Vangl2Lp/+ genotype causes 
craniorachischisis and increases the frequency of other types of NTDs when 
combined with mutations in other PCP, and non-PCP, genes. For more details, and 
a list of these genetic interactions, see Chapter 3 (Table 3.1). 
 
1.4.3 The loop-tail mouse model 
1.4.3.1 Lp alleles 
The Lp mutation arose spontaneously within an inbred strain over 60 years ago and 
was named according to the appearance of a looped or kinked tail phenotype. 
Heterozygous mice also displayed ‘wobbly’ head behaviour and approximately one 
third of females had an imperforate vagina. When these animals were intercrossed, 
litters contained offspring with a severe malformation that closely resembled human 
craniorachischisis (Strong and Hollander, 1949; Stein and Rudin, 1953). The 
authors of the original study noted: ‘If the parents were both abnormal, some of the 
fetuses were monsters, having craniorachischisis’ (Strong and Hollander, 1949). 
 
Several early positional cloning studies led to the identification of Vangl2 (also 
originally called Lpp1 and Loop-tail associated protein; Ltap) as the gene mutated in 
loop-tail mice. Two loop-tail alleles were initially characterised, the naturally 
occurring Lp and the N-ethyl-N-nitrosourea (ENU)-induced Lpm1Jus (Kibar et al., 
2001a; Kibar et al., 2001b; Murdoch et al., 2001a). Both alleles were identified as 
semi-dominant mutations, producing craniorachischisis in homozygous mice and tail 
defects or rare, low spina bifida in heterozygotes (Copp et al., 1994; Kibar et al., 
2001a). In Lp, a single nucleotide substitution (G→A) was found to change serine 
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464 to asparagine (S464N). Similarly, a T→A missense mutation was found at 
position 765 of the Lpm1Jus sequence, changing aspartate 255 to glutamate (D255E) 
(Kibar et al., 2001b; Murdoch et al., 2001a). Both of these mutations affect highly 
conserved residues within the intracellular, C-terminal portion of the Vangl2 protein 
(Figure 1.7).  
 
Recently, two further loop-tail alleles have been reported (Figure 1.7). A second 
ENU-induced allele, Lpm2Jus, was found to contain a single G→T substitution, 
changing arginine 259 to leucine (R259L). Despite affecting another highly 
conserved residue only three amino acids away from the D255E mutation, R259L 
was found to be recessive; homozygous mice do not exhibit craniorachischisis but 
show spina bifida (12%) or a looped tail (47%), while all heterozygous mice are 
apparently normal (Guyot et al., 2011). Lpm2Jus does not cause a reduction in the 
level of Vangl2 mRNA, but results in a 10% decrease in protein level, suggesting it 
is a hypomorphic allele (Guyot et al., 2011). A third chemically-induced allele, 
Vangl2m1Yzcm, has also been published (Chen et al., 2013). The authors of this study 
observed tail defects in heterozygous mice and craniorachischisis in homozygotes. 
A C→T mutation was identified in the Vangl2 sequence, which converts glutamine 
449 to a stop (nonsense) codon. Although the level of Vangl2 expression was not 
analysed, Lpm1Yzcm was predicted to be a loss of function allele on the basis that its 
translation would produce a truncated protein lacking the PDZ-binding domain 
(Chen et al., 2013).  
 - 59 -  
                       
Figure 1.7 Positions of the loop-tail mutations 
Schematic of the Vangl2 protein. All of the published Lp mutations map to the cytoplasmic, 
C-terminal tail; arrows indicate their approximate positions. Image modified from (Guyot et 
al., 2011). 
 
1.4.3.2 NTDs in loop-tail 
Loop-tail is the most extensively studied mouse model of craniorachischisis and 
was the first mutant to implicate a role for PCP signalling in neurulation. Early 
studies of the embryonic mechanism underlying NTDs in loop-tail embryos found 
that homozygous Lp/Lp mutants fail to initiate neural tube closure at the hindbrain-
cervical boundary (closure 1) at the 5-7 somite stage. Heterozygous Lp/+ embryos 
successfully close their neural tubes, but exhibit delayed PNP closure, leading to tail 
defects and occasional low spina bifida (Copp et al., 1994). Prior to the normal 
stage of closure 1, E8.5 Lp/Lp embryos display an abnormally broad and flat midline 
of the neural plate. While a sharp midline bend produces a V-shaped neural plate in 
wild type and Lp/+ (Figure 1.6C), in Lp/Lp the sites of neuroepithelial bending are 
displaced to more lateral positions, producing a U-shaped neuroepithelium (Figure 
1.6D) which is accompanied by an abnormally wide underlying notochord (Greene 
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et al., 1998). Consistent with the abnormal morphology of the midline tissues, 
markers of the floor plate and notochord display broadened expression domains at 
E8.5 and E9.5 (Greene et al., 1998; Ybot-Gonzalez et al., 2007b). 
 
Defective axis elongation in Lp homozygotes was first suggested by Smith and 
Stein (1962), who noted that at E9.5 ‘their bodies are relatively shorter than normal’ 
and that at late gestation ‘the trunk of the Lp/Lp embryo appears compressed along 
the anterior-posterior axis’. Like other PCP mutants, Lp/Lp embryos also display an 
abnormally short and wide body axis at E8.5 (Lu et al., 2004; Paudyal et al., 2010; 
Wang et al., 2006a; Ybot-Gonzalez et al., 2007b). To directly analyse CE at pre-
neurulation stages, our lab previously performed vital labelling of midline cells by 
injecting DiI into the node or electroporating a GFP-expressing vector into the 
neural plate at E7.5. After 18 hours in culture, Lp homozygotes displayed greatly 
reduced midline extension compared to wild type embryos. Heterozygous Lp/+ 
embryos displayed a variable, intermediate phenotype (Ybot-Gonzalez et al., 
2007b).  
 
As described in more detail later, further experiments found this to be a cell-
autonomous defect, affecting both the neural plate and underlying axial mesoderm 
(see Chapter 4) (Ybot-Gonzalez et al., 2007b). Together these data demonstrate 
that PCP-dependent CE is required prior to the initiation of mammalian neural tube 
closure in order to reduce the distance between the neural folds, allowing them to 
meet and fuse. Whether a similar mechanism underlies the delayed spinal 
neurulation in Lp/+ heterozygotes, or the spina bifida in homozygous Lpm2Jus;Lpm2Jus 
embryos, has not been examined to date.    
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In addition to NTDs, loop-tail embryos display PCP-related defects in several other 
tissues. These include open eyelids, disrupted polarity of stereociliary bundles in the 
cochlea, defective reproductive system development and altered optic nerve 
trajectories (Montcouquiol et al., 2003; Rachel et al., 2000; Vandenberg and 
Sassoon, 2009). A complex cardiovascular phenotype has been described in 
Vangl2Lp/Lp mice, which includes double-outlet right ventricle (where the aorta and 
pulmonary artery both originate from the same ventricle), ventricular septal defects 
and aortic arch defects (Henderson et al., 2001; Henderson et al., 2006). Vangl2Lp/Lp 
embryos also exhibit aberrant lung and kidney morphogenesis (Yates et al., 2010a; 
Yates et al., 2010b).  
 
1.4.3.3 Effect of the Vang2Lp mutation 
Both of the original Lp mutations (S464N and D255E) disturb binding of Vangl2 to 
Dvl proteins, suggesting this interaction is crucial for PCP signalling (Torban et al., 
2004). Similarly in the zebrafish embryo, while wild type Vangl1 is able to rescue the 
CE defect in Vangl2 morphants, this phenotype cannot be rescued by injection of 
Vangl1 containing either of the two Lp mutations (Reynolds et al., 2010). Expression 
studies have shown that Lp mutations do not alter the abundance of Vangl2 mRNA 
(Guyot et al., 2011; Kibar et al., 2001b), but do cause a reduction in Vangl2 protein 
expression in the embryo (Belotti et al., 2012; Guyot et al., 2011; Torban et al., 
2007). 
 
In cells of the neural tube and cochlea, Lp mutations have been found to cause a 
reduction in the normal membrane localisation of Vangl2 protein (Torban et al., 
2007). In vitro studies of the Vangl1 protein also showed that its normal membrane 
association is disrupted when Lp mutations are introduced, and that it is retained in 
the ER, which likely leads to its degradation by the proteasome. The authors of 
these studies suggested that the retention of the mutant protein could be due to 
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mis-folding, and when protein stability was analysed they found an approximately 
four-to-seven-fold reduction in half life for the mutant variants compared with wild 
type Vangl1 (Gravel et al., 2010; Iliescu et al., 2011). The findings that Lp mutations 
interfere with protein targeting are consistent with two reports of severe PCP 
phenotypes in mice carrying loss-of-function mutations in Sec24b, a component of 
COPII vesicles which play a key role in transport of proteins from the ER to the 
Golgi. Analysis of these mutants revealed that Sec24b is required for the trafficking 
and correct membrane localization of Vangl2 (Merte et al., 2010; Wansleeben et al., 
2010). Furthermore, Vangl2Lp protein fails to package into COPII vesicles and fails 
to reach the plasma membrane, presumably due to defective exit from the ER 
(Merte et al., 2010).  
 
The data described above suggest that Vangl2Lp represents a loss-of-function allele 
and that the semi-dominance of the loop-tail phenotype is caused by 
haploinsufficiency due to the partial loss of Vangl2 in a gene-dosage dependant 
pathway. On the other hand, recent studies have provided strong evidence for a 
dominant negative effect of Vangl2Lp, whereby the mutant protein alters the normal 
activity of wild type Vangl2 protein or other PCP components. The data in these 
reports demonstrate that the presence of the Vangl2Lp protein has a greater 
phenotypic effect than the loss of wild-type Vangl2 (see Chapter 6 for more details) 
(Song et al., 2010; Yin et al., 2012). In summary, Lp mutations appear to exert 
complex effects on the biochemical properties of Vangl2; there is evidence for both 
a reduction in protein abundance and a dominant negative effect exerted by the 
remaining mutant protein. 
 
1.4.3.4 Vangl genes 
In mice, humans and zebrafish two homologues of the Drosophila Strabismus/Van 
gogh gene have been identified (Vangl1 and Vangl2) while only one gene has been 
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found in Xenopus. Among vertebrate species, Vangl1 proteins share approximately 
67% similarity, while Vangl2 proteins are 74% conserved (Torban et al., 2004). The 
mouse Vangl1 and Vangl2 genes are located on chromosomes 3 and 1, 
respectively and their sequence similarity is, on average, 70%, but varies at 
different positions. Particularly high conservation (>80%) is observed within their C-
terminal cytoplasmic domain, the region to which Lp mutations map  (Torban et al., 
2004). The patterns of Vangl1 and Vangl2 expression during neurulation are shown 
later in this thesis (see Chapter 5 and Chapter 7). Briefly, the two genes are co-
expressed within the neuroepithelium, but with some differences. Vangl2 is more 
widely expressed, with transcripts found throughout the dorsoventral axis of the 
neuroepithelium prior to and during neural tube closure, while Vangl1 is largely 
confined to the ventral midline region (Doudney et al., 2005; Kibar et al., 2001b; 
Torban et al., 2007; Torban et al., 2008).  
 
The role of Vangl1 during development is not well understood but, like Vangl2, 
Vangl1 protein can bind to Dvl, suggesting functional conservation among the family 
members. Furthermore, this interaction is disrupted when Lp mutations are 
introduced into the Vangl1 sequence (Torban et al., 2004). Differences in 
expression pattern have been suggested to underlie the lack of redundancy 
between the two genes during neurulation in mice (Vangl1 doesn’t compensate for 
the loss of Vangl2 function in loop-tail) (Doudney et al., 2005). However in zebrafish 
ectopic expression of Vangl1 can partially rescue the CE defect in trilobite (Vangl2) 
mutants (Jessen and Solnica-Krezel, 2004). Surprisingly, Vangl1-null mutant mice 
do not develop NTDs, although a proportion of double heterozygous 
Vangl1genetrap/+;Vangl2Lp/+ embryos display craniorachischisis and cochlear polarity 
defects, demonstrating a genetic interaction during neurulation and inner ear 
development (Torban et al., 2008). Interestingly, recent co-immunoprecipitation 
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studies have shown that Vangl1 and Vangl2 interact physically in vitro, forming 
heteromeric protein complexes (Belotti et al., 2012; Yin et al., 2012).  
 
1.4.4 Neural crest cell migration 
Another aspect of early nervous system development for which a role for PCP 
signalling has been described is the migration of neural crest (NC) cells. The NC is 
a transient, multipotent vertebrate cell population that is induced at the boundary 
between the future neural and non-neural ectoderm (the ‘neural plate border’) by a 
complex network of signalling pathways and transcription factors (Sauka-Spengler 
and Bronner-Fraser, 2008; Steventon et al., 2005; Stuhlmiller and Garcia-Castro, 
2012). After their specification, NC cells undergo an epithelial to mesenchymal 
transition (EMT), delaminating from the dorsal neuroepithelium in a rostrocaudal 
wave, and migrating extensively throughout the embryo. On reaching their target 
locations, they give rise to a wide range of cell types, including neurons and glia of 
the peripheral and enteric nervous systems, heart cells, melanocytes and the bone, 
cartilage and smooth muscle of the head (Sauka-Spengler and Bronner-Fraser, 
2008).  
 
1.4.4.1 Delamination 
Before commencing their migration, NC cells undergo an EMT in order to 
delaminate from the neuroepithelium and invade the surrounding mesenchyme. 
Pre-migratory NC cells reside within a tightly packed epithelial layer; they are joined 
by intercellular adherens and tight junctions, exhibit apical-basal polarity and are 
supported by components of the basement membrane (basal lamina). Therefore, 
three processes in particular are key to the EMT of the NC: alterations in cell 
adhesion molecules, the dissolution of cell junctions and remodelling of the 
surrounding extracellular matrix (ECM) (Strobl-Mazzulla and Bronner, 2012). 
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An early feature of the EMT, common to NC cells in different species and at varying 
axial levels, is a change in cell-cell adhesion via the modulation of cadherin 
expression. In particular, down-regulation of type I cadherins such as E-cadherin 
and N-cadherin and up-regulation of type II cadherins such as Cadherin7 and 
Cadherin11 is a hallmark of EMTs. These changes represent a switch from strong, 
classical cadherin-based cell-cell adhesions that are required to maintain 
neuroepithelial integrity, to weaker adhesions that allow increased cell motility. The 
regulation of cell adhesion molecules also appears to prevent mixing between pre-
migratory NC and non-NC cells. For example in the chick neural tube, NC cells 
weakly express N-cadherin and strongly express Cadherin6B, while the surrounding 
cells express N-cadherin. It has been suggested that the subsequent loss of 
Cadherin6B and activation of Cadherin7 and 11 in the NC promotes delamination 
via a ‘cell sorting-like mechanism’ whereby NC cells are pushed out of the dorsal 
neural tube (Theveneau and Mayor, 2012).  
 
The changes in cell-cell interactions that occur during the initial stages of EMT are 
also linked to the replacement of tight junctions by gap junctions. This involves the 
downregulation of major structural components of tight junctions, such as Occludins 
and Claudins, and the upregulation of gap junction proteins such as Connexin-43 
(Cxn-43) (Kuriyama and Mayor, 2008). In the mouse, Cxn-43 (also called alpha-1 
connexin) is expressed in the delaminating NC at all axial levels and its knockout 
produces defects in NC derivatives (Lo et al., 1997; Reaume et al., 1995). In 
mammalian NC explant cultures, Cxn-43 has been shown to modulate the migration 
of cardiac NC cells; its overexpression increases the rate of migration, while 
abrogation of its function causes a decrease in migration rate (Huang et al., 1998).  
 
As NC cells separate from the neuroepithelium, they must also invade and migrate 
through the surrounding ECM. This element of EMT requires the controlled 
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digestion of ECM components, such as collagens, laminins, proteoglycans and 
fibronectin, in the basement membrane overlying the dorsal neuroepithelium. ECM 
degradation is regulated by a fine balance between the proteolytic activity of matrix 
metalloproteases (MMPs) and the expression of tissue inhibitors of MMPs (TIMPs) 
(Kuriyama and Mayor, 2008). For example, MMP2 and its natural inhibitor, TIMP-2, 
have been found to play important roles in chick cardiac NC migration (Cantemir et 
al., 2004; Duong and Erickson, 2004) and MMP-8 is expressed in the mouse NC 
(Giambernardi et al., 2001). NC cells also express members of the ADAM 
metalloprotease family, cell surface-bound enzymes that cleave extracellular 
portions of transmembrane proteins (Sauka-Spengler and Bronner-Fraser, 2008). In 
Xenopus, ADAM-13 is expressed in both premigratory and migratory cranial NC 
cells and is required for their migration (Alfandari et al., 2001) and in the chick NC 
cells express ADAM-10 (Hall and Erickson, 2003).     
 
1.4.4.2 Timing and routes of early migration 
After undergoing EMT, NC cells embark on defined routes of migration towards their 
final destinations. In general NC migration initiates around the time of neurulation, 
although the timing varies between species. Cranial NC cells begin their migration 
shortly after neural tube closure in the chick, while in mouse and Xenopus they 
depart prior to closure of the cranial neural folds (at the 4-5 somite stage in the 
mouse). Migration of the trunk NC starts following neural tube formation in all animal 
models, although the time between the end of neurulation and NC delamination can 
vary along the A-P axis (Theveneau and Mayor, 2012). 
 
The cranial NC segregate into distinct streams, the pattern of which is highly 
conserved between species. Cells that terminate at a relatively dorsal position 
contribute to the cranial ganglia, while others continue further ventrally, invade the 
branchial arches and form the cartilage and bones of the face and neck. Caudal 
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forebrain (diencephalon) and midbrain-derived NC cells migrate both anteriorly to 
populate the periocular and frontonasal regions of the face, and ventrally to colonise 
the first branchial arch. In the hindbrain the NC predominantly migrate from the 
even-numbered rhombomere segments, creating three streams from rhombomeres 
two, four and six that colonise the first, second and third branchial arches (Kuo and 
Erickson, 2010; Trainor, 2005). The cranial streams are separated by two neural-
crest free zones adjacent to rhombomeres three and five, from which relatively few 
NC cells emigrate. Lineage tracing studies in the mouse have shown that the cells 
from these odd-numbered rhombomeres migrate anteriorly or posteriorly to join the 
adjacent streams (Trainor et al., 2002) (Figure 1.8A). Caudal to the hindbrain, a 
subpopulation of cells, termed the vagal NC, arises from the axial level of somites 1-
7. These cells migrate long distances, differentiating into neurons and glia of the 
enteric nervous system (ENS; predominantly cells from the level adjacent to 
somites 3-6) and cardiac cells (cells from the level of somites 1-3), as well as PNS 
cells and melanocytes (Kuo and Erickson, 2011). 
 
Trunk NC cells migrate along two major pathways, a ventromedial route and a 
dorso-lateral route, the timings and trajectories of which show interspecies variation. 
In amniote embryos the NC initially migrate ventrally between the neural tube and 
somites, before proceeding through the anterior half of the sclerotome and along 
the basement membrane of the dermamyotome upon somite maturation (Figure 
1.8B). Those which travel the furthest differentiate to produce neurons and glia of 
the sensory and sympathetic ganglia, while more dorsally-terminating NC aggregate 
to form the dorsal root ganglia (DRG) and boundary cap cells. Another wave of NC 
cells embark on a dorsolateral route between the somites and the overlying 
ectoderm (Figure 1.8B). These cells populate the skin and differentiate into 
melanocytes. In the mouse embryo NC cells travel along ventromedial and 
dorsolateral routes simultaneously, while in the chick the dorsolateral path is 
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invaded approximately 24 hours later than the ventral path (Theveneau and Mayor, 
2012).   
 
 
Figure 1.8 Early routes of NC cell migration in the mouse 
Schematic diagram showing the major paths taken by NC cells emigrating from the cranial 
(A) and trunk (B) neuroepithelium. (A) In the cranial region, NC cells segregate into distinct 
streams (blue). The pattern of hindbrain NC migration is related to the rhombomere 
segments (r1-r7) and leads to the appearance of NC-free zones adjacent to r3 and r5. Blue 
arrows indicate major contributions to the branchial arches and black arrows indicate minor 
contributions. (B) In the trunk, NC cells take ventral routes (1 and 2) and dorsolateral routes 
(3). See text for details. 
 
1.4.4.3 Molecular guidance of migration 
Most of the molecules that are known to guide NC migration act as inhibitory cues, 
patterning the NC into their stereotypical streams by excluding them from restricted 
areas. One group of important signalling molecules are membrane-bound ephrin 
ligands and their Eph receptors (members of the receptor tyrosine kinase family), 
which are expressed in different combinations by the NC and their surrounding 
tissues. Interactions between ligand-receptor pairs regulates NC cell motility by 
inducing the collapse of cell protrusions (Theveneau and Mayor, 2012). In Xenopus 
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for example, the expression of ephrin-B2 in the second branchial arch NC and 
mesoderm is complementary to that of EphA4 and EphB1 receptors in the third 
arch, targeting the NC cells to their correct destination. Blocking or ectopic 
activation of the receptors leads to aberrant migration and intermingling of NC cells 
from different streams (Smith et al., 1997). In mouse and chick embryos, the 
organisation of trunk NC migration involves the expression of ephrin-B ligands in the 
posterior half of the sclerotome, while the NC cells express EphA/B receptors and 
are therefore restricted to the anterior half. Inhibition of the pathway results in 
ectopic entry of NC cells into the posterior part of the sclerotome. Eph-ephrin 
interactions in the chick also regulate the early repulsion of trunk NC cells from the 
dorsolateral pathway (Krull et al., 1997; Santiago and Erickson, 2002). 
 
Another important class of molecules are class3-semaphorins and their 
transmembrane receptors, neuropilins and plexins. Ligand-receptor binding leads to 
downstream signalling that can alter the cytoskeleton (Kuriyama and Mayor, 2008; 
Santiago and Erickson, 2002). Studies in mouse, zebrafish and chick have identified 
a role for semaphorin signalling in cranial NC patterning: Sema3 genes are 
expressed in the NC-free zones, while their neuropilin receptors are expressed in 
the migratory NC cells. When signalling is impaired, cells are able to divert from 
their normal streams and invade adjacent NC-free regions (Gammill et al., 2007; 
Osborne et al., 2005; Yu and Moens, 2005). The signalling pathway is also required 
in the trunk to mediate the guidance of NC cells through the somites. For example, 
in the mouse, NC cells express neuropilin2 (Npn2), while expression of its repulsive 
semaphorin3F (Sema3F) ligand is restricted to the posterior sclerotome. Both 
Sema3F and Npn2 mutant mice lose their segmented pattern of trunk NC cell 
migration and cells are seen ectopically migrating throughout the sclerotome 
(Gammill et al., 2006). 
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Other negative regulators have also been implicated in trunk NC migration 
(Theveneau and Mayor, 2012). Of these, the most well understood is Slit/Robo 
signalling. Chick NC cells express members of the Robo receptor family and are 
exposed to their secreted Slit ligands as they navigate through the embryo. The 
expression of Slit2 in the dermamyotome has been suggested to prevent the 
premature entry of Robo1- and Robo2-positive NC cells into the dorsolateral path, 
as overexpression of a dominant negative Robo receptor leads to the early invasion 
of this route (Jia et al., 2005). Slit/Robo signalling also appears to regulate the 
specific migration of vagal NC cells into the gut (De Bellard et al., 2003).   
 
1.4.4.4 Directionality and a role for PCP signalling 
The signalling molecules described above play important roles in establishing and 
maintaining the segregation of NC streams during their migration. Nevertheless, 
they do not explain how NC cells migrate collectively with such a high level of 
persistence and directionality. The consideration of positive regulators of NC 
migration has led to the identification of several candidate attractant molecules. For 
example, growth factors such as members of the VEGF and PDGF families are 
expressed in cranial regions such as the branchial arches and cause NC-related 
phenotypes when their signalling is impaired (Theveneau and Mayor, 2012). FGFs 
have also been suggested to be chemotactic factors for NC in the midbrain and 
heart (Kubota and Ito, 2000; Sato et al., 2011). Recently, the chemokine stromal 
cell-derived factor 1 (Sdf1) has emerged as a strong candidate for a NC 
chemoattractant. Sdf1 plays well characterised roles as an attractant in other 
contexts and is required for migration of the cranial NC in Xenopus and zebrafish 
(see Chapter 7 for more details) (Theveneau and Mayor, 2012).  
 
However, it has been argued that the directionality of the NC cannot simply arise 
from a balance of positive and negative external cues (Theveneau and Mayor, 
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2012). As described in Chapter 7, recent studies in Xenopus and zebrafish have 
shown that cell-cell contacts between migratory NC cells influence their 
directionality, and that an important driving force of polarised NC migration is a 
phenomenon known as contact inhibition of locomotion (CIL). In these species, PCP 
signalling has been found to play a key role in controlling these cell behaviours 
(Carmona-Fontaine et al., 2008b; De Calisto et al., 2005; Matthews et al., 2008). 
Whether PCP signalling is similarly required during NC cell migration in the mouse 
embryo has not yet been determined.  
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1.5 Thesis summary 
This thesis aims to investigate two main questions: 1) what role does the PCP 
pathway play during mammalian low spinal neural tube closure, and is this 
equivalent to its well established role prior to closure 1, and 2) is PCP signalling 
required during NC cell migration in the mouse embryo? Chapter 3 begins to 
address the first question by investigating the exacerbating effect of loop-tail 
(Vangl2Lp) heterozygosity on spinal neurulation in curly tail (Grhl3ct/ct) embryos. The 
spina bifida phenotype of doubly mutant Lp/ct embryos is described and evidence 
for various mutant effects is assessed. In particular, the work in this chapter 
identifies initial morphological evidence of defect CE in Lp/ct embryos.  
 
In Chapters 4 and 5 the developmental basis of the Lp/ct interaction is explored 
further. Chapter 4 investigates the hypothesis that mutations in Vangl2 and Grhl3 
affect distinct processes in different tissues, namely CE in the midline and the 
regulation of axial progenitors in the tail bud, while Chapter 5 investigates possible 
molecular interactions between the two genes. In Chapter 6 a parallel, genetic 
approach is taken to investigate a requirement for Vangl2 and Grhl3 in the same 
cells of the embryo. Consistent with the data in Chapters 4 and 5, the findings of 
this chapter suggest that the interaction between Vangl2 and Grhl3 during spinal 
neurulation predominantly reflects their tissue-specific roles.  
 
Finally, in Chapter 7, a requirement for the PCP signalling pathway during mouse 
NC cell migration is investigated. In contrast to recent data from Xenopus and 
zebrafish, evidence that PCP signalling is dispensable for early mammalian NC 
migration is presented. 
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2.  Materials and Methods 
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2.1 Animals 
Mouse colonies were maintained by Dawn Savery in the animal facility at the UCL 
Institute of Child Health. The animal rooms were kept at 22oC with a 24-hour cycle 
of 12 hours light/12 hours dark. On reaching sexual maturity (6-8 weeks of age) 
female mice were housed in communal cages with a maximum capacity of either 6 
or 10 adult animals. Males were housed individually. Water and standard pelleted 
food were freely available at all times. 
 
2.1.1 Vangl2Lp 
Loop-tail mice (Jackson Laboratories, U.S.) were maintained as a heterozygous 
(Vangl2Lp/+) colony by backcrosses to CBA/Ca inbred mice (Harlan Laboratories, 
UK).  
 
2.1.2 Vangl2flox  
Vangl2flox/flox mice were a gift from Prof. Deborah Henderson (Newcastle University). 
They were maintained as a homozygous colony; further animals were generated by 
crossing to C57BL/6J mice and intercrossing the heterozygous (Vangl2flox/+) 
offspring. 
 
2.1.3 Grhl3ct  
The curly tail mutation arose spontaneously in 1950 in the GFF inbred strain (Glaxo 
Laboratories, UK) and the original stock was derived from the offspring of a cross 
between an affected female and a CBA/Gr male (Van Straaten and Copp, 2001). 
Since then, curly tail mice have been maintained as a closed, random-bred colony 
of homozygous (ct/ct) individuals. Due to the lack of suitable wild type controls, a 
congenic (+ct/+ct) strain that are wild type at the curly tail locus, but share over 95% 
of the curly tail genetic background was generated previously (Gustavsson et al., 
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2007). This strain was derived from an initial cross between curly tail and the SWR 
inbred strain, followed by successive backcrosses to curly tail. 
 
2.1.4 Grhl3flox  
Grhl3flox/flox mice were from Dr Bogi Anderson. To generate Grhl3flox/- mice for 
experimental crosses, heterozygous animals (Grhl3flox/+ on a C57BL/6J background) 
were crossed to β-actinCre/+ mice. This produced Grhl3+/-;β-actinCre/+ (25% of 
offspring), which were then backcrossed to Grhl3flox/flox or Grhl3flox/+ mice to remove 
the Cre.  
 
2.1.5 Grhl3Cre  
Grhl3Cre mice were provided by Dr Shaun Coughlin and were as described 
previously (Camerer et al., 2010). They were maintained as a heterozygous 
(Grhl3Cre/+) colony on a C57BL/6J background.  
  
2.1.6 Wnt1-Cre  
Wnt1-Cre transgenic mice were from J.P. Martinez-Barbera and were as described 
previously (Jiang et al., 2000). The colony was maintained on a C57Bl/6J 
background. 
 
2.1.7 Rosa26YFP  
Rosa26YFP reporter mice were from the Jackson Laboratories and were as 
described previously (Srinivas et al., 2001). They were maintained as a 
homozygous colony (R26YFP/YFP) on a C57BL/6J background. 
 
2.1.8 β-actinCre 
β-actinCre mice were from J.P. Martinez-Barbera and were maintained as a 
heterozygous colony (β-actinCre/+) on a C57BL/6J background. 
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2.2 Mouse embryology 
2.2.1 Embryo collection and dissection 
Experimental litters were obtained from timed matings according to the 
developmental stage of embryos required. Mice were paired overnight and the 
following morning females were checked for the presence of a copulation plug. 
Noon on the day of finding a plug was designated embryonic day E0.5. 
Alternatively, morning matings were set up and females were checked later that 
afternoon. In these cases, noon on the day of finding a plug was designated E0. 
Pregnant females were killed by cervical dislocation, the abdomen was surgically 
opened and the uterus was removed by cutting at the level of the cervix and below 
each of the ovaries. Uteri were transferred to a bijoux tube containing pre-warmed 
(37oC) dissecting medium (Dulbeco’s Modified Eagle Media containing 25 mM 
HEPES [DMEM, Invitrogen] supplemented with 10% heat-inactivated fetal bovine 
serum [FBS, Invitrogen]), transported to the laboratory and placed in a dish of fresh 
medium under a stereo-microscope (Zeiss SV6 or SV11) for dissection. 
  
Embryos were dissected from the uterus using flame-sterilised watchmakers’ 
forceps (number 5, Dumont) (Figure 2.1). Fat and blood vessels were first trimmed 
away from the mesometrial surface of the uterus, before opening the uterine wall at 
the site of each decidual implantation. The deciduae were then gently removed from 
the uterus and transferred to a fresh dish of dissecting medium. Each decidua was 
opened and dissected away to reveal the mural trophoblast layer, which envelops 
the embryo. Trophoblast tissue and the underlying Reichert’s membrane were 
peeled away, exposing the embryo within its yolk sac. Finally the yolk sac and 
amnion were removed and the dissected embryos were numbered for future 
reference. Yolk sacs were washed twice in cold phosphate-buffered saline (PBS) 
that had been treated with 0.1% v/v diethyl pyrocarbonate (DEPC; inactivates 
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RNase enzymes) and stored at -20oC for genotyping (see Section 2.5). 
Alternatively, embryos were dissected for whole embryo culture (see Section 2.2.2). 
In this case, the ectoplacental cone was left intact during dissection of the 
trophoblast layer. Reichert’s membrane was trimmed up to the edges of the 
ectoplacental cone as it can become ‘sticky’ during culture, causing the embryo to 
adhere to the culture tube. Care was taken not to rupture the yolk sac. 
 
 
Figure 2.1 Embryo dissection 
(A) Three implantations within the uterus. The wall of the uterus was opened to release the 
deciduae (B). Each individual decidua was opened to reveal the embryo within its yolk sac 
(C, D; in this example the trophoblast layer has been peeled back along with the decidual 
tissue). (E) The yolk sac was then removed (in this example the underlying amnion was left 
intact and can just be seen encasing the embryo). (F) Completely dissected embryo with its 
yolk sac and amnion removed. (G) Alternatively the yolk sac was left intact for whole embryo 
culture. Abbreviations: ys = yolk sac, am = amnion, epc = ectoplacental cone. Scale bars: 
500 µm.  
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Dissected embryos were washed twice in cold PBS-DEPC and transferred to ice-
cold paraformaldehyde (PFA) solution (4% w/v in PBS-DEPC; aliquoted and stored 
at -20oC). Fixation was carried out at 4oC for approximately 6-8 hours (E8.5) or 
overnight (E9-E10.5). Following fixation, embryos were washed twice in PBS-DEPC 
and dehydrated through a series of methanol washes (25%, 50% and 75% 
methanol in PBS-DEPC), followed by 2 washes in 100% methanol. All wash steps 
were performed on ice on a shaking platform for 20-30 minutes, depending on 
embryonic stage. Dehydrated embryos were stored at -20oC in 100% methanol for 
further use. Alternatively, older embryos were fixed at room temperature (RT) 
overnight in Bouin’s fixative (Sigma). They were then washed thoroughly in PBS, 
dehydrated to 70% ethanol and stored at 4oC. Those required for histology were 
later dehydrated to 100% ethanol.  
 
2.2.2 Whole embryo culture 
The ability to culture mouse embryos throughout the stages of neurulation allows 
experimental studies and chemical manipulations which would not otherwise be 
possible in a mammalian system (Copp et al., 2000; Pryor et al., 2012). To optimise 
the success of culture experiments, high quality rat serum was used and embryos 
were carefully dissected using flame-sterilised instruments.  
 
2.2.2.1 Preparation of rat serum 
Blood serum from adult male rats was prepared at UCL Biological Services. 
Animals were anaesthetised by isoflurane inhalation, with anaesthesia confirmed by 
pinching of one of the paws. After surgical opening of the abdomen, blood was 
withdrawn from the abdominal aorta using a syringe, until the animal had been 
exsanguinated. Death was confirmed by cutting of the diaphragm. Blood was 
immediately centrifuged at RT for 5 minutes (10,000 g) to separate the blood cells 
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from the serum supernatant, which then rapidly clots. The clot was squeezed using 
flat-tipped forceps and the serum was transferred to a new 15 ml tube. If it appeared 
pink in colour rather than pale yellow, indicating contamination by red blood cells, it 
was centrifuged again, or discarded if persistently pink-coloured. All tubes of serum 
were then pooled, heat-inactivated at 56oC for 30 minutes, chilled on ice and 
aliquoted (1-5 ml volumes) for storage at -20oC. Aliquots of rat serum were thawed 
immediately before use, warmed to 37oC and passed through a Millipore filter (0.45 
µm pore size).  
 
2.2.2.2 Culture method 
After dissection for culture (Section 2.2.1), embryos were transferred to a fresh dish 
of pre-warmed dissecting medium. Meanwhile, 30 ml plastic culture tubes (Nunc) 
were prepared by smearing the outer rim with a small amount of silicone grease 
(Borer Chemie) to create an airtight seal. The required volume of rat serum (0.5 ml 
serum per E8.5 embryo, 1 ml per E9.5 embryo) was pipetted into the culture tubes 
and gassed for 1 minute with the appropriate mixture (Table 2.1) by attaching a 
glass Pasteur pipette to the cylinder with plastic tubing. Gas was blown gently on to 
the inner wall of the tube, causing the surface of the serum to gently ripple without 
bubbling. Culture tubes were then equilibrated for at least 15 minutes in a 37oC 
roller culture incubator (B.T.C Engineering). 
 
Embryos were transferred to the serum using a plastic Pasteur pipette, ensuring 
that a minimal amount of dissecting medium was introduced. Serum was then re-
gassed as before and the tubes were returned to the culture incubator, with the lid 
covered to protect from light. For short cultures (around 6 hours) embryos did not 
need to be gassed again after the start of the experiment. For longer cultures 
embryos were re-gassed every 6-12 hours. 
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Embryonic day Composition of gas mixture 
E7.5-E9.5                 
(cranial neural tube open) 
5% O2, 5% CO2, 90% N2 
E9.5-E10.5                
(cranial neural tube closed) 
20% O2, 5% CO2, 75% N2 
Older than E10.5 40% O2, 5% CO2, 55% N2 
 
Table 2.1 Gas mixtures administered during whole embryo culture 
 
2.2.2.3 Assessment of embryos after culture period 
At the end of the culture period, embryos were transferred into pre-warmed 
dissecting medium and assessed immediately. Yolk sac appearance and 
circulation, which develops at E8.5-E9.0, were scored as an indicator of embryonic 
viability.  The categories used for scoring are detailed in Table 2.2; embryos with a 
score of 1 or 0 were excluded from further analyses. After opening the yolk sac and 
amnion, developmental progression was assessed by counting the number of fully-
formed somite pairs. The crown-rump length (CRL) was also measured as an 
indicator of overall growth (see Section 2.2.3). Any gross abnormalities, for example 
embryos which had not turned by the appropriate stage or those with opaque tissue, 
were also recorded.  
 
Yolk sac score Description 
3 
Round, smooth yolk sac with a strong, 
unidirectional circulation 
2 
Moderate circulation, yolk sac surface 
may be slightly crinkled 
1 Weak circulation, crumpled yolk sac 
0 No yolk sac circulation 
 
Table 2.2 Categories for scoring yolk sac circulation after whole embryo culture 
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2.2.2.4 DiI labelling 
To fluorescently label cells in the midline (see Chapter 4), E9.0 embryos were 
injected with DiI (1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate; 
Molecular Probes, USA) prior to culture. DiI solution was prepared by dissolving in 
DMSO (4 mg/100 μl) and diluting ten-fold in 3 mol/L sucrose. Aliquots were 
wrapped in foil to protect them from light and stored at −20°C; they were thawed 
before use and any unused DiI solution was kept at 4°C for short term storage. 
Glass microinjection needles were pulled on a Flaming-Brown horizontal pipette 
puller (Sutter Instrument Co., USA) and were prepared by breaking the end using a 
microforge (Narishige, Japan). Ideally, the orifice diameter was wide enough to 
allow DiI solution to be drawn up into the needle, but narrow enough to prevent the 
solution leaking when the needle was placed in the dissecting medium. Needles 
were attached to a hand-held mouth pipetting tube.    
 
Embryos were dissected for culture as shown in Figure 2.1G. To prepare them for 
injection, embryos were then transferred to a 55 mm petri dish containing 2% 
agarose (w/v in PBS; 2-3 mm deep) and fresh dissecting medium. A small ‘window’ 
was made in the yolk sac overlying the PNP, taking care not to damage the amnion 
layer (Figure 2.2A). A drop of DiI was placed on to a petri dish lid and a small 
amount was drawn up into the needle. Embryos were held in place by lodging them 
in a small well in the agarose. Injections were made by piercing the amnion and just 
penetrating the dorsal surface of the neuroepithelium. Two marks were made in the 
midline at the level of the open PNP by releasing the DiI while slowly withdrawing 
the needle (Figure 2.2C).  
 
When several embryos had been labelled, they were examined under a 
fluorescence stereomicroscope (Leica MZ FLIII) to check for correct DiI localisation. 
When viewed from the side, successful injections appeared as two marks in the 
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ventral region of the neural plate (Figure 2.2D). The caudal region was 
photographed from the dorsal side using a digital camera attached to the 
microscope and any additional, ectopic DiI marks in the amnion were recorded. To 
allow the identification of individual embryos at the end of the culture, they were 
labelled by pushing strands of suture thread (different combinations of long and 
short pieces) through a small region of the yolk sac at the opposite side to the PNP 
(Figure 2.2B). Embryos were then cultured as described in Section 2.2.2.2 
(maximum of three per tube). 
 
At the end of the culture period the embryos were assessed as described above 
(Section 2.2.2.3). Some appeared abnormal, likely due to the damage caused to the 
yolk sac or damage to the embryonic tissue by the injections themselves, and these 
were excluded from further analysis. Further photographs were taken, to allow 
‘before and after’ measurements of the DiI marks to be made (see Chapter 4). 
Importantly, the localisation of DiI was evaluated by viewing the embryo from the 
side (Figure 2.2E) and, for some, this was confirmed by embedding the embryos in 
wax for transverse histological sectioning. Embryos for which DiI labelled tissues 
other than the neuroepithelium were excluded from the analysis.        
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Figure 2.2 DiI labelling   
(A) E9.0 embryo dissected for culture for which a ‘window’ has been cut in the yolk sac at 
the level of the PNP (arrows). (B) Embryo labelled with individual strands of suture material 
(arrows) ready for culture. (C) Dorsal view of the caudal region of an embryo immediately 
after DiI labelling. C’ and C’’ show fluorescent and merged images, respectively. Arrows 
point to the two midline marks; an additional, ectopic mark is visible in the amnion overlying 
the PNP. (D) The caudal region in C viewed from the side. In this orientation, the correct 
localisation of DiI in the ventral neural plate can be confirmed (arrows). Fluorescent and 
merged images are shown in D’ and D’’. Marks from where the needle has pierced the 
amnion can also be seen. (E) Side view of the caudal region of an embryo at the end of the 
culture. Arrows indicate DiI correctly localised in the (now closed) ventral neural tube. 
Abbreviations: bf = bright field, am = amnion.          
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2.2.2.5 Whole embryo culture with the ROCK inhibitor, Y27632 
Inhibition of Rho-kinase (ROCK) during PNP closure was achieved by culturing 
E9.0 embryos with the pharmacological inhibitor Y27632 (Calbiochem; see Chapter 
5). Y27632 was prepared by dissolving in sterile Milli-Q H2O (5 mMol/L) and 
aliquoting on ice. Aliquots were wrapped in foil to protect them from light and stored 
at −20°C; they were thawed on ice before use and any unused solution was 
discarded due to the inhibitor’s high sensitivity to light. 
 
Intitally, a range of Y27632 concentrations (3-10 μMol/L) was tested in order to find 
a suitable dose. These were based on concentrations used previously for embryos 
with a similar genetic  background (Ybot-Gonzalez et al., 2007b). Wild type 
(CBA/Ca) embryos were dissected for culture and evenly distributed (in terms of 
embryonic stage) between treatment groups. Culture serum was supplemented with 
Y27632 or sterile Milli-Q H2O (vehicle control). When embryonic viability was 
assessed after culture, a concentration of 5 μM Y27632 (ie 1 μl of 5 mMol/L stock 
solution added to 1 ml of serum) was deemed suitable. It was found to be the 
highest dose at which normal development progressed, with higher concentrations 
causing toxic effects such as poor yolk sac circulation and failure of embryonic 
turning. As detailed later in this thesis, 5 μM Y27632 allowed normal development 
but had a specific effect on PNP closure in mutant embryos (Chapter 5). 
 
2.2.3 Embryonic measurements 
Throughout this project, various morphometric measurements were taken. Live 
embryos were measured after dissection using an eyepiece graticule on a stereo-
microscope. Distance in graticule units was converted to mm for the objective used 
(Table 2.3). Caudal length and axial curvature were measured later from 
photographs using Image J software (version 1.47k). 
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Objective 
magnification 
mm per 100 
graticule units 
mm per 1    
graticule unit 
0.8 12.5 0.125 
1 10 0.1 
1.2 8.33 0.0833 
1.6 6.25 0.0625 
2 5 0.05 
2.5 4 0.04 
3.2 3 0.03 
4 2.5 0.025 
5 2 0.02 
6.6 1.515 0.01515 
 
Table 2.3 Measurement conversions  
Table used to convert embryonic measurements made using various microscope objectives. 
For example, a measurement of 20 graticule units under a 5x objective was converted to 0.4 
mm (20 x 0.02). 
 
2.2.3.1 Crown-rump length 
Embryonic CRL was assessed as an indicator of overall embryonic growth. CRL 
was measured as the distance from the top of the head, diagonally to the furthest 
point along the trunk (Figure 2.3A). 
 
2.2.3.2 Posterior neuropore size 
The size of the PNP was assessed immediately after dissection. For E8.5-E9.5 
embryos, PNP length was measured as the distance from the rostral limit of the 
open PNP to the caudal end of the embryo. At E10-E10.5, the stage at which tail 
bud development begins, PNP length was measured as the distance from the 
rostral to caudal end of the open neuroepithelium (Figure 2.3B, C). PNP width was 
 - 86 -  
measured by taking a dorsal view of the caudal region and recording the longest 
distance between the two open neural folds (Figure 2.3D). 
 
2.2.3.3 Caudal parameters 
The width of the caudal region was measured by taking a dorsal view and 
measuring the widest point of the embryo, at the same axial level as the PNP width 
measurement (Figure 2.3D). The length of the caudal region was measured from 
photographs of the caudal half of the embryo, taken from a lateral view. The 
allantois was used as a ventral morphological marker, on the assumption that the 
position of this structure would not be affected by any changes in convergence and 
extension of dorsal tissues (see Chapters 3 and 4). A straight line was drawn up 
through the centre of the allantois to the dorsal surface of the embryo, and the 
curved distance between this point and the tip of the tail was recorded. Caudal 
length was also analysed by measuring the length of the region occupied by the 
most recently formed six somites; this was again measured from photographs 
(Figure 2.3E). 
 
2.2.3.4 Axial curvature 
The ventral curvature of the caudal region was measured from photographs using 
the method described previously (Brook et al., 1991). A straight line was drawn 
along the middle of the caudal end of the embryo, parallel to and equidistant from 
the dorsal and ventral surfaces. A second line was drawn tangential to the ventral 
edge of the penultimate somite, and the angle at which these two lines intersected 
was measured (X; Figure 2.3F). 
 
2.2.3.5 Midline tissues 
The width of the notochord and ventral neuroepithelial midline were measured from 
photographs of histological sections (Figure 2.3G). 
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Figure 2.3 Embryonic measurements 
Crown-rump length (CRL; A), PNP length (B, C), PNP width and caudal width (D) were 
measured immediately after dissection. Caudal length measurements (E) and the angle of 
ventral curvature (F) were measured from photographs of the caudal region (lateral view). 
The width of the ventral neuroepithelial (NE) midline and notochord was measured from 
photographs of haematoxylin and eosin stained histological sections (G). 
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2.3 Histology 
Embryos were processed in one of the following ways: 1) Embryos for 
immunohistochemistry, haematoxylin and eosin (H and E) staining and DiI-labelled 
embryos were embedded in paraffin wax for microtome sectioning (see Section 
2.3.1), 2) Embryos that had been used for whole mount in situ hybridisation were 
embedded in gelatine/albumin or agarose and sectioned using a vibratome (see 
Section 2.3.3).  
 
2.3.1 Wax embedding 
PFA-fixed embryos were taken from -20oC storage in 100% methanol and washed 
twice in 100% ethanol for 30 minutes, rocking at room temperature. Embryos that 
had been fixed in Bouin’s fixative were taken from 4oC storage in 70% ethanol and 
dehydrated to 100% ethanol (80%, 90% and 100% washes for 1 hour, followed by a 
further wash in 100%). Embryos were then transferred to individual glass 
embedding moulds (Agar Scientific) and cleared by two Histo-Clear (National 
Diagnostics) washes, the first at room temperature and the second in a 60oC oven 
(ThermoScientific). Histo-Clear incubation times were: 15 minutes for E8.5, 20 
minutes for E9-9.5 and 30 minutes for E10-10.5 and pieces of tissue from older 
embryos. The Histo-Clear was replaced with molten paraffin wax and embryos were 
incubated in four 45-minute washes at 60oC. Moulds were transported on heated 
metal trays during the wax changes, to prevent the wax from solidifying. After the 
fourth incubation, moulds were viewed under a stereomicroscope and embryos 
were orientated using heated forceps. The wax was then allowed to set overnight at 
room temperature. 
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2.3.2 Microtome sectioning 
Solid wax blocks were removed by placing the moulds at -20°C until they could be 
easily pushed out (15-20 minutes). Blocks were then cut to shape, mounted on to a 
wooden cube using molten wax and left on ice to harden. Sections were cut on a 
microtome (Thermo Scientific) at a thickness of 7 μm (for immunohistochemistry) or 
10 μm (for H and E staining). Ribbons or individual sections were then transferred to 
SuperFrost Plus slides, which had been covered with Milli-Q water and placed on a 
heated plate. When all the wrinkles had flattened out the water was drained from 
the slides, they were transferred to metal racks and then left to dry in a 37°C 
incubator overnight. Slides were stored in a plastic slide box at RT.  
 
2.3.3 Gelatine/albumin and agarose embedding 
Following whole mount in situ hybridisation, embryos in PBT (PBS-DEPC with 0.1% 
Tween-20) were embedded in a gelatine/albumin (G/A) mixture for vibratome 
sectioning. A gelatine solution (Sigma; 1.5% w/v in PBS) was added to an albumin 
solution (albumin from chicken egg white, Sigma; 45% w/v in PBS) and stirred by 
hand until smooth. Sucrose (Sigma) was then added to the mixture (20% w/v) and 
dissolved. Aliquots of the G/A solution were stored at -20°C until further use. 
Embryos were transferred into individual bijoux tubes containing G/A (0.5 ml for 
E8.5 embryos, 1 ml for E9.5 embryos), ensuring that no bubbles were introduced, 
and left overnight at 4°C. For embedding, 300 μl of G/A was pipetted into a small 
plastic embedding mould, again taking care not to introduce bubbles. 
Gluteraldehyde (30 μl) was added, quickly stirred and the embryo was immediately 
transferred into the well using syringe needles. The embryo was orientated and the 
block was left to set for approximately 1 hour. Blocks were removed from the plastic 
mould using a scalpel, transferred to a bijoux tube containing PBS and left at 4°C 
until required. 
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Alternatively, embryos were embedded in agarose (2% w/v in PBS). In this case 
warm agarose was poured into a plastic embedding mould and an embryo was 
transferred to the mould. The embryo was orientated using forceps as the agarose 
polymerised. Blocks were left on ice to allow the agarose to set completely.         
 
2.3.4 Vibratome sectioning 
Gelatine/albumin (or agarose) blocks were attached to the specimen disc of the 
vibratome (Leica) with super glue. The vibratome tray was filled with PBS and the 
specimen disc was secured within it. Sections were cut at a thickness of 40 μm (G/A 
blocks) or 50 μm (agarose blocks) and arranged in order on dry SuperFrost slides. 
When the excess PBS had dried, slides were mounted with coverslips using 50% 
glycerol (v/v in Milli-Q water; G/A sections) or Mowiol mounting medium (Sigma; 
agarose sections). Slides were sealed at the corners with nail varnish and stored at 
4°C until required. 
 
2.3.5 H and E staining 
Wax was removed by incubating the slides in Histo-Clear (2 x 10 minutes). Sections 
were then washed twice in 100% ethanol (2 minute washes), rehydrated (95%, 
75%, 50% and 25% ethanol; 2 minute washes) and incubated in tap water for at 
least 2 minutes. Slides were incubated in filtered Mayer’s haematoxylin (to stain the 
nuclei) for approximately 1 minute, before washing under running tap water. Next, 
slides were incubated in filtered eosin (to stain the cytoplasm; 1% w/v in H2O; Acros 
Organics) for approximately 3 minutes and again washed in water. After each 
incubation the intensity of staining was checked under a light microscope and a 
further incubation step was performed if necessary. The sections were then 
dehydrated by brief ethanol washes (25%, 50%, 75%, 100%), allowed to dry at RT 
and mounted with DPX mounting medium (Grale Scientific).     
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2.4 Neural tube explant culture 
2.4.1 Preparation of cover-glasses 
Circular, 13 mm cover-glasses were placed into individual wells of a 12-well tissue 
culture plate, under sterile conditions. A large drop (150 µl) of poly-D-Lysine (Sigma; 
stock solution of 0.5 mg/ml in PBS aliquoted and stored at -20oC; fresh working 
solution of 40 µl into 1 ml PBS prepared for each experiment) was pipetted on to the 
centre of each cover-glass and left at RT for 30 minutes. This volume was sufficient 
to completely cover the surface of the glass, but not enough to overflow on to the 
bottom of the well. The poly-D-Lysine was then removed and the plate allowed to air 
dry in the tissue culture cabinet for a further 30 minutes. The same volume of 
fibronectin (Sigma; stock solution of 1 mg/ml in PBS stored at -20oC; working 
solution of 50 µl into 1 ml PBS) was then pipetted on to the cover-glasses; again 
this was left for 30 minutes and removed. The plates were allowed to air dry again 
for 30 minutes; care was taken not to over dry the plates at this stage, as this was 
found to adversely affect the attachment of the explants.    
 
2.4.2 Dissection and culture 
To prepare embryonic neural tubes for explant culture, the cranial region was first 
removed, and the embryo was digested in 2% Pancreatin (Sigma) in PBS at 37oC 
for 15 minutes to facilitate dissection. The neural tube adjacent to the most caudal 
five somites was then dissociated from the surrounding tissues (Figure 2.4) and 
transferred to a cover-glass in a 12-well tissue culture plate. Explants were cultured 
at 37oC (5% CO2/95% air) in a large droplet of phenol red-free DMEM (which does 
not auto-fluoresce) containing 10% fetal calf serum and 1% penicillin/streptomycin 
for 1-2 hours, until they attached to the cover-glass. A further 2 ml of medium was 
then added to each well. For 48 hour cultures, the culture medium was replaced 
after 24 hours with serum-free medium containing supplements for neural cell 
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culture (N2 and B27; Invitrogen) and growth factors (EGF and FGF). At the end of 
the culture period, explants were rinsed in PBS, fixed for 10 minutes in 4% PFA and 
stored in PBS at 4oC. 
 
2.4.3 Analysis  
The rate of cell migration over two days was assessed by measuring the area of 
outgrowth of the explant as a percentage increase of the area covered by the 
central explant tissue at 24 hours (see dotted lines in Figure 7.13A, Chapter 7). This 
allowed for any variation due to differences in the original size of the explant, or to 
pieces of the tissue detaching and floating away during the first few hours of culture. 
The migration rate was also analysed by measuring the distance travelled by YFP-
positive leading edge NC cells from the periphery of the central explant tissue.  
 
The polarity of NC cells at the leading edge was assessed by measuring the 
distribution of cell area relative to the direction of migration, with ‘forward’ defined as 
the direction away from the central mass of neuroepithelial tissue. The cell area 
within six circular sectors, centred on the nucleus, was measured, allowing each cell 
to be designated ‘front’, ‘sides’ or ‘back’ based on the direction in which the majority 
of their area was distributed (see examples in Figure 7.18, Chapter 7). Cells which 
did not display a majority of at least 5% in any direction were designated ‘none’. 
Cells which were polarised in the direction of forward migration were therefore 
defined as those with the majority of their area distributed towards the front. All area 
and distance measurements were performed using ImageJ software. 
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Figure 2.4 Dissection of neural tube explants 
Method of preparing neural tube explants for outgrowth culture. After enzymatic digestion, 
the neural tube was isolated adjacent to the most posterior five somites (white bracket in 1). 
Surrounding surface ectoderm and somitic tissues were removed (2, 3) to produce a 
cleanly-dissected explant (4). Scale bars: 200 µm. 
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2.5 Genotyping 
Genotyping of mice and embryos was carried out by polymerase chain reaction 
(PCR) amplification of DNA extracted from ear punches and yolk sacs respectively. 
Mouse genotyping was performed by Dawn Savery. A master mix of the reaction 
mixture was prepared and dispensed into 0.2 ml or 0.5 ml tubes before adding the 
DNA samples and amplifying using specific primers in a thermal cycler. Positive and 
negative control tubes were included for each batch of samples.  
 
2.5.1 DNA extraction  
Frozen yolk sacs were thawed at room temperature and briefly centrifuged. 
DNAreleasyTM (Anachem), a lysing reagent which releases DNA from cells, was 
added to each sample (20 µl of solution, diluted 20% v/v in Sigma water) and tubes 
were processed in a thermal cycler (see Table 2.4 for running conditions). At the 
end of the programme, tubes were briefly centrifuged and stored at -20oC. 
 
Step Temperature (
o
C) Duration 
1 65 15 minutes 
2 96 2 minutes 
3 65 4 minutes 
4 96 1 minute 
5 65 1 minute 
6 96 30 seconds 
7 20 10 minutes 
 
Table 2.4  Thermal cycler programme for cell lysis using DNAreleasy 
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2.5.2 Vangl2 genotyping assays 
Vangl2Lp genotyping was performed by PCR amplification of the polymorphic Crp 
microsatellite region, which is closely linked to Lp on mouse chromosome 1 (Copp 
et al., 1994). The PCR reaction mixture and running conditions were as shown in 
Table 2.5 and Table 2.7. On the CBA background the Vangl2+ and Vangl2Lp alleles 
co-segregated with 150 and 140 base pair (bp) fragments, respectively. On the 
C57BL/6J background (that is, when Lp was crossed to Wnt1-Cre or R26YFP; see 
Chapter 7) the Vangl2+ and Vangl2Lp alleles co-segregated with 95 bp and 140 bp 
fragments, respectively. For Vangl2+, Vangl2flox and Vangl2- genotyping, two PCRs 
were performed: one to detect the wild type (+) and floxed alleles and another to 
detect the deleted (-) allele. The PCR reaction mixtures and running conditions were 
as shown in Table 2.6 and Table 2.7. Amplification gave PCR products of the 
following bp lengths: 560 (wild type), 701 (floxed) and 203 (deleted). 
 
Reaction component Volume (µl) 
10x NH4 Reaction buffer (Bioline) 5 
50 mM MgCl2 (Bioline) 1.5 
2 mM dNTPs (Promega) 5 
40 µM Primer mix (Sigma) 0.3 
5 U/µl Taq DNA polymerase (Bioline) 0.5 
H2O (Sigma) 35.7 
Genomic DNA 2 
Total volume: 50 
Primers (5’-3’) :  Forward: GAGGGAGAAGAATTATGTCTG 
                           Reverse: AGAATCTGACTTACCCATGGT              
 
Table 2.5 PCR reaction mixture for Vangl2
Lp
 genotyping 
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Reaction component Volume (µl) 
5x GoTaq Flexi buffer (Promega) 4 
25 mM MgCl2 (Promega) 0.8 
2 mM dNTPs (Promega) 2 
10 µM F primer (wild type/flox or deleted)  1 
10 µM common R primer  1 
5 U/µl GoTaq Flexi DNA polymerase (Promega)  0.5 
H2O (Sigma) 8.7 
Genomic DNA 2 
Total volume: 20 
Primers (5’-3’) :  Wt/flox forward:  CCGCTGGCTTTCCTGCTGCTG 
                           Del forward:  TTGACCTCAGTGCAGCGCCC 
                           Common reverse:  TCCTCGCCATCCCACCCTCG            
 
Table 2.6 PCR reaction mixture for Vangl2
+
, Vangl2
flox
 and Vangl2
-
 genotyping 
 
Step Vangl2
Lp
 
Vangl2
+
/Vangl2
flox
         
and Vangl2
-
 
1. Heating 95
o
C, 2 minutes 95
o
C, 2 minutes 
2. Denaturation 94
o
C, 1 minute 95
o
C, 30 seconds 
3. Annealing 58
o
C, 1 minute 67.5
 o
C, 30 seconds 
4. Extension 72
o
C, 1 minute 72
o
C, 30 seconds 
5. Final extension 72
o
C, 10 minutes 72
o
C, 10 minutes 
 
Table 2.7 PCR running conditions for Vangl2 genotyping 
For Lp PCRs, steps 2-4 were repeated for 35 cycles. For wild type/flox and deleted PCRs, 
steps 2-4 were repeated for 16 cycles, with the annealing temperature decreasing by 0.5
 o
C 
per cycle until it reached 60
 o
C. Steps 2-4 were then repeated for a further 19 cycles with the 
annealing temperature at 60
 o
C. 
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2.5.3 Grhl3 genotyping assays 
Grhl3ct genotyping was performed by PCR amplification of the region upstream of 
Grhl3 containing the C21350T enhancer mutation (Gustavsson et al., 2007). The 
PCR reaction mixture and running conditions were as shown in Table 2.8 and Table 
2.10. Amplification gave a 551 bp product for both the wild type and mutant alleles. 
The curly tail mutation causes loss of one of the two Aci1 restriction sites (CCGC) 
that are normally located within the 551 bp region. Therefore, PCR products were 
digested with Aci1 restriction enzyme (New England BioLabs) for a minimum of 6 
hours (usually overnight) at 37oC. The reaction contained 1.5 µl 10x NEB3 buffer, 
0.15 µl Aci1, 0.15 µl BSA, 3.2 µl H2O and 10 µl PCR product (total volume of 15 µl). 
Digested samples were separated on a 2% agarose gel: the wild type Grhl3 allele (+ 
or +ct) produced three bands (165, 271 and 115 bp) and the mutant (ct) allele 
produced two bands (436 and 115 bp). Four bands were therefore visible for 
heterozygous samples. 
 
For Grhl3+, Grhl3flox and Grhl3- genotyping, two PCRs were performed: one to 
detect the wild type and floxed alleles and another to detect the deleted allele. The 
PCR reaction mixtures and running conditions were as shown in Table 2.9 and 
Table 2.10. Amplification gave PCR products of the following bp lengths: 300 (wild 
type), 400 (floxed) and 250 (deleted). 
 
 
 
 
 
 
 - 98 -  
Reaction component Volume (µl) 
10x NH4 Reaction buffer (Bioline) 3 
50 mM MgCl2 (Bioline) 0.7 
2 mM dNTPs (Promega) 1.5 
40 µM Forward primer (Sigma) 1.5 
40 µM Reverse primer (Sigma) 1.5 
5 U/µl Taq DNA polymerase (Bioline) 0.15 
5 M Betain (Sigma) 5 
H2O (Sigma) 15.65 
Genomic DNA 1 
Total volume: 30 
Primers (5’-3’):  Forward:  TTGTATTTTCTTGCTTGAAACG 
                          Reverse:  TCAGCGTAAGAAAGCTGTGG 
 
Table 2.8 PCR reaction mixture for Grhl3
ct
 genotyping 
 
Reaction component Volume (µl) 
10x NH4 Reaction buffer (Bioline) 5 
50 mM MgCl2 (Bioline) 1.5 
2 mM dNTPs (Promega) 5 
40 µM Primer mix (Sigma) 0.3 
5 U/µl Taq DNA polymerase (Bioline) 0.5 
H2O (Sigma) 35.7 
Genomic DNA 2 
Total volume: 50 
Wt/flox primers (5’-3’):  F: CCCCTGAGCAGTTTGGAATA 
                                     R: TGGCCACACTGACAAGAGAG 
Del primers (5’-3’):        F: GAATTACAAGTCTGTGCCACCA 
                                     R: ATTTGCTGACCTTTTTCTGAGC            
 
Table 2.9 PCR reaction mixture for Grhl3
+
, Grhl3
flox
 and Grhl3
-
 genotyping 
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Step Grhl3
ct
 
Grhl3
+
/Grhl3
flox
             
and Grhl3
-
 
1. Heating 96
o
C, 5 minutes 95
o
C, 2 minutes 
2. Denaturation 96
o
C, 30 seconds 94
o
C, 30 seconds 
3. Annealing 54
o
C, 30 seconds 60
o
C, 30 seconds 
4. Extension 72
o
C, 45 seconds 72
o
C, 45 seconds 
5. Final extension 72
o
C, 5 minutes 72
o
C, 5 minutes 
 
Table 2.10 PCR running conditions for Grhl3 genotyping 
Steps 2-4 were repeated for 35 cycles for each PCR. 
 
2.5.4 Cre and sex genotyping assays 
The presence of the Cre recombinase sequence was detected by PCR amplification 
of a 500 bp fragment. The PCR reaction mixture and running conditions were as 
shown in Table 2.11 and Table 2.13 and amplification gave a 500 bp product. To 
reliably distinguish between Cre-negative samples and those that had simply not 
amplified, primers that amplified a 145 bp fragment of the wild type Mthfr sequence 
were also added to the reaction mix (see Table 2.11).  
 
Finally, the sex of some embryos was determined (see Chapter 6) by amplifying a 
fragment of the smc locus. The PCR reaction mixture and running conditions were 
as shown in Table 2.12 and Table 2.13. Female and male samples generated one 
and two bands, respectively (due to an intron difference between the X and Y 
genes). 
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Reaction component Volume (µl) 
10x NH4 Reaction buffer (Bioline) 5 
50 mM MgCl2 (Bioline) 1.5 
2 mM dNTPs (Promega) 6 
40 µM Cre primer mix (Sigma) 0.3 
40 µM Mthfr F primers (Sigma) 0.3 
40 µM Mthfr R primer (Sigma) 0.3 
5 U/µl Taq DNA polymerase (Bioline) 0.5 
H2O (Sigma) 35.7 
Genomic DNA 2 
Total volume: 50 
Primers (5’-3’):    Cre F:  ACCCTGATCCTGGCAATTTCGGC 
                           Cre R:  GATGCAACGAGTGATGAGGTTCGC  
                           Mthfr F: GAAGCAGAGGGAAGGAGGCTTCAG 
                           Mthfr R: GACTAGCTGGCTATCCTCTCATCC 
 
Table 2.11 PCR reaction mixture for Cre genotyping 
 
Reaction component Volume (µl) 
10x NH4 Reaction buffer (Bioline) 5 
50 mM MgCl2 (Bioline) 1.5 
2 mM dNTPs (Promega) 5 
40 µM Forward primer (Sigma) 0.3 
40 µM Reverse primer (Sigma) 0.3 
5 U/µl Taq DNA polymerase (Bioline) 0.25 
H2O (Sigma) 35.65 
Genomic DNA 2 
Total volume: 50 
Primers (5’-3’):  Forward: CCGCTGCCAAATTCTTTGG 
                          Reverse: TGAAGCTTTTGGCTTTGAG              
 
Table 2.12 PCR reaction mixture for sex genotyping 
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Step Cre PCR Sex PCR 
1. Heating 94
o
C,  2 minutes 94
o
C,  5 minutes 
2. Denaturation 94
o
C,  30 seconds 94
o
C,  1 minute 
3. Annealing 63
o
C,  30 seconds 58
o
C,  1 minute 
4. Extension 70
o
C,  45 seconds 72
o
C,  1 minute 
5. Final extension 72
o
C,  5 minutes 72
o
C,  5 minutes 
 
Table 2.13 PCR running conditions for Cre genotyping and sexing of embryos  
Steps 2-4 were repeated for 30 cycles for the Cre PCR and 35 cycles for the sex PCR 
 
2.5.5 Agarose gel electrophoresis 
PCR products were separated by agarose gel electrophoresis and analysed by 
comparison to appropriate molecular weight markers (Bioline Hyperladders; ladder 
V for 25-500 bp bands and ladder I for 200-10,000 bp bands). Gel concentrations 
were 1-4 % w/v agarose dissolved in TAE buffer (40 mM Tris acetate and 1 mM 
EDTA in water) with ethidium bromide dye added. Orange G (Sigma) solution was 
used as a loading buffer (50% glycerol and 50% 1x TE buffer [10 mM Tris EDTA pH 
8.0] with Orange G powder added to colour).  
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2.6 Quantitative reverse transcription PCR 
For qRT-PCR whole embryos, or the embryonic caudal region containing the last 
two somites, were washed twice in cold PBS-DEPC following dissection and 
transferred to sterile eppendorf tubes. Excess PBS-DEPC was removed and 
samples were immediately frozen on dry ice, before storing at -80°C. 
 
2.6.1 RNA extraction and purification 
Total RNA was extracted using TRIzol Reagent (Invitrogen). Volumes given are for 
an E9-E9.5 caudal sample and were doubled for whole embryos. Samples were 
taken from storage and kept on dry ice before being homogenised with 500 µl 
TRIzol by pipetting up and down (tubes were left on wet ice until the whole batch 
had been processed). Samples were then incubated at RT for 5 minutes, 100 µl of 
chloroform was added and the tubes were vigorously shaken by hand for 15 
seconds. They were then incubated at RT for a further 2-3 minutes, centrifuged at 
4oC for 15 minutes (12,000 g) and the upper aqueous phase (containing the RNA) 
was transferred to a clean eppendorf tube. To precipitate the RNA, 250 µl of 
isopropanol was added, samples were shaken and incubated at RT for 10 minutes 
and then centrifuged at 4oC for 10 minutes (14,000 g). The supernatant was 
removed, taking care not to disturb the gel-like RNA pellet, which was then washed 
with 500 µl of 75% ethanol in DEPC-H2O, briefly vortexed and centrifuged at 4
oC for 
5 minutes (10,000 g). The RNA pellet was dried at RT for no longer than 10 minutes 
and re-suspended in 15 µl DEPC-H2O and 0.5 µl RNase inhibitor. Unless 
immediately proceeding to DNase treatment, RNA samples were frozen on dry ice 
and stored at -80oC. 
 
To remove DNA contamination from samples, DNase treatment was performed 
using the DNA-free Kit (Ambion): 1.5 µl of 10x DNase I buffer and 1 µl of DNase I 
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enzyme was added to the tube, followed by incubated at 37°C for 30 minutes. The 
reaction was stopped by the addition of 2 µl DNase inactivation buffer, incubating at 
RT for 2 minutes with occasional flick-mixing. Samples were centrifuged at 4°C for 2 
minutes (10,000 g) and the supernatant was transferred to a new tube. RNA 
concentration was measured using a spectrophotometer (NanoDrop 1000; Thermo 
Scientific). RNA purity was also assessed by recording the ratio of sample 
absorbance at 260 and 280 nm (a 260/280 ratio of 2.0 is considered to be pure). 
Samples generally had a ratio of 1.6-1.8; those with lower values were discarded. 
   
2.6.2 Complementary (c) DNA synthesis 
First-strand cDNA was synthesised using the Superscript VILO cDNA Synthesis Kit 
(Applied Biosystems). RNA samples were thawed on ice and 300 ng was 
transferred to a clean eppendorf tube (on ice; made up to a volume of 14 µl with 
DEPC-H2O), before 4 µl of 5x VILO Reaction Mix and 2 µl of 10x SuperScript 
Enzyme Mix were added (total volume of 20 µl). Tubes were run in a thermal cycler 
using the following programme: 25°C for 10 minutes, 42°C for 60 minutes and 85°C 
for 5 minutes. cDNA samples were diluted by adding 40 µl DEPC-H2O. 
 
To check that the reverse transcription reaction had worked, cDNA samples were 
amplified in a standard PCR reaction using primers against the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh), which produced a 177 bp 
product. The PCR reaction mixture and running conditions were as shown in Table 
2.14 and Table 2.15. cDNA quality was also assessed by running a test qRT-PCR 
plate, again using Gapdh primers. 
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Reaction component Volume (µl) 
10x NH4 Reaction buffer (Bioline) 3 
50 mM MgCl2 (Bioline) 0.7 
2 mM dNTPs (Promega) 1.5 
10 µM Forward primer (Sigma) 1.5 
10 µM Reverse primer (Sigma) 1.5 
5 U/µl Taq DNA polymerase (Bioline) 0.15 
H2O (Sigma) 20.65 
cDNA 1 
Total volume: 30 
 
Table 2.14 Standard PCR reaction mixture 
 
Step Temperature, Duration 
1. Heating 94
o
C, 5 minutes 
2. Denaturation 94
o
C, 30 seconds 
3. Annealing 60
o
C, 30 seconds 
4. Extension 72
o
C, 30 seconds 
5. Final extension 72
o
C, 10 minutes 
 
Table 2.15 Running conditions for a standard PCR 
Steps 2-4 were repeated for 35 cycles 
 
2.6.3 qRT-PCR 
2.6.3.1 Primers 
The primers used for qRT-PCR were all from Sigma and are listed in Table 2.16. 
Primers were designed in NCBI Primer-BLAST to amplify an approximately 200 bp 
fragment of the target gene, with an optimum annealing temperature of 60oC. This 
programme was also used to ensure that primers would amplify unique products as 
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it highlighted other potential targets within the mouse genome (by running against 
the RefSeq RNA database). All primers were tested on a qRT-PCR run using a 
control cDNA sample (from a wild type embryo); amplification and dissociation 
(melting) curves were analysed as described in Section 2.6.3.3.    
 
Gene name Sequence (5’-3’) PCR product size 
ArhGEF3 
F: GAAGTGCGGCTGGGTGGCTC 
R: TGGCCGGCAGCAGACAGAAC 
194 bp 
ArhGEF7 
F: CCGGCTGGTTCCCCAGCAAC 
R: GCAGTGGCCGCAGGTAGGTG 
216 bp 
Gapdh 
F:  ATGACATCAAGAAGGTGGTG 
R:  CATACCAGGAAATGAGCTTG 
177 bp 
Grhl3 
F: CCAGACTCCAGTAACAATG 
R: AAGGGTGAGCAGGTTCGCTT 
218 bp 
p190RhoGAP 
F: TGGATGCGTGGTCAAGCCAAGG 
R: CAAACCGCCCCAGGCGAGTG 
233 bp 
RhoGEF19 
F: AGCGAAGGCGTTTCTCGGCCTCA 
R: CTTGCGTGTCCAGCCTGGGTTCC 
243 bp 
ROCK1 
F: CTGCCGGGTGGGATGCGACT 
R: CCGCGGTGGGTTTGTAGCCG 
173 bp 
Vangl2 
F: CCGGGGATTGGGTAGCGTGT 
R: GGTCCCACAGCCACCTCCTTCA 
214 bp 
 
Table 2.16 Primers for qRT-PCR 
 
2.6.3.2 Sample preparation 
qRT-PCR was performed using a fluorescence-based method to measure the 
amplification of a target gene normalised to an endogenous reference control gene. 
Here, Gapdh was used as the reference gene for all experiments. qRT-PCR plates 
(Optical 96-Well Fast Thermal Cycling Plate; Applied Biosystems) were prepared on 
ice using designated pipettes and pipette tips to prevent contamination of samples 
with genomic DNA. Each sample was analysed in triplicate for both target gene and 
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Gapdh amplification. A master mix was prepared on ice for each set of primers (see 
Table 2.17); 23 µl was dispensed into each well after loading 2 µl of the relevant 
cDNA. A negative control well (2 µl water instead of cDNA) was also included for 
each primer pair. Plates were then sealed with an adhesive film (MicroAmp Optical 
Adhesive Film; Applied Biosystems), taking care to keep the surface clean and seal 
all the wells, before being briefly vortexed and centrifuged.   
 
Reaction component Volume (µl) 
Mesa Blue* 12.5 
10 µM Forward primer 2 
10 µM Reverse primer 2 
H2O (Sigma) 6.5 
Total volume: 23 
 
Table 2.17 Master mix for qRT-PCR 
*The Mesa Blue qPCR Master Mix Plus for SYBR Assay (Eurogentec) contains a 
fluorescent reporter dye that binds to double stranded DNA. As the DNA is amplified, the 
dye is incorporated into newly synthesised DNA. The fluorescent signal can therefore be 
measured to quantify the level of target gene expression, relative to the Gapdh control. 
 
2.6.3.3 Thermal cycling 
The qRT-PCR plate was run on a 7500 Fast Real-Time PCR System (Applied 
Biosystems) using a standard thermal cycling programme consisting of a pre-run 
(50oC for 2 minutes, 95oC for 5 minutes) and 40 cycles (denaturation at 95oC for 15 
seconds, annealing/extension at 60oC for 1 minute). At the end of the programme a 
dissociation (melting) curve analysis was run; this programme gradually reheated 
the plate to 95oC while continually monitoring the fluorescence emitted, producing a 
dissociation curve of fluorescence against temperature. Separation of the two cDNA 
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strands causes a rapid decrease in fluorescence and, as all PCR products for a 
primer pair should have the same melting temperature, a single sharp peak should 
be seen on the graph.    
 
2.6.3.4 Analysis 
Analysis of data (amplification and dissociation) was performed using 7500 
Software (Applied Biosystems). The dissociation curves for each well were checked 
first; the presence of additional peaks indicates unwanted PCR products 
(contamination or primer dimmer) which emit fluorescence and can therefore 
interfere with the results. Wells with a poor dissociation curve were excluded from 
further analysis at this point. The amplification graph, showing fluorescence against 
cycle number, was then examined for each well. The baseline (cycles during which 
background fluorescence is emitted prior to amplification) and ‘threshold’ levels (see 
below) were adjusted for each target gene and Gapdh.  
 
The analysis of gene expression levels was based on the principle that, as the 
target gene is amplified, the level of fluorescence emitted will at some point begin to 
increase exponentially. This is manually designated as the threshold level on the 
amplification curve, with the cycle at which the fluorescence reaches this threshold 
defined as CT (‘threshold cycle’). The CT value varies depending on the initial level 
of gene expression and can therefore be used to calculate the relative quantity of 
the target gene in each sample (with each normalised to Gapdh). The consistency 
of CT values for triplicates was checked, as were the negative control wells. One 
wild type sample was also selected as a reference for the relative quantification 
(RQ) of all other samples on the plate; this was given an RQ value of 1 by the 
software. Data were exported to Microsoft Excel and the mean RQ value for each 
sample triplicate was tabulated to allow comparisons of mRNA expression level.  
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2.7 Whole mount in situ hybridisation 
RNA probes for whole mount in situ hybridisation (WISH) were transcribed from 
DNA templates, obtained from various sources (Table 2.18).   
 
2.7.1 Plasmid DNA templates 
Plasmid DNA was first transformed into competent DH5α cells in order to grow up 
bacterial cultures. Eppendorf tubes were placed on ice and the appropriate volume 
of plasmid DNA was added (0.5-1 µl; approximately 0.1 µg DNA). Single use, 50 µl 
aliquots of competent cells were taken from -80oC storage and placed on ice to 
thaw for approximately 5 minutes before being transferred to the plasmid DNA tube 
and gently flick-mixed. A negative control tube (no DNA) was also included. Tubes 
were then placed on ice for 20 minutes, incubated at 42oC for 50 seconds to heat 
shock the cells and immediately returned to the ice for a further 2 minutes. Next, 
950 µl of RT Luria Bertani broth (LB broth; Invitrogen) was added to each tube and 
cells were incubated at 37oC, shaking, for 60-90 minutes. Samples were plated on 
to LB agar (Invitrogen) plates containing 50 μg/ml ampicillin (Sigma; all plasmids 
contained an ampicillin resistance gene). Two plates, containing 50 µl and 200 µl of 
the culture, were spread for each sample. Plates were incubated upside down at 
37oC overnight (12-16 hours). 
 
The following morning, plates were removed from the incubator and checked for 
bacterial colonies. The negative plate was examined to ensure that no colonies 
were present. Pipette tips were used to pick individual colonies (minimum of two per 
plate) and were dropped into 50 ml falcon tubes containing 5 ml LB broth (and 
ampicillin). Cultures were incubated at 37oC overnight, shaking. The bacterial cells 
were then harvested by centrifugation at 4oC (4,600 rpm for 20 minutes); a 0.5 ml 
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aliquot of the culture was also taken in case larger cultures (for midi preps) were 
later required.  
 
Plasmid DNA was purified using a mini prep kit (Qiagen) according to the 
manufacturer’s protocol (QIAprep Spin Miniprep Kit using a microcentrifuge). Briefly, 
cells were resuspended in 250 µl of Buffer P1 (containing RNase A and Lyse Blue 
reagent) and lysed by addition of 250 µl Buffer P2 (inverted to mix; solution turns 
blue if Lyse Blue is included). The samples were neutralised by adding 350 µl Buffer 
N3 (mixed thoroughly until the solution becomes colourless), than cleared by 
centrifugation at 13,000 rpm for 10 minutes. The supernatant was transferred to a 
QIAprep spin column; this was centrifuged for 1 minute and the flow-through 
discarded (DNA remains bound to the membrane). The column was washed with 
750 µl Buffer PE, again the column was centrifuged for 1 minute and the flow 
through was discarded before centrifuging for a further 1 minute. Plasmid DNA was 
eluted into a clean eppendorf in 50 µl Buffer EB or Sigma water and the 
concentration was measured using a spectrophotometer. 
 
2.7.2 Preparation of RNA probes 
Purified plasmid DNA was linearised by restriction enzyme (restriction 
endonuclease) digestion. Where possible, small scale digests were initially used to 
verify the expected insert. In these cases a 20 µl reaction mixture was set up (0.2-
0.5 µg DNA, H2O, 2 µl 10x buffer, 1 µl BSA and 1 µl [10U] enzyme) and incubated 
at the required temperature for 1-2 hours. Half of the sample was then run on an 
agarose gel. For large scale digests the volume was scaled up to 200 µl (5-10 µg 
DNA, H2O, 20 µl 10x buffer, 10 µl BSA and ~5 µl [50U] enzyme) and the digest was 
incubated for 2-4 hours. 
 
 - 110 -  
After checking a sample of the linearised plasmid on a gel, the DNA was purified by 
phenol-chloroform extraction. An equal volume of phenol chloroform isoamyl alcohol 
(Sigma) was added to the digest, vortexed briefly and centrifuged for 2 minutes at 
13,000 rpm. The upper aqueous layer was transferred to a clean eppendorf tube 
and the DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 
5.2) and 3 times the volume of 100% ethanol and incubating at -80oC for 30-60 
minutes (or -20oC overnight). DNA was pelleted by centrifuging at 4oC for 15 
minutes (13,000 rpm), the supernatant was removed and the pellet was washed 
with 500 µl of 70% ethanol. The pellet was allowed to dry at RT for approximately 
10 minutes before being resuspended in 20 µl Sigma water.    
 
In general, mini preps yielded 0.2-1 µg/µl of plasmid DNA. Digoxygenin (DIG) 
labelled, single stranded RNA probes were transcribed in a 20 µl reaction 
containing: 1 µg linearised plasmid DNA, H2O, 2 µl DIG labelling mix (Roche), 2 µl 
10x transcription buffer (Roche), 0.5 µl RNAse inhibitor and 2 µl RNA polymerase. 
Reactions were incubated at 37oC for 2-4 hours and the efficiency of transcription 
was assessed by running 0.5 µl of the sample on a gel. Finally, the sample volume 
was increased by adding 40 µl of DEPC-water and probes were purified by passing 
through Chroma Spin-1000 DEPC-H2O columns (Clontech), according to the 
manufacturer’s instructions. Approximately 50 µl of clean probe was collected from 
the column, to which 40 µl formamide and 1 µl RNase inhibitor was added. Probes 
were stored at -20oC.  
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Probe name Vector Insert size 
RE and RNA 
polymerase for AS 
probe 
RE and RNA 
polymerase for S 
probe 
Source Reference 
Brachyury M13 1660 bp  SacII, T7 - R. Beddington (Wilkinson et al., 1990) 
Erbb3 pBlueScript - DR3 1400 bp EcoRI, T7 XhoI, T3 C. Birchmeier (Meyer and Birchmeier, 1995) 
FoxD3 pBlueScript 558 bp BamHI, T3 HindIII, T7 P. Labosky (Hanna et al., 2002) 
Grhl3 pGEM-T 494 bp SalI, T7 SP6, NcoI N. Greene (Gustavsson et al., 2007) 
Sox9 pBlueScript SK 500 bp EcoRI, T3 XbaI, T7 R. Lovell-Badge (Morais da et al., 1996) 
Vangl1 pGEM-T easy 324 bp PstI,  T7  Apa1, SP6 D. Henderson (Doudney et al., 2005) 
Vangl2 pGEM-T easy 554 bp ApaI, Sp6 PstI, T7 D. Henderson (Doudney et al., 2005) 
Wnt3a pGEM 3Zf 1250 bp ScaI, Sp6 BamHI, T7 A. McMahon (Takada et al., 1994) 
Wnt5a pGEM 7Zf 2500 bp XhoI, Sp6 - A. McMahon (Takada et al., 1994) 
 
Table 2.18 Probes used for whole mount in situ hybridisation 
All probes were directed against mouse transcripts. Abbreviations: RE = restriction enzyme, AS = antisense, S = sense. 
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2.7.3 In situ hybridisation 
All solutions used were DEPC-treated until after the hybridisation step. Washes 
were performed on ice on a rocking platform, unless otherwise stated.   
 
2.7.3.1 Tissue pre-treatment and hybridisation 
Embryos were taken from -20 oC storage and placed on ice. For those which had 
completed cranial neural tube closure, small holes were made in the hindbrain and 
ventral forebrain to prevent trapping of the probe. If direct comparison of gene 
expression between genotypes was required, stage-matched embryos were 
processed in the same tube. Embryos were then rehydrated in bijoux tubes in a 
series of methanol washes (75%, 50% and 25% methanol in PBT), washed twice in 
PBT and bleached for 1 hour in 6% hydrogen peroxide (30% stock solution, Sigma) 
in PBT to inactivate endogenous phosphatases and remove pigmentation. Embryos 
were then washed 3 times in PBT before being treated with 5 µg/ml proteinase K in 
PBT at RT to permeabilise the tissue. Treatment times depended on embryonic 
stage and were: 1 minute for E8.5 embryos, 2-5 minutes for E9.5 and 5-8 minutes 
for E10.5. The reaction was stopped by briefly washing in glycine (2 mg/ml in PBT), 
followed by a further wash in PBT and re-fixation in freshly prepared 0.2% v/v 
gluteraldehyde (25% stock) in 4% PFA for 20 minutes at RT.  
 
After fixation, embryos were washed twice in PBT and transferred to a tube 
containing 1 ml pre-hybridisation solution, pre-heated to 70oC (50% formamide, 1% 
sodium dodecyl sulphate [SDS], 5x SSC pH 4.5, 50 μg/ml yeast RNA and 50 μg/ml 
heparin in DEPC-H2O). When the embryos had sunk to the bottom of the tube, the 
pre-hybridisation solution was replaced and the embryos were incubated at 70oC for 
2-4 hours (HB-1000 Hybridiser oven; UVP). For hybridisation, 10 µl (approximately 
1 µg) of DIG-labelled probe was added and gently mixed by inverting the tube 
several times. Alternatively, recycled probe solution was used, in which case it was 
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pre-heated for 30 minutes and used to replace the pre-hybridisation solution after 
the 2-4 hour incubation period. Embryos were hybridised at 70oC overnight.  
 
2.7.3.2 Post-hybridisation and immunohistochemistry 
The following day any unbound probe, which had not hybridised to the target 
mRNA, was removed through a series of stringent washes. The hybridisation 
solution was carefully removed and kept at -20oC for further use, before being 
replaced with pre-heated ‘solution 1’ (50% formamide, 1% SDS and 5x SSC pH 4.5 
in DEPC-H2O). Embryos were then transferred back to bijoux tubes, washed twice 
in solution 1 at 70oC for 30 minutes each, followed by two 30-minute washes at 
65oC in ‘solution 2’ (50% formamide, 1% SDS and 2x SSC pH 4.5 in DEPC-H2O). 
Next, embryos were washed 3 times at room temperature for 10 minutes each in 
Tris-buffered saline containing 1% v/v Tween-20 (TBS-T) before being gently 
rocked at room temperature in TBST containing 10% heat-inactivated sheep serum 
(SS; Sigma) to block non-specific antibody binding sites. After 90 minutes, the 
blocking solution was replaced with alkaline phosphatase-conjugated sheep anti-
DIG Fab fragments (AP-anti-DIG, Roche), diluted 1:2000 in TBST containing 1% 
SS, and gently rocked at 4oC overnight. Binding of the AP-anti-DIG antibody to the 
DIG-labelled RNA probe therefore allowed detection and localisation of the bound 
probe.  
 
2.7.3.3 Post-antibody washes and developing 
To remove unbound antibody, embryos were washed 3 times in TBST for 5 minutes 
each, rocking at RT, followed by five 60-minute washes. They were then left 
washing in TBST at 4oC overnight. The following day embryos were washed three 
times for 10 minutes each in freshly-prepared NTMT solution (100 mM NaCl, 100 
mM Tris HCl pH 9.5, 50 mM MgCl2 and 1% Tween-20 in H2O). The in situ signal 
was then developed using a reaction for the colorimetric detection of alkaline 
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phosphatase activity. For this reaction embryos were incubated at room 
temperature, gently shaking and wrapped in aluminium foil to protect them from 
light, in a developing solution of NTMT containing 4.5 µl/ml nitro blue tetrazolium 
chloride (NBT, Roche) and 3.5 µl/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP, 
Roche). During this step, alkaline phosphatase catalyses the hydrolysis of BCIP, 
generating an intermediate compound which is oxidised by NBT to produce an 
insoluble, dark blue precipitate.  
 
Embryos were checked regularly for colour development and the developing 
solution was replaced when it began to turn pink. For probes which developed very 
rapidly, the developing solution was diluted to half-strength with NTMT. Conversely, 
if the staining had not developed sufficiently after one day, embryos were returned 
to TBST and incubated overnight at 4oC.  The following day they were re-washed in 
NTMT and transferred into fresh developing solution. When the signal had 
developed to the desired extent, the reaction was stopped by washing twice in PBT, 
followed by a further wash overnight at 4oC. Embryos were then re-fixed in 4% PFA 
and stored in the fridge in PBT for further processing.  
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2.8 Immunohistochemistry  
Primary and secondary antibodies and the concentrations used are listed in Table 
2.19 and Table 2.20, respectively. All primary antibodies were immuno-reactive 
against mouse tissue. 
 
2.8.1 Immunofluorescence on tissue sections 
Immunofluorescence was performed on 7 µm paraffin wax sections. Before 
beginning the protocol, one of the following two methods was used to de-wax and 
rehydrate the sections and to retrieve the antigen: 
  
1) Declere method: Slides were placed in cold Declere solution (Cell Marque; 20x 
stock diluted to 1x in Milli-Q H2O) in a plastic slide trough and steamed for 45 
minutes in a kitchen steamer. Five minutes before the end, a second trough 
containing fresh Declere was placed in the steamer to warm. Slides were then 
transferred to the fresh solution and allowed to cool to RT (approximately 2 hours). 
2) Citrate method: Wax was removed with Histo-Clear incubations (2 x 10 minutes) 
and sections were rehydrated in an ethanol series (100%, 75%, 50% and 25% 
ethanol followed by tap water; 2 minutes each). Antigen unmasking was then 
carried out by gently boiling the slides in citric acid buffer (2.1g per litre Milli-Q H2O, 
adjusted to pH6) in a microwave (3 mins. medium heat, allow to cool for 1 min., 3 
mins. medium, allow to cool for 1 min., 3 mins, high). Slides were left to cool to RT. 
 
For blocking and antibody incubations, 100-200 µl of solution was applied to the 
surface of the slide and overlaid with a piece of parafilm. All incubations were 
carried out in a humid chamber (containing tissue soaked in Milli-Q H2O); this was 
covered in foil during secondary antibody incubations to prevent photobleaching. 
Washing steps were performed in a plastic slide trough (approximately 200 ml 
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volume), gently rocking at RT for 10 minutes; this was also foil-covered following the 
secondary antibody incubation. A negative control slide (no primary antibody) was 
included for each experiment. Protocols varied slightly for individual antibodies and 
the steps were as follows: 
   
1) Anti-GFP/YFP: 3 washes in TBST (TBS with 1% Triton), RT for 90 minutes in 
blocking solution (2 mg/ml BSA, 0.15% glycine and 5% heat inactivated sheep 
serum in TBST), primary antibody at 4oC overnight, 3 washes in TBST, secondary 
antibody (fluorescein-labelled goat anti-chicken IgY) at RT for 1 hour. 
2) Anti-PH-H3: 3 washes in TBST, RT for 90 minutes in blocking solution (2 mg/ml 
BSA, 0.15% glycine and 5% heat inactivated sheep serum in TBST), primary 
antibody at 4oC overnight, 3 washes in TBST, secondary antibody (goat anti-rabbit 
IgG Alexa-488) at RT for 1 hour. 
3) Anti-Casp3: 3 washes in TBST, RT for 90 minutes in blocking solution (5% heat 
inactivated sheep serum in TBST), primary antibody at 4oC overnight, 3 washes in 
TBST, secondary antibody (biotinylated goat anti-rabbit) at RT for 1 hour, 3 washes 
in TBST, streptavidin (green; 1;250; Invitrogen) at RT for 90 minutes.  
4) Anti-Ki67: 3 washes in TBST, RT for 90 minutes in blocking solution (5% heat 
inactivated sheep serum in TBST), primary antibody at 4oC overnight, 3 washes in 
TBST, secondary antibody (biotinylated goat anti-rabbit) at RT for 1 hour, 3 washes 
in TBST, streptavidin at RT for 90 minutes. 
 
Finally, slides were washed 3 times in TBST, incubated with DAPI solution 
(1:10,000 in PBS) at RT for 5 minutes to stain the nuclei, washed 3 times in TBST 
and mounted with Mowiol. 
 - 117 -  
 
Target 
Species 
raised in 
Dilution and method Supplier 
Cleaved-caspase 3 
(Casp3) 
Rabbit 
(polyclonal) 
1:250 (wax sections, 
citrate method) 
Cell signalling 
technology 
GFP/YFP 
Chicken 
(polyclonal) 
1:100 (wax sections, 
citrate method) 
1:250 (explant cultures) 
Abcam 
Ki67 
Rabbit 
(polyclonal) 
1: 250 (wax sections, 
Declere method) 
Nova-Castra 
Phospho-Histone H3 
(PH-H3) 
Rabbit 
(polyclonal) 
1:250 (wax sections, 
Declere method) 
Miilipore 
P75 
Rabbit 
(polyclonal) 
1:200 (explant cultures) Santa Cruz 
 
Table 2.19 Primary antibodies used for immunofluorescence 
 
 
Target 
Species 
raised in 
Conjugate Dilution Suppier 
Rabbit IgG Goat Alexa-488 (green) 1:400 Invitrogen 
Rabbit IgG Goat Alexa-568 (red) 1:400 Invitrogen 
Chicken IgG Goat Alexa-488 (green) 1:400 Invitrogen 
Rabbit IgG Goat Biotin 1:300 Invitrogen 
Chicken IgY Goat Fluorescein 1:200 Aves Lab inc. 
 
Table 2.20 Secondary antibodies used for immunofluorescence 
 
 - 118 -  
2.8.2 Immunofluorescence on neural tube explant cultures 
Immunocytochemistry was performed on Wnt1-Cre/YFP neural crest cell cultures 
(see Section 2.4 and Chapter 7) after culturing explants for 24 hours. The culture 
medium was carefully removed from the wells of the tissue culture plate and 
migratory cells were fixed in 4% PFA at RT for 10 minutes. Cells were washed twice 
with PBS, gently rocking at RT for 10 minutes, and blocked at RT for 1 hour (1% 
BSA, 0.15% glycine and 10 % goat serum in PBS).  
 
Primary antibody incubation was carried out (anti-P75 at 4oC overnight followed 
by/or anti-GFP/YFP at RT for 2.5 hours), followed by two further PBS washes. 
Secondary antibody incubations were at RT for 1 hour and were performed 
simultaneously where relevant (mixture of goat anti-rabbit IgG Alexa-568 and goat 
anti-chicken IgG Alexa-488). After final PBS washes, cover-glasses were removed 
from the wells using forceps, turned upside down and mounted with Vectashield 
mounting medium with DAPI (Vector Labs). 
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2.9  RhoA activation assay 
To measure the level of activated (GTP-bound) RhoA in the embryonic caudal 
region (see Chapter 5), the G-LISA RhoA Activation Assay Biochem Kit was used 
(Absorbance Based; Cytoskeleton Inc.). This assay consists of individual wells, to 
which a Rho-GTP binding protein is linked. GTP-bound Rho in a cell/tissue lysate 
binds to the well during an incubation step and can then be detected with an 
antibody against RhoA, while inactive (GDP-bound) Rho is removed during washes. 
Compared to traditional pull-down methods, the assay is quicker, requires less 
cellular material (10-50 µg protein rather than 1-2 mg) and allows more samples to 
be processed simultaneously. 
 
2.9.1 Sample preparation 
Assay components and other required reagents were prepared prior to beginning 
the experiment, according to the manufacturer’s instructions. Tissue samples were 
E9.5 embryonic caudal regions that had been immediately snap-frozen on dry ice 
after dissection and stored at -80oC (see Section 2.6). Throughout the protocol, 
tissue samples and lysates were processed rapidly on ice to prevent the hydrolysis 
of GTP, which results in Rho inactivation. 
 
Frozen tissue samples were homogenised by sonication (High Intensity Ultrasonic 
Processor, Sonics and Materials Inc) in lysis buffer containing a cocktail of protease 
inhibitors. Samples were removed from -80oC storage and placed on dry ice. 
Immediately prior to sonication they were thawed in a RT water bath for a few 
seconds and placed on ice. Sonication was also performed on ice; four PNP 
samples for each genotype were combined into one of the sample eppendorf tubes 
(in a total volume of 100 µl lysis buffer). A 20 µl aliquot was retained for protein 
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quantification and the remaining lysate was snap frozen in liquid nitrogen before 
being returned to -80oC storage. 
 
2.9.2 Protein quantification 
Protein concentration was measured using a spectrophotometer (UVmini-1240, 
Shimadzu) and Precision RedTM Advanced Protein Assay Reagent. Samples were 
prepared by transferring 20 µl of lysate and 1 ml of Precision Red to disposable 
cuvettes and incubating at RT for 1 minute. A blank (lysis buffer and Precision Red) 
was also prepared. The absorbance of the blank and sample cuvettes was 
measured at a wavelength of 600 nm, and was then multiplied by five to obtain the 
protein concentration (mg/ml). Samples generally contained 0.7-0.9 mg/ml protein, 
with a concentration of 0.5-2 mg/ml required for the assay. The lysis buffer dilutions 
required to equalise the sample protein concentrations were then calculated, in 
preparation for the G-LISA assay.  
 
2.9.3 G-LISA assay protocol 
The assay was performed according to the instructions provided. For clarity the 
manufacturer’s protocol (as found at www.cytoskeleton.com/bk124) is provided 
below, with some notes omitted. Each sample was processed in duplicate. 
 
1. Aliquot 60 μl of Lysis Buffer into a labeled microfuge tube and dilute with 60 μl of ice cold 
Binding Buffer. Vortex for 3-5 s on high and place on ice. This is your buffer blank sample. It 
is normal for the buffer blank to have a raw reading between 0.1 – 0.4.  
2. Aliquot 12 μl of Rho Control Protein into a labeled microfuge tube and dilute with 48 μl of 
Cell Lysis Buffer and 60 μl of Binding Buffer. Vortex for 3-5 s on high and place on ice. This 
is your positive control sample. 
3. Take the Rho plate out of its bag. Gently peel up the seal from the strips and pull out the 
number of strips required. Place strips in the extra strip holder provided, and place on ice. 
Immediately after removing the assay strips, put the rest of the plate back in the pouch with 
desiccant, seal well and place back in storage.  
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4. Dissolve the powder in the wells with 100 μl ice cold water, keeping the plate on ice.  
5. Thaw the snap frozen cell lysates in a ROOM TEMPERATURE water bath. Immediately 
place on ice after they are thawed.  
6. Based on the calculation of equalization, add required amount of Lysis Buffer to 
respective tubes to equalize all lysate concentration.  
7. Immediately aliquot sufficient lysate for duplicate (60 μl) or triplicate (90 μl) assays into 
fresh ice cold microcentrifuge tubes.  
8. Add an equal volume of ice-cold Binding Buffer to each tube. Vortex each tube for 3-5 s 
on a high setting and return tubes to ice. Keep on ice.  
9. Completely remove the water from the microplate wells by patting on a paper towel  
10. Put plate back on ice.  
11. Immediately add 50 μl of equalized cell lysate to duplicate or triplicate wells.  
12. Pipette 50 μl of buffer blank control into duplicate wells.  
13. Pipette 50 μl of RhoA positive control into duplicate wells.  
14. Immediately place the plate on a cold orbital microplate shaker (400 rpm recommended, 
200 rpm minimum) at 4°C for exactly 30 min.  
15. During the incubation, dilute the anti-RhoA primary antibody to 1/250 in Antibody Dilution 
Buffer by adding 2 μl of antibody to every 500 μl Antibody Dilution Buffer.  
16. After 30 min, flick out the solution from the wells and wash twice with 200 μl Wash Buffer 
at room temperature using a multi-channel pipettor. Do not leave this plate unattended at 
this time. Vigorously remove the Wash Buffer after each wash by flicking and patting the 
plate as detailed in step 9.  
17. Place plate on the bench.  
18. Immediately pipette 200 μl of room temperature Antigen Presenting Buffer into each well 
using a multi-channel pipettor and incubate at room temperature for exactly 2 min.  
19. Vigorously flick out the Antigen Presenting Buffer, patting the inverted plate 5-7 times on 
a stack of paper towels as outlined in step 9.  
20. Immediately wash the wells three times with 200 μl of room temperature Wash Buffer. 
Vigorously remove Wash Buffer after each wash as detailed in step 9.  
21. Add 50 μl of diluted anti-RhoA primary antibody to each well and leave the plate on the 
orbital microplate shaker (200-400 rpm) at room temperature for 45 min.  
22. During the primary antibody incubation, dilute the secondary HRP labeled antibody to 
1/62.5 by adding 8 μl of antibody to every 500 μl Antibody Dilution Buffer. 
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23. Vigorously flick out the anti-RhoA primary antibody, patting the inverted plate 5-7 times 
on a paper towel as outlined in step 9.  
24. Immediately wash the wells three times with 200 μl of room temperature Wash Buffer. 
Vigorously remove Wash Buffer after each wash as detailed in step 9.  
25. Add 50 μl of diluted Secondary antibody to each well and leave the plate on a microplate 
shaker (200–400 rpm) at room temperature for 45 min.  
26. During the secondary antibody incubation thaw HRP detection reagents A and B in a 
room temperature water bath and remove as soon as they are thawed. Components A and 
B should be mixed in equal volumes immediately prior to use. Unused mixed solution should 
be discarded.  
27. Immediately prior to the end of the secondary antibody incubation, mix HRP detection 
reagents A and B in equal volumes.  
28. Vigorously flick out the secondary antibody, patting the inverted plate 5-7 times on a 
paper towel as outlined in step 9.  
29. Wash the wells three times with 200 μl of Wash Buffer, patting the inverted plate 5-7 
times on a paper towel as outlined in step 9.  
30. Pipette 50 μl of the mixed HRP detection reagent into each well and incubate at 37°C for 
10-15 min.  
31. Add 50 μl of HRP Stop Buffer. Check that the wells are free of bubbles.  
 
2.9.4 Analysis 
The colorimetric signal for each well was read by measuring the absorbance (490 
nm wavelength) using a microplate spectrophotometer. The mean value (minus the 
negative control value) was then calculated for each genotype sample and the 
positive control (see Chapter 5).  
 
2.10 Image processing and statistics 
Photographic images were analysed in Image J (version 1.47k) where relevant. 
Figures were compiled in Photoshop (CS3) and Inkscape (version 0.48). Statistical 
analyses were performed in SigmaStat (version 3.5). 
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3. Severe spina bifida in the    
.Vangl2
Lp/+
;Grhl3
ct/ct
 mouse model 
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3.1 Introduction 
3.1.1 NTDs caused by genetic interactions between Vangl2 
and other genes 
As described in Chapter 1, homozygous Vangl2Lp/Lp embryos fail to initiate neural 
tube closure at E8.5, leading to the appearance of the severe NTD, 
craniorachischisis (Greene et al., 1998; Kibar et al., 2001b; Murdoch et al., 2001a).   
Additionally, several genetic studies have demonstrated that the Vangl2Lp allele 
interacts with mutations in a number of other genes to cause NTDs in mice. Such 
interactions have been reported in mice with digenic and oligogenic mutant 
combinations, and are listed in Table 3.1. An interesting pattern emerging from 
these studies is that, while craniorachischisis is the predominant NTD phenotype 
produced by combinations of core PCP gene mutations (for example in 
Vangl2Lp/+;Vangl1gt/+, Vangl2Lp/+;Celsr1Crsh/+ and Vangl2Lp/+;Wnt5a-/-), it is not the only 
NTD that mutations in PCP genes can cause. The heterozygous Vangl2Lp/+ 
genotype also increases susceptibility to failure of neurulation at other axial levels 
when inherited with mutations in other, often non-PCP, genes.  
 
Vangl2Lp interacts genetically with mutations in the transcription factor Grhl3 (Caddy 
et al., 2010; Stiefel et al., 2003; Stiefel et al., 2007), the cargo-binding protein 
Sec24b (Merte et al., 2010) and the PCP-regulator Ptk7 (Lu et al., 2004; Paudyal et 
al., 2010) to produce spina bifida. Vangl2Lp also promotes exencephaly, for example 
in combination with mutations in the Wnt co-factor Cthrc1 (Yamamoto et al., 2008) 
and the actin nucleator Cordon-bleu (Carroll et al., 2003). It is not well understood 
why a combination of Vangl2Lp with mutant alleles of other genes can produce such 
variable phenotypes. 
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Mutant genotype 
Mouse 
chromosome 
NTD Phenotype 
(penetrance) 
Other phenotypes reported References 
Vangl2
Lp/+
;Vangl1
gt/+
 1, 3 CRN (63%) 
Tail flexion defects, inner ear defects, 
heart defects 
(Torban et al., 2008) 
Vangl2
Lp/+
;Celsr1
Crsh/+
 1, 15 
CRN (54-100%, 
depending on 
background) 
Some gastroschisis/omphalocele 
Dr Jennifer Murdoch,  
(unpublished data) 
Vangl2
Lp/+
;Dvl2
-/-
 1, 4 CRN (100%) 
Inner ear defects, heart defects, tail 
flexion defects 
(Wang et al., 2006a) 
Vangl2
Lp/+
;Dvl3
-/-
 
Vangl2
Lp/+
;Dvl3
+/-
 
1, 16 
CRN (38%) 
CRN (23%), EX (9%) 
Heart defects, inner ear defects 
Inner ear defects 
(Etheridge et al., 2008) 
Vangl2
Lp/+
;Scrib
Crc/+
 1, 15 CRN (54%), SB (4%) Tail flexion defects, heart defects 
(Murdoch et al., 2001b) 
(Phillips et al., 2007) 
Vangl2
Lp/+
;Wnt5a
-/-
 1, 14 CRN (100%) 
Inner ear defects, eyelid closure 
defects 
(Qian et al., 2007) 
Vangl2
Lp/+
;Ptk7
gt/+ 
Vangl2
Lp/+
;Ptk7
chz/+
 
1, 17 
SB (94%) 
CRN (6%), SB (23%) 
None described 
None described 
(Lu et al., 2004) 
(Paudyal et al., 2010) 
Vangl2
Lp/+
;Sfrp1
-/-
;Sfrp2
+/-
;Sfrp5
-/- 
Vangl2
Lp/+
;Sfrp1
-/-
;Sfrp2
-/-
;Sfrp5
+/- 
1, 8, 3, 19 
SB (62%) 
CRN (% not reported) 
None described 
None described 
(Satoh et al., 2008) 
Vangl2
Lp/+
;Fzd1
+/- 
Vangl2
Lp/+
;Fzd2
+/- 
Vangl2
Lp/+
;Fzd2
-/- 
Vangl2
Lp/+
;Fzd1
+/-
;Fzd2
+/- 
1, 5 
1, 11 
1, 11 
1, 5, 11 
SB (4%), EX (44%) 
SB (29%), EX (25%) 
SB (100%), EX (33%) 
EX (43%) 
 
Heart defects 
Inner ear defects 
(Yu et al., 2010) 
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Vangl2
Lp/+
;Ror2
-/-
 1, 13 SB and EX (‘>50%’) Inner ear defects (Gao et al., 2011) 
Vangl2
Lp/+
;Sec24b
Y613/+
 1, 3 SB (68%) None described (Merte et al., 2010) 
Vangl2
Lp/+
;Grhl3
+/-
 1, 4 SB (67%) 
Inner ear defects, defective wound 
repair 
(Caddy et al., 2010) 
Vangl2
Lp/+
;Grhl3
ct/ct
 1, 4 SB (86%) Tail flexion defects 
(Stiefel et al., 2003; Stiefel 
et al., 2007), W.Damith 
Jayatilake, unpublished. 
Vangl2
Lp/+
;Zic2
ku/+
 1, 14 SB (59%) None described 
Valentina Massa, 
unpublished. 
Vangl2
Lp/+
;Cthrc1
LacZ/LacZ
 1, 15 EX (100%) Inner ear defects (Yamamoto et al., 2008) 
Vangl2
Lp/+
;Cobl
C101/C101
 1, 2 EX (20%) None described (Carroll et al., 2003) 
 
Table 3.1 Vangl2 genetic interactions causing NTDs in mouse mutants 
CRN = craniorachischisis, EX = exencephaly, SB = spina bifida 
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3.1.2 PCP and spinal neurulation post-closure 1 
The modifying effect of Vangl2Lp towards later neurulation events raises questions 
about the role of PCP signalling during low spinal neural tube closure. In particular it 
is unclear whether the reported genetic interactions represent defects of 
convergence and extension, as has been described for closure 1. If so, this would 
implicate CE cell movements as an essential feature of low spinal neurulation in 
addition to their recognised role during post-gastrulation shaping.  
 
Heterozygous Vangl2Lp/+ mice never display craniorachischisis under normal 
developmental conditions. However PNP closure is delayed in Vangl2Lp/+ embryos 
compared with their wild type littermates, which is likely to be responsible for the 
rare spina bifida and the frequent tail flexion defects seen in heterozygotes (Copp et 
al., 1994). Furthermore, embryos which are homozygous for the more recently 
identified hypomorphic Vangl2Lpm2Jus mutation also display spinal phenotypes; 12% 
develop spina bifida and 47% have tail defects (Guyot et al., 2011). It is currently 
unknown whether the spinal defects in Vangl2Lp/+ and Vangl2Lpm2Jus/Lpm2Jus embryos 
result from a CE defect.  
 
3.1.3 Vangl2Lp interacts with Grhl3ct to cause severe spina 
bifida 
To investigate potential genetic interactions between Vangl2 and Grhl3, mice doubly 
mutant for the loop-tail and curly tail alleles were previously bred in our laboratory. 
The Vangl2Lp/+;Grhl3ct/ct genotype was found to be highly predisposing to spina 
bifida (86% penetrance), whereas on the same genetic background only 7% of 
Vangl2+/+;Grhl3ct/ct mice displayed this phenotype (W.Damith Jayatilake, 1997; 
unpublished data). The spina bifida in Vangl2Lp/+;Grhl3ct/ct embryos was also more 
severe than in Vangl2+/+;Grhl3ct/ct, with the rostral limit of the open region extending 
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further up the body, often as far as the level of the hindlimb buds at E11.5. Thus, 
these data identified the loop-tail mutation as a genetic modifier which increases the 
frequency and severity of the partially penetrant spina bifida observed in 
homozygous curly tail embryos. Notably the defect manifests as failure of PNP 
closure, while craniorachischisis is never seen. Since these findings, 
Vangl2Lp/+;Grhl3ct/ct  fetuses have been used to study pathological features of 
myelomeningocele, such as spinal  cord tethering and in utero neurodegeneration 
(Stiefel et al., 2003; Stiefel et al., 2007), but the developmental mechanisms 
underlying spina bifida in this model are not understood. 
 
The Vangl2Lp/+;Grhl3ct/ct mutant provides a model to examine the role of the PCP 
pathway during low spinal neural tube closure. Is the genetic predisposing effect of 
PCP mutations towards failure of spinal neurulation mediated via CE, as during 
closure 1, or does it reflect other functions for PCP genes? This mouse model also 
raises the question of how Vangl2 and Grhl3, two key genes which when mutated 
cause distinct NTD phenotypes with different underlying mechanisms, interact 
during neurulation? 
 
This chapter begins to elucidate the developmental mechanism(s) underlying the 
loop-tail/curly tail interaction. The phenotypes of embryos with different 
combinations of Vangl2 and Grhl3 mutant alleles are assessed and the following 
initial hypotheses are considered: (1) Vangl2Lp heterozygosity increases the 
frequency of spina bifida in Grhl3ct/ct embryos by a mechanism involving diminution 
of convergent extension; (2) Vangl2Lp heterozygosity increases the frequency of 
spina bifida in Grhl3ct/ct embryos via a non-PCP mechanism, involving exacerbation 
of the known curly tail mutant phenotype; (3) Vangl2Lp heterozygosity affects other 
events of spinal neurulation, thereby summating with the curly tail mutant pathway 
to increase the tendency towards spina bifida. 
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3.2 Results 
3.2.1 Spina bifida in Vangl2Lp/+;Grhl3ct/ct embryos 
Given that the previous data on the loop-tail/curly tail interaction was collected over 
15 years ago, the breeding was repeated to assess the Vangl2Lp/+;Grhl3ct/ct 
phenotype using our current mouse colonies. To generate experimental litters for 
analysis, Vangl2Lp/+;Grhl3ct/+ male mice were bred with Grhl3ct/ct females, producing 
offspring with the following four genotypes: Vangl2+/+;Grhl3ct/+, Vangl2+/+;Grhl3ct/ct, 
Vangl2Lp/+;Grhl3ct/+ and Vangl2Lp/+;Grhl3ct/ct (Figure 3.1). Embryos were collected 
between E11 and E12.5 and genotypes were obtained in the expected Mendelian 
ratios (Table 3.2).  
 
                                  X                                       
                                    
                     
 
 
 
 
Figure 3.1 Breeding scheme for the generation of experimental litters 
Matings between Vangl2
Lp/+
;Grhl3
ct/ct
 and Grhl3
ct/ct
 mice produce embryos with one of four 
possible genotypes. Numbers in brackets indicate the expected proportion of offspring for 
each genotype. 
Vangl2Lp/+ Grhl3ct/ct 
Vangl2Lp/+; Grhl3ct/+  (1/2) Grhl3
ct/ct 
 X 
Vangl2+/+;Grhl3ct/+  (1/4) 
Vangl2+/+;Grhl3ct/ct  (1/4) 
Vangl2Lp/+;Grhl3ct/+  (1/4) 
Vangl2Lp/+;Grhl3ct/ct  (1/4) 
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Genotype 
Expected Observed 
% Freq. % Freq. 
Vangl2
+/+
;Grhl3
ct/+  
 25.00 21/85 30.59 26/85 
Vangl2
+/+
;Grhl3
ct/ct  
 25.00 21/85 22.35 19/85 
Vangl2
Lp/+
;Grhl3
ct/+  
 25.00 21/85 20.00 17/85 
Vangl2
Lp/+
;Grhl3
ct/ct  
 25.00 21/85 27.06 23/85 
Deviation from 
Mendelian ratios: 
χ
2
=1.138 with 3 degrees of freedom (p = 0.768) 
 
Table 3.2 Genotype frequencies of offspring from Vangl2
Lp/+
;Grhl3
ct/+
 X Grhl3
ct/ct 
matings. 
Embryos were collected at E11-E12.5 and genotypes were obtained in the expected 
Mendelian ratios (p = 0.768, Chi-square test). 
 
Embryos were examined for NTDs at E11-E12.5, by which time spina bifida can be 
clearly identified, and as expected various spinal phenotypes were observed within 
litters. Embryos which had successfully completed neural tube closure were 
categorised according to the appearance of their tail; a straight tail was indicative of 
normal spinal development (Figure 3.2A) while a tail flexion defect (‘curly tail’) was 
suggestive of delayed neurulation (Figure 3.2B). Embryos which had failed to 
achieve PNP closure and had an open spina bifida were grouped according to the 
axial severity of the lesion. Somites 26 to 31 correspond to the future lumbar region, 
so an opening extending as far rostrally as the 31st somite pair or higher was 
defined as a ‘large spina bifida’ (lumbo-sacral; Figure 3.2D). An opening from the 
32nd somite pair or lower was defined as ‘small’ (sacral; Figure 3.2C). Somite 32 
marks the upper extremity of the future sacral region (somites 32-35). All embryos 
with spina bifida also displayed tail flexion defects.  
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Figure 3.2 Spectrum of spinal phenotypes observed in E11-12.5 litters from 
Vangl2
Lp/+
;Grhl3
ct/+
 X Grhl3
ct/ct
 matings 
(A) Phenotypically normal embryo with a straight tail. (B) Embryo which has completed 
primary neurulation but has a curly tail, most likely due to delayed PNP closure. (C, D) 
Appearance of the spina bifida at E11-E12.5. Arrows indicate the rostral limit of the open 
region. Higher magnification images are shown in the lower panels. Small and large spina 
bifidas correspond to sacral and lumbo-sacral lesions in humans, respectively. Scale bars: 
500 µm. 
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All of the Vangl2+/+;Grhl3ct/+ embryos collected had closed neural tubes, the majority 
in combination with a normal, straight tail and a small proportion (1/26 embryos) 
with a curly tail. Vangl2+/+;Grhl3ct/ct embryos displayed partially penetrant defects, 
manifesting as tail defects in approximately 30% of embryos and small spina bifida 
in 5%. The Vangl2Lp allele was associated with spinal defects in all cases, with no 
phenotypically normal Vangl2Lp/+;Grhl3ct/+ or Vangl2Lp/+;Grhl3ct/ct embryos recorded. 
Compound heterozygous Vangl2Lp/+;Grhl3ct/+ embryos exhibited 59% tail defects and 
41% spina bifida, while in Vangl2Lp/+;Grhl3ct/ct the penetrance of spina bifida was 
increased to 74%, with the remaining 26% of embryos displaying a curled tail (Table 
3.3; Figure 3.3). The difference in NTD frequency between the four genotypes was 
statistically significant (p < 0.001, Chi-square test). 
 
In summary, a shift in the severity of the spinal phenotype was observed in the 
presence of more mutant alleles, particularly the Lp mutation. All Vangl2Lp/+;Grhl3ct/ct 
embryos displayed defective spinal neurulation, with an incidence of 74% spina 
bifida compared to 5% in their Vangl2+/+;Grhl3ct/ct littermates. These data are similar 
to the frequencies of 86% vs 7% which were previously observed (W.Damith 
Jayatilake, 1997; unpublished data). Conversely, Vangl2Lp did not appear to 
exacerbate cranial NTDs in curly tail embryos; 5% exencephaly (1/19 embryos) was 
observed in Vangl2+/+;Grhl3ct/ct and no exencephalic Vangl2Lp/+;Grhl3ct/ct embryos 
were recorded (Table 3.3). 
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Genotype  
Caudal phenotype 
Straight tail 
% (freq.) 
Tail flexion 
defects         
% (freq.) 
Spina bifida 
% (freq.) 
Exencephaly 
% (freq.) 
Vangl2
+/+
;Grhl3
ct/+  
 96.15 (25/26) 3.85 (1/26) 0 (0/26) 0 (0/26) 
Vangl2
+/+
;Grhl3
ct/ct  
 63.16 (12/19) 31.58 (6/19) 5.26 (1/19) 5.26 (1/19) 
Vangl2
Lp/+
;Grhl3
ct/+  
 0 (0/17) 58.82 (10/17) 41.18 (7/17) 0 (0/17) 
Vangl2
Lp/+
;Grhl3
ct/ct  
 0 (0/23) 26.09 (6/23) 73.91 (17/23) 0 (0/23) 
 
Table 3.3 NTD phenotypes observed in E11-E12.5 embryos from Vangl2
Lp/+
;Grhl3
ct/+
 X 
Grhl3
ct/ct
 matings 
The percentage and frequency of each phenotype is shown. The proportion of embryos with 
tail defects and spina bifida varies significantly between genotypes (Chi-square test; 
χ
2
=75.003 with 6 degrees of freedom; p < 0.001). 
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Figure 3.3 Spinal NTD frequency at E11-E12.5 
Graph illustrating an association between the number of mutant alleles and the frequency 
and severity of spinal NTDs. Vangl2
Lp/+
;Grhl3
ct/ct 
 is the most severely affected genotype, with 
a frequency of 74% spina bifida. Among these embryos, approximately half of the spina 
bifida cases observed are classified as ‘large’ (right-hand column).  
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Figure 3.4 Sections through the spina bifida in Vangl2
Lp/+
;Grhl3
ct/ct
 
Transverse, H and E-stained sections through a Vangl2
+/+
;Grhl3
ct/ct
 embryo with a closed 
neural tube (A-D; rostral to caudal) and a Vangl2
Lp/+
;Grhl3
ct/ct
 embryo with a large spina 
bifida (E-H). Failure of PNP closure leads to widely splayed open neural folds in the double 
mutant (F, G). Panels D and H show a closed neural tube in embryos of both genotypes at 
the level of secondary neurulation. The slight opening in H is a histology artefact.  
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Sections through the caudal region of a phenotypically normal Vangl2+/+;Grhl3ct/ct 
embryo and a Vangl2Lp/+;Grhl3ct/ct with spina bifida are shown in Figure 3.4. In the 
lower trunk the neural tube of both embryos is closed, although the 
Vangl2Lp/+;Grhl3ct/ct neuroepithelium appears dysmorphic (Figure 3.4A, E). Further 
caudally, the widely open neural folds can be seen in the double mutant (Figure 
3.4F, G). In the tail, secondary neurulation appears to be ongoing in the 
Vangl2Lp/+;Grhl3ct/ct embryo, despite the failure of primary neurulation; indeed a 
lumen can be seen and the neural tube appears to be covered by surface ectoderm, 
as in the control (Figure 3.4D, H). 
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Figure 3.5 PNP length of embryos at the 29-33 somite stage  
Each individual embryo is represented by a single data point, with the mean ± SEM shown 
to the right of each group. A measurement of 0 indicates that PNP had completely closed. 
The mean PNP length varies significantly between genotypes (p < 0.001, Kruskal-Wallis 1-
Way ANOVA on Ranks). 
Vangl2+/+;Grhl3ct/+ 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3ct/+ 
Vangl2Lp/+;Grhl3ct/ct 
 
 - 136 -  
To confirm that the observed defects were due to the failure of primary neurulation 
and not, for example, a re-opening event, litters were also collected at E10-E10.5 
for examination of the PNP. An enlarged PNP is associated with the progression of 
spina bifida (Copp, 1985) so it was predicted that the Vangl2Lp/+;Grhl3ct/ct genotype 
would exhibit such a delay in neurulation. At the 29-33 somite stage, the difference 
in mean PNP length between genotypes was evident (Figure 3.5; see examples in 
Figure 3.7). PNP length in the Vangl2Lp/+;Grhl3ct/ct genotype was significantly 
increased compared to Vangl2+/+;Grhl3ct/ct and Vangl2+/+;Grhl3ct/+, and was larger 
than in Vangl2Lp/+;Grhl3ct/+, although this latter comparison did not reach statistical 
significance. Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/+ embryos had significantly 
larger PNPs than Vangl2+/+;Grhl3ct/+ embryos, many of which had completed PNP 
closure by this stage. In contrast, none of the Vangl2Lp/+;Grhl3ct/ct embryos had 
achieved closure.  
 
In general, a wide range of values was observed within each genotype group 
(Figure 3.5), consistent with the partial penetrance of the NTDs in older embryos 
(Figure 3.3). Embryonic crown-rump length and somite number did not differ 
between genotypes, indicating that the difference in PNP size does not simply 
reflect changes in overall growth or developmental stage (Figure 3.6). 
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Figure 3.6 Embryonic crown-rump length and somite number 
(A) Crown-rump length (CRL) for embryos with 29-33 somites. (B) Number of somite pairs 
for embryo data in Figure 3.5. Individual embryos for each genotype are shown as before. 
Error bars represent the mean ± SEM. CRL and somite number do not vary significantly with 
genotype (p = 0.35 and p = 0.163, respectively, 1-Way ANOVA). 
Vangl2
+/+
;Grhl3
ct/+ 
Vangl2
+/+
;Grhl3
ct/ct
 
Vangl2
Lp/+
;Grhl3
ct/+
 
Vangl2
Lp/+
;Grhl3
ct/ct
 
 
A 
B 
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Figure 3.7 Examples of the different PNP sizes at E9.5 
(A, A’) Embryo with a small PNP. (B, B’) Stage-matched embryo with a large PNP, which 
extends as far rostrally as the somite rows. This delay in closure is associated with the 
appearance of spina bifida and/or tail flexion defects. Arrows indicate the open region. Scale 
bars: 500 µm.   
 
3.2.2 DLHP formation in Vangl2Lp/+;Grhl3ct/ct embryos  
Bending of the neuroepithelium at DLHPs is a key feature of neurulation at low 
spinal levels. Failure of DLHP formation, for example in the Zic2 loss-of-function 
mouse mutant, Kumba (Zic2ku/ku), is incompatible with the caudal progression of 
neural tube closure, resulting in severe spina bifida (Ybot-Gonzalez et al., 2007a). 
Therefore, a detrimental effect of Vangl2Lp on events that regulate dorsolateral 
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bending, but are not primarily abnormal in curly tail (Grhl3ct/ct) embryos, could 
mediate its exacerbation of spina bifida in the double mutants. 
 
However, histological analysis of embryos at E9, shortly after the stage when 
DLHPs first appear (Shum and Copp, 1996) revealed apparently normal 
dorsolateral bending in Vangl2Lp/+;Grhl3ct/ct mutants (Figure 3.8). Neural plate 
morphology was characteristic of mode 2 of spinal neurulation in both 
Vangl2Lp/+;Grhl3ct/ct and Vangl2+/+;Grhl3ct/ct controls. At the level of PNP closure the 
tips of the folds were apposed at the midline, while more caudal sections showed 
comparable DLHPs and neural fold elevation at the PNP. Thus, the loop-tail 
mutation does not appear to have a deleterious effect on DLHP formation. 
 
 
Figure 3.8 DLHPs form normally in Vangl2
Lp/+
;Grhl3
ct/ct
 embryos at E9 
Transverse sections through the caudal region of a control Vangl2
+/+
;Grhl3
ct/ct
 embryo (upper 
panels) and a Vangl2
Lp/+
;Grhl3
ct/ct
 embryo (lower panels). DLHPs appear to form normally in 
the double mutant. N = minimum of 3 embryos per genotype. Arrows indicate DLHPs and 
brackets indicate the width of the floor plate and notochord (see Section 3.2.4). 
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3.2.3 Spina bifida in Vangl2Lp/+;Grhl3ct/ct is not due to an 
exacerbation of the curly tail defect 
Affected curly tail embryos exhibit an abnormally low rate of cell proliferation in the 
hindgut endoderm and notochord at E9.5. This imbalance between the growth of 
ventral and dorsal tissues precedes the increase in ventral curvature of the caudal 
region, and the resulting mechanical opposition of neural fold closure, that leads to 
spina bifida and tail flexion defects (Brook et al., 1991; Copp et al., 1988a). We 
therefore considered the possibility that the Lp mutation causes an additional 
increase in ventral curvature, perhaps by exerting a similar cell-type-specific effect 
on proliferation. 
 
Interestingly however, the Vangl2Lp allele was associated with a reduction in the 
angle of axial curvature (Figure 3.9, Figure 3.10). At each developmental stage 
analysed (14-19 somites, 20-25 somites and 26-31 somites), Vangl2Lp/+;Grhl3ct/+ and 
Vangl2Lp/+;Grhl3ct/ct   embryos displayed significantly less ventral curvature than their 
Vangl2+/+;Grhl3ct/+ and Vangl2+/+;Grhl3ct/ct littermates (p < 0.001 for each stage, 1-
Way ANOVA). In general, embryos without the Lp mutation showed an increase in 
axial curvature as development proceeded, while the curvature in embryos with the 
Lp mutation remained rather more constant over time (Figure 3.9). These data 
indicate that the spina bifida in Vangl2Lp/+;Grhl3ct/ct does not arise due to increased 
ventral curvature of the caudal region during spinal neurulation. 
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Figure 3.9 Vangl2
Lp
 is associated with a reduction in ventral axial curvature 
Each embryo is represented by a single data point, with the mean ± SEM to the right of each group. The mean PNP angle of curvature varies significantly      
between genotypes (p < 0.001 for each stage, 1-Way ANOVA). *Significantly reduced compared with Vangl2
+/+
;Grhl3
ct/+
 and Vangl2
+/+
;Grhl3
ct/ct
 ( p < 0.05).   
Vangl2+/+;Grhl3ct/+ 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3ct/+ 
Vangl2Lp/+;Grhl3ct/ct 
   *    * 
  *       *      * 
    * 
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Figure 3.10 Reduced axial curvature in Vangl2
Lp/+
;Grhl3
ct/ct
  
The angle of axial curvature (X) of the caudal region was measured as shown in A and B 
(and see Chapter 2). Curvature was reduced in Vangl2
Lp/+
;Grhl3
ct/ct 
compared to
 
Vangl2
+/+
;Grhl3
ct/ct
. Representative 21-22 and 30-31 somite stage samples are shown in A-B 
and C-D, respectively. Scale bars: 500 µm. 
 
In an early study of the curly tail mutant mechanism (Copp et al., 1988a), 27-29 
somite stage embryos were examined for changes in cell proliferation at different 
sites along the caudal axis. An informative comparison was made between the 
distal site of active neural fold elevation in unaffected (‘Category 1/2’) curly tail 
embryos versus the relatively more proximal site of active neurulation in curly tail 
embryos with severely enlarged neuropores (‘Category 4/5’). This approach 
revealed affected curly tail embryos to exhibit a significantly lower mitotic index (MI) 
in hindgut endoderm and notochord than their normally developing littermates.  
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Figure 3.11 Analysis of proliferation in the 27-29 somite stage hindgut endoderm 
(A, B) Schematic of the comparison between the equivalent distal and proximal regions of 
embryos with small and large PNPs, respectively. Dotted lines indicate the level of active 
neural fold elevation, through which transverse sections were cut. 
(C, D) Sections through representative control (C) and double mutant (D) embryos at the 
level of PNP closure, following immunofluorescence for PH-H3 (green). Nuclei are stained 
with DAPI (blue). White boxes outline the hindgut endoderm, within which a few mitotic 
nuclei can be seen. Scale bars: 100 µm. 
 (E) Mitotic indices in the hindgut. Each data point represents the mean MI for four-seven 
sections through an individual embryo. Error bars represent the mean MI ± SEM for all 
sections of the same genotype. Squares correspond to embryos with a smaller than average 
PNP and triangles denote those with a larger than average PNP. Mean MI did not vary 
significantly with genotype (p = 0.876, 1-Way ANOVA). 
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A similar method was used here (Figure 3.11), with an investigation of hindgut 
proliferation performed at 27-29 somites using the late-G2/M-phase marker, 
phospho-histone H3 (PH-H3). Control Vangl2+/+;Grhl3ct/+ embryos had a mean 
hindgut MI of 2.98 (± 0.43) and, while curly tail (Vangl2+/+;Grhl3ct/ct) mean MI was 
unaltered overall, individual embryos did show the expected trend towards reduced 
proliferation with increasing PNP size. MI was not significantly reduced in 
Vangl2Lp/+;Grhl3ct/ct compared to either of the other genotypes, indeed the mean MI 
was 2.76 (± 0.44), despite the presence of the ct alleles (Figure 3.11C). These data 
therefore demonstrate further that the exacerbating effect of the Vangl2Lp allele is 
not via the developmental mechanism demonstrated previously for the curly tail 
mutant. 
 
3.2.4 Morphological evidence of defective CE in 
Vangl2Lp/+;Grhl3ct/ct 
Prior to failure of closure 1 and the appearance of craniorachischisis, PCP mutant 
mouse embryos exhibit morphometric features that are indicative of defective CE. 
Typically they display an abnormally short and wide body axis during late 
gastrulation (Paudyal et al., 2010; Wang et al., 2006a; Ybot-Gonzalez et al., 2007b), 
and abnormally broad floor plate and notochord tissues at E8.5 (Greene et al., 
1998; Lu et al., 2004; Wang et al., 2006a). Abnormal somite morphology has also 
been described as evidence of defective CE: for example, Ptk7gt/gt embryos have 
wider somites with shorter spacing at E8.5 (Lu et al., 2004). Does Vangl2Lp, which 
increases susceptibility to defects later in neurulation, induce a similar ‘PCP 
phenotype’ at E9-E9.5? 
 
The length of the caudal embryonic axis was reduced in Vangl2Lp/+;Grhl3ct/ct by 
approximately 20% compared to Vangl2+/+;Grhl3ct/ct embryos (Figure 3.12A, B; p = 
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0.017, t-test). In addition, the embryonic length occupied by the most-recently 
formed 6 somites was measured. The somites in Vangl2Lp/+;Grhl3ct/ct appeared 
shorter along the A-P axis and wider mediolaterally than in Vangl2+/+;Grhl3ct/ct, and 
this reduction in length was statistically significant (Figure 3.12C, D; p = 0.007, t-
test). As well as the overall reduction in length, the morphology of the 
Vangl2Lp/+;Grhl3ct/ct   caudal region did not look entirely normal: it appeared less well 
defined, lacking the ventral narrowing that give the appearance of a ‘waist’ just 
caudal to the allantoic insertion in Vangl2+/+;Grhl3ct/ct (Figure 3.12B). 
 
Measurements of the midline tissues were also collected from histological sections 
at E9.5.  An apparent increase in the width of the Vangl2Lp/+;Grhl3ct/ct floor plate can 
be seen in Figure 3.8; at the level of PNP closure the ventral midline 
neuroepithelium is U-shaped, in contrast to the normal V-shaped appearance in 
Vangl2+/+;Grhl3ct/ct. Similarly, while the notochord becomes progressively narrower 
and rounder in more rostral sections through Vangl2+/+;Grhl3ct/ct embryos, it displays 
an abnormally flat and broad appearance at all levels in Vangl2Lp/+;Grhl3ct/ct (Figure 
3.8). Quantification of these observations revealed a significantly greater width of 
both tissues in Vangl2Lp/+;Grhl3ct/ct embryos compared with Vangl2+/+;Grhl3ct/ct 
(Figure 3.13A; p = 0.003 and p < 0.001 for the neuroepithelium and notochord, 
respectively). The overall width of the caudal end was unchanged (Figure 3.13B), 
suggesting that the midline tissues are specifically affected at this stage. 
 
Taken together, these data indicate that heterozygosity for the Vangl2Lp mutation 
causes a disruption of the normal lengthening of the embryonic axis and narrowing 
of the midline tissues during spinal neurulation. 
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Figure 3.12 Diminished length of the caudal region in Vangl2
Lp/+
;Grhl3
ct/ct 
during spinal 
neurulation 
(A, B) The caudal end (measured from the level at which a straight line drawn up from the 
allantois intersects the dorsal surface) is approximately 20% shorter in E9.5 
Vangl2
Lp/+
;Grhl3
ct/ct 
compared to
 
Vangl2
+/+
;Grhl3
ct/ct
 (*p = 0.017, t-test; n = minimum of eleven 
E9.5 embryos per genotype). Representative embryo caudal regions are shown in B; white 
arrows indicate the measured region and the yellow arrow in the upper panel indicates the 
‘waist’ seen caudal to the allantoic insertion (absent in Vangl2
Lp/+
;Grhl3
ct/ct
).  
(C, D) The region corresponding to the last six somites is approximately 14% shorter in 
Vangl2
Lp/+
;Grhl3
ct/ct
 (*p = 0.007, t-test; n = minimum of eleven E9.5 embryos per genotype). 
Arrows in D indicate the measured region. Graphs in A and C show the mean length ± SEM. 
Scale bars: 200 µm.  
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Figure 3.13 Increased relative width of axial tissues in Vangl2
Lp/+
;Grhl3
ct/ct
 embryos 
(A) The relative width of the midline ventral neuroepithelium (NE) and the notochord, as a 
proportion of total body width, is significantly increased in Vangl2
Lp/+
;Grhl3
ct/ct
. 
Measurements are from transverse histological sections as shown in Figure 3.8 (*p = 0.003 
and p < 0.001, respectively; Mann Whitney Rank Sum test). Bars represent the mean ± SEM 
(n = minimum of 22 sections from 3 embryos). (B) The overall width of the caudal end, 
measured as the total width of the section, does not vary between genotypes (p = 0.081; 
Mann Whitney Rank Sum test; n = minimum of 24 sections from 3 embryos). 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3ct/ct 
 A                                            B 
 * 
 * 
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3.3 Discussion 
3.3.1 The loop-tail/curly tail interaction is not due to an 
exacerbation of the Grhl3ct/ct mutant phenotype 
The observations that Vangl2Lp/+;Grhl3ct/ct embryos display a reduction in ventral 
axial curvature compared to Vangl2+/+;Grhl3ct/ct, and a similar hindgut mitotic index 
to control embryos, strongly suggest that the deleterious effect of the Lp allele is not 
via the known curly tail mutant mechanism. The pathogenesis of NTDs in curly tail 
embryos was elucidated by several studies in the 1980s and 1990s that 
investigated the connection between the observed caudal proliferation imbalance 
and the development of NTDs (Copp et al., 1988a; Peeters et al., 1998b). In 
normally developing embryos, ventral curvature progressively declines in the caudal 
region from the 27-29 somite stage as the PNP completes closure, and it has been 
proposed that this ‘unbending’ facilitates the final stages of primary neurulation 
(Brook et al., 1991). Abnormally developing curly tail embryos display enhanced 
curvature at this stage and, although a degree of axial unbending is observed, this 
occurs at a more caudal level than normal (Brook et al., 1991; Peeters et al., 1997). 
This increased curvature is not simply a secondary effect of delayed PNP closure, 
as experimentally inducing a delay in non-mutant embryos by physically reopening 
the PNP does not lead to an increase in curvature (Brook et al., 1991). Together, 
these early studies suggested a correlation between decreased curvature and 
successful PNP closure, and that stress forces generated by enhanced curvature in 
curly tail embryos impede the mechanical movements of the neural folds during 
neurulation.  
 
This hypothesis of a direct causal relationship was also tested experimentally. 
Firstly, ventral curvature was reduced by inserting the tip of a human eyelash into 
the hindgut lumen of curly tail embryos via the caudal end. After a period of whole 
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embryo culture, the normal ‘unbending’ was seen to be enhanced and the delay in 
PNP closure was significantly rescued (Brook et al., 1991). In another study caudal 
explants, in which the neuroepithelium was mechanically separated from the 
surrounding tissues, were cultured in vitro and displayed apparently normal closure, 
further demonstrating that the defect was extrinsic to the neuroepithelium (Van 
Straaten et al., 1993). In a third report, curvature was increased by culturing 
embryos with a collapsed, and therefore more tightly wrapped, amnion, which was 
found to promote ventral curvature and the incidence of open PNP (Peeters et al., 
1996). Besides physical manipulations, the curly tail defect can also be ameliorated 
by restoring the balance between the growth rates of dorsal and ventral structures. 
Embryonic growth retardation in vivo by maternal food deprivation, or in vitro culture 
by hyperthermia (40.5oC), normalises PNP closure and reduces the incidence of SB 
(Copp et al., 1988b; Peeters et al., 1996), as do the stimulation of hindgut 
proliferation by inositol treatment and the restoration of Grhl3 function via BAC 
transgenesis (Cogram et al., 2004; Gustavsson et al., 2007). 
 
The progression of neural tube closure also appears to correlate with curvature at 
other levels of the mouse neuraxis. For example, initiation of closure at the 
hindbrain-cervical boundary occurs before embryonic turning, in a region where the 
embryo exhibits concave (dorsal) bending. In the cranial region, closure correlates 
with axial unbending, with the last part to close being the midbrain, the most curved 
part of the cephalic neuroepithelium (Jacobson and Tam, 1982; Peeters et al., 
1997). An association between axial curvature and rate of neural tube closure has 
also been described in other vertebrate species, including chick, rabbit and human 
embryos (Peeters et al., 1998a).  
 
Given this generalised phenomenon, it would seem that the severe spina bifida 
phenotype in Vangl2Lp/+;Grhl3ct/ct embryos, despite their ‘straighter’ caudal regions, 
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must be the result of another, overriding defect. Indeed, the degree of straightening 
observed in Vangl2Lp/+;Grhl3ct/ct embryos would be predicted to normalise PNP 
closure in curly tail mutants yet, in contrast, closure is drastically diminished in 
Vangl2Lp/+;Grhl3ct/ct double mutants. Reasons for the straighter caudal region in 
embryos with the Lp mutation could include: (1) an increase in proliferation rate in 
the hindgut and notochord, (2) diminished proliferation in the neuroepithelium and 
(3) reduced CE in the neuroepithelium. Consistent with the reduction in curvature, 
no further decrease in hindgut proliferation was found in Vangl2Lp/+;Grhl3ct/ct. In fact, 
the hindgut mitotic index was found to be comparable to that in control 
(Vangl2+/+;Grhl3ct/+ and unaffected Vangl2+/+;Grhl3ct/ct) embryos (Figure 3.11E), 
which could be interpreted as support for explanation 1. Curvature is reduced from 
as early as 14-19 somites in embryos with the Lp mutation (Figure 3.9), suggesting 
that, if Vangl2Lp does promote ventral proliferation, it does so hours before the curly 
tail defect normally appears. With regards to explanation 2, the expression domains 
of Vangl2 and Grhl3 overlap in the neuroepithelium during spinal neurulation (see 
Chapter 5), so it will be interesting to determine cell proliferation in this region. 
However, the morphological data in Figure 3.12 and Figure 3.13 appear to support 
explanation 3: that is, the Lp mutation results in reduced caudal elongation and 
wider axial tissues, indicative of CE defects. 
 
3.3.2 Does Vangl2Lp promote failure of spinal neurulation by 
inducing a ‘PCP’ phenotype?  
The hypothesis that heterozygosity for Vangl2Lp impedes low spinal neurulation via 
a ‘PCP effect’ is consistent with CE studies of E8.5 Vangl2Lp/+ heterozygotes, which 
do achieve closure 1 but display tail defects and rare spina bifida (Copp et al., 
1994). Vangl2Lp/+ embryos show an intermediate length-to-width ratio and a mild 
axis elongation phenotype prior to the initiation of closure (Wang et al., 2006a; Ybot-
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Gonzalez et al., 2007b) and a slight delay in closure 1 compared to wild type 
embryos (Copp et al., 1994). Here, the Vangl2Lp/+ genotype strongly correlates with 
the severity of the spinal phenotype, with Vangl2Lp/+;Grhl3ct/+ embryos being the 
second-most severely affected genotype after Vangl2Lp/+;Grhl3ct/ct (Figure 3.3, 
Figure 3.5).  
 
The occurrence of NTDs in loop-tail heterozygotes does differ slightly within the 
literature, presumably due to differences in the genetic background of the strains 
used and the number of embryos analysed. For example one study observed a 
spina bifida frequency of 5% (Merte et al., 2010), while this was reportedly as high 
as 13% in other studies (Lu et al., 2004; Satoh et al., 2008). The variability of spinal 
defects in Vangl2Lp/+ embryos suggests that they are sensitive to sub-optimal 
genetic background conditions when bred with other strains. Moreover, as 
described in Chapter 1, modifier genes which increase susceptibility to NTDs are 
indeed present in the curly tail background. This raises the question of whether the 
Vangl2Lp/+;Grhl3ct/ct phenotype could be influenced by non-specific background 
effects. Genetic background-matched Vangl2Lp/+;Grhl3+/+ and Vangl2+/+;Grhl3+/+ 
embryos are, therefore, included as important controls in further analyses of this 
thesis (Chapter 4 and Chapter 5). 
 
Nonetheless the penetrance of NTDs in Vangl2Lp/+;Grhl3ct/ct  is particularly high (74% 
spina bifida), and is considerably more so than in Vangl2Lp/+;Grhl3ct/+ (41%). Thus, 
the Grhl3ct/ct genotype appears to make a specific contribution to the 
Vangl2Lp/+;Grhl3ct/ct phenotype. As the known curly tail mutant developmental defect 
appears not to play a role in this interaction, the role of Grhl3 here is intriguing. The 
abnormal tail bud morphology in Vangl2Lp/+;Grhl3ct/ct (Figure 3.12B) is of particular 
interest, given the presence of Grhl3 transcripts in a population of cells within the 
caudal end at E8.5-E9.5. This observation is pursued further in Chapter 4. 
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3.3.3 Spina bifida in Vangl2Lp/+;Grhl3ct/ct embryos is not due to 
failed DLHP formation 
At E9.0, Grhl3 is expressed in the neuroepithelium at the level of the open PNP, the 
region where DLHPs will form (see Chapter 5). However curly tail embryos develop 
DLHPs normally (Van Straaten and Copp, 2001), indicating that a reduction in Grhl3 
does not adversely affect the signals that regulate dorsolateral bending. The rescue 
of PNP closure in curly tail embryos by physically straightening the tail or abrogating 
the mechanical stress imposed by surrounding tissues (Brook et al., 1991; Van 
Straaten et al., 1993) further demonstrates that the defect in curly tail is not intrinsic 
to the neuroepithelium. DLHPs in Vangl2Lp/+;Grhl3ct/ct embryos appear comparable 
to Vangl2+/+;Grhl3ct/ct, indicating that the Lp/ct interaction does not involve disrupted 
DLHP formation. 
 
Grhl3 null mice (Grhl3-/-) display 100% penetrant spina bifida (Ting et al., 2003a; Yu 
et al., 2006) and it has been reported that these embryos fail to form DLHPs at E9.5 
(Rifat et al., 2010). However, the authors of this study only examined neural fold 
elevation at a distal level of the open PNP, away from the closure region where 
DLHP are normally seen. It is therefore possible that the absence of DLHPs they 
described is a secondary effect of the widely splayed open neural folds. Indeed, our 
group has consistently observed DLHPs in Grhl3-/- embryos at E9.0 (Caroline Hirst, 
unpublished data). 
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4. Do Vangl2
Lp
 and Grhl3
ct
 exert distinct 
.tissue-specific effects during spinal 
.neurulation?  
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4.1 Introduction 
4.1.1 Convergent extension during axis elongation 
During development, many embryonic tissues actively narrow in one axis 
(convergence) while simultaneously lengthening along the perpendicular axis 
(extension). Early studies of the amphibian gastrula revealed that as the 
presumptive axial (notochordal) and paraxial (somitic) mesoderm is internalised, 
cells undergo such convergent extension (CE) movements to close the blastopore 
and elongate the anterior-posterior (A-P) body axis. Meanwhile the overlying neural 
tissue also simultaneously converges and extends. The morphogenetic process of 
CE has since been shown to control body axis elongation in fish, worms, birds and 
mammals, as well as regulating processes such as germ band extension and 
imaginal leg disc evagination in the fruit fly (Keller et al., 2000) and elongation of the 
mammalian cochlea and limb buds (Gao et al., 2011; Wang et al., 2005). 
 
During Xenopus gastrulation, CE in neural and mesodermal tissues is driven by cell 
rearrangements, whereby cells intercalate with each other to change the tissue 
shape. Two distinct types of cell intercalation have been described: radial 
intercalation, as cells move between one another along the superficial-deep axis of 
the embryo leading to thinning of the tissue, and medio-lateral (ML) intercalation 
along the ML axis to produce a tissue which is narrower and longer. The 
movements of Xenopus CE are believed to be tissue-autonomous, as isolated 
explants continue to converge and extend in culture independently of external 
forces and surrounding tissues (Keller et al., 2000).  
 
While cell rearrangement represents a common type of movement driving CE, it is 
not the only mechanism employed by embryos to elongate their body (Tada and 
Heisenberg, 2012). During gastrulation in zebrafish, mesodermal cells display both 
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similar and different behaviours to Xenopus: progenitors of the prechordal plate 
migrate as a cohesive cluster without exchanging their neighbours, while later 
internalising notochord progenitors undergo ML intercalations to extend the body 
axis. At the same time, more lateral mesodermal precursors (somitic progenitors) 
first display collective migration towards the midline, followed by both ML and radial 
intercalation when they arrive near to the presumptive notochord. Thus, collective 
mesodermal cell migration is another important aspect of CE in zebrafish (Tada and 
Heisenberg, 2012). Orientated cell division has also been shown to contribute to CE 
in some systems. For example, divisions have been reported to predominantly 
occur in the A-P dimension in the presumptive neural plate of zebrafish embryos 
(Gong et al., 2004). In addition to cell intercalation, orientated divisions are also a 
feature of Drosophila germband epithelium morphogenesis and neural plate 
shaping in the chick embryo (Keller, 2002). 
 
CE processes also drive the shaping of the body axis in mouse embryos. After 
emerging from the node, the population of chordamesoderm cells narrows to form 
the mature notochord, while presomitic mesoderm derived from the primitive streak 
caudal to the node also undergoes CE movements. At the same time the overlying 
neurectoderm cells converge towards the midline, lengthening and narrowing the 
neural plate (Yamanaka et al., 2007; Ybot-Gonzalez et al., 2007b; Yen et al., 2009). 
The cellular behaviours underlying CE of the mammalian neural plate and 
underlying mesoderm are not fully understood although, as discussed in more detail 
later, labelling experiments and time lapse imaging have provided evidence of cell 
intercalation (Yamanaka et al., 2007; Yen et al., 2009). 
 
 - 158 -  
4.1.2 A stem cell population in the tail bud 
During elongation of amniote embryos, the axial tissues of the body (neural tube, 
notochord and somites) are laid down in a rostral-to-caudal sequence. During 
gastrulation the cells generating these structures are predominantly derived from 
the primitive streak and the surrounding epiblast which, together, will later form the 
tail bud. Regional organisation of progenitors within the primitive streak has been 
demonstrated by detailed fate-mapping and lineage analysis: at the rostral tip of the 
streak, cells emerging from the node generate the notochord, while cells from the 
‘node-streak border’ (NSB), the region encompassing the caudal end of the node 
and a portion of the rostral streak, additionally contribute to somitic tissue and the 
ventral midline of the neuroepithelium. More caudal regions of the primitive streak 
and the adjacent epiblast contain precursors of the lateral neural plate and somites 
(Cambray and Wilson, 2002; Selleck and Stern, 1991; Wilson and Beddington, 
1996). Later in development, the fate map of progenitors within the tail bud is similar 
to the map of the early streak and surrounding tissues. During low spinal 
neurulation the region at the caudal junction of the neural tube and notochord, 
termed the ‘chordo-neural-hinge’ (CNH), is considered to be homologous to the 
NSB, as it contains progenitors of the ventral neural tube, notochord and somites 
(Figure 4.1) (Cambray and Wilson, 2002; McGrew et al., 2008). 
 
As A-P development proceeds, most regional progenitors within the primitive streak 
are laid down and incorporated into axial tissues. Intriguingly, labelling studies have 
provided evidence that a small population of cells also remains within the streak and 
later comes to reside in the tail-bud, and that these cells constitute a self-renewing 
stem cell population (Cambray and Wilson, 2002; Cambray and Wilson, 2007; 
Wilson and Beddington, 1996). Early transplantation experiments demonstrated that 
small groups of cells isolated from the tail buds of mouse embryos at stages up to 
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E13.5 could contribute to axial tissue when grafted to the primitive streak of E8.5 
host embryos (Tam and Tan, 1992). It was later shown in both mouse and chick 
embryos that this potency is specifically a property of cells within the CNH, and that 
progeny from this region can be serially transplanted through the streaks of multiple 
embryos (Cambray and Wilson, 2002; McGrew et al., 2008). 
 
                  
Figure 4.1 Location of progenitor cells during axis elongation 
A stem-cell like population has been proposed to reside at the node-streak border, which is 
analogous to the chordo-neural-hinge at later stages (white boxes in the upper and lower 
images, respectively). Image taken from (Cambray and Wilson, 2002).    
 
The reports described above did not investigate whether individual cells of the CNH 
are indeed multipotent, or whether this region instead consists of a mixture of pre-
specified precursors. However, single cell labelling experiments have indicated that 
at least some cells within this region are multipotent; in both chick and mouse 
labelled cells were found to contribute progeny to more than one tissue (Forlani et 
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al., 2003; McGrew et al., 2008; Selleck and Stern, 1991). The contribution of the 
CNH to the elongation of the body axis is not fully understood (Wilson et al., 2009) 
although, recently, termination of body axis elongation in the chick was shown to be 
associated with a progressive reduction in size of this cell population (Olivera-
Martinez et al., 2012). 
 
In the previous chapter, evidence of defective CE and abnormal tail bud morphology 
were identified in Vangl2Lp/+;Grhl3ct/ct embryos during spinal neurulation. Here, the 
possibility that the Lp and ct alleles cause distinct mutant effects in different tissues, 
which then summate to cause failure of neural tube closure, was considered. In 
particular, I investigated whether Vangl2Lp causes defective CE in the midline, and 
whether Grhl3ct affects tail bud development.     
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4.2 Results 
4.2.1 When do the genotypes diverge phenotypically? 
In Vangl2Lp/+;Grhl3ct/ct embryos, a delay in spinal neurulation is evident at E10-E10.5 
(see Chapter 3). To determine the developmental stage at which this defect 
initiates, and when Vangl2Lp/+;Grhl3ct/ct embryos first differ phenotypically from 
Vangl2+/+;Grhl3ct/ct, a more detailed analysis of PNP size was performed. The 
findings of the previous chapter show that, after Vangl2Lp/+;Grhl3ct/ct, the genotype 
with the most severe effect is Vangl2Lp/+;Grhl3ct/+, raising the additional question of 
whether non-specific effects of the curly tail background may contribute to the Lp/ct 
interaction, in addition to the Grhl3ct mutation. To address this possibility, Vangl2Lp/+ 
mice were bred with congenic wild type mice, which share over 95% genetic 
background with the curly tail strain  (+ct/+ct; see Chapter 2). This cross generated 
background-matched wild type and loop-tail heterozygous embryos. The following 
embryos were therefore used for all analyses in this chapter, and in Chapter 5: wild 
type (Vangl2+/+;Grhl3+/+); ‘single mutants’ (Vangl2Lp/+;Grhl3+/+ and 
Vangl2+/+;Grhl3ct/ct); ‘double mutants’ (Vangl2Lp/+;Grhl3ct/ct). 
 
For each of the four genotypes the length of the PNP at different developmental 
stages was measured (Table 4.1, Figure 4.2). The PNP length of Vangl2Lp/+;Grhl3ct/ct 
embryos was first significantly increased compared to the other three genotypes at 
the 26-28 somite stage, when both single mutants displayed a milder delay in 
closure. At 29-33 somites none of the Vangl2Lp/+;Grhl3ct/ct embryos had completed 
closure, while Vangl2+/+;Grhl3ct/ct PNPs were variable (Figure 4.2; also see Chapter 
3), likely reflecting the spectrum of spinal phenotypes observed in this strain. By this 
stage there was no difference between Vangl2+/+;Grhl3+/+ and Vangl2Lp/+;Grhl3+/+ 
PNP length and a proportion of embryos of both genotypes had achieved closure 
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(Figure 4.2). At early stages (14-16 and 17-19 somites) the Lp allele was actually 
associated with a reduction in PNP length compared to wild type embryos.  
 
When PNP width was assessed, Vangl2Lp/+;Grhl3ct/ct diverged from 
Vangl2+/+;Grhl3ct/ct at an earlier stage than was observed for PNP length (Table 4.2, 
Figure 4.3). At 17-19 and 20-22 somites the double mutants had wider PNPs than 
wild type or curly tail embryos. Interestingly this difference was also observed in 
Vangl2Lp/+;Grhl3+/+ embryos, suggesting that the Lp allele causes an increase in 
PNP width regardless of the Grhl3 genotype. Finally, embryonic crown-rump length 
(CRL) was measured to check that the differences in PNP size were not secondary 
effects of differences in overall embryonic growth. Embryos of all genotypes 
displayed a comparable growth rate (Figure 4.4), with no difference in the CRL of 
embryos at 14-25 somites (1-Way ANOVA; p > 0.18 for each stage-category). At 
26-28 somites a small difference between genotypes was observed, likely due to 
the presence of outliers and the relatively small number of embryos (p = 0.04, 1-
Way ANOVA; no individual comparisons were significant). However by 29-33 
somites, when PNP size is dramatically increased in Vangl2Lp/+;Grhl3ct/ct compared 
to the other genotypes, no differences in CRL were observed. 
 
Together these data show that, in terms of PNP length, Vangl2Lp/+;Grhl3ct/ct embryos 
display larger neuropores than wild type and single mutant embryos at the 26-28 
somite stage. However, before this difference becomes apparent, both 
Vangl2Lp/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3+/+ embryos display an increase in PNP 
width. The finding that Vangl2Lp/+;Grhl3ct/ct embryos are phenotypically much more 
severe than background-matched Vangl2Lp/+;Grhl3+/+ embryos suggests that the 
curly tail genetic background does not make a significant contribution to the Lp/ct 
phenotype, independently of the Grhl3ct mutation. 
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Genotype 
Number of somite pairs 
14-16 17-19 20-22 23-25 26-28 29-33 
1)   Vangl2
+/+
; 
  Grhl3
+/+
 
0.59 
± 0.01 
0.55 
± 0.01 
0.52 
± 0.02 
0.29 
± 0.09 
0.26 
± 0.03 
0.10 
± 0.02 
2)   Vangl2
+/+
; 
  Grhl3
ct/ct
 
0.55 
± 0.02 
0.54 
± 0.01 
0.57 
± 0.02 
0.54 
± 0.02 
0.47 
± 0.06 
0.33 
± 0.04 
3)   Vangl2
Lp/+
; 
 Grhl3
+/+
 
0.52 
± 0.01 
0.46 
± 0.03 
0.49 
± 0.02 
0.44 
± 0.03 
0.43 
± 0.08 
0.12 
± 0.03 
4)   Vangl2
Lp/+
; 
  Grhl3
ct/ct
 
0.50 
± 0.02 
0.51 
± 0.01 
0.55 
± 0.02 
0.52 
± 0.02 
0.66 
± 0.04 
0.79 
± 0.08 
*Statistical  
differences 
(p < 0.05) 
1 > 3, 4 1 > 3 2 > 3 2 > 1 
2 > 1 
4 > 1, 2, 3 
2 > 1 
4 > 1, 2, 3 
 
Table 4.1 Comparison of PNP length between genotypes 
Table showing the mean PNP length (mm) ± SEM for progressive developmental stages. 
The difference between genotypes was significant at each stage analysed (1-Way ANOVA 
analysis; p < 0.03 for each somite category). * Significant differences revealed by multiple 
comparison testing. 
 
Genotype 
Number of somite pairs 
14-16 17-19 20-22 23-25 26-28 29-33 
1)  Vangl2
+/+
; 
  Grhl3
+/+  
 
0.16  
± 0.02  
0.16  
± 0.01  
0.20  
± 0.02  
0.13  
± 0.04  
0.09  
± 0.01  
0.04  
± 0.01  
2)  Vangl2
+/+
; 
  Grhl3
ct/ct  
 
0.21 
± 0.02  
0.19  
± 0.01  
0.20 
 ± 0.01  
0.19  
± 0.04  
0.17  
± 0.03  
0.11  
± 0.02  
3)  Vangl2
Lp/+
; 
 Grhl3
+/+  
 
0.18 
 ± 0.03  
0.24  
± 0.02  
0.32  
± 0.01  
0.32  
± 0.04  
0.27  
± 0.05  
0.10  
± 0.03  
4)  Vangl2
Lp/+
; 
  Grhl3
ct/ct  
 
0.24  
± 0.02  
0.29  
± 0.02  
0.32  
± 0.02 
0.35  
± 0.03  
0.39  
± 0.03  
0.42  
± 0.02  
*Statistical  
differences 
(p < 0.05) 
4 > 1 4 > 1, 2 
3 > 1, 2 
4 > 1, 2 
3 > 1 
4 > 1, 2 
3 > 1 
4 > 1, 2, 3 
2 > 1 
4 > 1, 2, 3 
 
Table 4.2 Comparison of PNP width between genotypes  
Table showing the mean PNP width ± SEM for progressive developmental stages. The 
difference between genotypes was significant at each stage analysed (1-Way ANOVA 
analysis; p < 0.03 for each somite category). *Significant differences revealed by multiple 
comparison testing. 
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Figure 4.2 Graph of PNP lengths for each genotype.  
Individual embryos are represented by a single data point, with the mean ± SEM shown to the right of each group. 
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Figure 4.3 Graph of PNP widths for each genotype.  
Individual embryos are represented by a single data point, with the mean ± SEM shown to the right of each group. 
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Figure 4.4 Graph of crown-rump lengths for each genotype.  
Individual embryos are represented by a single data point, with the mean ± SEM shown to the right of each group. 
Vangl2
+/+
;Grhl3
+/+ 
Vangl2
+/+
;Grhl3
ct/ct
 
Vangl2
Lp/+
; Grhl3
+/+
 
Vangl2
Lp/+
;Grhl3
ct/ct
 
 
 - 167 -  
4.2.2 Vangl2Lp causes defective midline convergent 
extension during spinal neurulation 
As described in Chapter 3, initial morphometric analyses indicate that 
Vangl2Lp/+;Grhl3ct/ct embryos exhibit a reduction in the normal lengthening of the 
embryonic axis and narrowing of the midline tissues during spinal neurulation. As 
loop-tail heterozygotes, like the double mutants, display abnormally wide posterior 
neuropores (Figure 4.3), I investigated whether they too display evidence of 
defective CE. As discussed earlier, Vangl2Lp/+ embryos show a mild CE phenotype 
at E8.5, prior to the initiation of neural tube closure (Wang et al., 2006a; Ybot-
Gonzalez et al., 2007b).  
 
As in Vangl2Lp/+;Grhl3ct/ct embryos, the length of the Vangl2Lp/+;Grhl3+/+ caudal region 
was reduced, as was the length of the region occupied by the most-recently formed 
six somites (Figure 4.5A, B). For both of these parameters, no difference was found 
between Vangl2+/+;Grhl3ct/ct and wild type. Similarly, a reduction in the angle of 
ventral curvature was observed in the posterior region of Vangl2Lp/+;Grhl3+/+ 
embryos, to a similar extent as that seen in Vangl2Lp/+;Grhl3ct/ct (Figure 4.5C). These 
measurements demonstrate that the caudal axis is significantly shorter and 
straighter in embryos that are heterozygous for Vangl2Lp, and that these phenotypes 
are not affected by the presence of Grhl3ct alleles.  
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Figure 4.5 Vangl2
Lp
 is associated with a reduction in caudal axis length and ventral 
curvature 
Data shown are for embryos with 20-25 somite pairs. Parameters were measured as shown 
in Chapter 2 with the data for Vangl2
+/+
;Grhl3
ct/ct
 and Vangl2
Lp/+
;Grhl3
ct/ct
 as shown before 
(see Chapter 3). (A) The Lp allele is associated with an approximately 20% reduction in 
caudal length compared to wild type and curly tail embryos (p = 0.001; n = min. of 8 
embryos per genotype). (B) The Lp allele is associated with an approximately 14% reduction 
in length of the most recently formed 6 somites compared to wild type and curly tail embryos 
(p < 0.001; n = min. of ten embryos per genotype). (C) Axial curvature is also reduced in 
Vangl2
Lp/+
;Grhl3
+/+ 
and Vangl2
Lp/+
;Grhl3
ct/ct
 (p < 0.001; n = min. of ten embryos per 
genotype). Bars represent the mean ± SEM. Genotypes were compared by 1-Way ANOVA 
and asterisks indicate results of multiple comparison testing: **signifcantly reduced 
compared to wild type and curly tail; *significantly reduced compared to wild type (p < 0.05).  
Vangl2+/+;Grhl3+/+ 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+; Grhl3+/+ 
Vangl2Lp/+;Grhl3ct/ct 
 
A                                          B 
C 
**  * 
**   ** 
 
 **   ** 
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The width of the midline tissues was assessed by examining transverse sections of 
embryos following WISH for the notochord marker, Brachyury. Previous analysis of 
this gene, and of sonic hedgehog (Shh), has revealed broader domains of 
notochordal expression in PCP mutant embryos prior to closure 1 (Greene et al., 
1998; Paudyal et al., 2010; Ybot-Gonzalez et al., 2007b). As observed for the 
histological sections shown previously (Chapter 3), Vangl2Lp/+;Grhl3ct/ct embryos 
displayed an abnormal widening of the notochord at the axial level of PNP closure, 
compared to both wild type and Vangl2+/+;Grhl3ct/ct, and this was accompanied by an 
increase in the width of the overlying ventral neuroepithelium. A similar phenotype 
was seen in Vangl2Lp/+;Grhl3+/+ (see yellow arrows in Figure 4.6), whereas 
Vangl2+/+;Grhl3ct/ct embryos appeared similar to wild type.  
 
A proportion of E9.0-E10.5 mutant embryos also displayed an unusual phenotype 
whereby the ventral neuroepithelium appeared to protrude dorsally through the 
open posterior neuropore, producing a convex neural plate. The appearance of this 
defect ranged in severity, from a slight ‘bulge’ at the caudal end to a distinct dorsal 
protrusion (Figure 4.7A). The phenotype was not seen in wild type embryos, 
became more frequent with an increasing number of mutant alleles, and was 
predominantly associated with the Vangl2Lp mutation (Figure 4.7B). Transverse 
sections through the abnormal region revealed an excess of neuroepithelial tissue, 
in which the neural folds appeared to have buckled and become displaced dorsally 
(Figure 4.8F, I). The phenotype was not a feature of an enlarged PNP per se, as it 
was not observed in affected curly tail embryos (Figure 4.8E, H).  
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Figure 4.6 Vangl2
Lp
 is associated with increased width of the midline tissues 
(A-D) Caudal regions of 20-25 somite stage embryos following whole-mount in situ 
hybridisation for Brachyury. Although no overt differences in expression were observed 
between genotypes, the length of the expression domain appeared slightly shorter for both 
genotypes carrying the Lp mutation, likely reflecting the shorter body axis in these embryos 
(arrows). (E-P) Transverse sections through the embryo in A-D at the level of the recently 
closed neural tube (E-H), the point of closure (I-L) and the level of active neurulation caudal 
to the closure point (M-P.  Arrows in I-L indicate the width of the Brachyury-positive 
notochord.    
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Genotype 
Normal PNP appearance 
% (freq.) 
‘Bulging’ PNP  
% (freq.) 
Vangl2+/+;Grhl3+/+ 100 (81/81) 0 (0/81) 
Vangl2+/+;Grhl3ct/+ 98.73 (78/79) 1.27 (1/79) 
Vangl2+/+;Grhl3ct/ct 97.96 (48/49) 2.04 (1/49) 
Vangl2Lp/+; Grhl3+/+ 81.48 (22/27) 18.52 (5/27) 
Vangl2Lp/+; Grhl3ct/+ 83.52 (76/91) 16.48 (15/91) 
Vangl2Lp/+;Grhl3ct/ct 76.60 (36/47) 23.40 (11/47) 
 
Figure 4.7 Dorsal bulging at the level of the PNP 
(A) Examples of the different phenotypes observed in the E9.5 embryonic caudal region. 
Scale bars: 200 µm. (B) Frequency of a ‘bulging’ PNP phenotype in embryos of each 
genotype at E9.0-E10.5. The Vangl2
+/+
;Grhl3
ct/+
 and Vangl2
Lp/+
; Grhl3
ct/+
 genotypes from the 
breeding strategy described in Chapter 3 are also included for comparison (grey text). A low 
frequency (1-2%) was observed in embryos carrying the Grhl
ct
 mutation, while the Vangl2
Lp
 
allele was associated with a higher occurrence of the defect (>16%). Vangl2
Lp/+
;Grhl3
ct/ct
 
embryos displayed the highest frequency, with nearly a quarter of embryos affected (23%). 
 
 
 
 
 A 
 
 
 
 
  
B 
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Figure 4.8 Dorsal bulging is associated with an excess of neural tissue  
(A-C) Caudal regions from E10.5 unaffected curly tail (A), affected curly tail (B) and Lp/ct 
double mutant embryos. (D-I) Sections through the caudal regions shown in A-C. In curly tail 
embryos, a delay in neurulation does not lead to the observed phenotype, as both 
unaffected and affected embryos display normal neural plate morphology at the level of the 
PNP and tail bud (D-E and G-H, respectively). White arrows indicate the level of the open 
PNP. Dotted lines indicate the level of the sections in D-I. The appearance of a bulging PNP 
appears to be due to excessive, dysmorphic neural tissue (yellow arrowheads). Scale bars: 
200 µm (A-C) and 50 µm (D-I). 
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Could the bulging PNP and apparent excess of neural tissue seen in individual 
sections occur due to defective CE cell movements in the caudal region? An 
alternative explanation is that Vangl2Lp causes an increase in neuroepithelial 
proliferation, leading to an increase in neuroepithelial cell number. The latter 
possibility was investigated by immunofluorescence for PH-H3 (Figure 4.9). 
Consistent with the sections shown above, the number of DAPI-stained nuclei was 
higher in the neuroepithelium of embryos carrying the Lp mutation than those which 
were wild type for Vangl2. Both Vangl2Lp/+;Grhl3+/+ and Vangl2Lp/+;Grhl3ct/ct  had, on 
average, over 200 cells per section compared to approximately 175 cells in 
Vangl2+/+;Grhl3+/+ and Vangl2+/+;Grhl3ct/ct embryos (Figure 4.9A). However, this 
increase in neuroepithelial cell number was not associated with a higher 
proliferation rate; in fact, while Vangl2Lp/+;Grhl3+/+ embryos were comparable to wild 
type, a lower mitotic index was observed in both Vangl2+/+;Grhl3ct/ct and 
Vangl2Lp/+;Grhl3ct/ct  (Figure 4.9B). 
 
Further evidence for a reduction in axis extension downstream of Vangl2Lp was 
provided by analysing the pattern of caudally-expressed genes in wild type and 
mutant embryos. As shown in Figure 4.6A-D, the region occupied by Brachyury was 
slightly shorter in the Vangl2Lp/+;Grhl3+/+ and Vangl2Lp/+;Grhl3ct/ct  caudal region. 
Similarly, the caudal region occupied by expression of the canonical Wnt ligand, 
Wnt3a, was also slightly reduced in both of these genotypes compared to wild type 
and curly tail embryos (Figure 4.10). For both genes, the overall intensity of staining 
and distribution of transcripts was unaltered.       
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Figure 4.9 Vangl2
Lp
 does not cause an increase in neuroepithelial proliferation  
(A) Comparison of neuroepithelial cell number at the 17-19 somite stage, counted from 
DAPI-stained sections. Each data point represents the mean number of nuclei per section, 
for a minimum of four sections through an individual embryo at the level of active neurulation 
(shown in C). Error bars represent the mean cell number ± SEM for all sections of the same 
genotype. An increase in cell number was observed in Vangl2
Lp/+
;Grhl3
+/+
 and 
Vangl2
Lp/+
;Grhl3
ct/ct
 (p < 0.001, 1-Way ANOVA). (B) Mitotic indices in the neuroepithelium. 
Mean MI was reduced in embryos with the Grhl3
ct/ct
 genotype, but did not vary significantly 
between wild type and Vangl2
Lp/+
;Grhl3
+/+
, or between Vangl2
+/+
;Grhl3
ct/ct
 and 
Vangl2
Lp/+
;Grhl3
ct/ct
 (p < 0.001, 1-Way ANOVA). 
Vangl2Lp/+;Grhl3+/+ 
Vangl2Lp/+;Grhl3ct/ct 
 
Vangl2+/+;Grhl3+/+ 
Vangl2+/+;Grhl3ct/ct
 A                                             B 
 C 
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Figure 4.10 Wnt3a expression in the caudal region 
(A-D) Whole-mount in situ hybridisation for Wnt3a at E9.5. Arrows indicate the embryonic 
region occupied by Wnt3a transcripts, which appears shorter in both Vangl2
Lp/+
;Grhl3
+/+
 and 
Vangl2
Lp/+
;Grhl3
ct/ct
. (E-H) Higher magnification dorsal views of the caudal regions in A-D. 
Besides the shorter body axis in embryos with the Lp mutation, no differences in Wnt3a are 
apparent and in each genotype the rostral limit of the expression domain is positioned at a 
similar level relative to the closure point (arrows).   
 
The data described so far suggest that embryos carrying the loop-tail mutation 
display defective midline convergent extension during low spinal neurulation. In pre-
neurulation stage embryos, CE can be studied by labelling the E7.5 midline tissues, 
either by microinjecting DiI (1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine 
perchlorate) into the node or electroporating a GFP-expressing vector into the 
neural plate (Pryor et al., 2012; Ybot-Gonzalez et al., 2007b). After continued 
development in whole embryo culture, the majority of wild type embryos exhibit 
striking axis extension, with a streak of labelled cells observed along the midline 
rostral to the node. In contrast, a large proportion of Vangl2Lp/Lp embryos display 
very limited rostral extension and labelled cells persist at the caudal site of injection 
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or electroporation. Heterozygous Vangl2Lp/+ embryos generally display a variable, 
intermediate phenotype (Ybot-Gonzalez et al., 2007b) 
 
To directly evaluate axis extension during PNP closure, DiI injection was used to 
label the cells in the midline of the caudal region at E9.0 (see Chapter 2). As it was 
first important to establish whether CE cell movements are indeed detectable in the 
midline at this stage, wild type embryos were initially labelled and cultured for 
different lengths of time (Figure 4.11). Two DiI marks were made in the midline via 
injections through the dorsal surface of the open neural plate, with the original 
prediction that these marks would move apart in the rostro-caudal dimension as 
development proceeds. After six hours in culture the distance between the labelled 
regions was not markedly increased, although the normal closure of the PNP did 
appear to have progressed (Figure 4.11A). Interestingly however, after 18 hours, a 
streak of fluorescently labelled cells was visible along the midline from the level of 
the closed neural tube to the open PNP more caudally. The distance between the 
most rostral and caudal labelled cells was approximately twice that of the original 
marks (Figure 4.11B). Correct localisation of DiI in the midline was confirmed by 
histological sectioning (Figure 4.11C).  
 
Next, DiI labelling was performed in Vangl2+/+;Grhl3+/+, Vangl2+/+;Grhl3ct/ct, 
Vangl2Lp/+;Grhl3+/+ and Vangl2Lp/+;Grhl3ct/ct E9.0 embryos to compare the degree of 
axis extension in the different mutant genotypes. The invasive nature of this 
technique meant that a proportion of embryos appeared abnormal at the end of the 
culture period and unfortunately had to be excluded from the analysis (Table 4.3). 
Nevertheless, consistent differences were seen between genotypes for the healthy 
embryos (Figure 4.12, Figure 4.13). In Vangl2+/+;Grhl3ct/ct embryos the streak of 
labelled cells appeared closely similar to wild type, with an approximately two-fold 
increase in the distance between the most rostral and caudal fluorescent cells 
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(Figure 4.12B, Figure 4.13). However in both Vangl2Lp/+;Grhl3+/+ and 
Vangl2Lp/+;Grhl3ct/ct embryos the midline DiI streak was shorter and did not extend 
as far into the caudal region (Figure 4.12C, D).  In these two genotypes the length 
of the labelled region was only 1.5 times that of the distance between the original 
marks (Figure 4.13).   
 
Together these results demonstrate that CE is indeed a feature of neurulation in the 
low spine, as has been shown previously for neurulation prior to closure 1, and that 
this process is compromised in the presence of the Vangl2Lp allele. On the other 
hand curly tail embryos display normal midline extension, showing that this process 
is not inhibited by mutations in Grhl3. 
 
Genotype 
No. of labelled  
embryos cultured 
Excluded from 
analysis (%) 
Reason for exclusion 
Vangl2
+/+
;Grhl3
+/+ 
14 7  (50%) 
Abnormal development (3), 
Mis-labelling (4) 
Vangl2
+/+
;Grhl3
ct/ct
 9 5  (56%) Abnormal development 
Vangl2
Lp/+
;Grhl3
+/+
 8 4  (50%) Abnormal development 
Vangl2
Lp/+
;Grhl3
ct/ct
 5 2  (40%) Abnormal development 
 
Table 4.3 Viability of DiI-labelled embryos 
Table showing the number of embryos successfully labelled and cultured for each genotype 
(second column) and the proportion excluded from further analysis at the end of the culture 
period (third column). Embryos were excluded if they appeared morphologically abnormal, 
or if cells had been mis-labelled. 
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Figure 4.11 Fluorescent labelling of the midline during PNP closure  
(A) Representative wild type caudal region immediately after labelling (t=0 hrs; left panels) 
and following six hours in culture (t=6 hrs; right panels). Bright field (bf) and fluorescent (diI) 
images are shown in the upper and lower panels, respectively. After six hours PNP closure 
has progressed (arrowheads indicate the points of closure) but the distance between the 
labels has not increased (arrows). (B) After 18 hours a rostrocaudal streak of DiI-labelled 
cells can be seen in the midline (right panels; arrows indicate the most rostral and caudal 
labelled cells). (C) Transverse sections through the caudal region of a labelled embryo, 
showing DiI in both neural tube floor plate and underlying notochord. Scale bars: 100 µm (A-
B) and 50 µm (C). 
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Figure 4.12 Defective CE in Vangl2
Lp/+
;Grhl3
+/+
 and Vangl2
Lp/+
;Grhl3
ct/ct
 embryos  
Panels show dorsal views of the caudal region immediately after labelling (t=0 hrs; top row 
of A-D) and following 18 hours in culture (t=18 hrs; bottom row of A-D). Arrows indicate the 
position of the DiI marks prior to culture, and the limits of the labelled region at the end of the 
culture period. Ectopic marks, in either the amnion (am) or on the surface of the embryo, are 
also indicated. (A-B) Wild type and curly tail embryos display comparable midline extension. 
(C-D) In Vangl2
Lp/+
;Grhl3
+/+
 and Vangl2
Lp/+
;Grhl3
ct/ct
 embryos axis extension is reduced. 
Scale bars: 50 µm 
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Figure 4.13 Quantification of DiI labelling experiments 
Comparison of axis elongation in the different genotypes during spinal neurulation. Each 
data point represents the length of the fluorescently labelled region in individual embryos 
after 18 hours in culture, expressed as the fold change of the distance between the original 
DiI marks. Error bars represent the mean MI ± SEM for each genotype. A reduction in axis 
extension was observed in both Vangl2
Lp/+
;Grhl3
+/+
 and Vangl2
Lp/+
;Grhl3
ct/ct
 (p = 0.006, 1-
Way ANOVA) Asterisks indicate results of multiple comparison testing: **signifcantly 
reduced compared to wild type and curly tail; *significantly reduced compared to curly tail (p 
< 0.05). 
 
4.2.3 A possible tail bud defect downstream of Grhl3ct 
If Grhl3 is not required for CE in the midline tissues during spinal neurulation, what 
contribution do the curly tail alleles make to the Lp/ct phenotype? Is their role in the 
interaction specific to another tissue? As introduced earlier, a population of 
multipotent progenitor cells is believed to reside in the caudal region of the embryo 
and contribute to the axial tissues as the trunk elongates (Cambray and Wilson, 
Vangl2+/+;Grhl3+/+ 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3+/+ 
Vangl2Lp/+;Grhl3ct/ct 
 
 **        * 
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2002). Interestingly, Grhl3 is expressed in a population of caudal cells which closely 
corresponds to this region from late E8.5-E9.5 (for a more detailed description of 
Grhl3 expression during neurulation see Chapter 5). WISH analysis revealed a 
strong patch of Grhl3 expression ventral to the neuroepithelium at the level of the 
open PNP (Figure 4.14A-C). This region presumably corresponds to the notochord 
expression described previously (Gustavsson et al., 2007), although at this axial 
level the notochord is not well defined morphologically and Grhl3 was not detected 
in the mature notochord more rostrally (see Chapter 5). Sagittal sections through 
the caudal region further suggested that this expression corresponds to the chordo-
neural-hinge (CNH; Figure 4.14D; compare to Figure 4.1), raising the intriguing 
question of whether Grhl3 plays a role in regulating or maintaining the putative 
population of caudal stem cells. Conversely, Vangl2 transcripts were not detected in 
this region (Figure 4.14E).     
 
The reduced rates of cell proliferation in the E10.5 curly tail hindgut (Copp et al., 
1988a) and in the E9.5 Vangl2+/+;Grhl3ct/ct  and Vangl2Lp/+;Grhl3ct/ct neuroepithelium 
(Figure 4.9B) both correspond to the expression of Grhl3 in these tissues. With this 
in mind, it was hypothesised that the cell cycle dynamics of the E9.5 caudal 
progenitor population might also be altered in embryos carrying the Grhl3ct/ct 
genotype. Immunofluorescence for the proliferation marker Ki67 showed this region 
to contain cycling cells (Figure 4.15E). The rate of proliferation in different 
genotypes was evaluated by calculating the mitotic index (MI) within a defined 
region ventral to the neuroepithelium, corresponding to the domain of Grhl3 
expression identified by WISH (Figure 4.16A; compare boxed areas to those in 
Figure 4.14B, C). While there was no difference in the mean MI between wild type 
and Vangl2Lp/+;Grhl3+/+ (4.0 ± 0.52 and 3.7 ± 0.40, respectively), a nearly 2-fold 
reduction in the rate of proliferation was observed in both Vangl2+/+;Grhl3ct/ct  and 
Vangl2Lp/+;Grhl3ct/ct E9.5 embryos (Figure 4.16B). 
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Figure 4.14 Grhl3 expression in the E9.5 caudal region 
(A-C) Whole-mount in situ hybridisation for Grhl3 in an E9.5 wild-type embryo. In addition to 
expression in the neural folds, transcripts are detected medially in a distinct region of the 
caudal end (arrow in A). Transverse sections through this region show a population of Grhl3-
expressing cells ventral to the open neural plate (boxed region in B and C). This expression 
domain extends to a level where the notochord and hindgut are no longer morphologically 
distinguishable. (D) Sagittal section through another embryo showing the location of the 
Grhl3-positive population relative to the caudal tissues. (E) Vangl2 expression, shown for 
comparison; it is not strongly expressed in this region (arrow). Abbreviations: ne = 
neuroepithelium, hg = hindgut, al = allantois, VER = ventral ectodermal ridge. Scale bars: 
200 µm (A) and 50 µm (B-E). 
 
Finally, to investigate possible changes in the survival rate of cells within the Grhl3-
expressing region, programmed cell death was analysed using immunofluorescence 
for the apoptotic marker activated Caspase3 (Casp3). In general the number of 
Casp3-positive nuclei in the caudal region was low (Figure 4.17). In the E9.5 spinal 
region a few apoptotic cells were observed within the neuroepithelium (Figure 
4.17A, 1-2), particularly at the dorsal midline of the recently closed neural tube as 
described previously (Massa et al., 2009). Further caudally, a small number of dying 
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cells were seen in the hindgut (Figure 4.17A, 3). Within the caudal Grhl3 expression 
domain the apoptotic index was generally less than 1% and was not significantly 
different between genotypes (Figure 4.17B). Together these results show that Grhl3 
is expressed within the caudal region of the embryo where a population of axial 
stem cells has been proposed to reside, and that it appears to regulate the 
proliferation of cells within this area. The observed reduction in the MI of this region 
was specific to embryos with the Grhl3ct/ct alleles.   
 
 
Figure 4.15 Ki67 immunofluorescence in the wild type caudal region 
(A-B) DAPI-stained sections through the caudal region of an E9.5 wild type embryo at the 
level of the PNP and tail bud. The boxed region in B corresponds to the location of Grhl3 
transcripts, as identified by WISH (compare to Figure 4.14). (D) Ki67-positive cells can be 
seen in numerous tissues at the level of the PNP, particularly throughout the 
neuroepithelium. In contrast, the notochord contains very few proliferative cells (arrow). (E) 
Further caudally, the majority of cells within the progenitor-containing region are Ki67-
positive (compare E to boxed region in B). Fluorescent signal was not observed in negative 
controls (C and F; no primary antibody). 
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Figure 4.16 Analysis of proliferation in the caudal progenitor region  
(A) Sections through representative wild type and curly tail embryos at the level of the 
caudal Grhl3 expression domain. Sections are stained for PH-H3 (green) and nuclei are 
stained with DAPI (blue). The boxed regions correspond to the location of Grhl3 transcripts, 
shown in Figure 4.14. Boxes were scaled to occupy an equivalent region of the tissue for 
each section. (B) Comparison of mitotic index within the selected region, calculated from 
DAPI-stained sections. Each data point represents the mean MI for an individual embryo 
with the mean MI ± SEM for all sections of the same genotype shown to the right (minimum 
total of 24 sections, across four embryos). MI was significantly reduced in embryos with the 
Grhl3
ct/ct
 genotype (p < 0.001, Kruskal-Wallis 1-Way ANOVA on Ranks). Asterisks indicate 
results of multiple comparison testing: **signifcantly reduced compared to wild type and 
Vangl2
Lp/+
;Grhl3
+/+
; *significantly reduced compared to wild type (p < 0.05). 
Vangl2
+/+
;Grhl3
+/+ 
Vangl2
Lp/+
;Grhl3
+/+
 
Vangl2
+/+
;Grhl3
ct/ct
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Lp/+
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Figure 4.17 Analysis of apoptosis in the caudal progenitor region 
(A) Sections through the caudal region of an E9.5 wild type embryo, from the level of the 
recently-closed neural tube (1) to the tail bud (4), following immunofluorescence for 
activated Caspase3 (green). Nuclei are stained with DAPI (blue; inset). Arrows in 1 and 2 
indicate dying cells within the neuroepithelium. The boxed region in 4 corresponds to the 
Grhl3-expression domain; no apoptotic cells were detected in this region of the section.  
Abbreviation: hg = hindgut.  
(B) Apoptotic indices (AI) within the boxed region in A4. Each data point represents the 
mean AI for an individual embryo with the mean AI ± SEM for all sections of the same 
genotype shown to the right. n = minimum total of 19 sections from 4 embryos for 
Vangl2
+/+
;Grhl3
+/+
, Vangl2
+/+
;Grhl3
ct/ct
 and Vangl2
Lp/+
;Grhl3
ct/ct
, and n = 16 total sections from 
3 embryos for Vangl2
Lp/+
;Grhl3
+/+
. Mean AI did not vary significantly with genotype (p = 
0.596, Kruskal-Wallis 1-Way ANOVA on Ranks). 
 
 
 - 186 -  
                    
 
  
0.0
0.5
1.0
1.5
2.0
2.5
3.0
A
p
o
p
to
ti
c
 i
n
d
e
x
 o
f 
s
e
le
c
te
d
 r
e
g
io
n
 (
%
)
 
 Vangl2+/+;Grhl3+/+ 
 Vangl2Lp/+;Grhl3+/+ 
 Vangl2+/+;Grhl3ct/ct 
 Vangl2Lp/+;Grhl3ct/ct 
 
 A 
 
 
 
 
  
 
 
 
 
 
 
 
B 
 - 187 -  
4.3 Discussion  
4.3.1 Evidence of a caudal CE defect downstream of Vangl2Lp 
The DiI labelling experiments described here indicate that convergent extension 
movements do contribute to elongation of the axial midline during low spinal 
neurulation, as has been described prior to the initiation of neural tube closure at 
E8.5. The current analyses of mutant embryos show that the presence of one 
Vangl2Lp allele is sufficient to perturb this process, indicating that it is PCP-
dependent. In this chapter, various lines of evidence support a role for Vangl2 in 
caudal CE: 1) both Vangl2Lp/+;Grhl3+/+ and Vangl2Lp/+;Grhl3ct/ct embryos display 
abnormally wide midline tissues, and an increase in PNP width, at E9-E9.5; 2) 
embryos of these two genotypes exhibit shortening of the caudal body axis, as 
shown by morphometric analyses and gene expression studies; 3) fluorescently-
labelled midline cells display diminished extension along the A-P axis during culture 
in embryos harbouring the Lp mutation. These data are reminiscent of the CE 
phenotypes reported in PCP mutant embryos at the time of closure 1 (Paudyal et 
al., 2010; Wang et al., 2006a; Ybot-Gonzalez et al., 2007b).  
 
Additionally, the Vangl2Lp/+;Grhl3+/+ and Vangl2Lp/+;Grhl3ct/ct genotypes were 
associated with a dysmorphic and dorsally-protruding neuroepithelium that 
contained more cells per transverse section than embryos which were wild type for 
Vangl2. This phenotype does not appear to be a consequence of increased cell 
proliferation, as neuroepithelial MI was not found to correlate with Vangl2 genotype. 
Similarly, no differences in cell proliferation were previously observed between the 
wild type and Vangl2Lp/Lp neuroepithelium (Gerrelli and Copp, 1997). Could an 
increase in cell number at a particular axial level instead reflect the ‘bunching up’ of 
the neural plate when CE is disrupted? 
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Labelling techniques such as the electroporation of GFP-expression vectors and DiI 
microinjection enable the examination of CE in living mouse embryos (Pryor et al., 
2012; Ybot-Gonzalez et al., 2007b). For the current study, the latter approach 
offered two main advantages over the former: DiI injections can be targeted to small 
groups of cells in the midline in a more precise manner than electroporation, and 
the fluorescence can be immediately detected. The second point crucially allows 
‘before and after’ measurements to be taken when evaluating the extent of axis 
elongation over a culture period. However, the experiment itself is not without 
difficulties. One particular challenge was producing microinjection needles with an 
appropriately-sized aperture; the tip needed to be sharp enough to pierce the 
amnion, cause minimal damage to the embryo and prevent DiI leakage, but the 
opening had to be large enough to allow DiI to be drawn up and expelled using a 
mouth pipette. It is therefore likely that the observed abnormal development of 
some cultured embryos is attributable to damage caused by the injections, along 
with the necessary opening of the yolk sac overlying the PNP. Nevertheless, there 
are a number of further experiments which could be performed using this technique. 
For example, it would be interesting to examine the movement of cells within more 
lateral regions of the neural plate and compare the extent of CE at different rostral-
caudal levels of the PNP.   
 
4.3.2 Cellular behaviours underlying mammalian CE  
As mentioned earlier, the mechanisms of CE during axis elongation in the mouse 
embryo are not fully understood, although in recent years studies have 
demonstrated a role for cell intercalation (Yamanaka et al., 2007; Yen et al., 2009). 
A role for the cell-autonomous rearrangement of cells at the midline was also 
suggested by examination of chimeric mouse embryos containing a mixture of wild 
type and Vangl2Lp/Lp cells (Ybot-Gonzalez et al., 2007b). In this study wild type 
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embryonic stem (ES) cells were injected into blastocysts from Vangl2Lp/+ X 
Vangl2Lp/+ matings, which were also homozygous for the ROSA26 beta-
galactosidase (β-gal) locus. In E8 +/+ ↔ +/+ chimeras a random mixture of host (β-
gal positive) and donor (β-gal negative) cells were observed throughout the 
neuroepithelium and notochordal plate, while +/+ ↔ Lp/Lp chimeras displayed a 
reduction in the proportion of PCP mutant cells at the midline. Quantification of this 
effect in the +/+ ↔ Lp/Lp neural plate revealed a predominance of up to 45% wild 
type cells in the midline compared with lateral regions. Consistent with the variable 
and intermediate elongation defects observed in heterozygous Vangl2Lp/+ embryos 
prior to neurulation, a range of phenotypes was seen +/+ ↔ Lp/+ chimeras (Ybot-
Gonzalez et al., 2007b).  
 
This study also demonstrated that lengthening of the notochord at positions more 
rostral to the node is less dependent on CE, with the authors suggesting that 
oriented cell divisions could account for the majority of elongation in this region 
(Ybot-Gonzalez et al., 2007b). A more detailed examination of mammalian 
notochord formation, involving live imaging and lineage analysis, revealed that 
distinct morphological processes form the node at different axial levels. In the trunk, 
the notochord is extended by CE driven by ML intercalation, while different 
mechanisms are employed during formation of the head process (prechordal plate) 
and tail notochord (Yamanaka et al., 2007). It would be interesting to investigate 
whether the rate of notochordal CE also varies at different rostro-caudal levels of 
the PNP during low spinal neurulation in the mouse. 
 
Together, the findings described above suggest a role for ML intercalation in the 
neural plate and underlying mesoderm prior to closure 1. As the data in the current 
chapter (and Chapter 3) appear to show a deleterious effect of Vangl2Lp on both of 
these tissues during PNP closure, it is tempting to speculate that analogous events 
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also occur later in neurulation. It would be interesting to assess whether the 
mechanisms controlling CE of cells emerging from the node are similar to those for 
cells recently laid down from the tail bud.  
 
The forces driving ML cell intercalation are thought to be generated within tissues 
by directional cell motility. In many systems this is controlled at the cellular level by 
the production of polarised protrusions (Keller et al., 2000). Such cell behaviours 
have been most extensively studied in the frog embryo, where mesoderm cells 
elongate and align along the ML axis, forming medially and laterally directed 
lamellipodia that appear to provide traction as the cells ‘crawl’ along their 
neighbours and intercalate (Shih and Keller, 1992). In the Xenopus neural plate, CE 
appears to be largely driven by monopolar, medially directed protrusions that pull 
the cells between each other towards the midline in a similar way to that seen for 
the bipolar mode (Elul and Keller, 2000). An analysis of CE in the mouse also points 
towards a mechanism involving cell intercalation driven by polarised protrusions. 
Cells of the presomitic mesoderm were observed to elongate mediolaterally and 
become aligned perpendicular to the midline, before extending bipolar, ML-
orientated protrusions and undergoing ML intercalation (Yen et al., 2009). 
Interestingly, this study also reported a role for radial intercalation in the presomitic 
mesoderm. Whether similar cell behaviours drive intercalation in the mammalian 
neural plate and notochord remains to be investigated. 
 
4.3.3 Role of Grhl3 in the caudal region 
The CE defects described here were exclusively associated with the presence of 
the Vangl2Lp allele. CE in Vangl2+/+;Grhl3ct/ct embryos appeared comparable to wild 
type, and was no more severe in Vangl2Lp/+;Grhl3ct/ct than in Vangl2Lp/+;Grhl3+/+. 
These findings raise the question of whether Grhl3 plays a specific role in another 
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tissue of the caudal region at E9.5. Interestingly Grhl3 was expressed within the 
CNH region at late E8.5-E9.5 (Figure 4.14; also see WISH analysis in Chapter 5) 
and the Grhl3ct/ct genotype was associated with reduced proliferation in this area a 
few hours before the spinal defect in the double mutants becomes apparent. 
 
The molecular characteristics of the caudal stem cell population have not been well 
defined. Several genes have been found to mark distinct subpopulations of cells 
within the primitive streak and adjacent epiblast during late gastrulation in both 
mouse and chick, and continue to be expressed in equivalent regions of the tail bud 
at later stages (Cambray and Wilson, 2007; Gofflot et al., 1997; Wilson et al., 2009). 
However these do not reliably label the stem cell population in both species. For 
example, in mouse embryos the node-streak border and CNH are marked by the 
transition between the posterior limit of the Foxa2 expression domain and the 
anterior limit of Fgf8 expression. However, such a molecular boundary cannot be 
used to locate these regions in avian embryos as Fgf8 extends further rostrally in 
the chick than in the mouse (Wilson et al., 2009). Recently, Sox2 and Brachyury 
were found to be uniquely co-expressed in the chick CNH and, intriguingly, also in a 
discrete group of cells in an equivalent caudal region of the human embryo (Olivera-
Martinez et al., 2012). It would be interesting to determine whether their expression 
also defines the CNH in the mouse and, if so, to perform co-labelling with Grhl3. 
 
Breeding Grhl3Cre/+ mice with the Rosa26YFP reporter strain also reveals the 
presence of Grhl3-positive cells and their descendents in the caudal region during 
late neurulation (see Chapter 6) and these embryos could be further examined, 
perhaps in combination with DiI labelling and whole embryo culture. The observed 
reduction of cell proliferation in the caudal region of curly tail embryos warrants 
further investigation. Double immunostaining for Grhl3 and cell cycle markers 
should be performed to precisely characterise cell cycle dynamics within sub-
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domains of the posterior tissues, and to specifically determine the phase of the cell 
cycle that is elongated/blocked in curly tail embryos. This could also be achieved via 
injections of the thymidine analogues BrdU (5-bromo-2-deoxyuridine) or EdU (5-
ethynyl-2-deoxyuridine); an examination of stained sagittal sections might reveal 
regions of proliferative heterogeneity. 
 
Finally, the significance of Grhl3 expression in the ventral ectodermal ridge (VER) is 
not understood and has not been addressed here. The VER was first described in 
the 1950s as a thickening of the ectoderm on the ventral side of the E10.5-E11.5 
mouse embryo tail bud. Given its morphological similarity to the apical ectodermal 
ridge (AER) of the developing limb bud, it was speculated that the VER is a source 
of signals for tail development (Gruneberg, 1956). Later studies showed that the 
VER first appears ventral to the PNP at the 17-18 somite stage, extends posteriorly 
to almost reach the tail tip by 30-33 somites and finally regresses at approximately 
E13, when tail elongation ceases (Gofflot et al., 1997; Goldman et al., 2000). VER 
ablation experiments revealed that the structure is required for somitogenesis and 
tail elongation, as well as the morphology of the neural tube, notochord and hindgut 
(Goldman et al., 2000). Signalling molecules including BMP2, BMP7, FGF17 and 
Wnt5a are expressed in the VER, as are components of the ECM (Gofflot et al., 
1997; Goldman et al., 2000; Lopez-Escobar et al., 2012; Ohta et al., 2007), but the 
expression of Grhl3 in this structure has not been previously reported.  
 
4.3.4 How do the mutant effects summate during 
neurulation?  
If Vangl2 regulates CE in the midline and Grhl3 plays a role in regulating 
proliferation of caudal progenitors, then how might the effects of mutations in these 
two genes interact? It could be that reduced proliferation downstream of Grhl3ct 
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reduces the size of the putative stem cell pool, so that fewer cells are available to 
exit this region and contribute to the midline tissues as the axis elongates. A 
combination of this effect with subsequent defects of CE, as seen for the Vangl2Lp 
allele, could produce a more severe phenotype than either of the single effects and 
contribute to the severe spinal defects in Vangl2Lp/+;Grhl3ct/ct (Figure 4.18). 
 
Further exploration of this hypothesis would require investigations of the specific 
requirements for Grhl3 at each of its sites of expression. A genetic approach would 
be to generate Vangl2Lp/+;Grhl3flox/+ mice and breed these with Sax1-Cre animals, 
which have recently been generated (Professor Kate Storey, personal 
communication). Sax1 (also called Nkx1-2) appears to be specifically expressed in 
the caudal neural plate during low spinal neurulation [Valentina Massa and Sandra 
C.P. De Castro, unpublished data; (Schubert et al., 1995)] so in 
Vangl2Lp/+;Grhl3flox/+;Sax1Cre/+ offspring Grhl3 would be reduced in this tissue. If the 
phenotype of these embryos was found to be milder than in Vangl2Lp/+;Grhl3+/- 
embryos, it would further suggest a requirement for Grhl3 in the CNH (and/or VER). 
 
Ultimately, to test the hypothesis that a ‘tissue-tissue’ interaction contributes to the 
spina bifida in Vangl2Lp/+;Grhl3ct/ct, it would be necessary to demonstrate a 
recapitulation of this severe phenotype in the Vangl2Lp/+ single mutant. One 
approach would be to attempt the targeted electroporation of a Cre-expression 
vector into the caudal region of Vangl2Lp/+;Grhl3flox/+ embryos, followed by whole 
embryo culture, to specifically ablate the CNH expression domain of Grhl3.  
Alternatively, siRNAs specific for Grhl3 could be introduced into CNH cells of 
cultured Vangl2Lp/+ embryos using chemical or viral transfection, or by 
electroporation.  In either case, the prediction would be that Vangl2Lp/+ embryos in 
which Grhl3 was locally inactivated in the tail bud would exhibit delayed PNP 
closure compared with mock-treated controls. 
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Figure 4.18 Proposed tissue-tissue interaction during spinal neurulation  
(A) Schematic diagram of caudal development. Red arrows indicate midline convergent 
extension. The CNH stem cells (blue) have been shown to contribute to the ventral neural 
tube, somitic mesoderm and notochord, as well as tail bud mesoderm progenitors more 
caudally (blue arrows) (Olivera-Martinez et al., 2012; Wilson et al., 2009). Abbreviations: nc 
= notochord, hg = hindgut. (B) Summary of the hypothesis that distinct mutant effects in the 
midline and tail bud contribute to the severe spinal defects in Vangl2
Lp/+
;Grhl3
ct/ct
 embryos. 
 
A 
B 
 - 195 -  
5. Is there a molecular interaction between 
.Vangl2 and Grhl3 during neurulation? 
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5.1 Introduction 
5.1.1 Published links between PCP and grainyhead genes  
In Drosophila, the grainyhead (grh) transcription factor is essential for the 
development of normal tissue polarity. This function was identified from a genetic 
screen for genes involved in the frizzled (fz) pathway, which revealed that mutations 
in grh produce polarity phenotypes in the wing, eye, abdomen and thorax (Lee and 
Adler, 2004). This work also demonstrated a strong interaction between grh and 
several fz pathway genes, including fz, Van Gogh (vang / strabismus) and Starry 
night (stan / flamingo). In each case the interaction caused disrupted polarity over a 
much larger region of the wing than was seen for either of the single mutants. Grh 
was found to be required for the normal localisation of fz pathway components in 
the wing cells, with a disruption of the normal Fz, Dsh, Vang and Stan accumulation 
observed in regions of abnormal hair morphology. Interestingly, reduced levels of 
Stan protein were also observed in grh mutant clones (Lee and Adler, 2004). 
 
In mice, a molecular link between PCP signalling and Grhl3 has been described 
during embryonic wound repair. Grhl3 was found to interact genetically with Vangl2 
during early (E12.5) and late (E16.5) wound healing and with Scribble during early 
wound healing (Caddy et al., 2010). The authors of this study found that Grhl3 
regulates the PCP pathway via direct transcriptional activation of RhoGEF19, a 
homologue of the Xenopus and human WGEF genes that have been shown to 
activate RhoA (Tanegashima et al., 2008; Wang et al., 2004). In Xenopus embryos, 
WGEF connects PCP signalling and RhoA activation; it can bind to Dvl and 
Dishevelled-associated activator of morphogenesis (Daam1), is required for PCP-
mediated CE and axis elongation and can rescue CE defects induced by expression 
of dominant negative Wnt11 (Tanegashima et al., 2008). In Grhl3 null mice, E18.5 
epidermal expression of RhoGEF19 is reduced, while in vitro transfection of Grhl3 
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leads to an upregulation of RhoGEF19 mRNA. Furthermore, knockdown of Grhl3 or 
RhoGEF19 in keratinocytes causes failure of RhoA activation and defective wound 
healing, a phenotype which can be rescued by overexpression of RhoGEF19 
(Caddy et al., 2010).   
 
Interactions between mammalian Grhl3 and PCP genes during neurulation and 
cochlea development were also reported by Caddy et al. (2010; see Chapter 3), 
though the molecular basis of these interactions was not investigated. Although 
these findings have led to the consideration, by some, of Grhl3 as a novel 
component of the mammalian PCP pathway (Dworkin et al., 2011), its wider role 
has not yet been characterized. It is possible therefore, that Grhl3-dependent 
regulation of signaling downstream of PCP is not a feature of all developmental 
events which require this pathway. Indeed, unlike the core PCP members, Grhl3 
does not regulate the initiation of neural tube closure (Rifat et al., 2010).  
 
Another possible link between PCP and Grhl3 is via Wnt5a, which functions in 
mammalian PCP signalling and interacts genetically with Vangl2 (Qian et al., 2007). 
Loss of Wnt5a in mouse embryos leads to gross morphological defects and 
perinatal lethality. Homozygous null embryos display caudal truncation, shortening 
of the A-P axis and outgrowth defects affecting multiple structures, such as the 
limbs, snout and external ear (Yamaguchi et al., 1999). Other studies of Wnt5a-/- 
embryos have also reported cochlear defects, low penetrance NTDs, defective 
septation of the cardiac outflow tract and abnormal lung and sexual development 
(Chawengsaksophak et al., 2012; Oishi et al., 2003; Qian et al., 2007; Schleiffarth et 
al., 2007). 
 
Wnt5a can signal through the receptor tyrosine kinase, Ror2 (Oishi et al., 2003) and 
Gao et al. showed that Wnt5a regulates PCP by inducing the formation of a Ror2-
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Vangl2 receptor protein complex at the plasma membrane (Gao et al., 2011). This 
Wnt5a signalling activity appears to be required for the cellular distribution of 
Vangl2, as in Wnt5-/- mice its normal localisation is lost (Gao et al., 2011; Qian et al., 
2007). Furthermore Wnt5a acts through Ror2 to induce Vangl2 phosphorylation, 
which is required for its function. Vangl2Lp protein, which remains trapped in the ER 
and cannot correctly localise to the plasma membrane, fails to form a complex with 
Ror2, leading to dramatically reduced levels of phosphorylation, both in vitro and in 
Vangl2Lp/Lp embryos (Gao et al., 2011).  
 
Interestingly, Wnt5a mRNA was previously found to be reduced in the caudal region 
of curly tail embryos during spinal neurulation (Gofflot et al., 1998). In this study, 
WISH revealed lower levels of Wnt5a expression in around 70% of affected ct/ct 
embryos at the 28-30 somite stage compared with their unaffected littermates. At 
20-22 somites, before a delay in PNP closure is detectable, 45% of ct/ct embryos 
showed a reduction compared to non-mutant controls. Closer examination revealed 
that Wnt5a was diminished in the ventral mesoderm, hindgut, VER, and to a lesser 
extent within the neuroepithelium. Whether Grhl3 regulates Wnt5a expression has 
not been investigated. 
 
In this chapter, the possibility of a molecular interaction between Vangl2 and Grhl3 
within the same cells of the caudal region during spinal neurulation is investigated.  
The following initial questions were considered: 1) Does the Lp/ct interaction involve 
a further change in the level or site of Grhl3 expression?; 2) Does the Lp/ct 
interaction involve a transcriptional effect of Grhl3 on the PCP genes?; 3) Could the 
interaction involve a transcriptional effect of Grhl3 downstream of the PCP 
pathway? 
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5.2 Results 
5.2.1 Comparison of Vangl2 and Grhl3 expression during 
spinal neurulation 
Grhl3 exhibits a dynamic pattern of expression during the period of neurulation. At 
E8.0 its transcripts are confined to a small region of non-neural ectoderm cells 
immediately adjacent to the folding neural plate (Auden et al., 2006; Ting et al., 
2003). By late E8.5-E9.0, expression is also detected in the ventral forebrain, 
caudal neural folds, and at the tip of the caudal end. As described in Chapter 4, 
Grhl3 transcripts are also abundant in a population of cells ventral to the caudal 
neural plate, which is hereafter referred to as the CNH (chordo-neural-hinge) 
expression domain (Figure 5.1). Expression in the neuroepithelium is 
downregulated by E10-E10.5, when Grhl3 appears in the hindgut ventral to the PNP 
and the allantois (Gustavsson et al., 2007; Gustavsson et al., 2008). This hindgut 
expression corresponds to the time and location of the cell proliferation defect in 
Grhl3ct/ct embryos (Gustavsson et al., 2007). 
 
Vangl2 is more widely expressed throughout the neuroepithelium during neural tube 
closure. At E8 it is restricted to the hindbrain and upper spine (Doudney et al., 2005; 
Ybot-Gonzalez et al., 2007b), the level at which neural tube closure initiates, before 
being expressed throughout the closed neural tube, the hindgut endoderm and the 
base of the allantois by E9-E9.5 (Kibar et al., 2001; Murdoch et al., 2001; Torban et 
al., 2007). At this stage Vangl2 expression diminishes in a rostral to caudal 
direction, with transcripts confined to the ventral neural plate at the level of the open 
PNP (see Chapter 7). 
 
We hypothesised that, if a molecular or cellular interaction between Vangl2 and 
Grhl3 within the cells of the same tissue(s) does contribute to the severe spina 
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bifida in Vangl2Lp/+;Grhl3ct/ct embryos, the two genes would be co-expressed in the 
relevant tissue(s) at the appropriate developmental stage. Therefore the 
spatiotemporal pattern of Vangl2 and Grhl3 expression during PNP closure was 
compared using WISH. In E9.0 wild-type embryos the two genes appeared to be 
co-expressed in a region of the neuroepithelium at the level of the open PNP and 
most-recently closed neural tube (arrows in Figure 5.2A’, F’). Transverse sections 
through this region revealed expression of both genes throughout the closed neural 
tube, with the exception of the dorsal-most cells (Figure 5.2B, G). Vangl2 
expression appeared progressively weaker and ventrally-restricted in more caudal 
sections (Figure 5.2C-E), while Grhl3 expression persisted, most strongly at the 
basal side of the neuroepithelium (Figure 5.2H, I) and in the CNH (Figure 5.2J). 
 
At E9.5 the apparent co-expression of Vangl2 and Grhl3 in the neuroepithelium 
persisted (Figure 5.3) and by this stage both genes also appeared to be expressed 
in the hindgut endoderm, albeit quite weakly (Figure 5.3C, H). Grhl3 transcripts 
were also detected in the allantois (Figure 5.3F) and ventral ectodermal ridge (VER; 
Figure 5.3J). These data indicate that the expression domains of Vangl2 and Grhl3 
do overlap in the neuroepithelium and hindgut during PNP closure, potentially 
allowing a functional interaction within these tissues. 
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Figure 5.1 Grhl3 expression domains at late E8.5 
Whole-mount in situ hybridisation for Grhl3 in a wild-type embryo with 10 somite pairs. 
Transcripts are detected in the neuroepithelium of the ventral forebrain (B) and in the 
surface ectoderm surrounding the PNP (C). Grhl3 is also beginning to be expressed in the 
neural folds of the PNP (arrow in C). More caudally, expression can be seen in a population 
of cells in the caudal region (‘tail bud’ expression domain; arrowhead in C) and in the 
surface ectoderm at the tip of the caudal end (arrow in D). Scale bars: 200 µm. 
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Figure 5.2 Overlapping expression of Vangl2 and Grhl3 at E9.0 
Whole-mount in situ hybridisation for Vangl2 (A-E) and Grhl3 (F-J) in E9.0 wild type embryos. Both genes are expressed in the neuroepithelium at the level of 
the PNP at this stage (arrows in A’ and F’). Transverse sections at the level of neural tube closure reveal a region of apparent co-expression (B-C and G-H). 
Further caudally Vangl2 expression is reduced (D-E) and Grhl3 expression is also seen in the tail bud (J). Scale bars: 200 µm (A, F) and 50 µm (B-E, G-J). 
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Figure 5.3 Overlapping expression of Vangl2 and Grhl3 at E9.5 
Whole-mount in situ hybridisation for Vangl2 (A-E) and Grhl3 (F-J) in E9.5 wild type embryos. The apparent co-expression of the two genes persists at this 
stage (arrows in A’ and F’). Transverse sections show reduced Vangl2 expression in the caudal region (B-E) and Grhl3 expression at various sites (G-J). 
Abbreviations: al = allantois, hg = hindgut, VER = ventral ectodermal ridge. Scale bars: 200 µm (A, F) and 50 µm (B-E, G-J). 
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5.2.2 Does the Lp/ct interaction involve further changes in 
Grhl3 expression? 
In a previous report from our laboratory, quantitative RT-PCR (qRT-PCR) was used 
to determine the level of Grhl3 expression in the caudal region of E10.5 Grhl3ct/ct 
embryos. At the 28-29 and 30-31 somite stages, when Grhl3 is strongly expressed 
in the hindgut, mRNA levels were reduced in curly tail embryos compared with wild 
type by 56% and 41%, respectively (Gustavsson et al., 2007). However the 
reduction of Grhl3 in curly tail embryos has not been investigated at earlier stages 
of neurulation. Here, Grhl3 expression in the caudal region at 19-20 somites was 
examined in order to answer the following questions: 1) What is the level of Grhl3 
expression in curly tail embryos at E9.5, when it is normally expressed in the 
neuroepithelium and tail bud? and 2) Is there a further alteration in Grhl3 expression 
in Vangl2Lp/+;Grhl3ct/ct embryos?  
 
Using qRT-PCR, Grhl3 expression was found to be reduced by approximately 20% 
in the Vangl2+/+;Grhl3ct/ct caudal region compared with wild type (Figure 5.4). No 
further decrease was observed in Vangl2Lp/+;Grhl3ct/ct, consistent with the findings 
that the Lp/ct interaction does not arise due to an exacerbation of the known curly 
tail mutant phenotype (see Chapter 3). Interestingly, Grhl3 was increased in loop-
tail heterozygotes by around 20% compared to wild type embryos (Figure 5.4). To 
investigate how the changes in mRNA level correlate with the different Grhl3 
expression domains at this stage, WISH was also performed (Figure 5.5). For the 
accurate comparison of different genotypes, all embryos were processed together 
within the same tube and incubated in developing solution for the same length of 
time. In Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct embryos, expression was 
diminished in the neuroepithelium at the level of the PNP compared to wild type 
(Figure 5.5, arrowheads in A’-C’; also see E-G). In the tail bud however, the 
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expression domain was similar in these three genotypes (Figure 5.5, arrows in A’-
C’; also see I-K). Consistent with the qRT-PCR experiment, Grhl3 expression 
appeared to be increased in loop-tail heterozygotes; more intense staining was 
observed in the neuroepithelium (Figure 5.5D’, H) and the tail bud expression 
domain extended more laterally compared to wild type (Figure 5.5L). Transcripts 
were also observed in the surface ectoderm adjacent to the PNP in 
Vangl2Lp/+;Grhl3+/+ at this stage (Figure 5.5L). Similar changes in expression were 
seen in the ventral forebrain (Figure 5.6). Weaker and more spatially restricted 
staining could be seen in both Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct embryos 
compared to wild type (Figure 5.6B, C, F, G), while the signal was expanded and 
more intense in Vangl2Lp/+;Grhl3+/+ (Figure 5.6D, H). Together these results 
demonstrate that Grhl3 expression is reduced in curly tail embryos at E9.5, and that 
there is no further decrease in Vangl2Lp/+;Grhl3ct/ct. 
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Figure 5.4 Quantification of Grhl3 expression in the caudal region at 19-20 somites 
Bars represent the mean ± SEM for each genotype. The level of expression varies 
significantly between the four genotypes (p = 0.019, 1-Way ANOVA). Grhl3
+/+
 and Grhl3
+/-
 
samples, from independently collected litters, were also included as controls. 
Vangl2+/+;Grhl3+/+ 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3+/+ 
(Grhl3+/+) 
(Grhl3+/-) 
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Figure 5.5 Expression pattern of Grhl3 in the E9.5 caudal region 
WISH for Grhl3 in Vangl2
+/+
;Grhl3
+/+
 (A, E, I), Vangl2
+/+
;Grhl3
ct/ct
 (B, F, J), Vangl2
Lp/+
;Grhl3
ct/ct
 
(C, G, K) and Vangl2
Lp/+
;Grhl3
+/+
 (D, H, L) embryos. Lateral views of whole embryos are 
shown in A-D, with higher magnification dorsal views of the caudal region shown in A’-D’. 
Arrowheads indicate the axial level at which Grhl3 is normally expressed in the 
neuroepithelium (see wild type expression in A’). Arrows indicate the region of CNH 
expression. Transverse sections at the level of the neuroepithelial and tail bud expression 
are shown in E-H and I-L, respectively.  n = four embryos per genotype. Scale bars: 200 µm 
(A-D) and 50 µm (E-L). 
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Figure 5.6 Expression pattern of Grhl3 in the E9.5 cranial region 
(A-D) Ventral views showing Grhl3 expression in the forebrain of the embryos in Figure 5.5. 
(E-H) Transverse sections through the brains of the embryos in A-D. Transcripts are present 
in the neuroepithelium and surface ectoderm in Vangl2
+/+
;Grhl3
+/+
 (E) and are reduced in 
Vangl2
+/+
;Grhl3
ct/ct
 (F) and Vangl2
Lp/+
;Grhl3
ct/ct
 (G). Expression appears increased in 
Vangl2
Lp/+
;Grhl3
+/+
, particularly in the surface ectoderm (H). Scale bars: 200 µm (A-D) and 
50 µm (E-H). 
 
5.2.3 Does the Lp/ct interaction involve changes in PCP gene 
expression? 
5.2.3.1 Vangl2 expression 
The level of Vangl2 expression in the caudal region at E9.5 was examined by qRT-
PCR. No significant changes were found between genotypes, although there was a 
trend towards slightly higher levels of expression in embryos carrying the Grhl3ct 
mutation (Figure 5.7). When wild type and curly tail embryos were examined by 
WISH, no apparent changes in the pattern of expression were observed (Figure 
5.8). As shown earlier in wild type embryos, Vangl2 was widely expressed 
throughout the neuroepithelium and in the hindgut. This pattern of expression was 
comparable in embryos of both genotypes and at the level of the PNP the 
expression appeared weaker, and was absent from the dorsal neural folds, in both 
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Vangl2+/+;Grhl3+/+ and Vangl2+/+;Grhl3ct/ct (Figure 5.8A’, B’). The similarity between 
the level of Vangl2 mRNA in wild type and Vangl2Lp/+;Grhl3+/+ embryos (Figure 5.7) 
is consistent with previous reports that the Lp mutation does not cause a reduction 
in the total level of Vangl2 mRNA, but rather leads to a decrease in the amount and 
stability of Vangl2 protein (Gravel et al., 2010; Guyot et al., 2011; Torban et al., 
2007).  
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Figure 5.7 Quantification of Vangl2 expression in the caudal region at 19-20 somites 
Bars represent the mean ± SEM for each genotype. The level of expression does not vary 
significantly between the four genotypes (p = 0.156, 1-Way ANOVA). 
 
 
 
 
 
 
 
Vangl2+/+;Grhl3+/+ 
Vangl2Lp/+;Grhl3+/+ 
Vangl2Lp/+;Grhl3ct/ct 
Vangl2+/+;Grhl3ct/ct 
 - 209 - 
                           
Figure 5.8 Expression pattern of Vangl2 in E9.5 wild type and curly tail embryos 
WISH for Vangl2 in Vangl2
+/+
;Grhl3
+/+
 (A) and Vangl2
+/+
;Grhl3
ct/ct
 (B). Higher magnification 
views of the caudal regions are shown in A’ and B’ (arrows indicate Vangl2 expression in the 
hindgut) Vangl2 becomes ventrally restricted within the neuroepithelium at a comparable 
level in both genotypes (arrowheads indicate the rostral limit of the PNP). n = three embryos 
per genotype. Scale bars: 500 µm (A-B) and 200 µm (A’-B’). 
 
5.2.3.2 Wnt5a expression  
As described earlier, Wnt5a was previously found to induce Vangl2 activation in 
vitro. In vivo, Wnt5a dosage correlates with the level of Vang2 activity, as measured 
by the degree of its asymmetrical localisation and phosphorylation (Gao et al., 
2011). The finding that Wnt5a expression is reduced in a proportion of curly tail 
embryos during neurulation (Gofflot et al., 1998), therefore raises the question of 
whether Vangl2 activity is also diminished in these mice. If reduced Wnt5a 
expression in curly tail causes a reduction in Vangl2 activation, could this summate 
with the reduction in PCP signalling in Vangl2Lp/+, thus contributing to the severe 
spina bifida in Vangl2Lp/+;Grhl3ct/ct embryos? 
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As previously reported (Gofflot et al., 1998; Yamaguchi et al., 1999), Wnt5a 
transcripts were abundant within the caudal region of wild type embryos at E10.0 
(Figure 5.9A). Transverse sections at the level of the hindlimb buds revealed strong 
expression in the AER and moderate expression throughout the limb bud 
mesenchyme, ventral neural tube and somites, and around the bilateral nephric 
ducts. Transcripts appeared to be absent from the dorsal neuroepithelium, 
dermamyotome and hindgut (Figure 5.9D). Further caudally, Wnt5a was strongly 
expressed throughout several tissues, with the exception of the dorsal neural tube 
and notochord (Figure 5.9J). In the most distal region expression appeared 
ubiquitous, with the neuroepithelium being the most intensely stained region (Figure 
5.9M).  
 
Contrary to previous findings, alterations in Wnt5a expression were not detected in 
curly tail (or in Vangl2Lp/+;Grhl3ct/ct) embryos by WISH (Figure 5.9B, C). When 
transverse sections through both Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct caudal 
regions were analysed, the pattern and intensity of staining was closely similar to 
Vangl2+/+;Grhl3+/+ at all axial levels examined (Figure 5.9). To examine quantitatively 
Wnt5a expression in the caudal region, qRT-PCR analysis was also performed. 
Consistent with the WISH data, no difference in mRNA level was detected between 
genotypes at E10.0, or at E9.5 (Figure 5.10). These results suggest that Wnt5a is 
expressed normally in the Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct caudal region 
during neurulation.  
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Figure 5.9 Pattern of Wnt5a expression in the E10.0 caudal region 
WISH for Wnt5a in 27-29 somite stage Vangl2
+/+
;Grhl3
+/+
 (A, D, G, J, M), Vangl2
+/+
;Grhl3
ct/ct
 
(B, E, H, K, N) and Vangl2
Lp/+
;Grhl3
ct/ct
 (C, F, I, L, O) embryos. Transverse sections of the 
caudal regions in A-C are shown in D-O. A comparable pattern of expression is observed in 
embryos of all three genotypes. In the hindlimb buds, Wht5a is strongly expressed in the 
VER and more weakly expressed in the underlying mesenchyme (D-F; the asterisk in D 
indicates absence of the AER, a histological artefact). In the neuroepithelium, expression is 
restricted to the ventral region (D-I), despite the open neural folds in Vangl2
Lp/+
;Grhl3
ct/ct
 (I). 
At this level, transcripts appear to be weakly expressed or absent from the notochord and 
hindgut. In the tail bud, Wnt5a was not reduced in Vangl2
+/+
;Grhl3
ct/ct
 and Vangl2
Lp/+
;Grhl3
ct/ct
 
compared to wild type (J-O). The embryo in B had an open PNP; the altered morphology 
and appearance of closed neural tube in N is due to the slightly different angle of sectioning. 
n = minimum of four embryos per genotype; the Vangl2
+/+
;Grhl3
ct/ct
 and Vangl2
Lp/+
;Grhl3
ct/ct
 
embryos all had larger than average PNPs. Abbreviations: hg = hindgut, AER = apical 
ectodermal ridge, nd = nephric duct, VER = ventral ectodermal ridge. Scale bars: 100 µm. 
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26-28 somites
  
Figure 5.10 Quantification of Wnt5a in the caudal region by qRT-PCR 
Bars represent the mean ± SEM for each genotype. Wnt5a mRNA was measured at two 
embryonic stages. The level of expression does not vary between the three genotypes (1-
Way ANOVA; p = 0.133 for 19-20 somites and p = 0.323 for 26-28 somites).  
 
5.2.4 Does Grhl3 have a transcriptional effect downstream of 
the PCP genes? 
In parallel to the work described above, a possible transcriptional effect of Grhl3 
downstream of the PCP genes was considered. Could the misregulation of Grhl3 
target genes downstream of PCP signalling in Grhl3ct/ct contribute to the Lp/ct 
interaction? To investigate this question a candidate gene approach was taken, with 
potential targets selected based on the literature and a microarray comparison of 
E9.5 Grhl3+/+ and Grhl3ct/ct caudal regions that was previously performed in our 
laboratory (Nick Greene, unpublished data). The expression of each gene in the 
caudal region of E9.5 Vangl2+/+;Grhl3+/+, Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct 
embryos was examined by qRT-PCR.  
Vangl2+/+;Grhl3+/+ 
Vangl2+/+;Grhl3ct/ct 
Vangl2Lp/+;Grhl3ct/ct 
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As described above, RhoGEF19 was recently identified as a direct target of Grhl3 in 
the E18.5 epidermis and was found to be downregulated in the skin of Grhl3-/- 
embryos at late gestation (Caddy et al., 2010). Here, however, an approximately 
two-fold increase in RhoGEF19 expression was observed in Vangl2+/+;Grhl3ct/ct  
embryos compared to wild type, with a similar increase also seen in 
Vangl2Lp/+;Grhl3ct/ct (Figure 5.11A; p = 0.05, 1-Way ANOVA). The second gene to be 
analysed was Rho kinase 1 (ROCK1), a downstream effector of RhoA that was 
previously reported to be significantly upregulated (1.8-fold increase) in the back 
skin of E18.5 Grhl3-/- mice (Yu et al., 2006). In agreement with this study, an 
increase of around 50% was seen in the Vangl2+/+;Grhl3ct/ct  caudal region. An 
intermediate level of expression was observed in Vangl2Lp/+;Grhl3ct/ct (Figure 5.11B; 
p = 0.032, 1-Way ANOVA).        
 
Two further GEF genes, ArhGEF3 and ArhGEF7, emerged from the microarray 
performed by Dr Nick Greene. In this previous study, the expression of ArhGEF3 
was increased by approximately two-fold in the caudal region of affected curly tail 
embryos (those with a large PNP) compared to wild type (Nick Greene, unpublished 
data). Mouse ArhGEF3 was identified in a screen for candidate genes involved in 
Hirschsprung’s disease (Heanue and Pachnis, 2006) but its function has not been 
studied. However, human ARHGEF3 has been shown to activate RhoA in vitro  
(Thiesen et al., 2000). Here, ArhGEF3 displayed an approximately two-fold 
upregulation in Vangl2+/+;Grhl3ct/ct  samples, consistent with the previous microarray 
data. Again, the increase in gene expression was not as marked in 
Vangl2Lp/+;Grhl3ct/ct  embryos (Figure 5.11C; p = 0.02, 1-Way ANOVA).        
 
Mouse ArhGEF7 (also called Beta-pix) has been shown to recruit and activate Rac1 
(ten Klooster et al., 2006). More recently, its role in promoting lamellipodia and 
negatively regulating focal adhesion maturation was documented (Kuo et al., 2011). 
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ArhGEF7 previously displayed a 2.2-fold increase in curly tail (affected and 
unaffected pooled) compared to wild type (Nick Greene, unpublished data). Here, 
however, no difference in ArhGEF7 expression was detected between genotypes 
(Figure 5.11D; p = 0.417, 1-Way ANOVA). 
 
The final gene to be analysed, P190RhoGAP (also called Grlf1), was included due 
to its association with NTDs in mice. P190RhoGAP is highly expressed within the 
nervous system during development and embryos homozygous for a loss-of-
function allele display numerous abnormalities, including 30% exencephaly, eye 
defects and low penetrance omphalocele (failure of abdominal cavity fusion) 
(Brouns et al., 2000). However, no alterations in P190RhoGAP expression were 
observed in the Vangl2+/+;Grhl3ct/ct  or Vangl2Lp/+;Grhl3ct/ct  caudal region at E9.5 
(Figure 5.11E). 
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Figure 5.11 Quantification of potential Grhl3 targets in the E9.5 caudal region 
Graphs show the results of qRT-PCR analysis using samples from embryos with 19-21 
somites. Bars represent the mean ± SEM for each genotype. (A) Expression of RhoGEF19 
varied significantly between genotypes (p = 0.05, 1-Way ANOVA) although individual 
pairwise comparisons did not quite reach significance. (B) Expression of ROCK1 varied 
significantly between genotypes (p = 0.032, Kruskal-Wallis One Way ANOVA on Ranks) * p 
< 0.05 (pairwise comparison).  (C) Expression of ArhGEF3 varied significantly between 
genotypes (p = 0.02, Kruskal-Wallis One Way ANOVA on Ranks) * p < 0.05 (pairwise 
comparison). Conversely, no difference in the abundance of ArhGEF7 (D) or p190RhoGAP 
(E) mRNA was detected (1-Way ANOVA; p = 0.417 and p = 0.695, respectively). 
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5.2.5 Signalling downstream of the PCP genes 
5.2.5.1 Level of active Rho protein 
If the presence of ct mutations leads to the misregulation of genes involved in 
RhoGTPase signalling, what are the consequences downstream? In mouse 
embryos a requirement for RhoA-ROCK signalling has been demonstrated 
downstream of the PCP genes during the initiation of neural tube closure (Ybot-
Gonzalez et al., 2007b): whole embryo culture from E7.5 with a pharmacological 
inhibitor of ROCK, Y27632, revealed a strong interaction between ROCK inhibition 
and the Lp mutation. Almost all Vangl2Lp/+ mice treated with a low dose of the 
inhibitor displayed failure of closure 1, a phenotype which is not seen in loop-tail 
heterozygotes under normal developmental conditions. Vangl2+/+ embryos were 
much less affected, with open neural tubes only observed in around 50% of 
embryos when using a near-toxic dose. Following inhibitor cultures, Vangl2+/+ and 
Vangl2Lp/+ embryos were also found to display morphological features characteristic 
of loop-tail homozygotes. In addition to Vangl2, ROCK inhibition summated with 
mutations in Celsr1 and Scribble. Nearly 100% of treated Celsr1Crsh/+ embryos had 
an open neural tube, as did a proportion of ScribbleCrc/+, although embryos of the 
latter genotype were more resistant to higher doses of the inhibitor (Ybot-Gonzalez 
et al., 2007b). 
 
To investigate a possible alteration in RhoA signalling downstream of Grhl3ct/ct, the 
level of active (GTP-bound) RhoA was measured using a G-LISA RhoA activation 
assay (Figure 5.12; see Chapter 2 for details). We hypothesised that a change in 
the level of activated RhoA in ct/ct could interact with a reduction of RhoA signalling 
downstream of Lp, thus contributing to the interaction in Vangl2Lp/+;Grhl3ct/ct 
embryos. When normalised to wild type samples, a reduction of around 25% was 
observed in the Vangl2Lp/+;Grhl3+/+ caudal region. Similarly the level of GTP-RhoA 
was reduced in Vangl2+/+;Grhl3ct/ct, this time by nearly 40%. Consistent with the 
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observed reduction in each of the single mutants, a reduction of around 55% was 
seen in Vangl2Lp/+;Grhl3ct/ct samples (Figure 5.12C). This result suggests that there 
is a reduction in GTP-RhoA in the Vangl2Lp/+;Grhl3ct/ct caudal region, and that this is 
a cumulative effect of reduced active Rho for each of the single mutant genotypes. 
Unfortunately there was insufficient lysate leftover to measure the total level of Rho 
protein in the samples. However, as detailed in Chapter 2, samples were 
normalised for the total amount of cellular protein. 
 
5.2.5.2 ROCK inhibitor cultures 
As described above, RhoA-ROCK signalling is required downstream of PCP 
signalling prior to closure 1. The observed reduction in activated RhoA in 
Vangl2Lp/+;Grhl3+/+, Vangl2+/+;Grhl3ct/ct, and Vangl2Lp/+;Grhl3ct/ct at E9.5 suggests that 
this pathway also plays a role during low spinal neurulation. To investigate this 
further, Y27632 was applied to E9.0 embryos in whole embryo culture. If a reduction 
in RhoA signalling in Vangl2Lp/+;Grhl3ct/ct contributes to the failure of neurulation, and 
this is a cumulative effect of reduced GTP-RhoA downstream of both Lp/+ and ct/ct, 
then would inhibition of this pathway summate with either single mutant genotype to 
delay PNP closure?  
 
A concentration of 5 μM Y27632 was deemed to be suitable, based on toxicity 
assays (see Chapter 2) and previous analyses (Ybot-Gonzalez et al., 2007b). Wild 
type embryos cultured in 5 μM Y27632 from E9.0 developed normally and appeared 
morphologically comparable to controls (Figure 5.13A-D). Somite number and CRL 
did not differ between control and inhibitor-treated embryos, indicating that Y27632 
did not retard embryonic development or growth (Figure 5.13E). Treatment with 
Y27632 did not delay closure of the wild type PNP after seven hours in culture 
(Figure 5.13F). 
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When mutant embryos (Vangl2Lp/+;Grhl3+/+, Vangl2+/+;Grhl3ct/ct and 
Vangl2Lp/+;Grhl3ct/ct) were cultured, an effect of 5 μM Y27632 on PNP size was 
observed. PNP length was significantly increased with inhibitor treatment (p = 
0.026, 2-Way ANOVA). For both Vangl2Lp/+;Grhl3+/+ and Vangl2+/+;Grhl3ct/ct embryos, 
treatment with Y27632 increased the mean PNP length to a size which was similar 
to that seen in Vangl2Lp/+;Grhl3ct/ct embryos (Figure 5.14A). The effect of ROCK 
inhibition on PNP width appeared more pronounced: the mean values for 
Vangl2Lp/+;Grhl3+/+ and Vangl2+/+;Grhl3ct/ct embryos were higher for treated embryos 
than for controls (Figure 5.14B; p < 0.001, 2-Way ANOVA). For both PNP 
parameters, inhibitor treatment appeared to affect Vangl2Lp/+;Grhl3+/+ and 
Vangl2+/+;Grhl3ct/ct embryos more dramatically than  Vangl2Lp/+;Grhl3ct/ct, although 
this observation could not be confirmed as only one control embryo was recovered 
for the latter genotype. The mean number of somite pairs did not differ between 
control and inhibitor-treated embryos, indicating that the differences in PNP size did 
not simply reflect differences in developmental stage (Figure 5.14D). 
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Figure 5.12 RhoA activation assay 
An absorbance based G-LISA assay was performed. For each genotype, protein lysates 
from four E9.5 caudal regions were pooled into one sample tube. Samples were normalised 
for total cellular protein prior to performing the experiment. Two replicates were processed 
for each sample. (A) Photograph of the experimental plate following incubation with HRP 
detection reagent. +ve control wells contain constitutively active RhoA, -ve controls were 
lysis buffer blanks for background readings. (B) Absorbance readings at 490nm for each 
genotype. Bars represent the mean and SEM after subtraction of the background values for 
each of the two replicates. The difference between the four genotypes was statistically 
significant (p = 0.010, Kruskal-Wallis 1-way ANOVA on ranks). The positive control shows a 
mean absorbance of around 1, as expected from the assay protocol. (C) Level of activated-
RhoA, normalised to wild type (Vangl2
+/+
;Grhl3
+/+
) samples.   
1:  Vangl2+/+;Grhl3+/+ 
2:  Vangl2Lp/+;Grhl3+/+ 
3:  Vangl2+/+;Grhl3ct/ct 
4:  Vangl2Lp/+;Grhl3ct/ct 
    B 
A 
  C 
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Treatment Number of somite pairs Crown-rump length (mm) 
Control 21.7 ± 0.5 p = 1.0        
(Mann Whitney 
Rank Sum test) 
2.3 ± 0.1 p = 0.738        
(t-test) 
5 μM Y27632 21.3 ± 0.8 2.4 ± 0.1 
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Figure 5.13  Viability of embryos after culture with 5 μM ROCK inhibitor  
Data shown are for wild type embryos with 19-23 somite pairs after seven hours in culture. 
Culture serum was supplemented with H2O (vehicle; control) or 5 μM Y27632. (A, B) Control 
and inhibitor-treated embryos displayed comparable morphology after culture. C and D are 
higher magnification views of the embryonic caudal regions in A and B, respectively. Scale 
bars: 500 μm. (E) Viability of cultured embryos: inhibitor treatment did not affect somite 
number or embryonic C-R length. (F) No differences in PNP length or width were observed 
between wild type control and inhibitor-treated embryos (t-test; p = 0.364 and p = 0.625, 
respectively). 
  F 
  E 
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Figure 5.14 Effect of ROCK inhibition on PNP size  
Data shown are for embryos with 16-20 somite pairs after seven hours in culture. Each 
individual embryo is represented by a single data point, with the mean ± SEM shown to the 
right of each group. 2-Way ANOVA using genotype and treatment as factors was performed:  
(A) PNP length varies significantly with treatment (p = 0.026) and with genotype (p = 0.027). 
No interaction between genotype and treatment was found (p = 0.111). 
(B) PNP width varies significantly with treatment (p < 0.001) and with genotype (p = 0.006). 
No interaction between genotype and treatment was found (p = 0.127). 
(C) Representative control and inhibitor-treated Vangl2
+/+
;Grhl3
ct/ct
 embryos after culture, 
demonstrating the effect of Y27632 on PNP width. 
(D) Somite number does not vary with treatment (p = 0.642) or with genotype (p = 0.154). 
No interaction between genotype and treatment was found (p = 0.623). 
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5.3 Discussion  
5.3.1 Overlapping expression of Vangl2 and Grhl3  
The WISH data presented in Figure 5.2 and Figure 5.3 show that Vangl2 and Grhl3 
occupy overlapping expression domains during spinal neurulation, potentially 
allowing a molecular interaction between the two genes to occur within the same 
cells. In particular, they are both strongly expressed in the caudal neuroepithelium 
and more weakly in the hindgut. This apparent co-expression corresponds to the 
time when delayed neurulation in Lp/ct embryos first becomes apparent (see 
Chapter 4). Aside from their overlapping expression at the level of PNP closure, the 
distribution of Vangl2 and Grhl3 transcripts appears to be somewhat 
complementary along the neuraxis. Indeed, at E9.5, Grhl3 transcripts in the 
neuroepithelium are most abundant caudally in the open neural folds, the level at 
which Vangl2 expression diminishes (compare A and F in Figure 5.3). A lack of 
suitable antibodies precluded a detailed immunohistochemical analysis of Vangl2 
and Grhl3 expression in the caudal region. However, other studies have shown their 
mRNA and protein distributions to be closely similar during development. The 
expression of Vangl2 transcripts throughout the neuroepithelium, as shown here 
and previously (Kibar et al., 2001b; Murdoch et al., 2001a), is comparable to the 
pattern of protein expression (Torban et al., 2007; Torban et al., 2008). Similarly, in 
situ hybridisation and immunofluoresence both reveal strong Grhl3 expression in 
the leading edge of the E15.5 developing eyelid (Hislop et al., 2008; Yu et al., 
2008).    
 
5.3.2 Effect of Lp and ct on Grhl3 expression 
The overlapping expression of Vangl2 and Grhl3 raises the question of whether 
each gene’s expression might be altered when the other gene is mutated. Unlike in 
Drosophila, where the level of stan (homologous to vertebrate Celsr1) was found to 
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be related to grh gene dosage (Lee and Adler, 2004), no evidence of perturbed core 
PCP gene expression was found in the epidermis of E18.5 Grhl3-/- mutant mice 
(Caddy et al., 2010). This study also found normal levels of Grhl3 mRNA in 
Vangl2Lp/Lp, Celsr1Crsh/Crsh, Ptk7-/- and ScribbleCrc/Crc mutant epidermis at the same 
stage. 
 
Further characterisation of Grhl3 expression dynamics in curly tail embryos is 
needed, as fundamental questions remain to be answered. For example, it is not 
known whether the ct mutation, predicted to lie upstream of the Grhl3 start codon in 
a putative enhancer region (Gustavsson et al., 2007), causes a reduction in Grhl3 at 
each of its different sites of embryonic expression. Alternatively there could be 
other, tissue-specific enhancers or upstream regulators of Grhl3 so that, in curly tail 
embryos, expression is specifically reduced in the hindgut at E10-10.5. In this 
thesis, an overall 20% reduction in Grhl3 expression was found in the caudal region 
of 19-20 somite stage Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct embryos (see 
Figure 5.4). WISH analysis suggested that this predominantly reflects a reduction of 
Grhl3 in the neuroepithelium at this stage. Compared with wild type, Grhl3 was also 
reduced in the Vangl2+/+;Grhl3ct/ct and Vangl2Lp/+;Grhl3ct/ct ventral forebrain by WISH, 
although this observation was not quantified by qRT-PCR. These results show that 
ct causes a reduction in Grhl3 expression earlier than has previously been 
described (Gustavsson et al., 2007) and does affect tissues other than the hindgut.  
 
Using WISH, changes in the intensity or location of Grhl3 expression in the CNH 
were not obsrved in Vangl2+/+;Grhl3ct/ct or Vangl2Lp/+;Grhl3ct/ct embryos (see Figure 
5.5). This was somewhat surprising in light of the reduced rate of proliferation 
observed in this region of embryos carrying the Grhl3ct/ct genotype (Chapter 4). 
However, this result could reflect the non-quantitative nature of the WISH technique 
or be due to the orientation of the sections (for example, sagittal sections may show 
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that expression is not expanded as far in the A-P direction). It would be useful to 
examine the expression in this region more precisely, for example by isolating 
precisely-dissected wild type and curly tail caudal regions for Grhl3 qRT-PCR,  and 
by immunohistochemistry.  
 
The experiments in Figure 5.4 and Figure 5.5 show that the Vangl2Lp/+;Grhl3ct/ct 
genotype is not associated with a further reduction of Grhl3 compared to 
Vangl2+/+;Grhl3ct/ct, suggesting that such an effect does not contribute to the Lp/ct 
interaction. However, the apparent increased level of Grhl3 in Vangl2Lp/+ single 
heterozygous mutants is intriguing (see Figure 5.4 and Figure 5.5). This effect was 
rather pronounced using WISH, and continued to be seen when embryos of each 
genotype were allowed to continue their colorimetric development beyond the 
desired stage (data not shown). As the increase was observed in numerous tissues, 
it is unlikely that it simply reflects changes in tissue architecture; indeed, the gross 
morphology of the Vangl2Lp/+;Grhl3+/+ caudal region is relatively normal at this stage. 
The reason for the absence of a similar increase in Vangl2Lp/+;Grhl3ct/ct  remains 
unclear but could perhaps be explained by an epistatic effect: that is, if the Lp-
related increase in Grhl3 expression requires the aforementioned enhancer, then 
such a rise might be prevented by the presence of ct mutations in 
Vangl2Lp/+;Grhl3ct/ct embryos.   
 
5.3.3 PCP gene expression in mutant embryos 
In agreement with the normal levels of Vangl2 expression observed in E18.5 Grhl3 
null mouse embryos (Caddy et al., 2010), Vangl2 mRNA was not found to be 
differentially expressed in Vangl2+/+;Grhl3ct/ct at E9.5, suggesting that its expression 
is not transcriptionally regulated by Grhl3. Similarly, and in contrast to a previous 
report (Gofflot et al., 1998), no alterations in the level of Wnt5a mRNA were 
detected in Vangl2+/+;Grhl3ct/ct (or Vangl2Lp/+;Grhl3ct/ct) embryos. All of the mutants 
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included in the current analysis were ‘affected’ embryos; that is, they displayed an 
enlarged PNP indicative of a future delay or failure of spinal neurulation. A reduction 
in Wnt5a expression downstream of Grhl3ct/ct is therefore unlikely to contribute to 
the severe spina bifida in Vangl2Lp/+;Grhl3ct/ct embryos. If a reduction had been 
found, this hypothesis could have been pursued further. The next step would have 
been to examine the level of Vangl2 activation in mutant embryos, for example 
using antibodies against specific phosphorylated sites as previously described (Gao 
et al., 2011). Moreover, the expression of other PCP proteins could be examined in 
curly tail embryos. Celsr1 would be an interesting candidate, based on the finding in 
Drosophila that the level of stan protein correlates with grh gene dosage (Lee and 
Adler, 2004).  
 
5.3.4 A downstream effect on RhoA signalling? 
The Rho family of GTPases act as molecular switches, which cycle between an 
active (GTP-bound) and an inactive (GDP-bound) conformation. These two states 
are tightly regulated by three classes of conserved proteins; 1) Guanine nucleotide 
exchange factors (GEFs) which convert the GTPase into its active form by 
catalysing the exchange of GDP for GTP; 2) GTPase activating proteins (GAPs) 
which convert the GTPase back into its inactive form by accelerating its intrinsic 
GTPase activity; 3) Guanine nucleotide dissociation inhibitors (GDIs) which 
sequester inactive GTPases in the cytoplasm (Mulinari and Hacker, 2010). 
Downstream of active Rho, the ROCK family of serine/threonine kinases are a 
major group of effector proteins. Following their activation by Rho binding, ROCKs 
phosphorylate numerous downstream substrates, ultimately affecting many aspects 
of cell behaviour (Mulinari and Hacker, 2010). 
 
Increased expression of three genes involved in Rho-GTPase signalling, 
RhoGEF19, ArhGEF3 and ROCK1, was observed in the curly tail caudal region 
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(see Figure 5.11). The upregulation of RhoGEF19 was surprising, given the 
diminished expression in Grhl3-/- mice (Caddy et al., 2010). However this study only 
examined the expression of RhoGEF19 in vivo in the E18.5 skin, much later then 
the neurulation stage embryos studied here. The contradictory findings could 
therefore reflect differences in tissue- and stage-specific roles of Grhl3. Indeed, in 
our laboratory, RhoGEF19 was recently found to be unaltered in neurulation-stage 
Grhl3-/- embryos (Dr Nick Green, personal communication). On the other hand, the 
increased levels of ArhGEF3 and ROCK1 in curly tail are consistent with findings 
from a previous microarray (Nick Greene, unpublished data) and the literature (Yu 
et al., 2006), respectively. As mentioned earlier, there is evidence that RhoGEF19 
and ArhGEF3 are capable of activating RhoA (Caddy et al., 2010; Thiesen et al., 
2000). Interestingly, a feedback mechanism whereby ROCK1 indirectly mediates 
RhoA activity was recently described (Tang et al., 2012) so it is plausible that 
ROCK1, in addition to its function downstream of RhoA, could also regulate its 
activity upstream during neurulation.  
 
Given the information above, the altered expression of RhoGEF19, ArhGEF3 and 
ROCK1 in curly tail might be predicted to augment RhoA activity. However, when 
samples were assayed for levels of GTP-RhoA: this showed a reduction 
downstream of both Lp/+ and ct/ct (compared to wild type) and a cumulative effect 
in Vangl2Lp/+;Grhl3ct/ct. Although this experiment should be repeated with further 
samples, it does indicate that a decline in RhoGTPase signalling may contribute to 
the Vangl2Lp/+;Grhl3ct/ct phenotype. The deleterious effect of ROCK inhibition on 
PNP closure in both of the single mutants also supports this conclusion (see Figure 
5.14). Whether the reduction in GTP-RhoA reflects diminished activation by 
upstream regulators, or a reduction in the total abundance of available RhoA 
protein, warrants further investigation. How then, can the increased levels of GEF 
and ROCK1 expression be explained? Perhaps a compensatory feedback 
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mechanism activates transcription of these genes in response to a decline in RhoA 
activity. Another possible explanation is that the level of other GEF, GAPs or GDIs 
is also affected in curly tail, so that overall the balance of their activity causes a 
reduction in GTP-RhoA, rather than an increase. If this is the case then examining 
only a few family members, as was performed here, could yield results which do not 
accurately represent the ultimate outcome downstream.  
 
5.3.5 Which tissues are involved? 
As the expression analyses and G-LISA assay used samples extracted from the 
entire caudal region (see Chapter 2 for details of dissections), is it not clear which 
tissue(s) is involved in a possible molecular interaction between Vangl2 and Grhl3. 
In the following chapter, a requirement for the two genes in the same cells during 
neurulation is demonstrated genetically by crossing Vangl2flox and Grhl3Cre mice 
(see Chapter 6). Given their strong, overlapping expression in the neuroepithelium, 
it is tempting to speculate that this is where the two genes interact molecularly. This 
theory could be tested by examining embryos in which both genes have been 
conditionally ablated; this could be achieved by generating mice carrying both the 
Grhl3flox and Vangl2flox alleles and crossing these to Sax1-Cre animals, which have 
recently been generated (Professor Kate Storey, personal communication). Using 
embryos of each genotype, the abundance and spatial distributions of RhoA and 
ROCK1, along with the expression of ROCK targets such as myosin II regulatory 
light chain (MLC) and LIM-kinase (LIMK), could also be studied. This would 
hopefully reveal the precise regions or cells affected by the Lp/ct interaction.   
 
In summary, the results described here show that the domains of Vangl2 and Grhl3 
expression overlap during spinal neurulation and that they may interact at the level 
of RhoA-ROCK signalling. However, until the co-expression of Vangl2 and Grhl3 in 
the caudal region is confirmed at the protein level and on a single cell basis, I 
 - 231 - 
cannot rule out the possibility that similar downstream effects occur independently 
in different cells of the same tissue, but summate mechanistically. In other words 
there could, in reality, be reduced signalling downstream of Vangl2Lp in some 
(Vangl2-expressing) cells, and a deleterious effect of Grhl3ct on Rho-GTPase 
signalling in others (Grhl3-positive cells). 
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6.  A conditional genetic approach to  
..investigate the interaction between 
..Vangl2 and Grhl3 
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6.1 Introduction 
The developmental mechanisms underlying the severe spina bifida in 
Vangl2Lp/+;Grhl3ct/ct embryos are investigated in the previous two chapters. The 
findings of Chapter 4 support the hypothesis that Vangl2Lp and Grhl3ct aberrantly 
affect the development of different tissues, and that these defects summate to 
cause failure of neurulation. The data in Chapter five additionally provide evidence 
for the involvement of a second effect; a molecular interaction between Vangl2 and 
Grhl3 within the caudal region. In this chapter, a cell-autonomous requirement for 
Vangl2 and Grhl3, within the same tissue of the embryo during neurulation, was 
simultaneously investigated using a conditional genetic approach.  
 
Cre-loxP recombination has provided a powerful tool to precisely manipulate the 
mouse genome, and has allowed the production of many knockouts, conditional 
knockouts and reporter strains. Importantly, the technology provides the means to 
inactivate genes in a spatial and temporal manner, overcoming problems of 
embryonic and early postnatal lethality caused by genes which are indispensible for 
development, and allowing cell lineage or tissue-specific gene functions to be 
investigated. The system relies on the activity of the 38-kDa site-specific Cre 
recombinase, encoded by the P1 bacteriophage Cre gene, which recognises 34-
base pair loxP sites (Hamilton and Abremski, 1984). Cre efficiently catalyses 
recombination between two loxP sites that are oriented in the same direction to 
excise the intervening DNA sequence (leaving one loxP site at the site of excision). 
Therefore, mice carrying conditional knockout alleles of genes, which contain loxP-
flanked (‘floxed’) critical regions, can be crossed with mice carrying Cre under the 
control of a particular promoter to achieve targeted gene deletion. 
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For this study Vangl2flox/flox mice (a gift from Prof. Deborah Henderson) were bred 
with Grhl3Cre/+ mice, which have a Cre-IRES-NLSlacZ cassette inserted into the 
Grhl3 locus, making them effectively Grhl3 heterozygous loss-of-function (Camerer 
et al., 2010). The breeding strategies described below were used to generate 
Grhl3Cre/+;Vangl2flox/+ conditional embryos, which were Grhl3 heterozygous due to 
the presence of the Cre, and mosaically heterozygous for Vangl2 (Vangl2+/- in 
Grhl3-expressing cells but Vangl2flox/+ elsewhere). It was hypothesised that, if a 
molecular interaction between the two genes does indeed occur, the conditional 
embryos would exhibit defects of neural tube closure. 
 - 235 - 
6.2 Results 
6.2.1 Generation of conditional Grhl3Cre/+;Vangl2flox/+ embryos 
and negative controls 
 
6.2.1.1 Grhl3cre/+;R26YFP/+  X  Vangl2flox/flox 
Initially, Grhl3Cre/+ mice were bred with Rosa26YFP reporter mice (Srinivas et al., 
2001) before being crossed to Vangl2flox/flox mice, to allow fluorescent labelling of 
Grhl3-expressing cells and their descendents. The breeding strategy and embryonic 
genotypes are shown in Figure 6.1. Litters were collected at E9-E9.5 and E12.5, 
embryos were visualised for YFP expression and their phenotype was assessed. 
Embryos were obtained in the expected Mendelian ratios at both stages collected 
(Table 6.1).  
 
When characterising the Grhl3Cre allele, Camerer et al. described its tissue-specific 
expression in neurulation-stage embryos carrying a lacZ or Rosa26YFP reporter 
allele (Camerer et al., 2010). However when embryos from our Grhl3cre/+;R26YFP/+  X  
Vangl2flox/flox matings were collected, an unexpected pattern of YFP inheritance was 
observed. While some embryos did indeed display YFP fluorescence specifically in 
tissues such as the ventral forebrain, otic vesicles and tail (Figure 6.2C), around half 
of them instead displayed strong ubiquitous fluorescence (Figure 6.2B). 
Surprisingly, genotyping assays also revealed that a third of the ubiquitously-
labelled embryos were in fact Cre-negative (see the summary in Figure 6.2). The 
phenomenon did not appear to be associated with the sex of the embryo as males 
and females displayed both types of fluorescence. It also occurred irrespective of 
which parent had the Grhl3Cre/+;R26YFP/+ genotype, thereby ruling out genetic 
imprinting effects (Figure 6.2).  
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Figure 6.1 Breeding scheme to generate conditional Grhl3
Cre/+
;Vangl2
flox/+
 embryos 
Matings between Grhl3
Cre/+
;R26
YFP/+
 and Vangl2
flox/flox
 mice produce embryos with one of 4 
possible genotypes. However, offspring were not genotyped for the presence of the R26
YFP
 
allele, meaning that embryos were actually assigned to one of the following 3 categories: 
Fluorescent conditional (green text), non-fluorescent conditional and Cre-negative. Numbers 
in brackets indicate the expected proportion of offspring for each genotype. The ‘flox(-)’ 
notation indicates a floxed allele which has been recombined to produce a null allele due to 
the presence of Cre. 
 
Interestingly, embryos with ubiquitous YFP expression were not obtained from 
Grhl3Cre/+ X R26YFP/YFP matings (Dawn Savery, personal communication), suggesting 
that the phenomenon only occurs when the Grhl3Cre and R26YFP alleles are present 
in the same parent animal. It also transpired that the Grhl3Cre/+;R26YFP/+ animals 
used to produce experimental litters were in fact the offspring of a further backcross 
between Grhl3Cre/+;R26YFP/+  and R26YFP/YFP, leading us to hypothesise that we were 
Grhl3Cre/+ R26YFP/YFP 
Grhl3Cre/+;R26YFP/+  (1/2) Vangl2flox/flox X 
Cre +ve offspring: 
Grhl3Cre/+;R26YFP/+;Vangl2flox(-)/+ 
Grhl3Cre/+;R26+/+;Vangl2flox(-)/+ 
Cre –ve offspring: 
Grhl3+/+;R26YFP/+;Vangl2flox/+ 
Grhl3+/+;R26+/+;Vangl2flox/+ 
Cre -ve controls – wild type 
levels of both Grhl3 and Vangl2 
Conditional 
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observing a multi-generational effect. It was postulated that Grhl3 is variably 
expressed in the primordial germ cells (PGCs) and/or gametes, leading to 
recombination events when Grhl3Cre and R26YFP are both present. This could 
ultimately produce experimental embryos with the observed Cre and YFP 
inheritance patterns (see schematic in Figure 6.3).  For the hypothesis to be true, 
Grhl3 would have to be expressed at some point during germ cell development or 
gametogenesis. Although this was not investigated further here, gonads from first 
generation Grhl3Cre/+;R26YFP/+ adult mice (Figure 6.4) and embryos (Nick Greene, 
personal communication) were indeed found to contain fluorescent tissue. 
 
Genotype 
Category 
E9 - E9.5 E12.5 
Expected Observed Expected Observed 
% Freq. % Freq. % Freq. % Freq. 
Conditional 
(fluorescent) 
25.00 5/18 44.44 8/18 25.00 7/26 30.77 8/26 
Conditional   
(non-fluor.) 
25.00 5/18 16.67 3/18 25.00 7/26 19.23 5/26 
Cre -ve     
controls 
50.00 9/18 38.89 7/18 50.00 13/26 50.00 13/26 
Deviation from 
Mendelian ratios: 
χ
2
=1.416 with 2 degrees of freedom 
(p = 0.493) 
χ
2
=0.381 with 2 degrees of freedom 
(p = 0.826) 
 
Table 6.1 Genotype frequencies of offspring from Grhl3
Cre/+
;R26
YFP/+
 X Vangl2
flox/flox
 
matings 
Embryos were collected at E9-E9.5 and E12.5 and genotypes were obtained in the expected 
Mendelian ratios at both stages (p > 0.49, Chi-square test). 
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Figure 6.2 Pattern of Cre and YFP inheritance in embryos from Grhl3
Cre/+
;R26
YFP/+
  X  
Vangl2
flox/flox
 matings 
(A) Summary of embryos collected (E9-9.5 and E12.5 pooled). (B, C) Examples of embryos 
(with bright field inset) displaying ubiquitous (B) and tissue-specific (C) YFP fluorescence. 
Scale bars: 500 µm. 
A Grhl3Cre/+;R26YFP/+  X  Vangl2flox/flox 
 
24 Cre +ve embryos 
 
20 Cre -ve embryos 
 
5 Fluorescent 15 Non-fluor. 
 
16 Fluorescent 8 Non-fluor. 
 
5 ubiquitous fluorescence 
(1 female, 4 male) 
6 tissue-specific fluorescence  
(4 female, 2 male) 
 
10 ubiquitous fluorescence  
(3 female, 7 male) 
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Figure 6.3 Multi-generational hypothesis 
Schematic to explain the hypothesised multi-generational effect causing the observed YFP 
distribution in embryos from Grhl3
Cre/+
;R26
YFP/+
  X  Vangl2
flox/flox
 matings. Hatched regions 
indicate Cre expression and green regions indicate YFP expression. 
(Generation 1; G1) If Grhl3 is variably expressed in the PGCs or gametes, then 
recombination events will occur here in Grhl3
Cre/+
;R26
YFP/+
 animals, leading to expression of 
YFP. 
(Generation 2; G2) Offspring generated from gametes in which recombination has already 
occurred will be Grhl3
Cre/+
;R26
YFP/YFP
 (green text indicates an R26
YFP
 allele from which the 
STOP sequence has been removed in the previous generation). 
(Generation 3; G3) Embryos for analysis could therefore display one of five patterns of Cre 
and YFP inheritance (left to right): 1) Cre-positive, YFP-negative; 2) Cre-positive, tissue-
specific YFP; 3) Cre-positive, ubiquitous YFP; 4) Cre-negative, ubiquitous YFP and 5) Cre-
negative, YFP-negative. 
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 OR 
Grhl3Cre/+ X 
Grhl3Cre/+;R26YFP/+ 
X 
R26YFP/YFP 
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X 
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 (G2 – breeding stock ): 
 (G3 – experimental embryos): 
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Figure 6.4 Gonads from Grhl3
Cre/+
;R26
YFP/+
adult mice 
(A-B) Bright field (A) and fluorescent (A’) images of the uterus and ovaries taken from a 
Grhl3
Cre/+
;R26
YFP/+
 adult female. YFP-positive tissue can be seen at the base of the uterine 
horns and within the ovaries (A’). Higher magnification views of the ovaries are shown in B 
and B’. (C-D) Bright field (C) and fluorescent (C’) images of a testis taken from a 
Grhl3
Cre/+
;R26
YFP/+
 adult male, showing apparent YFP expression within the seminiferous 
tubules (C). A cross section through the testis is shown in D-D’. Scale bars: 500 µm. 
 
6.2.1.2 Grhl3cre/+ X Vangl2fl/+;R26YFP/+     
As an alternative approach, Grhl3cre/+ X Vangl2fl/+;R26YFP/+ matings were also set up 
(see breeding scheme in Figure 6.5). As the Grhl3Cre and R26YFP alleles were kept 
apart in this cross, it was hypothesised that only tissue-specific YFP distribution 
would be observed in the offspring. This was indeed the case; all fluorescent 
embryos displayed tissue-specific expression of YFP and no Cre-negative, YFP-
positive embryos were obtained, supporting the multigenerational hypothesis. 
Embryos were collected at E9.5 and E11.5-E12.5 and genotypes were obtained in 
the expected Mendelian ratios at both stages (Table 6.2).  
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Figure 6.5 Alternative breeding scheme for the generation of Grhl3
Cre/+
;Vangl2
flox/+
 
embryos 
Matings between Grhl3
Cre/+
 and Vangl2
flox
;R26
YFP/+
 mice produce embryos with one of 8 
possible genotypes. However, embryos were not genotyped for the presence of the R26
YFP
 
allele and Vangl2 genotyping assays were only performed for Cre-positive offspring, 
meaning that embryos were actually assigned to one of the following 5 categories: 
fluorescent conditional (green text), non-fluorescent conditional, fluorescent Cre-positive 
controls (green text), non-fluorescent Cre-positive controls and Cre-negative controls. 
 
X 
X 
Vangl2flox/flox R26YFP/YFP 
Vangl2flox/+;R26YFP/+ Grhl3Cre/+ 
Cre +ve offspring: 
Grhl3Cre/+;Vangl2flox(-)/+;R26YFP/+ 
Grhl3Cre/+;Vangl2flox(-)/+;R26+/+ 
Grhl3Cre/+;Vangl2+/+;R26YFP/+ 
Grhl3Cre/+;Vangl2+/+;R26+/+ 
 
Cre –ve offspring: 
Grhl3+/+;Vangl2flox/+;R26YFP/+ 
Grhl3+/+;Vangl2flox/+;R26+/+ 
Grhl3+/+;Vangl2+/+;R26YFP/+ 
Grhl3+/+;Vangl2+/+;R26+/+ 
Conditional  
Cre +ve controls – 50% reduction 
of Grhl3, wild type levels of Vangl2 
Cre -ve controls – wild type 
levels of both Grhl3 and Vangl2 
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Genotype 
Category 
E9.5 E11.5 - E12.5 
Expected Observed Expected Observed 
% Freq. % Freq. % Freq. % Freq. 
Conditional 
(fluorescent) 
12.50 4/29 13.79 4/29 12.50 12/97 10.31 10/97 
Conditional   
(non-fluor.) 
12.50 4/29 24.14 7/29 12.50 12/97 11.34 11/97 
Cre +ve controls 
(fluorescent) 
12.50 4/29 10.34 3/29 12.50 12/97 13.31 10/97 
Cre +ve controls 
(non-fluor.) 
12.50 4/29 0.00 0/29 12.50 12/97 18.56 18/97 
Cre -ve     
controls 
50.00 15/29 51.72 15/29 50.00 49/97 49.48 48/97 
Deviation from 
Mendelian ratios: 
χ
2
=4.900 with 4 degrees of freedom 
(p = 0.298) 
χ
2
=1.617 with 4 degrees of freedom 
(p = 0.806) 
 
Table 6.2 Genotype frequencies of offspring from Grhl3
Cre/+
 X Vangl2
flox/+
;R26
YFP/+
 
matings 
Embryos were collected at E9.5 and E11.5-E12.5 and genotypes were obtained in the 
expected Mendelian ratios at both stages (p > 0.29, Chi-square test). 
 
Whole Grhl3Cre/+;Vangl2flox(-)/+;R26YFP/+ (conditional) and Grhl3Cre/+;Vangl2+/+;R26YFP/+ 
(Cre-positive control) embryos were examined for the YFP lineage tracer, to 
examine the distribution of Grhl3-expressing cells and their descendants. No overt 
difference in the pattern of YFP expression was observed between the two 
genotypes. Representative examples of fluorescent embryos are shown in Figure 
6.6. At E9.5, YFP-positive cells were observed at numerous sites, most notably the 
ventral forebrain, otic vesicles, limb buds and caudal region. Labelled cells were 
also distributed more widely throughout the embryo, giving a speckled appearance 
(Figure 6.6A). Closer examination of the caudal region revealed fluorescent cells 
ventrally, and extending around the caudal tip (Figure 6.6B), as well as in the 
neuroepithelium and surface ectoderm more dorsally (Figure 6.6C). 
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Figure 6.6 YFP expression in embryos from Grhl3
Cre/+
 x Vangl2
flox/+
;R26
YFP/+
 matings 
(A-C) At E9.5 strong YFP expression is observed in the forebrain, otic vesicles and limb 
buds (A). In the caudal region, fluorescent cells are seen ventrally (arrow in B) and dorsally 
at the level of the PNP (arrows in C). (D-F) At E10.5 a similar tissue-specific distribution of 
YFP-positive cells is observed. A line of fluorescent cells can be seen along the dorsal 
region of the tail (arrow in E) and a speckled distribution of cells is apparent within the heart 
(F). (G-J) At E11.5-E12 Strong YFP-labelling is seen in the allantois and limb buds (G), the 
nasal region (H) and within the distal tail (I, J). Scale bars: 500 µm. 
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At E10.5 expression was also observed within the developing heart (Figure 6.6F). 
By E11.5-E12, YFP-positive cells could be seen in the allantois and the apical 
ectodermal ridge (AER) of the limb buds (Figure 6.6G) and in the frontonasal 
prominence (Figure 6.6H). A speckled distribution was observed in the tailbud at 
this stage, with labelled cells appearing as a midline streak in some embryos 
(Figure 6.6I, J). 
 
6.2.1.3 Grhl3cre/+ X  Vangl2fl/fl 
In a third cross, conditional embryos (Grhl3 heterozygote/Vangl2 conditional 
heterozygote) were also obtained from matings between Grhl3Cre/+ and Vangl2flox/flox 
mice, without the introduction of the R26YFP allele (Figure 6.7). Embryos from this 
cross were harvested at E12-E12.5 and genotypes were obtained in the expected 
Mendelian ratios (Table 6.3). 
 
 
 
 
 
 
 
 
Figure 6.7 Third breeding scheme for the generation of Grhl3
Cre/+
;Vangl2
flox/+
 embryos 
Matings between Grhl3
Cre/+
 and Vangl2
flox/flox
 mice produce embryos with one of 2 possible 
genotypes: conditional and Cre-negative controls. 
Grhl3Cre/+ Vangl2flox/flox 
X 
 
Grhl3Cre/+;Vangl2flox(-)/+        Conditional 
 
Grhl3+/+;Vangl2flox/+  
 
Cre -ve controls (wild type levels 
of both Grhl3 and Vangl2) 
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Genotype 
Expected Observed 
% Freq. % Freq. 
Grhl3
Cre/+
;Vangl2
flox(-)/+
 50.00 34/67 46.27 31/67 
Grhl3
+/+
;Vangl2
flox/+
 50.00 34/67 53.73 36/67 
Deviation from Mendelian 
ratios: 
χ
2
=0.0684 with 1 degree of freedom                  
(p = 0.794) 
 
Table 6.3 Genotype frequencies of offspring from Grhl3
Cre/+
 X Vangl2
flox/flox
 matings 
Embryos were collected at E12-E12.5 and genotypes were obtained in the expected 
Mendelian ratios (p = 0.794, Chi-square test). 
 
6.2.2 Spinal NTDs in conditional embryos 
Litters from the three breeding strategies described above were collected at E11.5-
E12.5 and embryos were examined for NTDs. Cre-negative embryos (wild type 
levels of both genes) obtained from each of the three matings were all 
phenotypically normal with a fully closed neural tube and a straight tail. Similarly, no 
abnormalities were observed in Grhl3Cre/+;Vangl2+/+;R26YFP/+ or 
Grhl3Cre/+;Vangl2+/+;R26+/+ ‘Cre-positive control’ (and therefore Grhl3 heterozygous) 
embryos obtained from Grhl3Cre/+ X Vangl2flox/+;R26YFP/+ matings (Table 6.4).  
 
In contrast, a small proportion of conditional Grhl3Cre/+;Vangl2flox/+ embryos from 
each of the three breeding strategies displayed defects of spinal neurulation (Figure 
6.8).  While the majority (87-95%) were phenotypically normal, tail flexion defects or 
spina bifida were observed in the remaining embryos. Interestingly, those with tail 
defects exhibited a ‘bent’ tail, rather than a ‘curly’ tail as described in Chapter 3, and 
of the two cases of spina bifida, one was accompanied by a bent tail and one by a 
straight tail. Examples of the different caudal phenotypes observed are shown in 
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Figure 6.8. The frequency of spinal defects in the conditional embryos did not differ 
significantly between the three breeding strategies used (Table 6.4; p = 0.535, Chi-
square test). 
 
Genotype category 
Caudal phenotype 
Straight tail 
% (freq.) 
Tail flexion 
defects alone         
% (freq.) 
Spina bifida 
% (freq.) 
1) Grhl3
Cre/+
;R26
YFP/+
 X Vangl2
flox/flox
 
Conditional 92.31 (12/13) 0 (0/13) 7.69 (1/13) (ST) 
Cre –ve controls 100 (13/13) 0 (0/13) 0 (0/13) 
2) Grhl3
Cre/+
 X Vangl2
flox/+
; R26
YFP/+
 
Conditional 95.24 (20/21) 4.76 (1/21) (BT) 0 (0/21) 
Cre +ve controls 100 (28/28) 0 (0/28) 0 (0/28) 
Cre -ve controls 100 (48/48) 0 (0/48) 0 (0/48) 
3) Grhl3
Cre/+
 X Vangl2
flox/flox
 
Conditional 87.10 (27/31) 9.68 (3/31) (BT) 3.23 (1/31) (BT) 
Cre –ve controls 100 (36/36) 0 (0/36) 0 (0/36) 
   
Table 6.4 Spinal phenotypes observed in E11-E12.5 conditional and control embryos 
The percentage and frequency of each phenotype is shown for embryos from each of the 
three breeding strategies used (numbered 1-3). The proportion of conditional embryos with 
tail defects and spina bifida does not vary significantly between the three matings (Chi-
square test; χ
2
=3.136 with 4 degrees of freedom; p = 0.535). Abbreviations: ST = straight 
tail, BT = bent tail. 
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Figure 6.8 Grhl3
Cre/+
;Vangl2
flox/+
 phenotypes  
Examples of the different phenotypes observed in conditional embryos at E11-E12.5. (A) 
Phenotypically normal embryo with a straight tail. (B-D) Spectrum of spinal defects 
observed. Higher magnification views are shown in the right hand panels. Arrows indicate 
the axial level of the open neural tube. Scale bars: 200 µm. 
 
6.2.3 Generation of Vangl2+/-;Grhl3+/- ‘positive controls’  
The finding that conditional Grhl3Cre/+;Vangl2flox/+ embryos display partially penetrant 
spinal NTDs indicates that Grhl3 and Vangl2 do interact within cells in which they 
are co-expressed, to affect the outcome of spinal neurulation. To test whether such 
a mechanism can fully explain the gene interaction (such as that observed in 
Vangl2Lp/+;Grhl3ct/ct embryos; Chapter 3), compound heterozygous Grhl3+/-;Vangl2+/- 
embryos, in which one allele of Vangl2 and Grhl3 has been lost in all cells, were 
also generated for analysis.  
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Figure 6.9  Breeding scheme to generate compound heterozygous control embryos 
Vangl2
flox/flox
 mice were initially bred with β-actin
Cre/+ 
mice to produce the null (Vangl2
-
) allele. 
Numbers in brackets indicate the expected proportion of offspring for each genotype.  
Matings between Grhl3
flox/-
 and Vangl2
+/-
;β-actin
Cre/+
 mice produce embryos with one of 8 
possible genotypes. (r) indicates a null allele produced by recombination. Genotyping did not 
distinguish between the Grhl3
-
 and Grhl
-(r)
 alleles, meaning that embryos were actually 
assigned to one of 6 categories (see Table 6.5). 
 
 
Grhl3flox/-  Vangl2+/-(r);β-actinCre/+  (1/2) X 
Vangl2flox/flox β-actinCre/+ X 
 
Grhl3+/-;Vangl2+/-;β-actin+/+ 
Grhl3+/-;Vangl2+/-;β-actinCre/+ 
Grhl3+/-(r);Vangl2+/-;β-actinCre/+ 
 
Grhl3+/-;Vangl2+/+;β-actin+/+ 
Grhl3+/-;Vangl2+/+;β-actinCre/+ 
Grhl3+/-(r);Vangl2+/+;β-actinCre/+ 
 
Grhl3+/flox;Vangl2+/-;β-actin+/+        Vangl2 heterozygous  
 
Grhl3+/flox;Vangl2+/+;β-actin+/+        Wild type levels of both Grhl3 and Vangl2 
 
Compound heterozygous 
(positive control embryos) 
Grhl3 heterozygous  
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Genotype  
E12.5 
Expected 
% (freq.) 
Observed 
% (freq.) 
Grhl3
+/-
;Vangl2
+/-
;β-actin
+/+ 
12.50 (19/151) 15.89 (24/151) 
Grhl3
+/-
;Vangl2
+/-
;β-actin
cre/+ 
25.00 (38/151) 25.83 (39/151) 
Grhl3
+/-
;Vangl2
+/+
;β-actin
+/+ 
12.50 (19/151) 10.60 (16/151) 
Grhl3
+/-
;Vangl2
+/+
;β-actin
cre/+ 
25.00 (38/151) 26.49 (40/151) 
Grhl3
+/flox
;Vangl2
+/-
;β-actin
+/+
 12.50 (19/151) 9.93 (15/151) 
Grhl3
+/flox
;Vangl2
+/+
;β-actin
+/+
 12.50 (19/151) 11.26 (17/151) 
Deviation from Mendelian 
ratios: 
χ
2
=1.481 with 5 degrees of freedom             
(p = 0.915) 
 
Table 6.5 Genotype frequencies of offspring from Grhl3
flox/-
 x Vangl2
+/-
;β-actin
Cre/+
 
matings 
Genotypes were obtained in the expected Mendelian ratios (Chi-square test).  
 
It was reasoned that, if the incidence of NTDs in Grhl3+/-;Vangl2+/- embryos was 
found to be no higher than in Grhl3Cre/+;Vangl2flox/+, it would suggest that an 
interaction between Grhl3 and Vangl2 during neurulation can be fully explained by a 
cellular/molecular interaction within the same tissue(s). On the other hand, if Grhl3+/-
;Vangl2+/- embryos develop NTDs at a significantly higher frequency it would point to 
an additional contribution from another mechanism, such as the summation of 
distinct effects in more than one tissue. The breeding strategy described in Figure 
6.9 was used to generate Grhl3+/-;Vangl2+/- embryos for analysis. Litters were 
collected at E12.5 and genotypes were obtained in the expected Mendelian ratios 
(Table 6.5). 
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6.2.4 Spinal NTDs in Grhl3+/-;Vangl2+/- embryos 
As expected, spinal abnormalities were observed in a proportion of compound 
heterozygous embryos. The presence of the β-actinCre allele, which was not bred 
out due to time constraints, did not affect the incidence of NTDs: both Grhl3+/-
;Vangl2+/-;β-actin+/+ and Grhl3+/-;Vangl2+/-;β-actinCre/+ embryos developed normally in 
69-75% of cases, while the remaining proportion displayed tail flexion defects alone 
or with spina bifida (Table 6.6). Among the embryos affected by spina bifida, 4/7 
had a bent tail while 3/7 developed a more tightly curled tail similar to that seen in 
Vangl2Lp/+;Grhl3ct/ct embryos (Chapter 3). Embryos of all other genotypes (Grhl3 
heterozygous, Vangl2 heterozygous and those with wild type levels of both genes) 
developed normally (Table 6.6). 
 
Genotype 
Caudal phenotype 
Straight tail 
% (freq.) 
Tail flexion 
defects alone                
% (freq.) 
Spina bifida 
% (freq.) 
Grhl3
+/-
;Vangl2
+/-
;β-actin
+/+ 
75.00 (18/24) 16.67 (4/24) 8.33 (2/24) (1BT, 1CT) 
Grhl3
+/-
;Vangl2
+/-
;β-actin
cre/+ 
69.23 (27/39) 17.95 (7/39) 12.82 (5/39) (3BT, 2CT) 
Grhl3
+/-
;Vangl2
+/+
;β-actin
+/+ 
100 (16/16) 0 (0/16) 0 (0/16) 
Grhl3
+/-
;Vangl2
+/+
;β-actin
cre/+ 
100 (40/40) 0 (0/40) 0 (0/40) 
Grhl3
+/flox
;Vangl2
+/-
;β-actin
+/+
 100 (15/15) 0 (0/15) 0 (0/15) 
Grhl3
+/flox
;Vangl2
+/+
;β-actin
+/+
 100 (17/17) 0 (0/17) 0 (0/17) 
 
Table 6.6 Spinal phenotypes observed in E12.5 compound heterozygous and control 
embryos 
The presence of the β-actinCre allele does not affect the frequency of defects in compound 
heterozygous embryos, shown in rows 1 and 2 (Chi-square test; χ
2
=0.352 with 2 degrees of 
freedom; p = 0.838). Abbreviations: BT = bent tail, CT = curly tail. 
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Figure 6.10 Spina bifida in Grhl3
+/-
;Vangl2
+/-
 embryos 
Examples of the different phenotypes observed in compound heterozygous embryos at 
E12.5. (A) Embryo with spina bifida and a bent tail. (B) Embryo with spina bifida and a 
curled tail. Higher magnification views are shown in C and D. Scale bars: 500 µm (A-B) and 
250 µm (C-D). 
 
6.2.5 Summary of spinal NTD data 
Having established that the NTD prevalence in Grhl3Cre/+;Vangl2flox/+ was not 
affected by the breeding strategy used (Table 6.4), and that the incidence of defects 
in Grhl3+/-;Vangl2+/- was not affected by the presence of the β-actincre allele (Table 
6.6), data from embryos of the same genotype were pooled. As in Chapter 3, spina 
bifida cases were also categorised by severity according to the axial level of the 
open region.  
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Genotype  
Caudal phenotype 
Straight tail 
% (freq.) 
Tail flexion 
defects alone         
% (freq.) 
Small spina 
bifida 
% (freq.) 
Large spina 
bifida 
% (freq.) 
Negative control pooled 
(Grhl3
+/+
;Vangl2
flox/+ 
or Grhl3
+/+
;Vangl2
+/+
) 
100 (97/97) 0 (0/97) 0 (0/97) 0 (0/97) 
Conditional pooled 
(Grhl3
Cre/+
;Vangl2
flox/+
) 
90.77 (59/65) 6.15 (4/65) 3.08 (2/65) 0.00 (0/65) 
Compound heterozygous 
pooled  
(Grhl3
+/-
;Vangl2
+/-
) 
71.43 (45/63) 17.46 (11/63) 0.00 (0/63) 11.11 (7/63) 
 
Table 6.7 Summary of NTD frequencies  
The phenotypic proportions observed in Grhl3
Cre/+
;Vangl2
flox/+
 differ significantly from those in 
Grhl3
+/-
;Vangl2
+/-
 (Chi-square test; χ
2
=14.123 with 3 degrees of freedom; p = 0.003). 
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Figure 6.11 Graphical summary of NTD frequencies at E11-E12.5 
Graph illustrating a significantly more severe phenotype in Grhl3
+/-
;Vangl2
+/-
 (compound het.) 
embryos than in Grhl3
Cre/+
;Vangl2
flox/+
 (conditional). The NTD frequency in 
Vangl2
Lp/+
;Grhl3
ct/ct
 (Chapter 3) is also included for comparison. 
-ve 
control 
Conditional Compound 
het. 
Lp/+;ct/ct 
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Overall, 28% of compound heterozygous Grhl3+/-;Vangl2+/- embryos displayed a 
spinal neurulation defect, compared with only 9% of conditional Grhl3Cre/+;Vangl2flox/+ 
embryos. Hence, there was a three-fold increase in defect frequency in compound 
heterozygotes compared with conditional embryos (Table 6.7). Of the spina bifida 
cases recorded, Grhl3+/-;Vangl2+/- displayed increased axial severity compared to 
Grhl3Cre/+;Vangl2flox/+ (Figure 6.11).  
 
6.2.6 Cranial NTDs 
One exencephalic Grhl3+/-;Vangl2+/- embryo was recorded (1.59%), while no cranial 
defects were observed in conditional Grhl3Cre/+;Vangl2flox/+ embryos or in any other 
control genotypes. 
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6.3 Discussion 
This chapter aims to investigate the interaction between Vangl2 and Grhl3 during 
neurulation using a conditional genetic approach. Spinal defects  (tail defects and/or 
spina bifida) were observed in nearly 10% of conditional Grhl3Cre/+;Vangl2flox/+ 
embryos, demonstrating that when embryos are heterozygous for Grhl3 with the 
additional loss of one Vangl2 allele in Grhl3-expressing cells, neurulation is 
compromised. Compound heterozygous Grhl3+/-;Vangl2+/- embryos were more 
severely affected, developing abnormalities in around 30% of cases. These 
experiments suggest that a molecular interaction in the same population of cells 
only partially accounts for the phenotype observed when both genes are mutated.  
 
Defects were not observed in Vangl2 heterozygotes (Vangl2+/-; Table 6.6), 
consistent with a report by Song et al., in which embryos heterozygous for a Vangl2 
null allele (Vangl2Δ/+) have normal, straight tails (Song et al., 2010). However, a 
more recent study found that 11% of mice carrying one copy of another null allele 
(Vangl2ΔTMs/+) display a looped or kinked tail (Yin et al., 2012). Grhl3 heterozygotes 
were found to be normal here (Table 6.6), as previously reported (Caddy et al., 
2010). Importantly, Cre-positive control embryos were also phenotypically normal, 
confirming the finding by Camerer et al. that the Grhl3Cre allele has no deleterious 
effect on neurulation in the absence of a relevant floxed allele (Camerer et al., 
2010). No NTDs were observed in embryos with wild type levels of both Vangl2 and 
Grhl3. 
 
The data in this Chapter support the findings in Chapters 4 and 5, which suggest 
that in Vangl2Lp/+;Grhl3ct/ct embryos there are two different effects underlying the 
NTD phenotype: (1) cell autonomous effects of the mutated forms of Vangl2 and 
Grhl3 in the same cells and (2) non-cell autonomous effects due to the activities of 
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Vangl2 and Grhl3 in different tissues. As discussed in Chapter 5, it will be important 
to accurately determine the spatiotemporal co-expression of the two proteins within 
the caudal tissues of the embryo. The dynamic nature of Grhl3 expression also 
suggests that the Vangl2flox allele could be recombined in descendants of Grhl3-
expressing cells prior to neurulation, and/or in regions where Grhl3 is no longer 
being transcribed. A thorough analysis of Grhl3 and Vangl2 expression at earlier 
embryonic stages would help to explore this further. 
 
6.3.1 Why the variable effects of different Vangl2 and Grhl3 
mutant alleles? 
The frequencies of NTDs in conditional Grhl3Cre/+;Vangl2flox/+ and compound 
heterozygous Grhl3+/-;Vangl2+/- embryos are both considerably lower than in 
Vangl2Lp/+;Grhl3ct/ct (Figure 6.11) or indeed than in Vangl2Lp/+;Grhl3ct/+ (see Chapter 
3). When designing the current breeding schemes, a partially penetrant NTD 
phenotype was predicted in Grhl3+/-;Vangl2+/- embryos, based on the observation 
that  Vangl2Lp/+;Grhl3+/- embryos display spina bifida at a frequency of 67% (Caddy 
et al., 2010). However, the incidence of spina bifida observed here (11%) is mild in 
comparison. These observations raise the question of why mice carrying the 
Vangl2Lp allele are more predisposed to NTDs than those with a Vangl2- (null) allele. 
 
6.3.1.1 Does Vangl2Lp exert a dominant negative effect? 
Recent comparisons between the phenotypes of loop-tail mutants and Vangl2 
knockout embryos have demonstrated that loop-tail is, in fact, a dominant negative 
allele. A Vangl2 null allele (Vangl2Δ) was previously generated by deleting exons 
four and five, a region which includes the four Vangl2 transmembrane domains. The 
authors of this study found that, compared with Vangl2Lp, the Vangl2Δ allele had a 
weaker phenotypic impact: all Vangl2Lp/+ mice developed tail defects while 99% of 
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Vangl2Δ/+ mice were normal and, while many Vangl2Lp/+ females were infertile due to 
an imperforate vagina, all Vangl2Δ/+ were fertile. Vangl2Lp also had a stronger effect 
in combination with a Vangl1 gene-trap allele, with an exacerbation of cochlea 
polarity defects observed in Vangl2Lp/Lp and Vangl2Lp/+;Vangl1gt/gt, compared to 
Vangl2Δ/Δ  and Vangl2Δ/+;Vangl1gt/gt, respectively (Song et al., 2010). 
Vangl2Δ/+;Vangl1gt/+ were otherwise morphologically normal, which contrasts with the 
craniorachischisis reported in a proportion of Vangl2Lp/+;Vangl1gt/+ embryos (Torban 
et al., 2008). 
 
A similar effect was recently reported in embryos carrying an independent Vangl2 
null allele (Vangl2ΔTMs) (Yin et al., 2012). While Vangl2Lp/Lp mutants develop 
craniorachischisis with 100% penetrance, only 74% of Vangl2ΔTMs/ΔTMs animals 
exhibited this severe neural tube defect, with the remaining 26% displaying a milder 
spina bifida phenotype. Similarly, only 11% of Vangl2ΔTMs/+ mice showed tail defects, 
a characteristic feature of the majority of Vangl2Lp/+ animals. When the polarity of 
hair cells in the developing inner ear was examined, more severe phenotypes were 
observed in Vangl2ΔTMs/Lp compound mutants than in Vangl2ΔTMs/ΔTMs embryos. 
Together, these findings indicate that the presence of the Lp mutant protein has a 
greater effect than the loss of wild-type Vangl2. 
 
The Lp mutation has previously been shown to disrupt Vangl2 protein trafficking 
from the endoplasmic reticulum to the plasma membrane (Merte et al., 2010). One 
possible molecular explanation for the loop-tail dominant effect is that disrupted 
Vangl2Lp protein trafficking also affects the cellular distribution of other PCP 
proteins, leading to an overall reduction in planar polarity. Indeed, both in vitro and 
in vivo experiments indicate that the presence of the Vangl2Lp protein alters the 
normal localisation of wild type Vangl2, Vangl1 and the putative Vangl2-interacting 
protein, Prickle-like2 (Yin et al., 2012). Moreover, phosphorylation of wild type 
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Vangl2, which is required for its function, was reduced when it was co-expressed 
with Vangl2Lp in vitro (Gao et al., 2011). Hence, the loop-tail mutation may disturb 
PCP signalling through an adverse effect on wild type Vangl2 and several key 
interacting proteins, producing a more profound disturbance than loss of Vangl2 
alone. 
 
6.3.1.2 Grhl3ct versus Grhl3- 
Conversely, the low-frequency NTDs in homozygous curly tail (Grhl3ct/ct) embryos 
represent a milder phenotype than the fully penetrant spina bifida observed in 
homozygous Grhl3 null mice (Ting et al., 2003a; Van Straaten and Copp, 2001; Yu 
et al., 2006). Genetic complementation studies have also shown the incidence of 
spina bifida to be 31% in Grhl3-/ct embryos, compared to 12% in Grhl3ct/ct (Ting et 
al., 2003a; Van Straaten and Copp, 2001). These alleles result in different levels of 
gene expression; Grhl3 mRNA is reportedly absent in null (-/-) mice (Ting et al., 
2003a; Yu et al., 2006), which contrasts with the hypomorphic nature of the Grhl3ct 
allele (see Chapter 5) (Gustavsson et al., 2007; Ting et al., 2003a).  
 
As described in Chapter 1, genetic modifier loci are present within the background 
of the curly tail strain. However, non-specific modifier effects are unlikely to account 
for the variation in NTD prevalence observed between Grhl3Cre/+;Vangl2flox/+ and 
Grhl3+/-;Vangl2+/- embryos as, here, the differences in genetic background are 
predicted to be minimal: The Grhl3Cre/+, R26YFP/YFP and Vangl2flox/flox mouse strains 
were all maintained on a C57BL/6J background for generation of conditional 
embryos, as were the β-actinCre/+ and Grhl3flox/- animals used to produce compound 
heterozygotes.  
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6.3.2 Development of tail defects 
Although it has been established that spina bifida and tail flexion defects are 
alternative outcomes of delayed PNP closure, the mechanism by which the tail curls 
or bends dorsally is not well understood. An early study showed that, although the 
neural tube is fully closed in embryos with tail flexion defects alone, this region is 
morphologically abnormal: the neural tube is positioned above the somites rather 
than lying between them, possibly due to mechanical stress imposed by the 
persistently open neural folds (Copp et al., 1982). Interestingly, the curled region of 
the tail is actually formed during secondary neurulation, suggesting that there could 
be defects in the transition from primary to secondary neurulation. In curly tail 
embryos tail defects are strongly, but not absolutely, associated with spina bifida, 
demonstrating that the two phenotypes are occasionally uncoupled (Van Straaten 
and Copp, 2001). It would be interesting to investigate whether the development of 
tail defects in curly tail embryos is linked to the expression of Grhl3 in the tailbud.  
 
The relationship between spina bifida and tail defects appears to differ between the 
strains examined here: in Vangl2Lp/+;Grhl3ct/ct embryos spina bifida was always 
accompanied by a curled tail (Chapter 3), while the Grhl3Cre/+;Vangl2flox/+ and Grhl3+/-
;Vangl2+/- embryos with spina bifida exhibited either a straight, curled or more 
sharply bent tail (Figure 6.8, Figure 6.10). These findings are reminiscent of 
previous observations that a proportion of transgenic curly tail embryos, which over-
express Grhl3 from a BAC (ctTgGrhl3/ctTgGrhl3), display spina bifida with a straight 
rather than a curled tail (Sandra C.P. de Castro, unpublished data). Together these 
data suggest that there may be different mechanisms underlying the NTDs in 
different Grhl3-mutant strains. 
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6.3.3 Additional roles of Grhl3? 
As described in Chapter 5, Grhl3 transcripts are present at various embryonic sites 
during neurulation, including the forebrain, caudal neural plate, tail bud and hindgut. 
In Grhl3Cre/+;R26YFP/+ embryos, YFP-positive cells are also observed in regions such 
as the otic vesicles and limb-buds, and they appear to be more widely distributed 
throughout the embryo, giving a overall speckled appearance. This pattern of 
labelled cells suggests that there could be, or have previously been, low level 
expression of Grhl3 at additional sites during development, perhaps below the level 
that would be detected by WISH. Alternatively, the speckled distribution could 
reflect a very early recombination event, for example in a few cells of the inner cell 
mass (ICM), which could lead to the observed mosaic pattern of fluorescence. To 
address these possibilities, it would be interesting to examine YFP expression in 
early Grhl3Cre/+;R26YFP/+ embryos, in combination with detailed WISH or IHC studies 
of Grhl3 expression dynamics. 
 
Additionally, the multigenerational pattern of YFP inheritance (see Figure 6.3) and 
the expression of YFP in the gonads of Grhl3Cre/+;R26YFP/+ adult mice (Figure 6.4) 
suggest that Grhl3 is activated in the germ cell precursors (PGCs) and/or gametes. 
In the mouse embryo, PGCs arise in the posterior primitive streak at E7.5, from 
where they migrate into the adjacent endoderm (future hindgut). By E8.5 they are 
highly motile and migrate along the hindgut as it extends anteriorly. Between E9.5-
E10.5 germ cells exit the hindgut tissue and migrate dorsally, then bilaterally 
towards the genital ridges, the mesodermal precursors to the gonads. By E11.5, the 
majority of PGCs have reached the genital ridges where they undergo extensive 
reprogramming and associate with somatic cells during gonad formation 
(Molyneaux et al., 2001; Richardson and Lehmann, 2010).  
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A potential role for Grhl3 in germ cell development is interesting and warrants 
further investigation. Although this was beyond the scope of the current project, our 
group is currently examining Grhl3 expression during gonad development in 
collaboration with members of Dr Andrew Greenfield’s laboratory (MRC Harwell). 
So far, YFP-positive cells have been identified in the developing gonads of both 
male and female Grhl3Cre/+;R26YFP/+ adult mice (Figure 6.4) and in embryos at E14.5 
(Nick Greene, personal communication). Whether Grhl3 is required for PGC 
migration, differentiation, or later during oogenesis and spermatogenesis, remains 
to be determined.  
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7.  PCP and neural crest cell migration 
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7.1 Introduction 
The signals and pathways known to regulate neural crest (NC) cell migration are 
described in Chapter 1. Most of these molecules act as inhibitory cues, preventing the 
NC from entering prohibited areas while allowing them to populate permissive zones. 
However, while such factors can explain how the segmented pattern of NC migration is 
achieved, they do not explain how the persistent directionality of their migration is 
controlled. In recent years, studies of the molecular mechanisms that control this 
directional migration in Xenopus and zebrafish embryos have demonstrated an 
essential role for the non-canonical Wnt/PCP signalling pathway.  
 
7.1.1 PCP signalling regulates Xenopus and zebrafish neural 
crest migration 
In Xenopus embryos, the expression of mutant PCP pathway components has been 
shown to ‘dramatically’ inhibit the migration of cranial NC cells (De Calisto et al., 2005). 
De Calisto et al. injected two-cell-stage embryos with mutated Dishevelled constructs 
(Dsh-DEP+ or Dsh-∆N) that specifically interfere with Wnt/PCP signalling, without 
affecting the canonical pathway (Tada and Smith, 2000). Injected embryos displayed 
greatly reduced cranial NC migration, while NC induction appeared normal. The same 
effect on migration was seen when Dsh-DEP+ expressing NC cells were transplanted 
to an uninjected host embryo, suggesting that the PCP pathway works in a cell-
autonomous manner (Figure 7.1A, B). This phenotype was also observed after 
disrupting the activity of the PCP ligand Wnt11, by injecting either Wnt11 itself, or its 
dominant negative mRNA (dnWnt11). Xenopus Wnt11 is expressed just ahead of the 
laterally migrating NC cells, while the Frizzled7 (Fz7) receptor is expressed in the pre-
migratory and migrating NC themselves. It was observed that early NC cells move 
beneath the Wnt11-expressing cells as they migrate, leading the authors of this study 
to propose that NC cells are attracted to regions with high Wnt11 activity, before 
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making way for later-migrating cells (De Calisto et al., 2005). In zebrafish embryos, 
similar NC migration defects have been reported in the trunk after injection of mutant 
Dishevelled (Dsh-DEP+) or Wnt5 morpholino, and in the trilobite (Stbm/Vangl2) mutant 
(Figure 7.1E-H) (Matthews et al., 2008).  
 
7.1.2 Mechanism of PCP signalling in the neural crest 
When Xenopus NC cells are cultured in vitro, the migration of those explanted from 
PCP-mutant embryos is strongly inhibited (Figure 7.1C, D), as in vivo. At a cellular 
level, PCP signalling is required to stabilise the production of polarised cell protrusions 
in leading edge NC cells; control cells extend large lamellipodia towards the front, while 
PCP-mutant cells display fewer, less stable, protrusions (De Calisto et al., 2005). 
 
                   
Figure 7.1 PCP signalling is required for neural crest migration in Xenopus and zebrafish 
(A) Control Xenopus embryo following transplantation of fluorescein dextran (FDX)-labelled 
cranial NC cells. (B) Embryo grafted with NC from an embryo expressing Dsh-DEP+. (C,D) 
Culture of NC explants taken from control (C) and Dsh-DEP+ injected (D) embryos. (E-H) 
Zebrafish trunk NC migration in control and PCP-mutant embryos. Images taken from (De 
Calisto et al., 2005) (A-D) and (Matthews et al., 2008) (E-H). 
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More recently it was reported that Xenopus and zebrafish NC cells achieve directional 
migration via contact inhibition of locomotion (CIL) (Carmona-Fontaine et al., 2008b), a 
phenomenon that was originally discovered around 60 years ago and describes how 
fibroblast cells in vitro ‘cease to continue moving in the same direction after contact 
with another cell’ (Abercrombie and Heaysman, 1953; Abercrombie and Heaysman, 
1954). Carmona-Fontaine and colleagues studied the interactions between 
neighbouring NC cells and found that migratory cells exhibit CIL, both in vitro and in 
vivo. This behaviour requires intact non-canonical Wnt signalling; while control NC 
cells retract their lamellipodia and change direction on contact with one another, those 
lacking PCP components (cells from Dsh-DEP+, dnWnt11, Stbm MO or Pk MO-treated 
embryos) fail to do so. Instead, these cells extend protrusions between their 
neighbours and migrate on top of one other (Carmona-Fontaine et al., 2008b).  
 
Together these studies propose a model whereby the collision of two NC cells leads to 
an accumulation of PCP components (Dsh, Wnt11 and Fz7) at the points of contact 
between adjacent cells. Analysis of Rho GTPase activity revealed that an increase in 
PCP signalling results in a local increase in RhoA activity, which inhibits Rac. Rac is 
also inhibited by the proteoglycan Syndecan-4 (Syn4), which is expressed in the 
migrating NC of Xenopus and zebrafish embryos and is required for their directionality. 
The NC phenotype produced by inhibition of Syn4 is reminiscent of that caused by 
PCP inhibition, and convergence of the two pathways has been found to occur via the 
regulation of the small GTPases. Thus, the model postulates that a decrease in Rac 
activity at cell-cell contacts directs the collapse of cell protrusions at the back of the NC 
cell, while an enrichment of Rac at the leading edge promotes actin polymerisation and 
lamellipodia. This brings about a change in polarity and the direction of migration 
(Carmona-Fontaine et al., 2008a; Matthews et al., 2008). This chapter aims to 
investigate whether there is a comparable role for PCP signalling during mammalian 
NC cell migration. 
 - 266 - 
7.2 Results 
To investigate whether PCP plays an essential role in mammalian NC migration the 
loop-tail (Vangl2Lp) mouse, which carries a likely dominant negative allele of the core 
PCP gene Vangl2 (Kibar et al., 2001b; Murdoch et al., 2001a; Song et al., 2010; Yin et 
al., 2012), was studied. 
 
7.2.1 Neural crest specification and migration are normal in 
Vangl2Lp/Lp embryos 
The specification of NC cells in wild-type and loop-tail embryos was examined using 
WISH for markers of pre-migratory and early migrating NC cells. The forkhead 
transcription factor FoxD3 is one of the earliest markers of the NC lineage (Sauka-
Spengler and Bronner-Fraser, 2008) and in E8.5 wild type embryos, FoxD3 labelled 
NC cells along the edges of the dorsal neural folds in the cranial region and as far 
caudally as the closed neural tube adjacent to the fourth somite pair (Figure 7.2A). In 
Vangl2Lp/Lp embryos a similar pattern of expression was observed, despite the failure of 
closure 1 in these mutants (Figure 7.2B). In both genotypes, FoxD3 expression was 
absent at the level of rhombomeres 3 and 5, the so-called ‘neural crest-free’ zones 
(Trainor et al., 2002). 
 
WISH for the transcription factor Sox9, another NC specifier, was also performed. At 
E9.5 a dorsal line of Sox9-positive NC cells was visible along the neural tube of wild-
type embryos, with a caudal limit at the level of the most recently formed somites 
(Figure 7.3A). A similar pattern of Sox9 staining was observed in the equivalent rostro-
caudal region on the tips of the open neural folds in Vangl2Lp/Lp embryos (Figure 7.3B). 
Together, these data suggest that NC cells are specified similarly in both genotypes, 
despite the failed neural tube closure in Lp homozygotes.  
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Figure 7.2 Vangl2
Lp/Lp
 embryos display normal neural crest specification at E8.5. 
Whole-mount in situ hybridisation for FoxD3 in wild-type (Vangl2
+/+
; A) and Vangl2
Lp/Lp
 (B) 
embryos. (A, B) Dorsal views showing FoxD3 labelling of pre-migratory NC cells in the dorsal 
neuroepithelium. In both genotypes the rostro-caudal wave of NC specification has reached as 
far caudally as somite 4 (arrows). (A’, B’) Lateral views of the embryos shown in A and B. In 
both genotypes FoxD3-positive NC cells are absent at the level of rhombomeres 3 and 5 
(arrowheads). n = minimum of 4 embryos per genotype. Scale bars: 200 µm. 
 
Next the spatiotemporal pattern of NC migration was compared in wild-type and 
Vangl2Lp/Lp embryos by WISH for Erbb3, a member of the neuregulin receptor tyrosine 
kinase family which is expressed by NC cells during their migration (Meyer and 
Birchmeier, 1995) In wild-type embryos at the 13-somite stage, characteristic streams 
of cranial NC cells were observed migrating from the hindbrain towards the first and 
second branchial arches and around the optic vesicles (Figure 7.4A, B). More caudal 
sections also revealed Erbb3-positive trunk NC cells delaminating from the 
neuroepithelium and migrating ventrally (Figure 7.4C). When stage-matched 
Vangl2Lp/Lp embryos were examined, no differences in the pattern of NC migration were 
detected, despite the widely open neural folds (Figure 7.4D-F). By 20-22 somites, 
Erbb3-labelled trunk NC cells could be seen migrating from the dorsal neural tube of 
wild-type embryos (Figure 7.5A-F) and from the equivalent (lateral) region of the 
neuroepithelium in Vangl2Lp/Lp embryos (Figure 7.5G-L). By the 25-somite stage, 
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distinct migratory streams were observed in embryos of both genotypes (Figure 7.5M-
N). Notably, the axial level and rostro-caudal progression of NC migration in Vangl2Lp/Lp 
was comparable to wild-type at all stages analysed, despite the failure of body axis 
extension and neural tube closure in the mutants. 
 
           
Figure 7.3 Vangl2
Lp/Lp
 embryos display normal neural crest specification at E9.5. 
Whole-mount in situ hybridisation for Sox9 in wild-type (Vangl2
+/+
; A, C, E) and Vangl2
Lp/Lp
 (B, 
D, F) embryos. (A, B) Lateral views of wild-type and Vangl2
Lp/Lp 
embryos showing Sox9 
labelling of pre-migratory NC cells in the dorsal neural tube and tips of the open neural folds, 
respectively. Sox9 labels NC cells as far caudally as the most recently formed somites in both 
genotypes (arrows). (C, D) Higher magnification images of the trunk region of embryos shown 
in A and B. (E, F) Dorsal views of Sox9-positive NC cells in the dorsal midline of the wild-type 
neural tube (E) and at the tips of the persistently open neural folds of Vangl2
Lp/Lp
 (F). n = 3 
embryos per genotype. Scale bars: 500 µm. 
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As an alternative, genetic approach to identifying NC cells, transgenic mice expressing 
Cre recombinase under the control of the Wnt1 promotor (Jiang et al., 2000) and 
Rosa26YFP reporter mice (Srinivas et al., 2001) were used to generate wild-type and 
Vangl2Lp/Lp embryos in which the NC and their derivatives were fluorescently labelled. 
The breeding strategy outlined in Figure 7.6 was used to produce Vangl2+/+;Wnt1-
Cre/YFP and Vangl2Lp/Lp;Wnt1-Cre/YFP embryos for analysis. As expected, loop-tail 
homozygous mutants (Vangl2Lp/Lp) displayed craniorachischisis with 100% penetrance, 
while all Vangl2Lp/+ and Vangl2+/+ embryos had successfully completed closure 1 and 
were undergoing low spinal neurulation. 
           
Figure 7.4 Erbb3 expression in Vangl2
+/+
 and Vangl2
Lp/Lp
 at E9.0 
WISH Erbb3 in wild-type (A-C) and loop-tail (D-F) embryos. Cranial NC cells can be seen 
migrating in two distinct streams towards the first and second branchial arches and to surround 
the optic vesicles, in both Vangl2
+/+
 and Vangl2
Lp/Lp
 embryos (arrows in A, D). Transverse 
sections reveal colonisation of the branchial arches (B, E) and migrating NC cells (arrows in C, 
F) in both genotypes. Scale bars: 500 µm (A, D) and 100 µm (B, C, E, F). 
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Figure 7.5 Erbb3 expression in Vangl2
+/+
 and Vangl2
Lp/Lp
 at E9.5 
WISH for the NC marker Erbb3 in wild-type (A-F, M) and loop-tail (G-L, N) embryos.  
(A-L) By 20-22 somites, Erbb3 marks the rostral-caudal progression of trunk NC cells 
emigrating from the dorsal neural tube. A similar pattern of emigration is observed in Vangl2
+/+
 
and Vangl2
Lp/Lp
,
 
despite the widely open neural folds and failure of body axis elongation in the 
latter. Transverse sections confirm closely similar NC migration in both genotypes (B-F, G-L).  
(M, N) At the 25 somite stage, streams of NC cells can be seen migrating in the trunk of both 
Vangl2
+/+
 (M) and Vangl2
Lp/Lp
 (N) embryos. Higher magnification views of the boxed areas in M 
and N reveal comparable NC migration in both genotypes (M’, N’). Abbreviations: ba = 
branchial arch, da = dorsal aorta, f = facial NC, ov = optic vesicle. n = minimum of 3 embryos 
per genotype. Scale bars: 500 µm (A, G, M, N) and 200 µm (B-F, H-L, M’, N’).  
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                          X                                      X 
                                    
 
Offspring Genotype 
Category 
Genotype(s) 
1 Vangl2
+/+
;
 
Wnt1-Cre;
 
R26
YFP/+ 
 (1/16) 
2 Vangl2
Lp/+
;
 
Wnt1-Cre;
 
R26
YFP/+  
(2/16)
 
3 Vangl2
Lp/Lp
;
 
Wnt1-Cre;
 
R26
YFP/+  
(1/16)
 
4 
Vangl2
+/+
;
 
Wnt1
+/+
;
 
R26
+/+
 (1/16)
 
Vangl2
+/+
;
 
Wnt1
+/+
;
 
R26
YFP/+
 (1/16)
 
Vangl2
+/+
;
 
Wnt1-Cre;
 
R26
+/+
 (1/16)
 
5 
Vangl2
Lp/+
;
 
Wnt1
+/+
;
 
R26
+/+
 (2/16)
 
Vangl2
Lp/+
;
 
Wnt1
+/+
;
 
R26
YFP/+
 (2/16)
 
Vangl2
Lp/+
;
 
Wnt1-Cre;
 
R26
+/+ (2/16) 
6 
Vangl2
Lp/Lp
;
 
Wnt1
+/+
;
 
R26
+/+
 (1/16)
 
Vangl2
Lp/Lp
; Wnt1
+/+
;
 
R26
YFP/+
 (1/16)
 
Vangl2
Lp/Lp
;
 
Wnt1-Cre;
 
R26
+/+ (1/16) 
    
Figure 7.6 Breeding scheme used to generate Vangl2
+/+
; Wnt1-Cre/YFP and Vangl2
Lp/Lp
; 
Wnt1-Cre/YFP embryos for analysis. 
Matings between Vangl2
Lp/+
;
 
R26
YFP/+ 
and Vangl2
Lp/+
;
 
Wnt1-Cre mice produces embryos with 
one of 16 possible genotypes. However, offspring were only examined for YFP expression and 
genotyped for the presence of the Vangl2
Lp
 allele, meaning that embryos were actually 
assigned to one of the following 6 categories: (1) fluorescent Vangl2
+/+
, (2) fluorescent 
Vangl2
Lp/+
, (3) fluorescent Vangl2
Lp/Lp
, (4) non-fluorescent Vangl2
+/+
, (5) non-fluorescent 
Vangl2
Lp/+
 and (6) non-fluorescent Vangl2
Lp/Lp
. Numbers in brackets indicate the expected 
proportion of offspring for each genotype. Green text indicates fluorescent embryos. 
X 
Vangl2Lp/+ R26YFP/YFP 
Vangl2Lp/+; R26YFP/+  (1/2) 
Vangl2Lp/+ Wnt1-Cre 
Vangl2Lp/+; Wnt1-Cre  (1/4) 
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Whole-mount embryos were examined by direct visualisation of the YFP fluorescence, 
and anti-GFP/YFP immunostaining was performed on transverse sections. Both 
analyses revealed a similar NC migration pattern in Vangl2+/+;Wnt1-Cre/YFP and 
Vangl2Lp/Lp;Wnt1-Cre/YFP embryos (Figure 7.7), consistent with the WISH data. At 13-
14 somites migrating, YFP-positive NC cells were visible within the forebrain, peri-
ocular region and branchial arch 1 (also entering arch 2) in both Vangl2+/+;Wnt1-
Cre/YFP and Vangl2Lp/Lp;Wnt1-Cre/YFP embryos (Figure 7.7A-C, E-G). At the level of 
the heart, migrating NC could be seen in both genotypes (Figure 7.7D, H). By 22-23 
somites, branchial arches 1 and 2 were colonised by NC, and cells were also entering 
the lower arches, similarly in both Vangl2+/+;Wnt1-Cre/YFP and Vangl2Lp/Lp;Wnt1-
Cre/YFP embryos (Figure 7.7I, M). Sections again revealed closely comparable 
patterns of NC cell distribution at different axial levels. Thus, WISH and fluorescent 
labelling of the neural crest and its descendants reveal normal migration in Vangl2Lp/Lp 
embryos at E9-E9.5. 
 
I also quantified the numbers of migrating NC cells in Vangl2+/+;Wnt1-Cre/YFP and 
Vangl2Lp/Lp;Wnt1-Cre/YFP embryos between E9 and E10.5. When migrating YFP-
positive cells at three different embryonic regions were counted, no significant 
differences in cell number were found between genotypes (Figure 7.8). These data 
indicate that the numbers of NC cells emigrating from the neural tube of Vangl2Lp/Lp 
embryos are comparable to wild-type. 
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Figure 7.7 Fluorescent labelling of the neural crest lineage at E9-9.5 
Neural crest cell migration in Vangl2
+/+
;Wnt1-Cre/YFP (Hereafter denoted +/+; A-D, I-L) and 
Vangl2
Lp/Lp
;Wnt1-Cre/YFP (Hereafter denoted Lp/Lp; E-H, M-P) embryos. Whole mount 
embryos (A,E,I,M) show directly visualised YFP. Transverse sections (B-D, F-H, J-L, N-P; at the 
level of the dashed lines in bright field inset images) are immunostained with anti-GFP/YFP.  
(A-H) At 13-14 somites, YFP-positive NC cells have colonised the forebrain, peri-ocular region 
and first branchial arch, and are entering the second branchial arch, with similar appearance in 
both +/+ (A) and Lp/Lp (E) embryos. Transverse sections show forebrain and branchial arch 
colonisation (B, C, F, G) and active NC migration at the level of the heart (arrows in D, H).   
(I-P) At 22-23 somites, fluorescently labelled cells are observed in the lower branchial arches of 
both +/+ and Lp/Lp embryos (arrows in I and M). Transverse sections show extensive NC 
colonisation of forebrain and hindbrain in both genotypes (J, N). Neural crest emigration from 
the neural tube (arrows in K,L,O,P) and NC colonisation of the region lateral to the foregut 
(arrowheads in K,O) and adjacent to the paired aortae (arrowheads in L,P) appear closely 
similar in +/+ and Lp/Lp.  Scale bars: 100 µm. 
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Figure 7.8 Quantification of migrating neural crest cells in Vangl2
+/+
; Wnt1-Cre/YFP and 
Vangl2
Lp/Lp
; Wnt1-Cre/YFP embryos.  
Mean numbers of migrating, YFP-positive neural crest cells at different regions of E9-10.5 
embryos. (A) Sections at the level of the developing heart as shown in Figure 7.7D and H (p = 
0.183, t-test; n = at least 4 sections per genotype). (B) Trunk sections as shown in Figure 7.7L 
and P (p = 0.446, t-test; n = 3 sections per genotype). (C) Sections at the level of the 
foregut/trachea as shown in Figure 7.10L and Q (p = 0.664, t-test; n = 5 sections per genotype). 
 
7.2.2 Neural crest derivatives are patterned normally in Vangl2Lp/Lp 
embryos 
We next investigated whether loop-tail embryos display any abnormalities in NC cell 
distribution or the patterning of NC-derived structures at E10.5, which could be 
indicative of earlier defective migration. WISH for Erbb3 revealed the cranial ganglia to 
be appropriately sized and patterned in Vangl2Lp/Lp compared to stage-matched wild-
type embryos (Figure 7.9A, D).  The dorsal root ganglia (DRG), which come to lie 
either side of the closed spinal neural tube in wild-type embryos (Figure 7.9B), 
appeared normal in Vangl2Lp/Lp embryos. Despite the grossly abnormal morphology of 
loop-tail mutants, distinct ganglia were seen along the trunk adjacent to the equivalent 
region of open neural folds (Figure 7.9E). More caudally, at the level of the hindlimb 
buds, NC cells were beginning to delaminate as ‘segmental’ streams from the 
neuroepithelium in both wild-type and Vangl2Lp/Lp embryos (Figure 7.9C and F). 
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Examination of the distribution of NC cells and their derivatives in Vangl2+/+;Wnt1-
Cre/YFP and Vangl2Lp/Lp;Wnt1-Cre/YFP embryos at E10.5 revealed no differences in 
the pattern of YFP-labelled cells between genotypes (Figure 7.10A, F). NC derivatives 
were similarly distributed throughout the cranial and pharyngeal regions of 
Vangl2+/+;Wnt1-Cre/YFP and Vangl2Lp/Lp;Wnt1-Cre/YFP embryos (Figure 7.10B-E, G-J) 
and the DRG were similarly sized in both genotypes (Figure 7.10M-N, R-S). NC cells 
were also seen migrating towards the heart and around the foregut in embryos of both 
genotypes (Figure 7.10K-L, P-Q). More caudal sections revealed no difference in the 
ventral migration of NC cells from the neuroepithelium (Figure 7.10O,T). Hence, these 
data show that the colonisation of numerous tissues by NC cells occurs normally in 
Vangl2Lp/Lp mutants, further indicating that NC migration is not impaired by the 
disruption of PCP signalling. 
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Figure 7.9 Erbb3 expression in Vangl2
+/+
 and Vangl2
Lp/Lp
 at E10.5 
WISH for the NC marker Erbb3 in wild-type (Vangl2
+/+
; A-C) and loop-tail (Vangl2
Lp/Lp
; D-F) 
embryos. Erbb3 expression is seen in the trigeminal (v), facio-acoustic (vii/viii), 
glossopharyngeal (ix), and vagal (x) cranial ganglia in both Vangl2
+/+
 and Vangl2
Lp/Lp
 embryos 
(A and D; higher magnification views of the boxed areas are shown in A’ and D’). A dorsal view 
shows Erbb3 expression in developing dorsal root ganglia (DRG) throughout the trunk of wild-
type embryos (arrows in B). Despite the widely open neural folds in Vangl2
Lp/Lp
 embryos, the 
DRG appear normally sized and patterned (arrows in E). Further caudally, segregated streams 
of NC cells can be seen migrating from the dorsal neural tube in both Vangl2
+/+
 (arrow in C) and 
Vangl2
Lp/Lp
 (arrow in F). Scale bars: 500 µm. n = minimum of 3 embryos per genotype. 
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Figure 7.10 Fluorescent labelling of the neural crest lineage at E10.5 
Whole mounts (A, F) and sections (B-E,G-J, K-O and P-T) through E10.5 Vangl2
+/+
; Wnt1-
Cre/YFP (Hereafter denoted +/+) and Vangl2
Lp/Lp
; Wnt1-Cre/YFP (Hereafter denoted Lp/Lp) 
embryos showing YFP-positive NC cells and their derivatives.  
(A, F) Fluorescent images (with bright field inset) show labelled cells within the nasal process, 
branchial arches and branchial pouches (arrowheads) with closely similar appearance in +/+ (A) 
and Lp/Lp (F). YFP positive cells are also seen in the dorsal root ganglia of both genotypes 
(arrows).  
(B-E, G-J) Sections through the embryos in A and F, immunostained with anti-GFP/YFP. Auto-
fluorescent cells appear yellow (by overlay with the red channel). Despite the widely open 
neural folds and overall abnormal morphology in Lp/Lp, no differences in the distribution of 
YFP-expressing NC cells are observed between genotypes. Neural crest derivatives are 
detected sub-epidermally (B, G), around the developing eye (C, H), in the branchial pouches 
(D, I), and in the pharyngeal region and aortic sac (E, J).  
(K-O, P-T) Labelled cells can be seen migrating towards the developing heart (arrows in F and 
P) and around the foregut (asterisks in G and Q). YFP-positive dorsal root ganglia appear 
normally sized in Lp/Lp despite the open neural folds (M, N, R, S; arrows). Caudally, at the level 
of the hindgut (O, T), ventrally migrating neural crest cells can be seen in both +/+ and Lp/Lp 
embryos (arrows). Scale bars: 500 µm (A, K) and 100 µm (B-E, G-J, K-O, P-T).  
 
.
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Figure 7.10 (continued) 
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7.2.3 Vangl1 does not compensate for the loss of Vangl2 during 
neural crest migration 
Although loop-tail is a well-established, severe PCP mutant that displays a wide 
spectrum of related defects, the possibility that the Vangl1 might compensate for the 
loss of Vangl2 during NC migration was considered. As described in Chapter 1, Vangl1 
is a highly conserved, structurally similar paralogue of Vangl2 (Torban et al., 2004) and 
is the only other known mammalian orthologue of Drosophila Strabismus/Van gogh. 
Like Vangl2, the Vangl1 protein has been shown to interact physically with mammalian 
Dishevelled (Dvl) proteins (Torban et al., 2004). Moreover, Vangl1 interacts genetically 
with Vangl2 during neurulation, although homozygous loss of Vangl1 alone does not 
disturb neural tube closure (Torban et al., 2008). 
 
The expression of Vangl1 was studied in wild-type and Vangl2Lp/Lp embryos by WISH. 
At E8.5, Vangl1 was expressed along a narrow region of the ventral neuroepithelium in 
wild-type embryos, from the level of the hindbrain to the PNP (Figure 7.11A-D), 
consistent with previous reports (Doudney et al., 2005; Liu et al., 2008). In Vangl2Lp/Lp 
embryos, the expression pattern appeared unaltered and Vangl1 was not expressed 
ectopically in other regions of the neuroepithelium (Figure 7.11E-H). Importantly, 
Vangl1 transcripts were absent from the upper hindbrain and midbrain regions of both 
wild-type and Vangl2Lp/Lp embryos which, at E8.5, is the level from which NC cells are 
migrating (compare with Erbb3 expression marking NC cells in Figure 7.11I-J). 
Furthermore, Vangl1 expression was not seen at the edges of the trunk neural folds, 
the site of NC induction and subsequent delamination, in either wild-type (Figure 
7.11C,D) or Vangl2Lp/Lp (Figure 7.11G,H). The highly restricted pattern of Vangl1 
expression at E8.5, in the neuroepithelial midline, contrasts with the more generalised 
nervous system expression of Vangl2 at this stage (Figure 7.11M-P). 
 
 - 283 - 
By E9.5, Vangl1 expression could be seen extending further along the embryonic axis 
of both wild-type and Vangl2Lp/Lp embryos, from midbrain to low spine (Figure 7.12A, 
D), although this was difficult to visualise in whole mutant embryos due to their 
abnormal morphology. Transverse sections at the level of the migrating trunk NC 
revealed Vangl1 expression only in the ventral half of the neural tube in wild-type 
embryos, and in an equivalent region of the open neuroepithelium of Vangl2Lp/Lp 
embryos (Figure 7.12B-C, E-F). This Vangl1 expression domain was clearly distinct 
from, and non-overlapping with, the more dorsal NC progenitor domain (compare with 
Erbb3 expression in Figure 7.12G-I). In contrast, Vangl2 is expressed throughout the 
neuroepithelium at all axial levels at this stage (Figure 7.12J-L). These results show 
that, in wild-type embryos, Vangl1 is neither expressed by NC, nor by neighbouring 
cells, prior to or during NC cell emigration from the dorsal neuroepithelium. Moreover, 
Vangl1 expression was not detected ectopically in the NC region of loop-tail embryos. 
These data therefore argue against the idea that Vangl1 acts redundantly with Vangl2 
during NC migration. 
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Figure 7.11 Vangl1 is not ectopically activated at E8.5 
(A-H) WISH for Vangl1 in wild-type (Vangl2
+/+
; A-D) and loop-tail (Vangl2
Lp/Lp
; E-H) embryos. 
Dorsal (A) and lateral (A’) views show that Vangl1 expression is confined to a narrow region of 
the ventral neuroepithelium in Vangl2
+/+
, with a rostral limit at the level of the hindbrain (arrows 
in A’). Transverse sections (B-D; at the level of the dotted lines in A) confirm midline 
neuroepithelial expression. Vangl2
Lp/Lp
 embryos exhibit a closely similar Vangl1 expression 
domain to that seen in wild-type, both in whole mount (E,E’) and sections (F-H). n = minimum of 
3 embryos per genotype. 
(I-L) WISH for the NC marker Erbb3 at E8.5 for comparison with Vangl1. The wild-type embryo 
in I and I’ shows expression in the migrating cranial NC, and this is confirmed in sections (J-L).  
There is no overlap in expression of Erbb3 and Vangl1.  
(M-P) WISH for Vangl2 at E8.5 showing expression within the neuroepithelium at all levels of 
the body axis. Co-expression of Vangl1 and Vangl2 occurs only in ventral midline neural tube 
cells.  Scale bars: 200 µm (A, E, I, M) and 50 µm (B-D, F-H, J-L, N-P). 
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Figure 7.12 Vangl1 is not ectopically activated at E9.5 
(A-F) Whole-mount in situ hybridisation for Vangl1 in wild-type (Vangl2
+/+
; A-C) and loop-tail 
(Vangl2
Lp/Lp
; D-F) embryos. Transcripts are detected in the ventral half of the neural tube from 
midbrain to level of the posterior neuropore in Vangl2
+/+
 (A, asterisk indicates probe trapped 
within the hindgut). This expression pattern is confirmed in transverse sections (B,C; at level 
indicated by dotted lines in A). The pattern of Vangl1 expression in Vangl2
Lp/Lp
 appears 
unaltered compared with wild-type (D-F). While staining appears marginally more intense in 
Vangl2
Lp/Lp
 (D), this is likely an experimental artefact due to the widely open neural folds. 
Indeed, transverse sections (E-F) reveal Vangl1 expression confined to the ventral 
neuroepithelium at a similar intensity as wild-type. n = minimum of 3 embryos per genotype. 
(G-I) Erbb3 mRNA expression is confined to migrated NC in the cranio-facial region (G) and 
actively migrating NC cells in the trunk (H,I). There is no overlap between Vangl1 and Erbb3 
expression in either wild-type or Vangl2
Lp/Lp
 embryos.  
(J-L) Vangl2 mRNA expression at E9.5 is present at greatest intensity throughout the 
neuroepithelium, and at low intensity in mesoderm and gut endoderm (asterisk in J indicates 
probe trapped within the hindgut). As at E8.5, co-expression of Vangl1 and Vangl2 occurs only 
in ventral midline neural tube cells. Scale bars: 500 µm (A, D, G, J), 200 µm (all sections). 
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7.2.4 Analysis of neural crest migration in vitro 
The migration of Xenopus and zebrafish NC cells in vitro is strongly inhibited when 
components of the PCP pathway are mutated, and PCP signalling is required to restrict 
lamellipodial protrusions to the leading edge of migratory cells (Carmona-Fontaine et 
al., 2008a; Carmona-Fontaine et al., 2008b; De Calisto et al., 2005; Matthews et al., 
2008). Therefore, to extend the analysis of NC migration in mammalian PCP mutants, 
neural tube explants from wild-type and Vangl2Lp/Lp embryos were dissected and 
cultured over a 2 day period. After 24 and 48 hours, comparable outgrowth of 
migratory cells from both wild-type and Vangl2Lp/Lp explants was observed, with cells 
spreading radially from the central explant (Figure 7.13A). In all cultures, cells at the 
leading edge of the migratory population displayed various morphologies: some 
appeared to be polarised in the direction of migration, while others did not display any 
obvious polarity (Figure 7.13B). 
 
To confirm the identity of NC cells in this assay, explants from E9.5 Vangl2+/+;Wnt1-
Cre/YFP and Vangl2Lp/Lp;Wnt1-Cre/YFP embryos were cultured. Immediately after 
explantation, YFP-positive pre-migratory NC cells could be seen along the dorsal 
margin of Vangl2+/+;Wnt1-Cre/YFP neural tube explants, and in the equivalent 
dorsolateral regions of the open Vangl2Lp/Lp; Wnt1-Cre/YFP explant tissue (Figure 7.14; 
0 hours). After 24 hours, similar numbers of YFP-positive migratory cells had emerged 
from the explants of both genotypes (Figure 7.14; 24 hours). The rate of outgrowth was 
measured as the percentage increase in outgrowth area (see Chapter 2); the increase 
in explant culture area did not differ between genotypes at either 24 or 48 hours 
(Figure 7.15), arguing for a closely similar rate of NC migration in wild-type and mutant 
explants. Further analysis of the Wnt1-Cre/YFP neural tube explant cultures revealed 
that, whilst the majority of migratory cells were YFP-labelled NC cells, non-NC cells 
were also present (Figure 7.16). This suggests that other mammalian neuroepithelial 
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cells display migratory potential when cultured in vitro, consistent with previous findings 
for the avian neural tube (Duband et al., 2009). Double immunostaining of cells in vitro 
confirmed that the majority of YFP-positive NC cells also expressed the NC cell marker 
P75 (Figure 7.17). 
 
         
Figure 7.13 In vitro culture of neural tube explants 
 (A) Vangl2
+/+
 and Vangl2
Lp/Lp
 neural tube explants cultured for 24 and 48 hours. Inner yellow 
dotted lines indicate the area covered by the central mass of neuroepithelial tissue; outer dotted 
lines indicate the leading edge of the migratory population. (B) Examples of the variable 
morphology of leading edge cells. Red asterisks: Vangl2
+/+
 and Vangl2
Lp/Lp
 cells which appear 
polarised. Yellow asterisks: cells which extend protrusions in all directions. Scale bars: 200 µm 
(A) and 50 µm (B). 
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Figure 7.14 Wnt1-cre/YFP explants in culture 
Vangl2
+/+
; Wnt1-Cre/YFP and Vangl2
Lp/Lp
; Wnt1-Cre/YFP neural tube explant cultures. At 0 
hours, YFP expression can be seen along the dorsal margin of the +/+ explant, and at the 
equivalent dorsolateral regions of the persistently open neural folds in the Lp/Lp explant. After 
24 hours, similar numbers of YFP-positive migratory cells have emerged from the explants of 
both genotypes. Abbreviations: bf = bright field image. Scale bars: 100 µm. 
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Figure 7.15 Outgrowth of neural tube explant cultures  
Explant outgrowth over two days measured as the percentage increase in area. There is no 
significant difference in rate of NC emigration between genotypes (p = 0.91, Kruskal-Wallis 1-
way ANOVA on ranks; n = at least 5 explants per genotype for 24 hours and 3 explants per 
genotype for 48 hours). Explants from both fluorescent and non-fluorescent embryos were 
included for this analysis. 
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Figure 7.16 Anti-GFP/YFP immunostaining of neural tube explant cultures 
Representative Vangl2
+/+
;Wnt1-Cre/YFP neural tube explant culture immunostained with anti-
GFP/YFP (A, A’). Higher magnification views of the boxed regions are shown in B and C. While 
the majority of migratory cells are YFP-positive NC cells (B, B’), other cell types, which do not 
express YFP, are also present (C, C’). Nuclei are stained with DAPI. Scale bars: 100 µm. 
 
Control Xenopus NC cells at the leading edge of an in vitro migratory population 
extend large, polarised lamellipodia in the direction of migration, while those 
expressing mutant forms of PCP proteins are not polarised and extend a higher 
proportion of filopodia in all directions (Carmona-Fontaine et al., 2008b; De Calisto et 
al., 2005). In our explant cultures, YFP-positive NC cells at the leading edge exhibited 
a variety of morphologies: some extended large sheet-like lamellipodia at the front of 
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the cell, while others extended numerous protrusions around their periphery and did 
not appear to be polarised in any particular direction. No difference was observed in 
this cell behaviour between Vangl2+/+;Wnt1-Cre/YFP and Vangl2Lp/Lp;Wnt1-Cre/YFP 
explants (Figure 7.18A). The polarity of leading edge NC cells was assessed by 
measuring the distribution of cell area relative to the direction of migration (Figure 
7.18B and see Chapter 2). The proportion of cells polarised in the direction of migration 
did not differ significantly between genotypes (Figure 7.18C) although the tendency 
was for Vangl2Lp/Lp cells to show enhanced polarity compared with wild-type. The 
distance migrated by leading edge NC cells from the central explant tissue was also 
measured. Distance did not differ significantly between genotypes (Figure 7.19). 
Together, these data demonstrate that loss of function of the core PCP gene Vangl2 
does not impair NC cell migration in vitro. 
               
Figure 7.17 Identification of neural crest cells in vitro 
Representative Vangl2
+/+
;Wnt1-Cre/YFP neural tube explant culture immunostained with anti-
GFP/YFP and anti-P75 (nuclei stained with DAPI). Most YFP-positive cells also express the NC 
marker P75 in vitro. Scale bars: 100 µm. 
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Figure 7.18 Neural crest cell polarity in vitro 
(A) Examples of the variable morphology of Vangl2
+/+
 and Vangl2
Lp/Lp
 NC cells at the leading 
edge of the migratory population after 24 hours in culture (immunostained with anti-GFP/YFP, 
nuclei stained with DAPI). For both genotypes, some cells appear highly polarised in the 
direction of migration while others do not.  
(B) Analysis of NC cell polarity in leading edge cells (e.g. boxed area). Forward is defined as 
the direction away from the central mass of explant tissue (arrows). Distribution of cell area was 
compared between six circular sectors, centred on the nucleus. Most of this cell occurs in 
sectors 1 (yellow dotted line) and 2, indicating a highly polarised cell that is migrating.  
(C) The proportion of leading edge cells polarised in the direction of migration does not differ 
significantly between genotypes (p = 0.09, Chi-square test; n = at least 64 cells from 3 explants 
for each genotype). Scale bars: 20 µm (A). 
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Figure 7.19 Distance migrated by neural crest cells in culture 
The mean distance migrated by leading edge NC cells does not differ between genotypes (p = 
0.21, Kruskal Wallis 1-way ANOVA on ranks; n = at least 64 cells from 3 explants for each 
genotype). 
 
7.2.5 Acute ablation of Vangl2 function in the neural crest 
lineage 
Finally, we considered the possibility that absence of PCP signalling from Vangl2Lp/Lp 
embryos, throughout their development, might allow a compensatory mechanism such 
as the activation of a non-Vangl2-dependent pathway to arise in the NC or surrounding 
tissue, allowing normal NC migration (Figure 7.20A). This was addressed by crossing 
Vangl2Lp/+;Wnt1-Cre/YFP (obtained from the breeding scheme shown in Figure 7.6) 
with Vangl2flox/flox mice, to produce Vangl2Lp/flox;Wnt1-Cre and Vangl2Lp/flox;Wnt1-
Cre/YFP offspring in which Vangl2 expression was acutely ablated specifically in the 
NC lineage. That is, in non-Wnt1-expressing tissues, such embryos were heterozygous 
for the Vangl2Lp allele, whereas in the Wnt1-positive NC cells they were Vangl2Lp/- (See 
Figure 7.21 for breeding strategy). It was hypothesised that acute ablation of Vangl2 
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would prevent the ‘compensatory mechanism’ that putatively results from constitutional 
abrogation of Vangl2 function. Hence, if NC migration is, in fact, PCP-dependent, the 
conditional Vangl2Lp/flox; Wnt1-Cre/YFP embryos should exhibit NC defects (Figure 
7.20B). 
 
         
Figure 7.20 Hypothesis being tested by acutely ablating Vangl2 in the neural crest 
Schematic diagram of the hypothesis being tested. (A) Could the constitutional ablation of PCP 
signalling in Vangl2
Lp/Lp
 embryos lead to a compensatory mechanism (blue) by the NC or 
surrounding tissue, resulting in normal NC migration? (B) Predicted effect on NC migration in 
Vangl2
Lp/flox
;Wnt1-Cre embryos if such a mechanism exists. Would acute ablation of Vangl2 in 
the NC (Vangl2
Lp/-
; purple region) prevent the compensatory effect, resulting in defective NC 
migration? 
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                                                                            X                          
 
Cre +ve offspring: 
Vangl2+/flox(-);R26+/+  
Vangl2+/flox(-);R26YFP/+  
Vangl2Lp/flox(-);R26+/+  
Vangl2Lp/flox(-);R26YFP/+  
 
Cre -ve offspring: 
Vangl2+/flox;R26+/+  
Vangl2+/flox;R26YFP/+  
Vangl2Lp/flox;R26+/+  
Vangl2Lp/flox;R26YFP/+  
 
 
Figure 7.21 Breeding scheme used to generate Vangl2
Lp/flox
;Wnt1-cre embryos  
Matings between Vangl2
Lp/+
;Wnt1-Cre;R26
YFP/+
 and Vangl2
flox/flox
 mice produces embryos with 
one of 8 possible genotypes. However, Cre-negative offspring were not genotyped for the 
presence of the R26
YFP
 allele, meaning that embryos were actually assigned to one of the 
following 6 categories: non-fluorescent type 1 control, fluorescent type 1 control, non-
fluorescent experimental, fluorescent experimental, Type 2 control or Type 3 control. Green text 
indicates fluorescent embryos. 
Vangl2Lp/+;Wnt1-Cre;R26YFP/+ Vangl2flox/flox 
‘Type 1 controls’ – deletion of one copy of 
Vangl2 in the NCC 
‘Experimental’ – Lp heterozygous plus deletion 
of other Vangl2 allele in the NCC 
‘Type 2 controls’ – wild type levels of Vangl2 
‘Type 3 controls’ – Lp heterozygous 
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Embryos from Vangl2Lp/+;Wnt1-cre;R26YFP/+  X  Vangl2flox/flox matings were collected at 
E9.5 for analysis and genotypes were obtained in the expected Mendelian ratios 
(Table 7.1). Unlike in loop-tail litters, craniorachischisis was never seen; all embryos 
had successfully completed closure 1 and were undergoing PNP closure. Whole-
mount analysis of Vangl2Lp/flox;Wnt1-Cre/YFP embryos revealed a pattern of 
fluorescently-labelled NC cells that was indistinguishable from Vangl2+/flox;Wnt1-
Cre/YFP controls (Figure 7.22). YFP-positive NC cells appeared normally distributed 
within the pharyngeal region (Figure 7.22D) and could be seen migrating in organised 
streams within the trunk (Figure 7.22E, arrows). Further caudally, NC cells were 
observed beginning to migrate from the neuroepithelium in both genotypes (Figure 
7.22C and F). Similarly, WISH for Erbb3 at E9.5 revealed no difference between 
Vangl2Lp/flox; Wnt1-Cre embryos and controls (Figure 7.23). Together these findings 
show that acute ablation of Vangl2 in the NC does not lead to migratory defects, 
indicating that the normal pattern of NC migration observed in Vangl2Lp/Lp embryos is 
not due to a compensatory mechanism masking a role for the Vangl2 protein. 
 
Offspring Category 
Expected Observed 
% Freq. % Freq. 
Type 1 controls (non-fluorescent) 12.50 3/23 26.09 6/23 
Type 1 controls (fluorescent) 12.50 3/23 8.70 2/23 
Experimental (non-fluorescent) 12.50 3/23 8.70 2/23 
Experimental (fluorescent) 12.50 3/23 13.04 3/23 
Type 2 controls 25.00 6/23 21.74 5/23 
Type 3 controls 25.00 6/23 21.74 5/23 
Deviation from Mendelian ratios: χ
2
=1.561 with 5 degrees of freedom (p = 0.906) 
 
Table 7.1 Genotype frequencies of E9.5 offspring from Vangl2
Lp/+
;Wnt1-Cre;R26
YFP/+
 X 
Vangl2
flox/flox
 matings 
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Figure 7.22 Neural crest cells migrate normally following acute ablation of Vangl2. 
Control Vangl2
+/flox
; Wnt1-Cre/YFP and experimental Vangl2
Lp/flox
; Wnt1-Cre/YFP E9.5 embryos 
showing directly visualised YFP-positive NC cells, which have colonised branchial arches 1 and 
2, with similar appearance in both genotypes (A and D). Comparable streams of NC cells can 
be seen migrating from the dorsal neural tube in the trunk (arrows in B and E), and beginning to 
delaminate more caudally (arrows in C and F). n = minimum of 2 embryos per genotype. Scale 
bars: 100 µm. 
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Figure 7.23 Erbb3 WISH reveals normal NC migration in Vangl2Lp/flox; Wnt1-Cre 
embryos.  
Whole-mount in situ hybridisation for the NC marker Erbb3 in E9.5 Vangl2
Lp/flox
; Wnt1-Cre (B) 
and control (A, C, D) embryos. No difference in the pattern of NC migration was observed 
between genotypes (A-D show dorsal views, A’-D’ show lateral views of the same embryos). 
Transverse sections through the embryos in A-D show a closely similar pattern of NC 
emigration from the neural tube and colonisation of the region adjacent to the paired aortae in 
Vangl2
Lp/flox
; Wnt1-Cre (F) and controls (E, G, H). n = 3 embryos per genotype.  
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7.3 Discussion 
The data described in this chapter demonstrate that Vangl2, a highly conserved, core 
component of the PCP signalling pathway, is not required for NC migration in mouse 
embryos. These findings indicate that PCP signalling is not essential for this process 
during mammalian development and, therefore, that PCP-dependence of NC migration 
is not a universal phenomenon among vertebrate species.  
 
NC cell distribution in Vangl2Lp/Lp embryos was examined using both gene expression 
markers and YFP lineage tracing. Despite the many severe developmental defects in 
loop-tail, including complete failure of neural tube closure, NC specification and 
migration were found to proceed normally. No differences in the spatiotemporal 
patterns of cranial and trunk NC migration were identified between loop-tail and wild 
type embryos, and Vangl2Lp/Lp NC-derived structures appeared to be appropriately 
sized and patterned. Normal NC development was also observed when Vangl2 was 
diminished specifically in the NC lineage, arguing against the possibility that 
constitutional absence of PCP signalling, as in loop-tail, results in a compensatory 
mechanism masking PCP-dependence of NC migration. In vitro, the migration of cells 
from loop-tail neural tube explants was found to be indistinguishable from controls.  
 
7.3.1 Support from previous studies 
The data presented here are consistent with previous reports which allude to species 
differences in the role of PCP signalling during NC migration. Evidence against an 
essential role in mammals comes from a study examining cardiovascular development 
in loop-tail mutant mice. Henderson and colleagues (Henderson et al., 2001) identified 
outflow tract and aortic arch abnormalities in Vangl2Lp/Lp embryos, problems which are 
often related to defects in the cardiac NC. However an examination of NC markers at 
E10.5, when NC cells are migrating towards the developing outflow tract, did not reveal 
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any migratory defects in these mice. Histological analysis also showed that NC-derived 
structures such as cranial and dorsal root ganglia appear to form normally. However, 
this study did not provide a detailed examination of NC migration in PCP mutants at 
earlier stages, or in other regions of the developing embryo.  
 
Support for our data is also provided by studies of Ptk7, a regulator of PCP signalling 
during convergent extension, neural tube closure, heart morphogenesis, lung 
development and inner ear hair cell formation in mice, and neural convergent 
extension in Xenopus (Lu et al., 2004; Paudyal et al., 2010; Yen et al., 2009). In 
Xenopus Ptk7 has also been found to regulate NC migration (Shnitsar and Borchers, 
2008), with its disruption causing a NC phenotype similar to that of the PCP morphants 
described earlier (De Calisto et al., 2005). Xenopus Ptk7 is thought to promote PCP 
signalling by forming part of a protein complex with Dsh and Fz7 that localises Dsh to 
the plasma membrane (Shnitsar and Borchers, 2008). However, the Ptk7 mutant 
mouse, chuzhoi, does not exhibit overt NC migration defects and has normally 
patterned NC derivatives (Paudyal et al., 2010).  
 
Downstream of the core PCP genes, the small GTPase Rac1 is involved in the 
directional migration of Xenopus NC cells (Matthews et al., 2008). In mouse embryos 
the proliferation and cell cycle control of post-migratory NC is Rac1 dependent (Fuchs 
et al., 2009). However Rac1 is not required for the migration of mouse NC cells from 
the neural tube to their initial target structures and, in vitro, migration from Rac1 knock-
out NT explants is not impaired (Fuchs et al., 2009; Thomas et al., 2010).  
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7.3.2 Is PCP signalling completely abolished in loop-tail 
embryos? 
Vangl2 is widely accepted to be a core component of the PCP pathway and is highly 
conserved from Drosophila to vertebrates. Loop-tail homozygous embryos are among 
the most severe mouse PCP mutants, displaying a broad spectrum of developmental 
abnormalities (see Chapter 1) All of the affected tissues have been identified as sites 
of Vangl2 expression during embryogenesis (Montcouquiol et al., 2003; Torban et al., 
2007; Vandenberg and Sassoon, 2009; Yates et al., 2010a; Yates et al., 2010b). In 
mammals Vangl2 interacts directly with all three Dishevelled family members, leading 
to their recruitment to the membrane. These associations appear to be crucial in 
establishing the asymmetric localisation of PCP protein complexes needed for signal 
transduction, and are abrogated or severely impaired when Lp-associated mutations 
are introduced (Torban et al., 2004). Furthermore, in loop-tail embryos the normal 
membrane localisation of Vangl2 protein is lost (Torban et al., 2007). As discussed in 
Chapter 6 there is now emerging evidence that Vangl2Lp is, in fact, a dominant 
negative allele (Song et al., 2010; Yin et al., 2012). These findings indicate that the 
presence of the Lp mutant protein has an adverse effect on several of the key 
interacting proteins, hence producing a more profound disturbance of PCP function 
than the loss of wild-type Vangl2 alone. 
 
7.3.3 Possible functional redundancy between Vangl1 and 
Vangl2 
Although not expressed by migrating NC cells themselves, Vangl2 transcripts are 
present throughout the dorso-ventral axis of the neuroepithelium before, and at the 
stage of, NC migration (see Figure 7.11 and Figure 7.12), as has been reported 
previously (Kibar et al., 2001b; Torban et al., 2007). It is likely, therefore, that Vangl2 is 
expressed by NC progenitors prior to their emigration from the neural tube. It was 
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therefore asked whether the closely-related gene Vangl1 might compensate for the 
loss of Vangl2 in pre-migratory loop-tail NC cells, masking an essential role for Vangl2. 
However in loop-tail, as in wild-type embryos, Vangl1 transcripts are restricted to the 
ventral neuroepithelium and are not detected in either dorsal neuroepithelial cells or 
migratory NC cells. These data suggest that the loop-tail mouse model represents a 
complete abrogation of PCP signalling, without functional redundancy with Vangl1. 
However, the pattern of expression observed here differs slightly to that described 
previously using LacZ staining (Song et al., 2010), a more sensitive method than 
WISH. We are currently analysing NC migration in Vangl1/2 double mutant embryos, in 
collaboration with Dr Yingzi Yang.  
 
7.3.4 How can the species difference be explained? 
Despite the high level of similarity in NC migration among different vertebrate groups, 
some fundamental differences do exist, possibly reflecting variations in the signalling 
pathways and molecular mechanisms involved. For example, the timing of onset of 
migration varies between species (see Chapter 1). Indeed, while members of the core 
PCP pathway are expressed in migrating Xenopus NC cells, we did not detect 
expression of Vangl2 at any stage of mouse NC migration, and there is published 
evidence that other core PCP components are also not expressed in mouse migratory 
NC cells.  For example, Celsr1, whose homozygous mutants display craniorachischisis 
and cochlear disorganisation (Curtin et al., 2003), is expressed in a similar pattern to 
Vangl2; that is, within the neuroepithelium but not in the migrating NC cells (Formstone 
and Little, 2001; Shima et al., 2002).  
 
Similarly the non-canonical Wnt ligand, Wnt5a, is not expressed in the NC cells in 
mouse ambryos; rather, transcripts are found in outgrowing areas of the embryo such 
as the facial primordial, limb buds and tail (Yamaguchi et al., 1999). Moreover, mouse 
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and frog Dvl homologues display very different expression patterns during 
development. Xenopus Dvl1 and Dvl2 exhibit strong tissue-specific expression in 
migrating NC cells and otic placodes, whereas no NC-specific expression has been 
described for any of the mouse Dvl genes (Gray et al., 2009b). Hence, it appears 
unlikely that an alternative, Vangl2-independent PCP pathway is activated in 
mammalian NC cells. 
 
While non canonical Wnt/PCP signalling may regulate directional NC migration in 
Xenopus and zebrafish, our data suggest that other mechanisms are involved in the 
mouse. As described in Chapter 1, there is some evidence that positive cues such as 
chemoattractants have a role to play, with members of the VEGF, PDGF and FGF 
families of growth factors among the candidate molecules described (Theveneau and 
Mayor, 2012).  Perhaps the best candidate for a NC chemoattractant is the chemokine 
stromal cell-derived factor 1 (Sdf1) (Theveneau and Mayor, 2012), which is required for 
cranial NC migration in Xenopus and zebrafish (Olesnicky Killian et al., 2009; 
Theveneau et al., 2010). Theveneau and colleagues (Theveneau et al., 2010) 
demonstrated that NC cells in culture actively track moving Sdf1-soaked beads and 
that this chemotactic behaviour requires interactions with other neighbouring cells 
(termed ‘collective chemotaxis’). While not required for the initial cell polarisation, Sdf1 
was found to stabilise the polarised protrusions promoted by cell-cell interactions. N-
cadherin is also required for the response to Sdf1, with disruption of N-cadherin 
impairing cells’ ability to ‘sense’ each other and exhibit contact inhibition of locomotion. 
Interestingly, N-cadherin blocking antibody (NCD2) treatment significantly reduced 
polarised Rac1 activity in the migrating cells, although the authors do not speculate 
about how N-cadherin and non canonical Wnt/PCP signalling might interact 
mechanistically (Theveneau et al., 2010).  
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In mice Sdf1 is thought to play a role in the migration of various cell types, including 
melanoblasts and sensory neuron progenitors (Belmadani et al., 2005; Belmadani et 
al., 2009), suggesting that similar or unknown chemoattractants contribute to the 
directionality of NC migration in mammals, perhaps in combination with cell adhesion 
molecules and the RhoGTPases. It would appear, therefore, that the factors regulating 
cell-cell interactions, CIL, chemotaxis, and the restrictive signals which pattern the NC 
streams, must all be integrated in order for the NC to migrate with persistence and 
directionality.  
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8.  General Discussion 
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8.1 PCP and low spinal neurulation 
8.1.1 Summary of findings 
The crucial role of PCP signalling in regulating CE prior to the initiation of neural tube 
closure has been well established in mice (see Chapter 1). One of the initial aims of 
this project was to investigate the requirement for PCP genes during a later event of 
spinal neurulation, closure of the posterior neuropore. To this end, the loop-tail/curly 
tail (Vangl2Lp/+;Grhl3ct/ct) mouse mutant provides a valuable model, not only to analyse 
the specific requirement for core PCP components, but also to unravel the nature of 
genetic interactions between Vangl2 and Grhl3, two genes with important roles in 
neurulation. The Vangl2Lp/+;Grhl3ct/ct spina bifida phenotype was found to be severe, 
both in terms of its frequency (>70% penetrance) and the axial level from which neural 
tube closure fails (Chapter 3). Initial analyses revealed that the defect arises due to 
primary failure of neural tube closure, but is not caused by a disruption of the 
dorsolateral bending that occurs in the neuroepithelium at this level. The phenotype is 
also not the result of an exacerbation, by Vangl2Lp, of the known curly tail 
developmental defect (reduced hindgut proliferation and increased ventral body 
curvature). 
 
Morphometric analyses showed that the Vangl2Lp allele causes reduced CE in the 
midline of the caudal region (Chapters 3 and 4), evidence that this process is indeed 
an important aspect of neurulation at low spinal levels. When compared to wild type 
embryos, both Vangl2Lp/+;Grhl3+/+ and Vangl2Lp/+;Grhl3ct/ct embryos display a shorter 
caudal embryonic axis and an increase in width of the ventral neuroepithelium and 
notochord, with the latter also accompanied by wider domains of marker gene 
expression. The effect of Vangl2Lp on CE was confirmed by DiI labelling and whole 
embryo culture; these experiments demonstrated that the presence of the Vangl2Lp 
allele is associated with a significant reduction in caudal axis extension.  
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However, with regards to the Lp/ct interaction, the severe spina bifida in 
Vangl2Lp/+;Grhl3ct/ct is not solely explained by a ‘PCP effect’. Grhl3ct mutations were not 
found to influence the CE phenotype, raising the question of whether Grhl3 is required 
for a different aspect of caudal development at E9-E9.5 (in addition to regulating 
hindgut and notochord proliferation at E10.5). Analysis of cell proliferation in the 
chordo-neural-hinge (CNH), one of several sites of Grhl3 expression, revealed an 
abnormally low mitotic index in embryos carrying ct mutations, suggesting that Grhl3 
regulates cell cycle dynamics within the axial stem cell population of the tail bud. Thus, 
two distinct, tissue-specific effects appear to summate and contribute to the phenotype 
of Vangl2Lp/+;Grhl3ct/ct mice; defective midline CE downstream of Vangl2Lp and altered 
cell cycle dynamics in the tail bud downstream of Grhl3ct. This ‘tissue-tissue interaction’ 
hypothesis is supported by the results of genetic experiments (Chapter 6). Here, the 
frequency of spinal neurulation defects is shown to be three-fold lower in conditional 
Grhl3Cre/+;Vangl2flox/+ embryos (9%) than in compound heterozygous Grhl3+/-;Vangl2+/- 
embryos (29%) where one allele of Vangl2 and Grhl3 has been lost in all cells. This 
shows that a requirement for the two genes within the same cells of the embryo only 
partially accounts for the phenotype observed when they are both mutated.  
 
The association between the presence of Grhl3ct alleles and a reduced rate of cell 
proliferation in the CNH (and also in the neuroepithelium; see Chapter 4) corresponds 
to the timing and site of normal Grhl3 expression. These data are consistent with the 
reduced proliferation seen in the hindgut of E10.5 curly tail embryos and with the 
finding that reinstating Grhl3 function in this tissue via BAC transgenesis restores cell 
proliferation (Copp et al., 1988a; Gustavsson et al., 2007). However, the mechanism 
by which Grhl3 regulates the cell cycle is not understood. As it is a transcription factor, 
the effects of reduced expression levels in curly tail are presumably exerted via the 
mis-regulation of downstream target genes, with Grhl3 likely able to act as both a 
transcriptional activator and repressor (Kudryavtseva et al., 2003). Very few Grhl3 
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targets have been identified to date. Indeed, as described earlier in this thesis, the only 
known direct targets are transglutaminase 1 (TGase1) and RhoGEF19, both of which 
were identified from analyses of expression levels in the skin at late gestation. It is 
possible, therefore, that these downstream genes are specific to the function of Grhl3 
during epidermal development and wound repair (Caddy et al., 2010; Ting et al., 2005). 
Work in our group is currently focused on trying to identify genes that are activated or 
suppressed by Grhl3 during neural tube closure, and are mis-regulated in embryos that 
develop NTDs.  
 
In addition to a tissue-tissue interaction, the finding that conditional 
Grhl3Cre/+;Vangl2flox/+ embryos develop low frequency spinal defects (Chapter 6) does 
also show that there is some interaction between Grhl3 and Vangl2 within cells in 
which they are co-expressed, and that this affects neurulation. This indicates that a 
second, cell-autonomous effect also makes a minor contribution to the Lp/ct 
phenotype. Possible mechanisms underlying this interaction were investigated in 
Chapter 5. The expression domains of Vangl2 and Grhl3 were found to overlap at E9-
E9.5, most notably in the neuroepithelium, consistent with a possible interaction at a 
molecular level. The expression level of each gene was found to be unaltered when 
the other gene was mutated, and expression of the PCP ligand Wnt5a was not 
diminished in curly tail (or Vangl2Lp/+;Grhl3ct/ct) embryos, contrary to a previous study 
(Gofflot et al., 1998). However, a possible transcriptional effect of Grhl3 at the level of 
RhoGTPase signalling was identified; in the curly tail (and to a lesser extent in the 
Vangl2Lp/+;Grhl3ct/ct) caudal region an increase in the RhoA activators, RhoGEF19 and 
ArhGEF3, as well as an increase in ROCK1, was identified. Interestingly, the level of 
active RhoA was reduced in both Vangl2Lp/+;Grhl3+/+ and Vangl2+/+;Grhl3ct/ct embryos 
and a cumulative reduction was observed in Vangl2Lp/+;Grhl3ct/ct, although whether this 
represents decreased RhoA activation or diminished levels of total RhoA protein 
remains to be determined. In support of this result, pharmacological inhibition of the 
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pathway by ROCK inhibition in whole embryo culture summates with the 
Vangl2Lp/+;Grhl3+/+ and Vangl2+/+;Grhl3ct/ct genotypes to delay PNP closure.  
 
These data point towards a requirement for RhoA-ROCK signalling downstream of 
PCP genes during low spinal neurulation, as has been shown previously for closure 1 
(Ybot-Gonzalez et al., 2007b). However, how this pathway ultimately affects caudal 
development is unclear. If Vangl2 and Grhl3 do interact in the neuroepithelium at the 
level of RhoA-ROCK signalling to regulate midline CE, then a more severe axis 
elongation phenotype might be expected in Vangl2Lp/+;Grhl3ct/ct embryos compared to 
Vangl2Lp/+;Grhl3+/+. This is not the case and, moreover, curly tail embryos do not 
display defective CE. Alternatively, the requirement for RhoA-ROCK might again reflect 
tissue-specific roles downstream of Vangl2 and Grhl3 during midline CE and tail bud 
proliferation, respectively. It would be interesting to determine whether ROCK inhibition 
adversely affects these processes.   
 
8.1.2 PCP and NTD spectrum in mice 
When considering the relationship between PCP gene mutations and NTDs in mice, 
several interesting patterns emerge (Juriloff and Harris, 2012a). For example, genetic 
redundancy between both homologous and non-homologous genes is common, as is 
the appearance of multiple phenotypic traits (such as neural tube, cochlea and heart 
defects) when a single gene is mutated, a phenomenon known as ‘pleiotropy’. Another 
theme is that, among the mutants with a craniorachischisis phenotype, the penetrance 
is usually high, often 100%. The work in this thesis is particularly relevant with regards 
to the link between PCP mutations and the types of NTD phenotypes that are 
produced. As described in Chapter 1, craniorachischisis in the mouse is caused almost 
exclusively by mutations in PCP genes or genes that affect the function of this 
pathway. However, this is not the only NTD associated with disturbed PCP signalling; 
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the Vangl2 genetic interactions listed in Chapter 3 are clear examples of the effects of 
mutant combinations on the development of spina bifida and exencephaly. These other 
conditions are either the sole NTD phenotype observed in such mutant strains, or they 
occur as an alternative phenotype to craniorachischisis (see Table 3.1 in Chapter 3). 
While defective CE has been found to underlie craniorachischisis in several PCP 
mutants, the cellular basis of spina bifida and exencephaly has not been clearly 
demonstrated (see below). An understanding of these mechanisms, and of the basis of 
the PCP ‘modifier gene’ effect, could also indicate how PCP signalling might increase 
genetic predisposition to different types of NTDs in humans. 
 
The findings of this thesis show that PCP-dependent CE is required for successful 
neurulation in the low spine. It seems likely, therefore, that spina bifida in other PCP 
mutants, including hypomorphic Vangl2Lpm2Jus;Lpm2Jus mice (Guyot et al., 2011) and 
digenic models such as Vangl2/Fzd and Vangl2/Ptk7 mutants (Lu et al., 2004; Paudyal 
et al., 2010; Yu et al., 2010), arises via a similar mechanism. For spina bifida models 
that comprise interactions between PCP and non-PCP genes (see Chapter 3; 
Vangl2Lp/+;Sec24bY613/+, Vangl2Lp/+;Grhl3+/-, Vangl2Lp/+;Grhl3ct/ct and Vangl2Lp/+;Zic2ku/+)  
there has not yet been published evidence demonstrating whether spinal neurulation 
fails due to molecular interactions between the genes influencing the same 
developmental process, or as a result of tissue-tissue interactions. While the former 
mechanism might be predicted to explain the interaction between Vangl2 and the 
COPII vesicle gene Sec24b (Merte et al., 2010), the data presented here (Chapters 4-
6) indicate that the Vangl2/Grhl3 interaction during neurulation is largely due to distinct, 
tissue-specific effects. 
 
The association between PCP and exencephaly is also interesting. Indeed, Vangl2 
interacts with a number of genes to cause this defect, with variable penetrance (see 
Chapter 3), and it is the only NTD phenotype produced by mutations in the PCP 
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effector genes Inturned (Intu) and Fuzzy (Fuz) (Gray et al., 2009a; Heydeck et al., 
2009; Zeng et al., 2010). The appearance of exencephaly could reflect other functions 
of PCP genes at different levels of the neuraxis. In particular it has been suggested 
that the link between PCP signalling and cilia, a seemingly complex relationship that 
has emerged in recent years, is involved. On one hand PCP proteins have been found 
to control the polarised beating of motile cilia in several tissues while, on the other 
hand, there is evidence to support a role for cilia in PCP signal transduction: mice 
mutant for several genes associated with the ciliopathy Bardet-Biedl syndrome (BBS) 
display PCP-like phenotypes and several ciliopathy genes interact genetically with 
Vangl2 (Wallingford and Mitchell, 2011). In mouse embryos, null mutations in Intu and 
Fuz cause exencephaly, defective ciliogenesis in various structures, abnormal 
patterning of the neural tube and limb buds and disrupted hedgehog signalling (Gray et 
al., 2009a; Heydeck et al., 2009; Zeng et al., 2010). However, these studies did not 
explore the cellular basis of the cranial NTDs in these mutants. The nature of the 
requirement for Intu and Fuz during neurulation remains elusive; indeed, a recent study 
found that they do not show genetic interactions with Vangl2 or regulate CE in the 
midline (Heydeck and Liu, 2011). 
 
8.1.3 Clinical relevance of findings 
Of the over 240 mouse models of NTDs, many arise from single-gene mutations and 
these are often syndromic. However, several others develop NTDs as a result of 
digenic or oligogenic interactions (Harris and Juriloff, 2007; Harris and Juriloff, 2010) 
and this latter group is likely to better reflect the complex aetiology of human NTDs. To 
explain the pattern of NTD inheritance observed in humans, the ‘multifactorial 
threshold model’ has been proposed (Harris and Juriloff, 2007; Zohn, 2012). This 
theory predicts that multiple genetic and environmental factors, which alone do not 
cause NTDs, interact to influence the outcome of neurulation. These may act in a 
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cumulative fashion to affect a single developmental process or act synergistically, 
involving processes in more than one tissue (Zohn, 2012). As a result, individuals with 
particular combinations of genetic variants and environmental influences have an 
elevated risk of disturbed neurulation; if neural tube closure is compromised beyond a 
certain threshold it fails, resulting in NTDs.   
 
This model seems to fit well with the known additive effects of PCP gene mutations in 
predisposing to failure of neurulation in mice, and with the well established modifying 
effect of the Vangl2Lp mutation (see Chapter 3). It is also particularly relevant to the 
findings described here for genetic interactions between Vangl2 and Grhl3. The 
heterozygous Vangl2Lp/+ genotype causes defective CE during spinal neurulation, but 
only when combined with a ‘second hit’ such as the presence of Grhl3ct alleles does it 
lead to a severe NTD phenotype. Similarly, the model is consistent with the effect of 
modifier loci on NTD phenotype, such as in the curly tail mouse (de Castro et al., 2012; 
Van Straaten and Copp, 2001). In these cases polymorphic modifier alleles vary 
between strains and exert little effect on their own. However, when suboptimal variants 
are inherited with a particular gene mutation, which already compromises neurulation, 
they can determine whether a cellular/developmental process falls above or below the 
threshold level required for successful neural tube closure.       
 
As described in Chapter 1, several recent studies have screened the coding 
sequences of candidate PCP genes in human NTD cases to look for rare, non-
synonymous, deleterious sequence variants that are not present in controls. The 
identification of such putative mutations in several PCP components suggests that 
variants of genes within this complex signalling network contribute to the aetiology of 
human NTDs and should be a focus of future studies. According to a recent review of 
these reports, overall, PCP mutations were detected in 44 out of over 500 cases with 
defects of primary neurulation. These included open NTDs as well as closed defects 
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such as lipomyelomeningocele, lipomyelocele and lipoma. In total, 44 mutations were 
identified; these were in eight PCP genes (CELSR1, VANGL1, VANGL2, FZD6, 
PRICKLE1, SCRIB, FUZ and the PCP-related gene, DACT1) and the majority were 
heterozygous, non-synonymous and affected highly conserved amino acids. For 
around half of them, biological assays were used to test whether the variant had a 
deleterious effect on the protein and, of these, 76% displayed functional abnormalities 
(Juriloff and Harris, 2012a). Interestingly, PCP mutations were also found in cases of 
defects thought to arise from aberrant secondary neurulation (such as tight filum 
terminale and lumbar myelocystocele) as well as cases of caudal regression and 
diastematomyelia, which are not NTDs but rather are gastrulation and notochord 
defects that were included in some NTD cohorts.  
 
When considering the evidence for a contribution of PCP mutations to human NTD 
aetiology, it should be noted that the approaches used so far raise the possibility that 
there are additional, undetected mutations. The general strategy has been to identify 
rare variants that are absent in controls. However, consistent with the multifactorial 
threshold model, studies that had available sequence data for family members 
sometimes showed that the mutation was transmitted from an apparently unaffected 
parent. If this is the case then the variants are presumably also present in other 
unaffected individuals within the same population and contribute to NTDs in 
combination with other genetic or environmental factors. Their absence in the majority 
of sequenced controls is likely to be explained by their rarity (Juriloff and Harris, 
2012a). It is likely, therefore, that other deleterious variants do exist and have been 
overlooked due to their presence in control samples. Moreover, the strategy of 
sequencing coding regions of PCP genes does also not detect other types of 
mutations, such as copy number variants and those in regulatory elements.  
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In contrast to PCP genes, no putative GRHL3 mutations have been identified in human 
NTD cases to date. However, as described earlier in this thesis, both insufficient and 
excessive levels of Grhl3 expression, as a result of either coding or regulatory 
mutations, cause NTDs in mice. GRHL3 therefore represents a candidate gene that 
could contribute to risk of human NTDs. It will be interesting to see if rare variants are 
found to be associated with NTD cases and, if so, whether these are present in 
combination with other mutations, for example in PCP family members. 
 
8.2 PCP and NC cell migration  
In recent years, several studies have reported an essential role for the PCP signalling 
pathway in NC cell migration (Carmona-Fontaine et al., 2008a; Carmona-Fontaine et 
al., 2008b; De Calisto et al., 2005; Matthews et al., 2008). The evidence in these 
papers came from Xenopus and zebrafish embryos and was based on the effects of 
expressing dominant negative constructs that perturb PCP signalling. Since these 
findings, the question of whether a similar relationship applies to mammalian 
development has not been investigated. Data in this thesis demonstrates that 
abrogation of the core PCP component, Vangl2, does not cause defects of early NC 
cell migration, or the initial formation of NC-derived structures in mice (findings 
summarised in Chapter 7). This is in stark contrast to various other developmental 
processes, which are strongly PCP-dependent in mammals, such as neural tube 
closure and inner ear development (see Chapter 1). Thus, these findings indicate that 
PCP-dependence is not a universal feature of NC cell migration and therefore 
represents an important species difference in the molecular regulation of NC 
development. 
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8.2.1 Clinical significance  
The biology of the NC is of considerable clinical significance as defects of their 
development contribute to medical conditions in humans. NC-related disorders 
comprise a heterogeneous group of diseases, collectively known as the 
‘neurocristopathies’ (Bolande, 1997). The extensive range of malformations seen 
within this group, such as craniofacial, heart and gut innervation defects, reflects the 
wide variety of NC cell derivatives in the embryo. For example, neurocristopathies 
include: Hirschsprung’s disease, a bowel motility disorder characterized by 
aganglionosis of the distal colon due to failure of NC colonization (Burzynski et al., 
2009); Waardenberg syndrome, which is classified into subtypes depending on its 
symptoms, but often combines sensorineural hearing loss, pigmentation defects and 
craniofacial abnormalities (Pingault et al., 2010; Read and Newton, 1997);  and 
DiGeorge syndrome, a severe form of the chromosome disorder 22q11 deletion, which 
can involve many symptoms, such as heart defects, cleft palate, facial dysmorphology 
and glandular defects (Wurdak et al., 2006). Some neurocristopathies also occur as 
aggressive tumours, derived from NC cells, such as neuroblastomas and melanomas 
(Bolande, 1997). 
 
The NC has also attracted attention as a model of invasive cell migration, as there are 
several similarities between NC cell migration and tumour cell metastasis (Theveneau 
and Mayor, 2012). Both NC and cancer cells express a combination of transcription 
factors (including Snail, Twist, and Sox family members), which enables them to 
undergo EMT. Also, as described in Chapter 1, an important aspect of EMT is a 
change in cell-cell adhesion properties, allowing cells to delaminate from their original 
tissue. Similar to NC cells, switches in the expression of cadherin molecules have been 
observed in several tumour cell types (Wheelock et al., 2008). Like NC cells, tumour 
cells also express members of the MMP and ADAM metalloprotease families and this 
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is often associated with a high invasive potential and poor disease prognosis 
(Theveneau and Mayor, 2012). Thus, it appears that the mechanisms controlling the 
release and migration of malignant cells from a primary tumour are similar to those 
used during the delamination of NC cells from the neuroepithelium. Furthermore, on 
reaching their final destination in the embryo, NC cells cease migration and undergo 
differentiation. During this process, the cells often reaggregate, for example during the 
formation of the ganglia of the PNS. Interestingly there is evidence that metastatic cells 
revert to a more epithelial-like state during the formation of secondary tumours, and 
that this increases their survival ability (Polyak and Weinberg, 2009). 
 
In summary, an understanding of the genes and pathways that trigger and regulate NC 
cell migration is essential in order to better understand neurocristopathies and tumour 
progression. Given the evidence for a crucial role of PCP signalling during NC cell 
migration in amphibia and fish, it might be predicted that PCP genes are strong 
candidates for the study of NC-related pathologies in humans. However, the findings of 
this thesis argue otherwise and suggest that attention should be focused elsewhere.    
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